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Thesis	  Summary	  	  The	  opportunistic	  human	  fungal	  pathogen,	  Candida	  albicans,	  undergoes	  morphological	  and	  transcriptional	  adaptation	  in	  the	  switch	  from	  commensalism	  to	  pathogenicity.	  Previous	  research	  on	  this	  switch	  has	  focused	  on	  genes	  involved	  in	  the	  morphological	  switch	  from	  yeast	  to	  hyphal	  growth.	  However,	  very	  few	  genes	  have	  been	  found	  that	  directly	  control	  hyphal	  morphogenesis,	  suggesting	  primary	  control	  at	  the	  post-­‐translational	  level.	  The	  Cyclin	  Dependent	  Kinases	  (CDK),	  Cdk1,	  has	  been	  previously	  implicated	  in	  this	  process;	  therefore	  it	  was	  sought	  to	  identify	  phospho-­‐regulatory	  targets	  of	  Cdk1	  involved	  in	  C.	  albicans	  hyphal	  morphogenesis.	  	  	   Fkh2	  was	  a	  likely	  CDK	  target	  that	  shows	  differential	  phosphorylation	  between	  yeast	  and	  hyphal	  growth;	  being	  phosphorylated	  in	  conjunction	  with	  cell	  cycle	  progression	  during	  yeast	  growth,	  but	  not	  in	  hyphae,	  where	  phosphorylation	  occurs	  for	  a	  short	  period	  on	  hyphal	  induction.	  Further	  investigations	  have	  found	  that	  Fkh2	  is	  phosphorylated	  at	  C-­‐terminal	  CDK	  consensus	  sites	  on	  hyphal	  induction,	  but	  is	  not	  a	  regulatory	  target	  of	  Cdk1,	  or	  any	  other	  CDK	  related	  protein	  present	  in	  C.	  albicans.	  	  
	   Although	  the	  kinase	  responsible	  remains	  elusive,	  the	  physiological	  consequences	  of	  the	  phosphorylation	  have	  been	  found	  to	  be	  quite	  profound,	  with	  phosphorylation	  of	  Fkh2	  being	  a	  requirement	  for	  the	  maintenance	  of	  invasive	  filamentous	  growth.	  Loss	  of	  Fkh2	  phosphorylation	  specifically	  prevents	  the	  expression	  of	  genes	  required	  for:	  filamentous	  growth,	  pathogenesis,	  host	  interaction	  and	  biofilm	  formation,	  which	  are	  required	  for	  the	  transition	  from	  commensalism	  to	  pathogenesis.	  Thus	  phosphorylation	  of	  Fkh2	  on	  hyphal	  induction	  provides	  a	  cell	  cycle-­‐independent	  function	  that	  contributes	  to	  pathogenesis.	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1	  	   	   	   	   	   	   	  	  	  	  General	  Introduction	  
 
1.1. Candida albicans  
 








Species: Candida albicans  	  
C.	  albicans	  is	  an	  opportunistic	  fungal	  pathogen	  commensal	  to	  the	  gastrointestinal	  and	  genitourinary	  tract	  of	  humans.	  It	  is	  only	  in	  immune-­‐compromised	  individuals	  that	  pathogenesis	  occurs;	  ranging	  from	  superficial	  mucosal	  infections	  in	  generally	  healthy	  people	  (Candidiasis),	  to	  systemic	  infections	  in	  severely	  immune-­‐deficient	  patients,	  resulting	  from	  tissue	  invasion	  and	  dissemination	  in	  the	  blood	  (Candidemia).	  Candidemia	  can	  affect	  patients	  taking	  immunosuppressive	  drugs	  for	  transplant	  therapy,	  sufferers	  of	  Human	  Immunodeficiency	  Virus	  (HIV),	  neutropenia,	  and	  individuals	  undergoing	  chemotherapy	  or	  at	  extremes	  of	  age.	  The	  use	  of	  assisted	  ventilation	  or	  an	  indwelling	  catheter	  has	  been	  shown	  to	  provide	  a	  route	  of	  entry	  for	  infection.	  Removal	  of	  the	  competing	  microbial	  flora	  has	  been	  shown	  to	  promote	  fungal	  colonisation	  (Pfaller	  &	  Diekema	  2010).	  It	  is	  the	  fourth	  most	  common	  cause	  of	  nosomical	  infections	  in	  the	  United	  States,	  with	  mortality	  rates	  from	  Candidemia	  up	  to	  50%.	  This	  was	  previously	  estimated	  to	  cost	  of	  more	  than	  $1	  billion	  annually	  (Miller	  et	  al.	  2001).	  In	  the	  United	  Kingdom	  Candida	  species	  are	  the	  eighth	  most	  common	  cause	  of	  nosocomial	  infections;	  with	  Candidemia	  costing	  the	  health	  service	  £16.2	  million	  and	  resulting	  in	  683	  deaths	  annually	  (Hassan	  et	  al.	  2009).	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1.2.	  C.	  albicans	  biology	  	  
C.	  albicans	  is	  generally	  found	  as	  an	  obligate	  diploid,	  only	  able	  to	  undergo	  mating	  in	  the	  elongated	  opaque	  state,	  which	  is	  homozygous	  at	  the	  mating	  type	  locus	  (Morschhäuser	  2010).	  This	  occurs	  through	  a	  parasexual	  cycle	  involving	  formation	  of	  a	  tetraploid	  intermediate	  followed	  by	  concerted	  chromosome	  loss	  in	  order	  to	  regenerate	  the	  diploid	  state	  (Fig.	  1.1.)	  (Noble	  &	  Johnson	  2007).	  However,	  recent	  evidence	  has	  shown	  that	  mating-­‐competent	  haploid	  C.	  albicans	  isolates	  can	  be	  generated	  in	  the	  laboratory	  on	  exposure	  to	  anti-­‐fungal	  drugs	  (Hickman	  et	  al.	  2013).	  It	  was	  previously	  thought	  impossible	  to	  form	  haploids	  as	  each	  haploid	  genome	  contains	  many	  recessive	  lethal	  mutations	  that	  can	  only	  be	  maintained	  in	  the	  diploid	  state;	  but	  in	  forming	  a	  haploid,	  selection	  against	  these	  deleterious	  mutations	  must	  be	  possible.	  	  	  	  	  	  	  	   	   	  	  	  	  
	  
Fig.	  1.1.	  Comparison	  of	  mating	  programs	  between	  S.	  cerevisiae	  and	  C.	  albicans.	  Adapted	  from	  Noble	  and	  Johnson	  2007.	  A)	  In	  S.	  cerevisiae	  two	  haploid	  cells	  of	  opposite	  mating	  types	  come	  together	  to	  form	  a	  diploid,	  which	  then	  undergoes	  meiosis	  to	  generate	  haploid	  progeny.	  B)	  In	  C.	  
albicans	  diploid	  cells	  have	  to	  undergo	  loss	  of	  heterozygosity	  at	  the	  mating	  type	  locus	  to	  become	  mating	  competent.	  	  Opaque	  cells	  of	  a	  and	  α	  mating	  types	  come	  together	  to	  make	  a	  tetraploid	  intermediate,	  which	  undergoes	  concerted	  chromosome	  loss	  to	  regenerate	  diploid	  cells	  that	  are	  heterozygous	  at	  the	  mating	  type	  locus.	  	  The	  fact	  that	  C.	  albicans	  is	  a	  non-­‐mating	  competent	  diploid,	  increases	  the	  difficulty	  in	  carrying	  out	  standard	  genetic	  analysis.	  Further,	  Candida	  species	  also	  have	  a	  modified	  genetic	  code,	  where	  the	  CTG	  codon	  in	  DNA	  encodes	  serine	  rather	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recombination may create variation among
cells from the starting strain, a discussed
above, there appear to be few opportunities
for genetically diverse strains (i.e., those from
different clades) to encounter each other and
exchange genetic material. Whether C. albi-
cans reservoirs other than the adult human
host allow for greater mingling of genetically
dis ant strains remains an open question.
Mating and the Parasexual Cycle in
C. albicans
For more than a century, C. albicans was
thought to be “imperfect” or asexual, based
largely on the inability to identify mating
forms in the laboratory. This idea was put into
question with the re ogn tion that a region of
DNA, the Mating Type-Like Locus or MTL,
strongly resembles the well-characterized
MAT locus of the budding yeast, Saccha-
romyces cerevisiae (28). The MAT locus in
S. cerevisiae exists as either of two alleles, a
and α, that determine the mating type of
haploid cells through expression of distinct
sets of transcriptional regulators [reviewed
in (7, 44)]. a type cells, which possess the
MATa allele, can mate only with α type cells,
which possess theMATα allele, and vice versa
(Figure 2a). The product of mating is
a diploid cell that is heterozygous at the









































Sexual and parasexual cycles of S. cerevisiae and C. albicans. (a) Sexual cycle of S. cerevisiae: Haploid cells
(1n) exist in either of two mating types, a or α, ep nding on the gen s prese t at MAT. Mating between
a and α cells results in a diploid cell (2n). Diploid cells can persist and grow indefinitely until, under
stringent environmental conditions, they undergo meiosis and sporulation to regenerate haploid cells.
(b) Parasexual cycle of C. albicans: Diploid cells (2n) of C. albicans are typically heterozygous at MTL.
On certain laboratory media such as sorbose, laboratory strains undergo loss of one copy of
Chromosome 5, thereby eliminating either the a or α allele, to create α or a diploid strains, respectively.
At a frequency of approximately 10−4, a and α strains undergo an epigenetic switch from the white to
opaque phase, a transition involving hundreds of changes at the transcriptional level and a dramatic
change in cell morphology. Diploid a and α opaque cells mate efficiently to create tetraploid (4n) a/a/α/α
cells. Tetraploid cells can grow stably or, under stressful environmental conditions (e.g., PRE-SPO
laboratory medium), undergo concerted chromosome loss to return to diploidy (2N).
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than	  leucine	  (Santos	  &	  Tuite	  1995).	  This	  means	  that	  reporter	  genes	  such	  as	  GFP	  have	  had	  to	  be	  modified	  in	  order	  for	  correct	  expression	  in	  Candida	  (Cormack	  et	  al.	  1997).	  The	  altered	  codon	  usage	  may	  affect	  the	  function	  of	  highly	  conserved	  proteins,	  with	  the	  polar,	  hydrophilic	  serine	  allowing	  more	  hydrogen	  bonding	  capacity	  compared	  with	  the	  non-­‐polar	  aliphatic	  leucine,	  which	  will	  have	  its	  functional	  group	  buried	  within	  the	  protein	  structure.	  The	  appearance	  of	  serine	  residues	  in	  proteins	  may	  have	  also	  brought	  about	  new	  phosphorylation	  sites,	  allowing	  proteins	  to	  undergo	  differential	  regulation.	  The	  study	  of	  C.	  albicans	  has	  been	  aided	  by	  the	  development	  of	  modified	  molecular	  biology	  tools.	  The	  CAI4	  (Fonzi	  &	  Irwin	  1993)	  and	  then	  BWP17	  (Wilson	  et	  al.	  1999)	  strains	  generated	  with	  the	  Ura-­‐Blaster	  method	  (Alani	  et	  al.	  1987),	  have	  provided	  strains	  with	  auxotrophic	  markers,	  allowing	  transformation	  of	  foreign	  genetic	  material,	  through	  prototrophic	  selection.	  PCR-­‐mediated	  gene	  tagging	  or	  deletion	  has	  further	  allowed	  quick	  and	  efficient	  generation	  of	  C.	  albicans	  mutants	  in	  the	  above-­‐mentioned	  strains.	  The	  CIP10	  plasmid	  allows	  insertion	  of	  modified	  genetic	  material	  or	  reporters	  into	  a	  gene’s	  native	  locus,	  or	  ectopically	  at	  the	  RP10	  locus	  (Murad	  et	  al.	  2000).	  For	  genes	  that	  are	  essential,	  regulatable	  promoters,	  such	  as	  the	  MET3	  (Care	  et	  al.	  1999)	  or	  tetracycline-­‐regulated	  promoters	  (Nakayama	  et	  al.	  2000),	  allow	  knock-­‐down	  or	  shut	  off	  of	  gene	  expression	  when	  desired.	  These	  regulatable	  promoters	  also	  allow	  the	  effect	  of	  over-­‐expression	  of	  a	  gene	  of	  interest	  to	  be	  studied.	  	  In	  addition	  to	  regulatable	  promoters,	  a	  variety	  of	  different	  epitope	  tags	  to	  study	  protein	  function	  have	  also	  been	  optimised	  (Berman	  &	  Sudbery	  2002).	  	  
1.3.	  C.	  albicans	  morphological	  forms	  and	  pathogenesis	  	  
C.	  albicans	  has	  an	  adaptive	  morphology,	  undergoing	  reversible	  morphogenetic	  switching	  in	  response	  to	  external	  environmental	  cues	  and	  internal	  stresses.	  C.albicans	  can	  grow	  in	  a	  budding	  yeast	  form,	  and	  two	  distinct	  filamentous	  forms	  of	  pseudohyphae	  and	  true	  hyphae	  depending	  on	  the	  environmental	  conditions	  (Fig.	  1.2.)	  (Sudbery	  et	  al.	  2004).	  It	  is	  also	  able	  to	  switch	  between	  white	  and	  mating-­‐competent	  opaque	  cells,	  and	  form	  chlamydospores	  –	  large	  rounded	  cells	  with	  thick	  cell	  walls,	  whose	  function	  is	  as	  yet	  unknown	  (Nobile	  et	  al.	  2003).	  The	  ability	  to	  switch	  between	  growth	  modes	  is	  thought	  to	  be	  essential	  for	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pathogenesis,	  allowing	  C.	  albicans	  to	  survive	  in	  varying	  niches	  through	  the	  different	  stages	  of	  infection.	  The	  filamentous	  forms	  are	  believed	  to	  be	  important	  during	  tissue	  invasion;	  while	  the	  yeast	  form	  is	  thought	  to	  facilitate	  dissemination	  in	  the	  blood	  stream,	  allowing	  the	  colonisation	  of	  major	  organs	  (Gow	  et	  al.	  2002).	  White	  opaque	  switching	  to	  allow	  a	  parasexual	  cycle	  to	  occur	  is	  thought	  to	  be	  important	  for	  adaption	  in	  the	  host	  during	  infection,	  allowing	  C.	  albicans	  to	  combat	  the	  host	  defences	  (Morschhäuser	  2010).	  	  
	  
Fig.	  1.2.	  C.	  albicans	  morphological	  forms.	  Adapted	  from	  Sudbery	  et	  al.	  2004	  and	  Sudbery	  2011.	  
A)	  Yeast,	  hyphal	  and	  pseudohyphal	  morphologies.	  B)	  Environmental	  cues	  that	  bring	  about	  phenotypic	  switching.	  Scale	  bar	  -­‐	  1μm.	  	  The	  best-­‐studied	  morphological	  transition	  in	  C.	  albicans	  is	  that	  from	  budding	  yeast	  to	  filamentous	  growth.	  The	  yeast,	  pseudohyphal	  and	  true	  hyphal	  forms	  have	  characteristic	  features	  that	  are	  indicative	  of	  growth	  mode.	  Yeast	  and	  pseudohyphal	  cells	  grow	  by	  budding,	  with	  constrictions	  at	  the	  neck	  boundary	  between	  mother	  and	  daughter	  cells;	  whereas	  hyphal	  cells	  form	  a	  highly	  polarised,	  rapidly	  extending,	  tubular	  structure	  from	  the	  mother	  that	  has	  parallel-­‐sided	  walls.	  In	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tube-like projection from a 
mother yeast cell that forms up 
to the end of the first cell cycle 
when an unbudded yeast cell is 
placed in hypha-inducing 
conditions.
that reflect the diversity of the microenvironments that 
it encounters in the host. For instance, hyphae form in 
response to the presence of serum18, neutral pH19, 5% 
CO2 (the partial pressure of CO2 in the bloodstream)20, 
N-acetyl-d-glucosamine (GlcNAc)21 and growth in an 
embedded matrix or in microaerophilic conditions 
under a coverslip in strains lacking the transcriptional 
regulator enhanced filamentous growth protein 1 
(Efg1)22,23. In addition, hyphal growth is often induced 
in synthetic growth media such as Lee’s medium (which 
contains a mixture of amino acids)24, Spider medium (a 
semi-synthetic medium based on mannitol as a carbon 
source)25 and mammalian tissue culture media such as 
M199. Generally, hyphal growth requires a temperature 
of 37 °C; an exception is filamentation in an embedded 
matrix and hypoxic growth, which occurs at 25 °C. The 
serum and 37 °C combination generates a powerful and 
robust signal for germ tube formation from yeast cells 
and forms the basis for a classic diagnostic test for the 
presence C. albicans in medical microbiology.
Two different stages of hyphal growth can be experi-
mentally distinguished. The first stage is the ability to 
establish and maintain hyphal growth in the short term. 
This involves the production of germ tubes and hyphae 
in liquid medium when yeast cells are challenged with 
hypha-inducing conditions such as serum at 37 °C 
(FIG. 1). In this case, the experimental observations are 
restricted to a few hours after yphal induction. The sec-
ond stage is the ability to maintain hyphal growth in the 
long term by assessing colony morphology after 5 days 
growth on a solid medium such as Spider medium or 
in serum at 37 °C. Hyphal formation on solid medium 
is manifested by feathery or spidery outgrowths from 
the main colony, which has an extensively crenulated or 
crinkled appearance (FIG. 1). Mature hyphal colonies will 
invade the agar, a phenomenon that can be readily tested 
by examining the persistence of cells in the agar after 
the surface colony has been washed off. The ability to 
form hyphae is often assessed either by the ability of the 
fungus to form hyphae in liquid culture or by the pro-
duction of hyphal colonies on solid medium. The liquid 
culture assay tests the immediate ability of the organ-
ism to respond to environmental cues and initiate the 
highly polarized growth characteristic of hyphae. The 
solid medium assay tests the ability of the organism to 
maintain hyphal growth in the complex and changing 
microenvironments in and around a colony as it devel-
ops. It also tests the ability to invade a solid substratum. 
It takes into account factors such as the changing avail-
ability of nutrients, oxygen tension, CO2 generation and 
the production of, and response to, quorum sensing 
molecules. A mutation that does not directly affect the 
hyphal growth process could nevertheless affect hyphal 
growth indirectly as a result of a change in any of these 
complex microenvironments.
The morphological switch between yeast and 
hyphal forms is also regulated by interaction with the 
microbiological flora that C. albicans encounters in its 
environment. Sophisticated mechanisms result in com-
munication not only with other C. albicans cells but also 
with bacterial cells (reviewed in REF. 26). C. albicans cells 
sense the density of the surrounding C. albicans popula-
tion by a quorum sensing mechanism that is based on the 
sesquiterpene farnesol, which is secreted into the envi-
ronment and inhibits hyphal formation27. By contrast, 
the aromatic alcohol tyrosol shortens the lag phase of 
quiescent yeast cells and promotes germ tube formation 
and hyphal formation in biofilms28. C. albicans also fre-
quently forms mixed infections with bacterial species. For 
example, C. albicans is often found in combination with 
Pseudomonas aeruginosa in biofilms forming in catheters, 
and both species are often recovered from lung infections 
of patients with cystic fibrosis or infections of patients 
with burns29. P. aeruginosa cells attach to C. albicans 
germ tubes and form a biofilm that results in the death of 
the germ tube. This process is specific to germ tubes; the 
yeast form is not affected. In response, C. albicans senses 
P. aeruginosa by the presence of 3-oxo-homoserine lac-
tone, which is a component of the P. aeruginosa quorum 
sensing mechanism; this leads to the repression of hyphal 
formation and the promotion of yeast-form growth29–32.
Regulation of hyphal morphogenesis. The pathways 
that operate to transduce hypha-inducing signals and 
the transcription factors that are targeted have been 
reviewed recently in detail33, and a summary is pro-
vided in FIG. 2. Hypha-specific gene expression is nega-
tively regulated by a complex consisting of the general 
transcriptional corepressor Tup1 in association with 
Nrg1 or Rox1p-like regulator of filamentous growth 
(Rfg1) (REFS 34–38) (FIG. 2). Cells lacking any of these of 
repressors grow constitutively as long pseudohyphae, 
and expression of hypha-specific genes is derepressed. 
Positive regulation of hypha-specific gene expression is 
Figure 1 | Morphology of yeast, hyphal and pseudohyphal forms. The inset in the 
hyphae panel shows the appearance of a hyphal colony that has be n growing for  
|FC[UQP5RKFGTOGFKWO5ECNGDCTUKPVJGOCKPRCPGNUTGRTGUGPV μm, and in the inset  
on the hyphae panel represents 1 mm. Figure is reproduced, with permission, from 
REF. 144  (2008) Wiley-Blackwell.
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addition	  to	  the	  morphological	  differences,	  there	  are	  also	  differences	  in	  septin	  organisation	  and	  nuclear	  kinetics	  between	  the	  morphologies	  (Sudbery	  et	  al.	  2004)	  (Fig.	  1.3.).	  	  
	  
	  
Fig.	  1.3.	  Differences	  in	  growth	  and	  cell	  cycle	  organisation	  between	  the	  three	  main	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C.	  albicans	  also	  secretes	  phospholipases	  that	  are	  thought	  to	  be	  involved	  in	  damaging	  host	  membranes	  (Ibrahim	  et	  al.	  1995).	  	   In	  order	  to	  avoid	  being	  killed	  by	  the	  hosts	  immune	  cells	  C.	  albicans	  has	  evolved	  a	  broad	  stress	  response	  network,	  regulated	  upstream	  by	  the	  Hog1	  kinase.	  Temperature	  and	  oxidative	  stresses	  are	  combated	  by	  a	  series	  of	  heat	  shock	  proteins	  such	  as	  Hsp70/90.	  These	  prevent	  protein	  unfolding	  and	  the	  formation	  of	  toxic	  aggregates	  (Leach	  &	  Cowen	  2013).	  Reactive	  oxygen	  or	  nitrogen	  species	  are	  produced	  in	  macrophages	  and	  neutrophils	  to	  kill	  phagocytised	  pathogens.	  Detoxification	  of	  the	  reactive	  oxygen	  species	  is	  accomplished	  by	  C.	  albicans	  through	  the	  catalase	  Cta1	  (Wysong	  et	  al.	  1998)	  and	  the	  superoxide	  dismutases	  Sod1	  and	  Sod5	  (Martchenko	  et	  al.	  2004);	  whereas,	  detoxification	  of	  reactive	  nitrogen	  species	  is	  carried	  out	  by	  the	  flavehaemoglobin	  Yhb1	  (Ullmann	  et	  al.	  2004).	  Osmotic	  stress	  is	  opposed	  by	  glycerol	  production	  to	  offset	  water	  loss.	  This	  is	  achieved	  through	  the	  glycerol-­‐3-­‐phosphatase	  Gpp1	  and	  glycerol-­‐dehydrogenase	  Gpd2	  (Wächtler	  et	  al.	  2011).	  	   C.	  albicans	  has	  to	  have	  an	  adaptive	  metabolism	  to	  allow	  survival	  in	  varying	  host	  niches,	  such	  as	  those	  where	  minimal	  glucose	  is	  available.	  It	  is	  also	  able	  to	  sequester	  essential	  minerals	  such	  as	  iron	  (Almeida	  et	  al.	  2009)	  and	  zinc	  (Citiulo	  et	  al.	  2012)	  from	  the	  host,	  a	  process	  that	  has	  been	  shown	  to	  be	  important	  for	  virulence.	  	   On	  biological	  and	  non-­‐biological	  surfaces	  C.	  albicans	  can	  form	  biofilms,	  which	  provide	  increased	  resistance	  to	  anti-­‐fungal	  drug	  treatment	  (Fanning	  &	  Mitchell	  2012).	  Biofilms	  are	  formed	  by	  the	  adherence	  of	  yeast	  cells	  to	  a	  surface	  before	  proliferation	  and	  hyphal	  production,	  forming	  a	  matrix	  where	  other	  extracellular	  material	  is	  deposited.	  Later	  yeast	  cells	  disperse	  from	  biofilms	  to	  invade	  other	  areas.	  Current	  research	  on	  this	  area	  has	  been	  focusing	  on	  the	  transcriptional	  pathways	  involved	  (Nobile	  et	  al.	  2012).	  	  
	  
1.4.	  Regulation	  of	  morphogenesis	  in	  C.	  albicans	  	   Morphogenesis	  from	  yeast	  to	  filamentous	  growth	  requires	  both	  positive	  and	  negative	  regulators.	  Studies	  on	  this	  have	  focused	  on	  how	  environmental	  signals	  are	  transduced	  to	  control	  the	  gene	  transcription	  program	  for	  the	  specific	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morphology.	  The	  two	  best	  characterised	  morphogenesis	  signalling	  pathways	  are	  the	  pheromone	  response	  Mitogen	  Activated	  Protein	  Kinase	  (MAPK)	  Pathway,	  targeting	  the	  Cph1	  transcription	  factor;	  and	  the	  cyclic	  Adenosine	  Monophosphate	  Protein	  Kinase	  A	  (cAMP-­‐PKA)	  Pathway,	  targeting	  the	  Efg1	  transcription	  factor.	  Both	  of	  which	  are	  downstream	  of	  the	  Ras1	  GTPase.	  There	  are	  also	  other	  pathways	  that	  complement	  those	  mentioned	  above	  as	  summarised	  in	  Fig.	  1.4.	  	  
1.4.1.	  cAMP-­‐PKA	  pathway	  	   The	  cAMP-­‐PKA	  pathway	  is	  the	  primary	  pathway	  controlling	  hyphal	  morphogenesis	  in	  response	  to	  serum	  (Harcus	  et	  al.	  2004).	  Activation	  of	  the	  pathway	  can	  occur	  through	  multiple	  routes,	  centering	  on	  the	  adenylyl	  cyclase	  Cyr1/Cdc35.	  The	  transmembrane	  ammonium	  permease	  Mep2	  activates	  the	  cAMP-­‐PKA	  pathway	  under	  low	  ammonium	  concentrations	  through	  its	  downstream	  effector	  Ras1	  (Biswas	  &	  Morschhäuser	  2005),	  a	  GTPase	  that	  interacts	  with	  Cyr1	  to	  increase	  cAMP	  production	  (Fang	  &	  Wang	  2006).	  The	  G-­‐protein	  coupled	  receptor	  (GPCR)	  Gpr1	  along	  with	  its	  associated	  Gα	  subunit	  Gpa2	  activate	  Cyr1	  in	  a	  glucose	  and	  amino	  acid-­‐dependent	  manner	  (Miwa	  et	  al.	  2004;	  Maidan	  et	  al.	  2005).	  Cyr1	  itself	  can	  also	  act	  as	  a	  receptor,	  being	  stimulated	  by	  intracellular	  carbon	  dioxide	  (CO2)	  levels	  (Klengel	  et	  al.	  2005),	  as	  well	  as	  a	  breakdown	  product	  of	  bacterial	  peptidoglycan	  present	  in	  serum,	  which	  binds	  to	  the	  leucine-­‐rich	  region	  of	  Cyr1	  (Xu	  et	  al.	  2008).	  Cyr1	  is	  the	  cells	  only	  source	  of	  cAMP	  and	  therefore	  deletion	  prevents	  hyphal	  morphogenesis	  from	  occurring	  (Rocha	  et	  al.	  2001).	  Cyr1	  acts	  in	  a	  tripartite	  complex	  with	  the	  cyclase-­‐associated	  protein	  Srv2/Cap1	  and	  monomeric	  actin.	  The	  complex	  is	  necessary	  for	  the	  serum	  response	  and	  provides	  a	  link	  between	  the	  serum	  response	  and	  actin	  cytoskeletal	  rearrangements	  that	  are	  a	  requirement	  of	  hyphal	  morphogenesis	  (Zou	  et	  al.	  2010).	  Negative	  regulation	  of	  cAMP	  levels	  occurs	  via	  the	  phosphodiesterases	  Pde1	  and	  Pde2,	  which	  convert	  cyclic-­‐AMP	  to	  AMP	  (Hoyer	  et	  al.	  1994;	  Bahn	  et	  al.	  2003).	  	  
	   8	  	  































































	   9	  	  
et	  al.	  2001).	  The	  best	  characterised	  target	  of	  the	  PKA	  in	  hyphal	  morphogenesis	  is	  the	  transcription	  factor	  Efg1,	  which	  PKA	  phosphorylates	  at	  T206	  to	  promote	  the	  expression	  of	  hyphal	  specific	  genes	  (Bockmühl	  &	  Ernst	  2001).	  Other	  transcription	  factors	  thought	  to	  be	  downstream	  targets	  of	  PKA	  signalling	  are	  the	  positive	  filamentation	  regulators	  Flo8	  (Cao	  et	  al.	  2006)	  and	  Mss11	  (Su	  et	  al.	  2009),	  along	  with	  the	  antagonistic	  Sfl1	  (Li	  et	  al.	  2007).	  	  	  	  
1.4.2.	  Cph1-­‐MAPK	  pathway	  	   The	  MAPK	  morphogenesis	  pathway	  was	  identified	  through	  homology	  with	  the	  pheromone	  response	  pathway	  in	  S.	  cerevisiae	  (Whiteway	  et	  al.	  1992;	  Leberer	  et	  al.	  1996).	  It	  is	  not	  as	  important	  for	  filamentous	  growth	  as	  the	  cAMP-­‐PKA	  pathway,	  with	  deletion	  of	  any	  of	  the	  kinases	  in	  the	  cascade	  only	  affecting	  morphogenesis	  on	  poor	  carbon	  sources	  (Leberer	  et	  al.	  1996;	  Liu	  et	  al.	  1994).	  Activation	  of	  this	  pathway	  can	  occur	  via	  Msb2-­‐Sho1	  under	  cell	  wall	  stress	  (Román	  et	  al.	  2005;	  Román,	  Cottier,	  et	  al.	  2009),	  or,	  as	  with	  the	  cAMP-­‐PKA	  pathway,	  through	  the	  Mep2-­‐Ras1	  module	  (Biswas	  &	  Morschhäuser	  2005).	  Ras1	  activates	  the	  GTPase	  Cdc42	  through	  its	  GEF	  Cdc24,	  leading	  to	  the	  activation	  of	  the	  p21-­‐activated	  kinase	  (PAK	  kinase)	  Cst20.	  The	  signal	  is	  then	  passed	  down	  the	  MAPK	  cascade	  through	  Ste11	  and	  Hst7	  to	  the	  MAPKs	  Cek1	  and	  Cek2.	  Cek1	  then	  directly	  activates	  the	  Cph1	  transcription	  factor	  to	  aid	  in	  the	  expression	  of	  hyphal-­‐specific	  genes	  (Sudbery	  2011).	  Negative	  regulation	  of	  this	  pathway	  may	  occur	  through	  the	  quorum	  sensing	  molecule	  farnesol,	  which	  has	  been	  shown	  to	  repress	  the	  expression	  of	  HST7	  and	  
CPH1	  transcripts	  (Sato	  et	  al.	  2004).	  	  
	  
1.4.3.	  pH	  regulation	  of	  morphogenesis	  	   	  pH	  regulation	  of	  morphogenesis	  centres	  on	  the	  Rim101	  transcription	  factor.	  In	  both	  alkaline	  and	  acidic	  environments,	  Rim101	  undergoes	  proteolytic	  cleavage	  of	  its	  C-­‐terminal	  domain,	  mediated	  by	  the	  protease	  Rim13	  (Li	  et	  al.	  2004)	  in	  conjunction	  with	  the	  endosomal	  sorting	  complex	  required	  for	  transport	  (ESCRT)	  component	  Snf7,	  and	  the	  scaffold	  protein	  Rim20	  (Xu	  &	  Mitchell	  2001;	  Wolf	  &	  Davis	  2010).	  It	  is	  however	  only	  in	  alkali	  environments	  that	  this	  cleavage	  event	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accomplishes	  activation	  of	  Rim101	  (Li	  et	  al.	  2004).	  The	  environmental	  pH-­‐sensing	  and	  subsequent	  signal	  transduction	  is	  thought	  to	  be	  carried	  out	  through	  the	  membrane	  spanning	  proteins	  Rim21	  and	  Dfg16	  (Barwell	  et	  al.	  2005),	  and	  requires	  the	  phosphorylation	  of	  the	  β-­‐arrestin-­‐like	  protein	  Rim8	  to	  signal	  between	  Rim21	  and	  Rim101	  (Gomez-­‐Raja	  &	  Davis	  2012).	  Rim101	  is	  required	  for	  the	  proper	  transcription	  of	  the	  pH-­‐responsive	  genes	  PHR1	  and	  PHR2,	  both	  of	  which	  encode	  cell	  surface	  glycophosphatidylinositol	  (GPI)-­‐anchored	  glycosidases	  (Fonzi	  1999).	  	  
PHR1	  is	  expressed	  under	  alkaline	  conditions,	  and	  is	  required	  for	  the	  maintenance	  of	  hyphal	  growth	  and	  host	  invasion	  (Calderon	  et	  al.	  2010);	  whereas	  PHR2	  is	  expressed	  under	  acidic	  growth	  conditions	  and	  is	  required	  for	  mucosal	  infections	  (De	  Bernardis	  et	  al.	  1998).	  The	  opposing	  expression	  patterns	  of	  these	  two	  genes	  may	  help	  contribute	  to	  adaptation	  within	  different	  host	  niches.	  	  
	  
1.4.4.	  Negative	  regulators	  of	  morphogenesis	  	  	   	  During	  yeast	  form	  growth,	  the	  transcriptional	  programs	  required	  for	  hyphal	  morphogenesis	  need	  to	  remain	  dormant.	  This	  is	  achieved	  through	  the	  general	  transcriptional	  repressor	  Tup1	  in	  conjunction	  with	  Nrg1	  or	  Rfg1,	  which	  target	  Tup1	  to	  the	  promoters	  of	  hyphal-­‐specific	  genes.	  	  Deletion	  of	  TUP1	  causes	  cells	  to	  grow	  constitutively	  as	  pseudohyphae	  (Braun	  &	  Johnson	  1997),	  and	  allows	  the	  expression	  of	  hyphal-­‐associated	  transcripts	  (Braun	  et	  al.	  2000).	  Tup1	  is	  thought	  to	  be	  regulated	  by	  the	  quorum	  sensing	  molecule	  farnesol	  (Kebaara	  et	  al.	  2008),	  causing	  repression	  of	  hyphal-­‐specific	  genes	  in	  dense	  cell	  populations.	  NRG1	  is	  required	  for	  yeast	  form	  growth,	  with	  deletion	  promoting	  filamentous	  growth.	  It	  encodes	  a	  zinc	  finger	  transcription	  factor	  which	  binds	  upstream	  of	  a	  subset	  of	  hyphal	  growth	  expression	  specific	  genes,	  such	  as	  ALS3,	  HYR1,	  HWP1	  and	  ECE1	  (Murad	  et	  al.	  2001;	  Braun	  et	  al.	  2001).	  Recently	  it	  was	  shown	  that	  the	  cAMP-­‐PKA	  pathway,	  along	  with	  reduced	  Target	  of	  Rapamycin	  (TOR)	  signalling,	  is	  required	  for	  removal	  of	  Nrg1	  from	  these	  promoters,	  which	  results	  in	  a	  change	  in	  the	  local	  chromatin	  structure	  (Lu	  et	  al.	  2011).	  Rfg1	  contributes	  in	  a	  similar	  manner	  to	  Nrg1,	  and	  again	  deletion	  of	  RFG1	  results	  in	  constitutive	  filamentous	  growth	  (Kadosh	  &	  Johnson	  2001).	  Rfg1	  may	  also	  however	  play	  a	  positive	  role	  in	  the	  regulation	  of	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pseudohyphal	  growth,	  as	  over-­‐expression	  can	  also	  cause	  filamentation	  to	  occur	  (Cleary	  et	  al.	  2010).	  	  	  
1.4.5.	  Temperature-­‐dependent	  regulation	  of	  morphogenesis	  	  	  	   Temperature-­‐dependent	  regulation	  of	  morphogenesis	  is	  believed	  to	  centre	  on	  the	  heat-­‐shock	  chaperone	  Hsp90.	  Depletion	  of	  Hsp90,	  or	  its	  pharmacological	  inhibition	  with	  geldanamycin	  results	  in	  filamentation	  in	  C.	  albicans	  (Shapiro	  et	  al.	  2009),	  suggesting	  a	  role	  for	  Hsp90	  in	  the	  repression	  of	  filamentous	  growth.	  Hsp90	  is	  thought	  to	  negatively	  regulate	  the	  cAMP-­‐PKA	  pathway	  through	  its	  co-­‐chaperone	  Sgt1,	  which	  can	  directly	  bind	  the	  adenylyl	  cyclase	  Cyr1	  (Shapiro	  et	  al.	  2009;	  Shapiro,	  Zaas,	  et	  al.	  2012).	  Hsp90	  has	  also	  been	  shown	  to	  regulate	  morphogenesis	  through	  Cyclin	  Dependent	  Kinase	  (CDK)	  signalling.	  Filaments	  formed	  when	  Hsp90	  function	  is	  compromised	  are	  delayed	  in	  mitosis,	  resembling	  those	  formed	  upon	  cell	  cycle	  arrest.	  This	  is	  thought	  to	  be	  due	  to	  Cdc28/Cdk1	  being	  a	  client	  of	  Hsp90,	  requiring	  it	  for	  stability	  (Senn	  et	  al.	  2012).	  	  Hsp90	  has	  also	  been	  shown	  to	  regulate	  morphogenetic	  signalling	  from	  the	  CDK	  Pho85	  and	  its	  cyclin	  Pcl1,	  to	  the	  transcriptional	  regulator	  Hms1	  that	  is	  required	  for	  the	  expression	  of	  some	  filamentation	  specific	  transcripts	  (Shapiro,	  Sellam,	  et	  al.	  2012).	  Hsp90	  genetic	  screens	  have	  also	  shown	  the	  possibility	  of	  other	  roles	  in	  adaption	  to	  different	  growth	  conditions	  (Diezmann	  et	  al.	  2012).	  There	  are	  also	  other	  heat	  shock	  proteins,	  such	  as	  Hsf1	  (Nicholls	  et	  al.	  2011)	  that	  are	  thought	  to	  contribute	  to	  morphogenesis.	  
	  
1.4.6.	  Cell-­‐cycle	  arrest-­‐dependent	  morphogenesis.	  	  	   Events	  that	  perturb	  cell	  cycle	  progression	  in	  C.	  albicans	  are	  associated	  with	  a	  terminal	  morphogenetic	  switch	  to	  filamentous	  growth.	  These	  include	  treatment	  with	  drugs	  such	  as	  hydroxyurea	  (Fig.	  1.5A.)	  (Bachewich	  et	  al.	  2005)	  and	  nocodazole	  (Bai	  et	  al.	  2002),	  which	  arrest	  cells	  in	  S-­‐phase	  or	  mitosis	  respectively;	  and	  mutants	  of	  genes	  that	  are	  involved	  in	  cell	  cycle	  regulation,	  a	  list	  of	  which	  can	  be	  found	  in	  Fig.	  1.5B	  (Berman	  2006).	  The	  associated	  filamentation	  appears	  dependent	  on	  the	  cell	  cycle	  stage	  that	  the	  cells	  are	  arrested	  in;	  with	  G1	  arrest	  by	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CLN3	  depletion	  resulting	  in	  cell	  enlargement	  followed	  by	  the	  formation	  of	  what	  appear	  to	  be	  true	  hyphal	  filaments	  (Chapa	  et	  al.	  2005);	  whereas	  arrest	  post	  initiation	  of	  S-­‐phase	  results	  in	  bud	  elongation	  to	  form	  a	  filament	  that	  still	  has	  a	  constriction	  at	  the	  mother	  daughter	  boundary	  (Fig.	  1.5A.)	  (Bachewich	  et	  al.	  2005).	  	  Such	  post	  S-­‐phase	  inhibition	  activates	  the	  spindle	  checkpoints,	  which	  are	  required	  for	  the	  associated	  filamentous	  growth	  phenotype.	  Nocodazole	  arrest	  filamentation	  requires	  the	  Mad2	  spindle	  assembly	  checkpoint	  (Bai	  et	  al.	  2002);	  whereas,	  CDC5	  repression	  (Fig.	  1.5A.)	  requires	  the	  Bub2	  mitotic	  checkpoint	  for	  filamentous	  growth	  (Bachewich	  et	  al.	  2005).	  It	  still	  remains	  unknown	  whether	  these	  pathways	  function	  during	  normal	  hyphal	  growth	  in	  C.	  albicans.	  	  
	  
Fig.	  1.5.	  Cell	  cycle	  arrest	  filamentation	  in	  C.	  albicans.	  Adapted	  from	  Berman	  2006	  and	  Bachewich	  et	  al	  2005.	  A)	  Filaments	  formed	  on	  depletion	  of	  CDC5	  or	  addition	  of	  hydroxyurea.	  B)	  Table	  of	  cell	  cycle	  alterations	  and	  how	  they	  affect	  polarised	  growth	  in	  C.	  albicans.	  	  	  
1.4.7.	  Hyphal-­‐specific	  genes	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., 2003). Both strains were transferred from succi-
nate-containing inducing medium to glucose-containing
repressing medium, collected, and prepared for microar-
ray analysis. Any changes in transcription due to switch-
ing of carbon source were cancelled out by treating the





). For investigations involving HU,
yeast-form cells of strain SC5314 were exposed to
200 mM HU, harvested, processed and compared with
cells without the drug. As filament emergence was initi-
ated at approximately 2 h in both conditions, this time
point represented an early response associated with
polarized morphogenesis, not exposure to the treatment
itself. We also chose a later time point to examine the
transcriptional responses associated with maintenance of
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general increase in the number of modulated transcripts
over time (Fig. 1A). Similar trends in gene expression
were observed across the time-course, reinforcing the
quality of the data. In contrast, treatment with HU induced
dramatic changes in transcript profiles at the early time
point of 2 h (Fig. 1A), when cells were also in a yeast form
or just initiating elongated growth. Many of the same pat-




Comparison of transcript profiles of cells depleted of CaCdc5p or exposed to HU over time.
A. The observed change in abundance of all measured transcripts was plotted against treatment incubation times. Each transcript is represented 




 repression (blue vertical line). Similarities 
in the change in transcript abundance between experimental groups are evident by the maintenance of the colour pattern.
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nocodazole (known as NZ), which depolymerizes micro-
tubules and locks cells in mitosis, give rise to cells that
continue to elongate despite their inability to divide
[40,42!!]. These cells have some features that are pseu-
dohyphal-like (they are constricted at the neck and>2 mm
in width) and others that are hyphal-like (they elongate
continuously, nuclei move into the elongating bud and
eventually they express somehyphal specific genes) [42!!];
however, unlike either cell type, they do not divide and
they eventually die. Thus, they represent a terminal phe-
notypedifferent fromeither pseudohyphae or true hyphae.
Whereas the morphology of arrested cells is similar in
cells treated with hydroxyurea or depleted for Cdc5p [39],
the gene expression patterns of the arrested cells have
significant differences that reflect the cell cycle stage at
which they are rrested [42!!]. They exhibit common
expression of a few genes encoding cell wall proteins and
virulence factors (e.g. CSA2, PHR1 and DDR48 that are
also expressed in elongating hyphal cells. Because pseu-
dohyphae express low levels of hyphal spec fic genes (P
Amornrattanapan, C Ketel, KR Finley, PE Sudbery and J
Berman, unpublished), this expression p tter is not
diagnostic of a specific cell type.
In general, arrest of the cell cycle triggers cell cycle
checkpoints: in nocodazole the polarized growth
response requires the Mad2p (for mitotic arrest defective)
spindle assembly checkpoint [40] and in Cdc5-depleted
cells the polarized growth response requires Bub2p, the
mitotic spindle checkpoint [42!!]. The Swe1pmorphogen-
esis checkpoint partially affects the elongation of hydro-
xyurea-treated cells (KR Finley, K Bouchonville, A Quick
and J Berman, submitted) and rad52D/D cells [43!].
Whereas S. cerevisiae Rad53p and Mec1p are required for
the elongation of hydroxyurea-arrested cells [44], the
orthologous C. albicans genes have not been tested.
Interestingly, Ras1p is required for polarized growth in
response to hydroxyurea, possibly by a mechanism that is
independent from its role in hyphal signaling [42!!]. An
intriguing question is whether Ras1p has a role in the S
phase checkpoint. In summary, different cell cycle arrest
conditions result in different gene expression patterns
Morphogenesis and cell cycle progression in Candida albicans Berman 599
Table 1
List of cell cycle conditions and mutants that cause changes in morphogenesis.
Gene or condition Cell cycle arresta/delay stage Altered morphology Refs
Cln3-depletion G1
a Large round, then hyphal [30!,31!]
cdc4D/D G1 Constitutive hyphal [26
!!]
Hydroxyurea treatment Sa Polarized growth [42!!,46]
rad52D/D S/G2 Polarized growth [43
!]
grr1D/D G2/M? Constitutive pseudohyphal [45]
fkh2D/D G2/M Constitutive pseudohyphal [24]
clb4D/D G2/M, spindle assembly Constitutive pseudohyphal [29
!]
Cdc5p-depletion Ma Polarized growth [39]
Nocodazole treatment Ma Polarized growth [40]
Clb2p-depletion Anaphasea Highly polarized tubes [29!]
SOL1 overexpression Late mitosis Highly polarized growth [26!!]
cdc14D/D Mitotic exit Cell separation defects, hyphal growth defective [27!]
a Essential genes that are terminally arrested.Genes or conditions are ordered by approximate cell cycle stage at which arrest or delay occurs.
G1 arrested cells tend to be more hyphal-like, S or G2 and M arrests tend to be polarized pseudohyphal-like.
Figure 3
Cell cycle progression and cyclin levels differ in yeast and hyphae. G1
phase yeast daughter cells were synchronized by elutriation and then
released into yeast (308C) or hyphal (378C, 5% serum) growth
conditions. Cell morphology and levels of G1 cyclin Ccn1p, and B-
cyclins Clb2p and Clb4p were followed using epitope-tagged proteins.
Ccn1p levels persisted longer and B-cyclins appeared later in hyphae,
relative to yeast. Adapted from [29!].
www.sciencedirect.com Current Opinion in Microbiology 2006, 9:595–601
A)#
B)#
	  13	  	  
the	  signal	  transduction	  pathways	  is	  to	  activate	  the	  expression	  of	  hyphal	  form	  specific	  genes.	  Gene	  expression	  studies	  in	  C.	  albicans	  have	  found	  a	  number	  of	  genes	  that	  are	  up-­‐regulated	  during	  hyphal	  growth	  (Kadosh	  &	  Johnson	  2005);	  and	  a	  common	  minimal	  set	  of	  genes	  that	  are	  required	  for	  hyphal	  growth	  under	  all	  conditions	  tested	  (Carlisle	  &	  Kadosh	  2013).	  These	  include:	  genes	  for	  cell	  surface	  proteins	  that	  likely	  promote	  interactions	  with	  host	  cells	  (HWP1,	  HYR1,	  ALS3/10	  and	  PHR1),	  genes	  required	  for	  host	  invasion	  (ECE1	  and	  SAP5),	  and	  for	  proteins	  that	  are	  possibly	  mechanistically	  involved	  in	  hyphal	  germ	  tube	  growth	  (CDC10,	  RDI1	  and	  KIP4).	  Up-­‐regulation	  of	  the	  transcription	  factor	  UME6	  on	  hyphal	  induction	  further	  activates	  the	  transcription	  of	  hyphal	  specific	  genes,	  forming	  a	  layer	  of	  positive	  feedback	  (Carlisle	  et	  al.	  2009).	  UME6	  regulates	  the	  expression	  of	  the	  hyphal	  specific	  cyclin	  HGC1,	  which	  needs	  to	  be	  present	  in	  order	  to	  maintain	  hyphal	  growth	  (Carlisle	  &	  Kadosh	  2010).	  HGC1	  is	  an	  example	  of	  a	  gene	  that	  is	  not	  significantly	  up-­‐regulated	  on	  hyphal	  induction,	  but	  is	  essential	  for	  prolonged	  filamentous	  growth	  (Zheng	  et	  al.	  2004).	  Many	  other	  such	  genes	  have	  been,	  and	  continue	  to	  be	  discovered	  through	  deletion	  studies	  (Uhl	  et	  al.	  2003;	  Noble	  et	  al.	  2010).	  	  
	  
1.5.	  Regulation	  of	  Polarised	  Growth	  	  
1.5.1.	  Budding	  yeast	  model	  	   Bud	  morphogenesis	  in	  S.	  cerevisiae	  is	  an	  extensively	  studied	  process,	  which	  highlights	  the	  conserved	  machinery	  used	  to	  bring	  about	  morphogenetic	  transitions	  (Howell	  &	  Lew	  2012).	  Bud	  formation	  and	  growth	  is	  also	  closely	  linked	  with	  cell	  cycle	  progression.	  Initiation	  of	  this	  process	  involves	  bud	  site	  selection;	  a	  process	  that,	  in	  budding	  yeast,	  is	  dependent	  of	  the	  genetic	  content	  and	  mating	  type	  of	  the	  cell	  (Hicks	  et	  al.	  1977).	  The	  primary	  machinery	  involved	  in	  this	  process	  is	  the	  Rsr1	  GTPase	  module.	  Rsr1	  is	  a	  Ras-­‐like	  GTPase,	  whose	  over-­‐expression	  can	  rescue	  cell	  with	  polarisation	  defects	  (Bender	  &	  Pringle	  1989).	  Regulation	  of	  Rsr1	  is	  carried	  out	  through	  the	  GTPase	  activating	  protein	  Bud2,	  and	  Guanine	  nucleotide	  Exchange	  Factor	  (GEF)	  Bud5	  (Fig.	  1.6.)	  (Bender	  1993).	  Deletion	  of	  any	  of	  these	  components	  results	  in	  random	  bud	  site	  selection	  (Ruggieri	  et	  al.	  1992;	  Park	  et	  al.	  1993).	  Rsr1	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localises	  to	  future	  sites	  of	  polarised	  growth	  and	  is	  required	  for	  the	  recruitment	  of	  the	  GEF	  of	  Cdc42,	  Cdc24,	  and	  possibly	  its	  subsequent	  activation	  (Park	  et	  al.	  2002;	  Shimada	  et	  al.	  2004).	  This	  leads	  on	  to	  polarisation	  of	  the	  actin	  cytoskeleton	  via	  the	  aforementioned	  GTPase	  Cdc42.	  Even	  in	  the	  absence	  of	  the	  above-­‐mentioned	  Rsr1	  module,	  Cdc42	  can	  still	  polarise	  cells,	  albeit	  in	  a	  random	  fashion.	  Interestingly	  in	  the	  absence	  of	  Rsr1	  only	  one	  bud	  still	  forms;	  this	  is	  thought	  to	  be	  due	  to	  multiple	  oscillatory	  clusters	  of	  Cdc42	  forming	  which	  compete	  for	  resources	  until	  the	  largest	  cluster	  wins,	  thus	  bringing	  about	  cell	  polarisation	  at	  its	  location	  (Howell	  et	  al.	  2009;	  Howell	  et	  al.	  2012).	  	  	  
	  
Fig.	  1.6.	  Roles	  of	  Cdc42	  in	  S.	  cerevisiae	  morphogenesis.	  Taken	  with	  permission	  from	  Sudbery	  2008.	  Bud	  site	  selection	  is	  followed	  by	  Cdc42	  activation	  to	  establish	  polarised	  growth	  via	  multiple	  signals.	  	  	   As	  mentioned	  above,	  after	  bud	  site	  establishment	  the	  Cdc42	  GTPase	  module	  becomes	  polarised	  to	  the	  incipient	  bud	  site,	  where	  it	  attached	  to	  the	  membrane	  through	  geranylgeranylation	  at	  its	  C-­‐terminus	  (Ziman	  et	  al.	  1993).	  Cdc42	  is	  positively	  regulated	  by	  the	  essential	  GEF	  Cdc24	  (Zheng	  et	  al.	  1994),	  and	  negatively	  regulated	  by	  the	  GTPase	  activating	  proteins	  (GAPs)	  Bem3,	  Rga2	  and	  its	  paralog	  Rga1	  (Fig.	  1.6.)	  (Smith	  et	  al.	  2002).	  The	  guanine	  nucleotide	  dissociation	  inhibitor	  Rdi1	  regulates	  Cdc42	  by	  inhibiting	  GTP	  hydrolysis	  and	  extracting	  Cdc42	  from	  the	  plasma	  membrane	  for	  recycling	  (Richman	  et	  al.	  2004).	  Active	  Cdc42	  at	  sites	  of	  polarised	  growth	  recruits	  a	  complex	  of	  Cdc24-­‐Bem1-­‐and	  the	  effector	  kinase	  Cla4,	  allowing	  activation	  of	  more	  Cdc42	  molecules,	  thus	  forming	  a	  positive	  feedback	  loop	  (Kozubowski	  et	  al.	  2008).	  Positive	  feedback	  is	  also	  thought	  to	  be	  obtained	  
a multiprotein complex called the polarisome, which nucle-
ates the formationof actin cables. Post-Golgi secretory vesicles
are transported along these actin cables to dock with a second
protein complex called the exocyst before fusion with the
plasma membrane mediated by the interaction between
v-SNARES on the vesicle and a t-SNARE complex on the
membrane (Fig 2). Polarised growth in S. cerevisiae has been
the subject of an excellent recent review to which the reader
is referred to for details of these processes (Park and Bi, 2007).
The yeast model serves to highlight the different stages in
this process where control over polarised growth can be
exerted. First, polarised growth requires the establishment
of the site, which may be subject to both temporal and spatial
control. Second, once the site has been established, the actin
or tubulin cytoskeletons must be polarised toward this site.
This requires the formation of a structure such as the polari-
some whose formation and activity may be controlled. Third,
the formation and flow of post-Golgi secretory vesicles along
the cytoskeletal tracks can be regulated. Fourth, the assembly
of the exocyst and the docking of secretory vesicles with the
exocyst may be controlled. Small GTPases, in particular
Cdc42p and the closely related Rac GTPase, play a key role at
many of these levels (Park and Bi, 2007).
This review takes the S. cerevisiae model as a base, but will
seek to consider to what extent the yeast paradigm can be ex-






























Exocytosis - Septin ring – Polarisome - Actin cortical patches –
Fig. 1 – Cdc42p orchestrates morphogenesis in Saccharomyces cerevisiae. Cdc42p is activated by its GEF Cdc24p and returned to
its GDP-bound state by its GAPs Rga1/2p and Bem3p. Cdc24p is activated by upstream bud site selection pathways and by the
gb G-protein dimer released from the tripartite G-protein complex when the cognate mating pheromone interacts with the
mating pheromone receptors. Acting through its immediate effectors, activated Cdc42p stimulates polarised growth,
activation of the pheromone response pathway, pseudohyphal growth and cytokinesis.
Fig. 2 – Polarised secretion in Saccharomyces cerevisiae. Secretory vesicles bleb off from the late Golgi compartments and travel
along actin cables, nucleated by the polarisome, to fuse with the plasmamembrane at sites of polarised growth. The process
is controlled by the Rab GTPase Sec4p which is activated by its GEF Sec2p. Numerals enclosed in circles refer to exocyst
components encoded by Sec genes (e.g. Sec15p, Sec6p, etc.). Encircled 70 and 84 refer to Exo70p and Exo84p. For details see
text.
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through	  active	  Cdc42	  orienting	  actin	  cables	  to	  the	  site	  of	  polarised	  growth,	  allowing	  more	  Cdc42	  to	  be	  delivered	  (Wedlich-­‐Soldner	  et	  al.	  2003).	  	  Active	  Cdc42-­‐GTP	  is	  responsible	  for	  controlling	  many	  processes	  involved	  in	  polarised	  growth;	  such	  as:	  actin	  cable	  assembly,	  actin	  patch	  polarisation,	  exocyst	  complex	  formation	  and	  septin	  ring	  assembly	  (Fig.	  1.6.).	  Active	  Cdc42	  is	  required	  for	  localisation	  of	  the	  formin	  Bni1	  (Evangelista	  et	  al.	  1997),	  which	  is	  part	  of	  the	  polarisome	  complex	  of:	  Spa2,	  Bud6,	  Pea1	  and	  Bni1.	  This	  complex	  nucleates	  the	  formation	  of	  actin	  cables	  away	  from	  the	  cell	  periphery,	  allowing	  secretory	  vesicles	  to	  be	  transported	  from	  the	  Golgi	  to	  the	  site	  of	  polarised	  growth	  (Sagot	  et	  al.	  2002).	  	  Cdc42	  and	  Cdc24	  are	  required	  for	  correct	  localisation	  of	  actin	  patches	  to	  sites	  of	  polarised	  growth	  (Adams	  et	  al.	  1990);	  possibly	  through	  the	  effector	  kinase	  Cla4	  or	  through	  Cdc42	  GAP	  interaction	  with	  the	  endocytic	  machinery	  (Bi	  &	  Park	  2012).	  Cdc42	  is	  known	  to	  interact	  with	  the	  exocyst	  landmark	  proteins	  Sec3	  and	  Exo70	  (Zhang	  et	  al.	  2001;	  Wu	  et	  al.	  2010),	  possibly	  allowing	  correct	  localisation	  of	  these	  components	  before	  delivery	  of	  the	  rest	  of	  the	  complex	  (Sec5,	  Sec6,	  Sec8,	  Sec10,	  Sec15,	  Exo84)	  on	  secretory	  vesicles.	  This	  complex	  then	  acts	  to	  promote	  fusion	  of	  secretory	  vesicles	  with	  the	  plasma	  membrane	  (He	  &	  Guo	  2009).	  	  The	  septins	  are	  a	  group	  of	  GTP	  binding	  proteins	  (Cdc10,	  Cdc11,	  Cdc3,	  Cdc12	  and	  Shs1/Sep7)	  that	  form	  into	  higher	  ordered	  structures,	  acting	  as	  scaffolds	  and	  diffusion	  barriers	  (Oh	  &	  Bi	  2011).	  Cdc42	  in	  conjunction	  with	  Gic1/2	  is	  required	  for	  the	  recruitment	  of	  septin	  complexes	  to	  the	  site	  of	  polarised	  growth	  (Cid	  et	  al.	  2001;	  Iwase	  et	  al.	  2006).	  Here	  the	  septin	  complexes	  attach	  to	  the	  plasma	  membrane,	  before	  undergoing	  a	  conformational	  change	  to	  ring	  structures	  that	  is	  dependent	  on	  the	  GTPase	  activity	  of	  Cdc42	  (Zhang	  et	  al.	  1999;	  Gladfelter	  et	  al.	  2002).	  Cla4	  has	  also	  been	  shown	  to	  be	  important	  for	  this	  process,	  further	  linking	  the	  role	  of	  Cdc42.	  The	  actin	  cytoskeleton	  is	  then	  thought	  to	  amend	  the	  septin	  ring	  into	  its	  final	  structure	  (Kadota	  et	  al.	  2004).	  Once	  the	  core	  machinery	  is	  in	  place	  transport	  of	  secretory	  vesicles	  to	  the	  polarisation	  site	  causes	  growth	  and	  expansion	  of	  the	  yeast	  bud	  to	  occur.	  Vesicles	  bleb	  off	  from	  the	  Golgi	  and	  associate	  with	  the	  type	  V	  myosin,	  Myo2,	  to	  be	  transported	  along	  actin	  cables	  to	  the	  polarisation	  site	  (Fig.	  1.7.)	  (Pruyne	  et	  al.	  2004).	  The	  process	  is	  regulated	  by	  the	  vesicle	  associated	  Rab	  GTPase	  Sec4	  and	  its	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GEF	  Sec2	  (Salminen	  &	  Novick	  1987;	  Walch-­‐Solimena	  et	  al.	  1997).	  Vesicles	  dock	  with	  the	  exocyst	  complex	  before	  fusion	  with	  plasma	  membrane,	  delivering	  membrane	  and	  materials	  required	  for	  new	  cell	  wall	  generation	  (Fig.	  1.7.)	  (He	  &	  Guo	  2009).	  	  	  	  	  	  	  	  	  	  	  
Fig.	  1.7.	  Polarised	  secretion	  in	  S.	  cerevisiae.	  Taken	  with	  permission	  from	  Sudbery	  2008.	  Vesicles	  from	  the	  Golgi	  associate	  with	  the	  Sec4	  GTPase	  complex,	  facilitating	  association	  with	  the	  Myo2	  motor,	  which	  carries	  the	  vesicle	  to	  sites	  of	  polarised	  growth	  via	  polarisome	  nucleated	  actin	  cables.	  Vesicles	  dock	  with	  the	  exocyst	  landmark	  proteins	  on	  the	  cell	  membrane	  allowing	  vesicle	  fusion	  and	  cell	  surface	  expansion.	  	  Polarisation	  of	  the	  yeast	  bud	  tip	  occurs	  through	  G1	  and	  G2	  phases	  of	  the	  cell	  cycle;	  but	  this	  then	  switches	  to	  isotropic	  growth	  at	  G2/M,	  with	  Cdc42	  localising	  around	  the	  cell	  periphery	  of	  the	  daughter	  bud	  (Park	  &	  Bi	  2007).	  During	  mitosis	  polarity	  components	  then	  localise	  to	  the	  mother-­‐daughter	  bud	  neck,	  regulating	  contraction	  of	  the	  actomyosin	  ring	  at	  cytokinesis	  (Bi	  &	  Park	  2012).	  
	  
1.5.2.	  Polarised	  growth	  of	  C.	  albicans	  hyphae	  	   Using	  the	  S.	  cerevisiae	  model,	  it	  has	  been	  possible	  to	  postulate	  how	  hyperpolarised	  growth	  can	  occur	  to	  generate	  the	  hyphal	  filaments	  observed	  in	  C.	  
albicans.	  Cdc42	  and	  Cdc24	  are	  again	  key	  regulators	  of	  this	  process,	  localising	  to	  a	  crescent	  at	  the	  hyphal	  tips;	  but	  are	  required	  at	  a	  higher	  concentrations	  than	  during	  yeast	  form	  growth	  (Bassilana	  et	  al.	  2003).	  Evidence	  for	  a	  higher	  Cdc42	  concentration	  comes	  from	  gene	  knockouts	  of	  the	  GAPs	  for	  Cdc42,	  Rga2	  and	  Bem3,	  which	  results	  in	  	  hyperpolarisation	  of	  cell	  growth	  with	  characteristics	  of	  true	  
a multiprotein complex called the polarisome, which nucle-
ates the formationof actin cables. Post-Golgi secretory vesicles
are transported along these actin cables to dock with a second
protein complex called the exocyst before fusion with the
plasma membrane mediated by the interaction between
v-SNARES on the vesicle and a t-SNARE complex on the
membrane (Fig 2). Polarised growth in S. cerevisiae has been
the subject of an excellent recent review to which the reader
is referred to for details of these pro esses (Park and Bi, 2007).
The yeast model serves to highlight the different stages in
this process where control over polarised growth can be
exerted. First, polarised growth requires the establishment
of the site, which may be subject to both temporal and spatial
control. Second, once the site has been established, the actin
or tubulin cytoskeletons must be polarised toward this site.
This requires the formation of a structure such as the polari-
some whose formation and activity may be controlled. Third,
the formation and flow of post-Golgi secretory vesicles along
the cytoskeletal tracks can be regulated. Fourth, the assembly
of the exocyst and the docking of secretory vesicles with the
exocyst may be controlled. Small GTPases, in particular
Cdc42p and the closely r lat d Rac GTPase, play a key role at
many of these levels (Park and Bi, 2007).
This review takes the S. cerevisiae model as a base, but will
seek to consider to what extent the yeast paradigm can be ex-






























Exocytosis - Septin ring – Polarisome - Actin cortical patches –
Fig. 1 – Cdc42p orchestrates morphogenesis in Saccharomyces cerevisiae. Cdc42p is activated by its GEF Cdc24p and returned to
its GDP-bound state by its GAPs Rga1/2p and Bem3p. Cdc24p is activated by upstream bud site selection pathways and by the
gb G-protein dimer released from the tripartite G-protein complex when the cognate mating pheromone interacts with the
mating pheromone receptors. Acting through its immediate effectors, activated Cdc42p stimulates polarised growth,
activation of the pheromone response pathway, pseudohyphal growth and cytokinesis.
Fig. 2 – Polarised secretion in Saccharomyces cerevisiae. Secretory vesicles bleb off from the late Golgi compartments and travel
along actin cables, nucleated by the polarisome, to fuse with the plasmame brane at sites of polarised growth. The process
is controlled by the Rab TPase Sec4p hich is activated by its GEF Sec2p. Numerals enclosed in circles refer to exocyst
components encoded by Sec genes (e.g. Sec15p, Sec6p, etc.). Encircled 70 and 84 refer to Exo70p and Exo84p. For details see
text.
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hyphal	  growth	  (Court	  &	  Sudbery	  2007).	  Rga2	  was	  found	  to	  be	  absent	  from	  hyphal	  tips,	  suggesting	  a	  mechanism	  by	  which	  removing	  a	  Cdc42	  GAP	  could	  increase	  the	  local	  concentration	  of	  active	  Cdc42-­‐GTP	  at	  the	  hyphal	  tip.	  The	  absence	  of	  Rga2	  from	  the	  hyphal	  tips	  was	  later	  found	  to	  be	  phosphorylation	  dependent	  (Zheng	  et	  al.	  2007).	  Localisation	  of	  Cdc42	  is	  partially	  dependent	  on	  the	  C.	  albicans	  bud	  site	  selection	  homologues	  Rsr1	  and	  Bud2.	  Absence	  of	  these	  proteins	  produces	  wider	  hyphae,	  suggesting	  that	  Rsr1	  and	  Bud2	  may	  be	  required	  for	  highly	  focused	  localisation	  of	  the	  Cdc42	  module	  (Hausauer	  et	  al.	  2005).	  	  Other	  polarity	  components	  regulated	  by	  Cdc42	  localise	  to	  a	  crescent	  at	  the	  hyphal	  tips.	  From	  here	  actin	  cables	  stretch	  5-­‐10μm	  back	  down	  the	  hypha	  to	  the	  Golgi	  apparatus	  (Fig.	  1.8.),	  which	  is	  present	  in	  the	  germ	  tube	  (Sudbery	  2011).	  The	  vesicle	  transport	  machinery	  (Myo2,	  Mlc1,	  Sec4/2)	  localise	  to	  a	  spot,	  just	  behind	  and	  distinct	  from	  the	  crescent	  of	  the	  exocyst	  and	  polarisome	  components	  (Jones	  &	  Sudbery	  2010).	  This	  is	  an	  area	  rich	  in	  secretory	  vesicles	  that	  resembles	  the	  Spitzenkörper	  (apical	  body)	  present	  in	  other	  filamentous	  fungi	  (Crampin	  et	  al.	  2005).	  Vesicles	  are	  thought	  to	  be	  delivered	  via	  actin	  cables	  to	  the	  Spitzenkörper	  (Fig.	  1.8.),	  where	  they	  then	  diffuse	  away	  to	  dock	  with	  the	  exocyst	  on	  the	  plasma	  membrane.	  The	  position	  of	  a	  Spitzenkörper	  ensures	  that	  the	  focus	  of	  vesicle	  delivery	  is	  highly	  polarised,	  producing	  the	  observed	  hyphal	  morphology	  (Bartnicki-­‐Garcia	  et	  al.	  1989).	  	  
	  































pseudohyphal growth (reviewed in REFS 99,100). In 
C. albicans, Cdc42 and its guanosine exchange factor 
(GEF) Cdc24 localize to the tips of hyphae73,87,101 and 
are required for viability102,103. However, decreasing the 
expression of Cdc42 or Cdc24 using a regulatable MET3 
promoter revealed that a reduced level of expression 
permits vegetative yeast-form growth but not hyphal 
growth102. Cdc42 GTPase-activating proteins (GAPs) in 
C. albicans are encoded by RGA2 and bud emergence 
protein 3 (BEM3). A mutant lacking both of these GAPs 
formed hyphae under conditions that would normally 
only allow pseudo hyphal formation104. Rga2 is phospho-
rylated by the Hgc1–Cdc28 kinase, which prevents its 
localization to the hyphal tip105, providing one mecha-
nism by which a hypha-specific gene (that is, HGC1) 
could lead to the sustained polarized-growth character-
istic of hyphae. In S. cerevisiae, localized activation of 
Cdc42 depends on Cdc24; this activation is also depend-
ent on another GTPase, the Ras-related protein Rsr1, its 
GEF bud site selection protein 5 (Bud5) and its GAP 
Bud2 (REF. 99). C. albicans mutants that lack Rsr1 or Bud2 
form hyphae that are wider than wild-type hyphae and 
Figure 4 | The polarized growth machinery. a | Model of secretory vesicle delivery to the hyphal tip incorporating 





(Bud6)145-148. Note that there is no Candida albicans homologue of the Pea2 protein, which is found in the 5|EGTGXKUKCG 









control 42 (Cdc42) orchestrates multiple functions that are required for polarized growth, as described in the text. b | The 
CEVKPE[VQUMGNGVQPCUTGXGCNGFD[)(2s.KHGCEVHWUKQPRTQVGKP149, which was expressed from the constitutive TEF1 promoter. 




to a surface crescent. e^ #EVKPRCVEJGUXKUWCNK\GFWUKPI#DRs;(2D[FKHHGTGPVKCNKPVGTHGTGPEGEQPVTCUVOKETQUEQR[5ECNG
bar in all images is 1 μm. Image in part bKUEQWTVGU[QH5|.GPUKPI&%CDCNNGTQ.KOCCPFJ. Greig, 7PKXGTUKV[QH5JGHHKGNF|7-
CPF2'5+OCIGUKPRCTVUc and d are reproduced, with permission, from REF. 83  (2010) #OGTKECP5QEKGV[HQT/KETQDKQNQI[
Image in part eKUEQWTVGU[QH5|.GPUKPICPF&%CDCNNGTQ.KOC
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During	  hyphal	  growth	  septin	  complexes	  form	  different	  structures	  to	  those	  observed	  during	  yeast	  growth.	  Upon	  germ	  tube	  formation	  the	  septin	  Cdc11	  localises	  to	  bands	  at	  the	  base	  of	  the	  germ	  tube,	  and	  a	  crescent	  at	  the	  tip	  of	  the	  germ	  tube	  (Sudbery	  2001).	  This	  persists	  until	  the	  septin	  ring	  is	  formed	  inside	  the	  germ	  tube,	  not	  at	  the	  mother	  daughter	  boundary	  as	  in	  yeast.	  Possibly	  due	  to	  this,	  the	  nucleus	  migrates	  into	  the	  germ	  tube	  before	  division	  occurs.	  Actin	  cables	  and	  patches	  are	  again	  key	  cytoskeletal	  components	  of	  polarised	  growth.	  Perturbing	  actin	  cable-­‐mediated	  transport	  causes	  hyphal	  tips	  to	  swell	  (Hazan	  &	  Liu	  2002),	  and	  deletion	  of	  components	  of	  the	  exocytic	  machinery	  prevents	  hyphal	  morphogenesis	  (Martin	  et	  al.	  2007).	  Microtubules	  are	  also	  present	  along	  the	  length	  of	  the	  hyphal	  tube	  (Barton	  &	  Gull	  1988),	  providing	  structures	  for	  nuclear	  migration	  and	  division	  (Finley	  &	  Berman	  2005).	  	  	  An	  important	  difference	  between	  hyphal	  morphogenesis	  and	  the	  production	  of	  a	  yeast	  bud	  is	  in	  the	  timing	  of	  events.	  Unlike	  during	  bud	  morphogenesis,	  hyphal	  elongation	  occurs	  independently	  of	  the	  cell	  cycle	  (Hazan	  et	  al.	  2002).	  However	  there	  are	  clear	  morphological	  differences	  in	  hyphae	  formed	  at	  different	  stages	  of	  the	  yeast	  cell	  cycle;	  as	  hyphae	  formed	  after	  the	  cell	  has	  committed	  to	  making	  a	  bud	  still	  retain	  a	  constriction	  at	  the	  mother	  daughter	  boundary.	  	  	  
1.6.	  Regulation	  of	  cell	  separation	  	   A	  key	  event	  that	  has	  to	  occur	  during	  hyphal	  morphogenesis	  is	  the	  prevention	  of	  cell	  separation.	  This	  allows	  the	  generation	  of	  a	  long,	  multi-­‐sectional	  hypha	  that	  can	  continue	  to	  extend	  from	  the	  apical	  compartment.	  	  	   As	  previously	  mentioned,	  during	  bud	  formation	  and	  growth	  the	  septin	  subunits	  assemble	  into	  a	  ring.	  When	  yeast	  cells	  divide	  at	  the	  end	  of	  mitosis,	  the	  septin	  ring	  splits	  and	  contraction	  of	  the	  actomyosin	  ring	  occurs	  between	  the	  two	  septin	  rings,	  dividing	  the	  cytoplasm	  between	  the	  mother	  and	  daughter	  cell	  (cytokinesis)	  (Bi	  &	  Park	  2012).	  A	  primary	  septum	  forms	  as	  the	  actomyosin	  ring	  contracts,	  where	  chitin	  is	  deposited	  to	  seal	  off	  the	  new	  daughter	  cell	  from	  the	  mother	  (Lesage	  &	  Bussey	  2006).	  The	  actomyosin	  ring	  is	  then	  disassembled	  and	  the	  primary	  septum	  is	  reinforced	  with	  new	  cell	  wall	  material,	  forming	  a	  secondary	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septum.	  Cell	  separation	  enzymes	  are	  then	  secreted	  to	  degrade	  the	  primary	  septum,	  allowing	  the	  mother	  and	  daughter	  cells	  to	  separate	  (Weiss	  2012).	  	  Mitotic	  exit	  is	  regulated	  by	  the	  Cdc14	  phosphatase,	  which	  is	  released	  from	  the	  nucleolus	  in	  early	  anaphase	  (Yoshida	  et	  al.	  2002).	  Cdc14	  activity	  is	  also	  required	  for	  cell	  separation,	  through	  the	  transcription	  factor	  Ace2,	  which	  controls	  transcription	  of	  genes	  required	  for	  septum	  degradation	  (Fig.	  1.9A.)	  (Weiss	  2012).	  During	  most	  of	  the	  cell	  cycle	  Ace2	  remains	  inactivated	  by	  CDK	  dependent	  phosphorylation	  and	  kinase-­‐independent	  functions	  of	  Pho85,	  retaining	  it	  in	  the	  cytoplasm	  (Mazanka	  &	  Weiss	  2010).	  At	  the	  end	  of	  mitosis	  Ace2	  is	  phosphorylated	  by	  the	  kinase	  Cbk1	  to	  allow	  it	  to	  enter	  the	  nucleus	  and	  activate	  the	  transcription	  of	  septum	  degrading	  enzymes	  (Fig.	  1.9A.).	  During	  early	  G1	  phase	  Ace2	  is	  then	  exported	  from	  the	  nucleus	  due	  to	  loss	  of	  Cbk1	  phosphorylation.	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig.	  1.9.	  Regulation	  of	  cell	  separation	  in	  yeast	  and	  hyphal	  cells.	  	  A)	  At	  the	  end	  of	  mitosis	  in	  yeast	  growth	  Cdc14	  activates	  Cbk1	  which	  then	  phosphorylates	  Ace2	  to	  allow	  entry	  into	  the	  daughter	  cell	  nucleus	  where	  Ace2	  activates	  the	  expression	  of	  cell	  separation	  enzymes,	  B)	  In	  hyphal	  growth	  Cdc14	  is	  excluded	  from	  the	  septum	  to	  prevent	  Cbk1	  activation	  and	  Ace2	  nuclear	  entry.	  Cdk1-­‐Hgc1	  phosphorylates	  Efg1	  to	  further	  prevent	  the	  expression	  of	  cell	  separation	  enzymes.	  	   In	  C.	  albicans	  hyphae	  karyokinesis	  and	  cytokinesis	  occur	  in	  the	  hyphal	  tube,	  which	  again	  are	  followed	  by	  the	  formation	  of	  a	  septum	  as	  a	  barrier	  between	  the	  apical	  and	  sub-­‐apical	  cell	  (Sudbery	  2001).	  However	  in	  C.	  albicans	  the	  primary	  





























The ability of hyphae to sense 
and grow along topographical 
cues in the environment such 
as cracks and ridges. This 
ability may help growth 
towards entry points in 
epithelia and endothelia.
Galvanotropism 
The ability to sense and 
orientate along an electric 
field; Candidia albicans hyphae 
grow towards the cathode.
are unable to maintain directed growth106. This obser-
vation suggests that Cdc24 localization is partly, but 
not fully, dependent on Rsr1 and Bud2. These mutants 
are also defective in hyphal guidance, showing a com-
plete lack of thigomotropism and galvanotropism107. Two 
other Rho-family GTPases play a part in hyphal growth. 
Rho3 is required for actin polarization and polarized 
growth108, and Rac1 and its GEF, Dck1, are required for 
hyphal growth when embedded in a matrix109,110.
Control of septation in hyphae. Hyphal growth is char-
acterized by the inhibition of cell separation after cyto-
kinesis, resulting in a mature hypha that consists of a 
linear chain of elongated cells. Research in S. cerevisiae 
has shown that cell separation occurs in yeast cells when 
the primary septum, which is composed of chitin, is 
hydrolysed by septum-degrading enzymes (SDEs) (such 
as a chitinase encoded by endochitinase 1 (CTS1) and a 
glucanase encoded by DSE4), leading to separation of the 
mother and daughter cells. Expression of SDEs is daughter 
cell specific and is programmed by the transcription fac-
tor Ace2, which is targeted to the daughter nucleus by the 
action of a kinase, Cbk1, and its regulatory subunit Mob2. 
In turn, expression of Cbk1 is dependent on triggering of 
the mitotic exit network by the release of the phosphatase 
Cdc14 from the nucleolus111.
In C. albicans, the inhibition of cell separation in 
hyphae is marked by a change in the properties of the 
septin ring and the action of the hypha-specific cyclin, 
Hgc1. Cdc14 translocates to the septin ring in the bud 
neck after mitosis in yeast cells but not to the septin ring 
in hyphae112 (FIG. 5). The exclusion of Cdc14 from the 
hyphal septin ring depends on Hgc1. In yeast cells, FRAP 
experiments show that Cdc3, Cdc10, Cdc12 and Sep7 
subunits of the septin ring are static (that is, no exchange 
takes place with free subunits)113. However, in hyphae the 
Cdc10 subunits are dynamic. Sep7 seems to play a key 
part in modifying the properties of the hyphal septin 
ring, as in sep7–/– mutants Cdc10 became less dynamic 
and the expression of SDEs and consequent cell separa-
tion increases. Moreover, phosphorylation of Sep7 is at 
least in part dependent on Hgc1. Hgc1 has another role 
in controlling cell separation after cytokinesis by phos-
phorylating the transcription factor Efg1, resulting in the 
downregulation of SDE expression. On phosphorylation 
by Hgc1–Cdc28, Efg1 associates with Ace2-target pro-
moters, presumably acting to suppress transcription of 
the SDE-associated genes114. A model for cell separation 
is shown in FIG. 5, in which the recruitment of Cdc14 to 
the septum in yeast is posited to activate Mob2–Cbk1 
by dephosphorylation, allowing Ace2 to be targeted to 
the nucleus and the consequent expression of SDEs. In 
hyphae, Cbk1 is localized to the tip, where it promotes 
polarized growth. It is also still localized to the septum. 
However, the Sep7- and Hgc1-dependent exclusion of 
Cdc14 from the septum and the action of Hgc1–Cdc28 
on Efg1 prevent activation of the SDEs.
Hyphal growth and the cell cycle. Polarized growth 
in hyphae is continuous throughout the ensuing cell 
cycle, in contrast to growth of yeast and pseudohyphal 
buds70. Accordingly, in hyphae the actin cytoskeleton 
remains continuously polarized72,115 and the polari-
some and Spitzenkörper are continuously present73 
(Supplementary information S2 (movie)). An extended 
G2 phase is thought to be responsible for the elon-
gated growth of pseudohyphal buds in S. cerevisiae116. 
However, this does not explain the highly polarized 
growth of C. albicans hyphae because after the cell cycle 
is initiated there is little difference in the timing of pro-
gression of the S and G2 phases when yeast cells and 
hyphal cells are compared. Moreover, there is no change 
in the degree of inhibitory Tyr18 phosphorylation of 
Cdc28 mediated by the mitosis inhibitor protein kinase 
Swe1 (REF. 72). Consistent with this observation, deletion 
of Swe1 does not abolish hyphal growth117.
Although alteration of cell cycle kinetics does not 
seem to have a role in normal hyphal growth, a striking 
feature of C. albicans biology is that a range of differ-
ent mutations or drug treatments that interrupt nuclear 
cycle progression result in unscheduled polarized or 
highly polarized growth. In some cases, these phenotypic 
alterations are accompanied by the expression of hypha-
specific genes (reviewed in REF. 118). To some extent, the 




at the septin ring dephosphorylates Mob2–Cbk1, which then licenses Ace2 to enter the 
PWENGWUYJGTGKVVTCPUETKDGUIGPGUGPEQFKPIUGRVWOFGITCFKPIGP\[OGU
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6JGUG
enzymes hydrolyse the primary septum, allowing mother and daughter to separate.  
b | Hyphal G1 cyclin protein 1 (Hgc1)–Cdc28 acts in two ways to suppress egradation  
of the primary septum. First, it phosphorylates enhanced filamentous growth protein 
('HIYJKEJVJGPDKPFUVQ#EGVCTIGVIGPGUKPJKDKVKPIVJGKTVTCPUETKRVKQP5GEQPF 
KVRJQURJQT[NCVGU5GRYJKEJVJGPOQFKHKGUVJGRTQRGTVKGUQHVJGUGRVKPTKPIUQVJCV
Cdc10 becomes dynamic. In this state, Cdc14 is unable to localize to the septin ring  
and Mob2–Cbk1 at th  septum can ot license Ace2 to enter the nucleus. Mob2–Cbk1 
remains at the hyphal tip, where it promotes polarized growth.
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septum	  is	  not	  degraded,	  thus	  allowing	  the	  compartments	  to	  remain	  attached.	  This	  process	  is	  regulated	  in	  part	  by	  the	  transcription	  factor	  Efg1,	  which	  is	  phosphorylated	  to	  prevent	  the	  expression	  of	  septum	  degrading	  enzymes	  during	  hyphal	  growth	  (Fig.	  1.9B.)	  (Wang	  et	  al.	  2009).	  There	  is	  also	  the	  possibility	  that	  Ace2	  itself	  is	  directly	  regulated	  to	  prevent	  expression	  of	  these	  enzymes.	  The	  phosphatase	  Cdc14	  is	  absent	  from	  the	  septum	  in	  C.	  albicans	  hyphae,	  but	  not	  during	  yeast	  growth	  (Fig.	  1.9B.).	  This	  is	  likely	  to	  prevent	  the	  activation	  of	  Cbk1	  and	  thus	  prevent	  Ace2	  from	  localising	  to	  the	  apical	  cell	  nucleus.	  Cdc14	  exclusion	  from	  the	  septum	  is	  thought	  to	  be	  partially	  dependent	  of	  the	  Cdk1	  cyclin	  and	  Hgc1	  (Clemente-­‐Blanco	  et	  al.	  2006),	  and	  the	  septin	  subunit	  Sep7	  (González-­‐Novo	  et	  al.	  2008).	  	  
1.7.	  Role	  of	  post-­‐translational	  modification	  in	  morphogenesis	  	   	  Although	  many	  proteins	  required	  for	  morphogenesis	  have	  been	  identified,	  how	  these	  proteins	  are	  regulated	  in	  the	  morphogenetic	  yeast	  to	  hyphae	  transition	  remains	  relatively	  unknown.	  This	  has	  made	  post-­‐translational	  control	  of	  morphogenesis	  become	  an	  area	  of	  significant	  interest.	  Many	  proteins	  undergo	  reversible	  and	  irreversible	  modifications	  to	  regulate	  their	  function.	  Such	  modifications	  include:	  phosphorylation,	  ubiquitination,	  methylation,	  acetlyation,	  sumoylation,	  neddylation	  and	  glycosylation.	  	   Phosphorylation	  is	  an	  extensively	  studied	  reversible	  protein	  modification,	  required	  for	  the	  control	  of	  a	  diverse	  range	  of	  cellular	  processes.	  It	  involves	  kinase-­‐mediated	  addition	  of	  the	  γ-­‐phosphate	  from	  ATP	  to	  a	  serine,	  threonine	  or	  tyrosine	  residue	  in	  the	  target	  protein,	  creating	  a	  negatively	  charged	  patch	  on	  the	  protein.	  Phosphorylation	  can	  occur	  on	  one,	  or	  multiple	  sites	  in	  the	  case	  of	  proteins	  that	  are	  hyper-­‐phosphorylated	  (Cohen	  2000).	  Reversion	  of	  this	  event	  (de-­‐phosphorylation)	  is	  through	  hydrolysis	  of	  the	  phosphate	  linkage,	  a	  process	  mediated	  by	  phosphatases.	  Phosphorylation	  can	  modify	  a	  proteins	  activity	  in	  several	  ways,	  such	  as:	  activating,	  deactivating	  or	  targeting	  a	  protein	  for	  degradation;	  it	  can	  change	  the	  subcellular	  localisation	  of	  a	  protein,	  or	  the	  interactions	  of	  the	  protein,	  be	  that	  with	  other	  proteins	  or	  molecules	  such	  as	  DNA/RNA	  and	  lipid	  structures	  (Cohen	  2000).Phosphorylation	  can	  be	  used	  to	  transduce	  external	  signals	  from	  receptors	  to	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intraceullular	  effectors,	  as	  is	  found	  in	  the	  aforementioned	  cAMP-­‐PKA	  and	  MAPK	  pathways.	  Another	  role	  of	  phosphorylation	  is	  during	  the	  shift	  to	  hyphal-­‐promoting	  temperatures,	  where	  the	  heat	  shock	  protein	  Hsf1	  is	  phosphorylated	  to	  aid	  in	  adaptation	  (Nicholls	  et	  al.	  2011).	  CDKs	  have	  also	  been	  shown	  to	  be	  required	  for	  control	  of	  hyphal	  growth	  (Wang	  2009).	  This	  will	  be	  covered	  in	  much	  greater	  detail	  in	  Chapter	  3.	  The	  nuclear	  Dbf2-­‐related	  kinase	  Cbk1	  appears	  to	  exert	  a	  strong	  effect	  upon	  hyphal	  growth,	  as	  cbk1∆/∆	  mutants	  are	  completely	  unable	  to	  form	  hyphae	  (McNemar	  &	  Fonzi	  2002).	  However	  the	  mechanisms	  by	  which	  Cbk1	  influences	  hyphal	  growth	  remain	  relatively	  unknown.	  Current	  investigation	  of	  Cbk1’s	  role	  in	  hyphal	  morphogenesis	  is	  focussed	  on	  how	  it	  regulates	  the	  hyphal	  repressor	  Nrg1	  (Alaalm	  et	  al.	  unpublished)	  	   Ubiquitination	  is	  a	  reversible	  addition	  of	  a	  ubiquitin	  moiety	  via	  isopeptide	  bond	  between	  the	  carboxyl	  terminus	  of	  ubiquitin	  and	  the	  amino	  group	  of	  a	  substrate	  lysine	  or	  cysteine.	  This	  occurs	  in	  a	  three	  step	  process	  involving	  activation	  (E1	  enzyme),	  followed	  by	  transfer	  of	  activated	  ubiquitin	  to	  a	  ubiquitin-­‐conjugating	  enzyme	  (E2	  enzyme),	  and	  then	  finally	  ligation	  of	  the	  ubiquitin	  to	  the	  target	  via	  a	  ubiquitin	  ligase	  (E3	  enzyme)	  (Fig.	  1.10.)	  (Komander	  2009).	  Multiple	  ubiquitin	  moieties	  can	  be	  added	  to	  form	  chains	  on	  a	  single	  target	  residue	  (E4	  ubiquitin	  ligase).	  Removal	  of	  ubiquitin	  is	  controlled	  by	  ubiquitin-­‐deconjugating	  enzymes.	  One	  of	  the	  first	  identified	  key	  roles	  of	  ubiquitin	  is	  the	  polyubiquitination	  of	  mitotic	  cyclins	  to	  target	  them	  to	  the	  proteasome	  for	  destruction	  at	  the	  end	  of	  the	  cell	  cycle	  (Seufert	  et	  al.	  1995).	  However	  ubiquitination	  can	  also	  alter	  protein	  function	  along	  with	  targeting	  to	  specific	  cellular	  compartments	  (Komander	  2009).	  
C.	  albicans	  genome	  encodes	  two	  ubiquitin	  genes;	  the	  ubiquitin	  hybrid	  UBI3	  involved	  in	  ribosome	  biogenesis	  (Roig	  et	  al.	  2000),	  and	  the	  polyubiquitin	  gene	  
UBI4	  that	  when	  deleted	  causes	  cell	  cycle	  arrest	  filamentation	  (Leach	  et	  al.	  2011),	  suggesting	  a	  possible	  role	  for	  ubiquitination	  in	  morphogenesis.	  Most	  ubiquitination	  targets	  in	  Candida	  so	  far	  have	  been	  found	  to	  be	  involved	  in	  metabolism	  (Fig.	  1.10.)	  (Leach	  et	  al.	  2011);	  however	  it	  is	  likely	  that	  roles	  in	  morphogenesis	  exist,	  as	  such	  in	  other	  related	  organisms.	  	   Sumoylation	  is	  the	  addition	  of	  a	  small	  ubiquitin-­‐like	  modifier	  (SUMO)	  to	  a	  target	  protein	  in	  a	  manner	  similar	  to	  that	  of	  ubiquitination	  (Fig.	  1.10.)	  (Gill	  2004).	  Deletion	  of	  the	  single	  SUMO	  gene	  SMT3	  in	  C.	  albicans	  results	  in	  morphological	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abnormalities	  that,	  like	  deletion	  of	  the	  polyubiquitin	  gene	  UBI4,	  appear	  to	  be	  due	  to	  cell	  cycle	  delay	  (Leach	  et	  al.	  2011).	  Proteomic	  analysis	  of	  sumoylation	  in	  C.	  
albicans	  revealed	  that	  components	  of	  the	  cytoskeleton	  Tub1	  and	  Mlc1,	  along	  with	  secretory	  pathway	  proteins	  Sec24	  and	  Sec7,	  are	  in	  vivo	  sumoylation	  targets	  (Fig.	  1.10.)	  (Leach	  et	  al.	  2011).	  Sumoylation	  may	  also	  regulate	  septin	  ring	  dynamics	  as	  is	  found	  in	  the	  related	  S.	  cerevisiae	  (Johnson	  &	  Blobel	  1999).	  Together	  this	  suggests	  a	  possible	  role	  for	  sumoylation	  in	  the	  initiation	  and	  maintenance	  of	  hyphal	  morphogenesis	  in	  C.	  albicans.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Fig.	  1.10.	  Roles	  of	  ubiquitination	  and	  sumoylation	  in	  C.	  albicans.	  Taken	  with	  permission	  from	  Leach	  and	  Brown	  2012.	  Diagram	  shows	  schematics	  of	  ubiquitin	  or	  SUMO	  addition,	  followed	  by	  ubiquitination	  and	  sumoylation	  targets	  in	  C.	  albicans	  and	  their	  functions.	  	  	  	  	   Glycosylation,	  although	  not	  required	  specifically	  for	  morphogenesis,	  is	  important	  for	  the	  modification	  of	  cell	  wall	  proteins	  involved	  in	  C.	  albicans	  host	  invasion.	  Glycosylation	  is	  the	  addition	  of	  an	  oligosaccharide	  moiety	  to	  a	  protein,	  which	  generally	  occurs	  along	  the	  secretory	  pathway	  (Spiro	  2002).	  Oligosaccharides	  can	  be	  added	  to	  an	  amino	  group	  of	  either	  asparagine	  (N-­‐linked)	  or	  to	  the	  carboxyl	  group	  of	  serine,	  threonine	  or	  tyrosine	  residues	  (O-­‐linked).	  Other	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carbohydrate	  attachments	  such	  as	  the	  GPI	  anchors	  occur	  through	  glypiation	  between	  the	  C-­‐terminus	  of	  the	  protein	  and	  cell	  membrane	  phospholipids	  (Spiro	  2002).	  	  This	  is	  important	  for	  the	  aforementioned	  pH	  regulatory	  proteins	  Phr1	  and	  Phr2.	  A	  similar	  mechanism	  is	  used	  to	  attach	  proteins	  to	  the	  mannan	  present	  in	  the	  fungal	  cell	  wall	  (Leach	  &	  Brown	  2012).	  	  	  
1.8.	  Methods	  for	  studying	  kinases	  and	  their	  targets	  	  	   Kinases	  carry	  out	  phosphorylation	  events,	  adding	  the	  γ-­‐phosphate	  group	  from	  ATP	  to	  the	  target	  protein	  in	  order	  to	  modify	  its	  function.	  In	  yeast	  the	  primary	  phosphorylation	  events	  occur	  on	  serine	  or	  threonine	  residues.	  Some	  tyrosine	  phosphorylation	  is	  present,	  however	  it	  is	  uncommon	  (Chi	  et	  al.	  2007).	  In	  order	  to	  determine	  whether	  a	  protein	  of	  interest	  is	  a	  phospho-­‐protein	  there	  are	  multiple	  lines	  of	  investigation	  that	  can	  be	  taken.	  Firstly	  the	  primary	  sequence	  of	  the	  protein	  can	  be	  analysed	  for	  the	  presence	  of	  known	  kinase	  phosphorylation	  motifs	  (Songyang	  et	  al.	  1996).	  This	  will	  also	  give	  suggestions	  of	  possible	  kinases	  that	  may	  phosphorylate	  the	  protein	  of	  interest.	  To	  determine	  whether	  the	  protein	  of	  interest	  is	  phosphorylated	  in	  vivo	  different	  biochemical	  methods	  can	  be	  used	  (Peck	  2006).	  In	  order	  to	  study	  the	  protein	  there	  needs	  to	  be	  a	  means	  of	  isolating	  it	  from	  the	  rest	  of	  the	  proteins	  in	  the	  cell	  and	  to	  detect	  it	  after	  Western	  blotting.	  To	  do	  this	  the	  protein	  can	  either	  be	  epitope	  tagged,	  or	  a	  specific	  antibody	  raised	  against	  the	  protein.	  A	  caveat	  to	  looking	  at	  the	  phosphorylation	  of	  a	  specific	  protein	  is	  that	  phosphorylation	  is	  a	  dynamic	  process,	  and	  may	  only	  occur	  at	  certain	  times,	  or	  under	  certain	  conditions.	  	  Addition	  of	  phosphate	  groups	  to	  proteins	  can	  alter	  their	  mobility	  on	  SDS-­‐PAGE	  (Wegener	  &	  Jones	  1984),	  which	  may	  be	  due	  to	  the	  negative	  charge	  from	  the	  phosphate	  preventing	  SDS	  from	  binding,	  and	  thus	  altering	  its	  electrophoretic	  mobility.	  An	  electrophoretic	  mobility	  shift	  due	  to	  phosphorylation	  should	  be	  sensitive	  to	  phosphatase	  treatment	  (Peck	  2006).	  It	  may	  not	  always	  be	  possible	  to	  detect	  such	  shifts,	  and	  can	  only	  be	  reliably	  done	  with	  proteins	  that	  are	  hyper-­‐phosphorylated.	  	   In	  order	  to	  better	  separate	  out	  phosphorylated	  isoforms	  of	  proteins	  2-­‐	  Dimensional	  gel	  electrophoresis	  can	  be	  performed.	  This	  first	  separates	  proteins	  by	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their	  isoelectric	  point,	  and	  then	  by	  their	  mass.	  This	  is	  a	  useful	  technique	  when	  multiple	  phosphorylated	  isoforms	  of	  a	  protein	  exist,	  or	  for	  carrying	  out	  global	  studies	  on	  changes	  in	  the	  phospho-­‐proteome	  (Hardie	  1999).	  	  	   In	  vivo	  phosphorylation	  of	  a	  protein	  can	  also	  be	  detected	  using	  specific	  antibodies	  that	  recognise	  phosphorylated	  residues,	  such	  as	  phospho-­‐serine	  or	  threonine	  (Tingley	  et	  al.	  1997).	  In	  order	  to	  do	  this	  the	  protein	  of	  interest	  has	  to	  be	  immunoprecipitated	  (IP’d)	  to	  avoid	  background	  signal	  on	  the	  subsequent	  Western	  blot.	  	  	   In	  order	  to	  to	  determine	  the	  exact	  sites	  that	  are	  phosphorylated	  in	  vivo,	  mass-­‐spectrometry	  based	  phospho-­‐peptide	  mapping	  can	  be	  carried	  out	  (Mann	  et	  al.	  2002).	  To	  do	  this	  a	  sufficient	  amount	  of	  the	  protein	  has	  to	  be	  purified	  from	  cells.	  The	  protein	  is	  then	  digested,	  ideally	  with	  multiple	  proteases,	  before	  running	  the	  sample	  on	  a	  Matrix	  Assisted	  Laser	  Desorption	  quantitative	  Time	  Of	  Flight	  (MALDI-­‐qTOF)	  machine.	  	  This	  will	  generate	  an	  ion	  spectrum	  for	  the	  protein	  fragments,	  which	  can	  be	  compared	  to	  the	  expected	  spectra	  for	  the	  fragments.	  In	  doing	  this,	  the	  change	  in	  mass	  to	  charge	  ratio	  by	  the	  addition	  of	  a	  phosphate	  group	  can	  be	  detected.	  	  	   Knowing	  the	  exact	  residues	  and	  motifs	  that	  are	  phosphorylated	  will	  provide	  suggestions	  to	  the	  kinase	  that	  is	  responsible;	  as	  previously	  mentioned	  the	  different	  classes	  of	  kinases	  have	  different	  target	  motifs.	  	  To	  test	  whether	  a	  kinase	  can	  directly	  phosphorylate	  a	  substrate,	  an	  in	  vitro	  kinase	  assay	  can	  be	  carried	  out	  (Peck	  2006).	  This	  involves	  epitope	  tagging	  and	  purifying	  the	  suspected	  kinase;	  and	  either	  purifying	  the	  substrate,	  or	  using	  a	  recombinant	  substrate	  expressed	  in	  E.	  
coli.	  The	  kinase	  and	  the	  substrate	  are	  then	  incubated	  at	  physiological	  temperatures	  with	  either	  radiolabelled	  γ-­‐P32	  Adenosine	  triphosphate	  (ATP),	  or	  non-­‐labelled	  ATP.	  Phosphorylation	  of	  the	  substrate	  is	  then	  detected	  by	  autoradiography	  or	  Western	  blot	  with	  a	  phospho-­‐specific	  antibody	  (Ross	  et	  al.	  2002).	  	   To	  determine	  the	  physiological	  consequences	  of	  phosphorylation,	  the	  phospho-­‐acceptor	  sites	  can	  be	  mutated;	  either	  preventing	  phosphorylation	  from	  occurring,	  or	  mimicking	  the	  phosphorylation	  charge	  to	  observe	  the	  effects	  of	  constitutive	  phosphorylation	  (Figurski	  2013).	  Mutating	  the	  serine,	  threonine	  or	  tyrosine	  in	  the	  phosphorylation	  motif	  to	  alanine	  removes	  the	  hydroxyl	  group,	  thus	  preventing	  kinase	  mediated	  addition	  of	  the	  γ-­‐phosphate	  from	  ATP.	  Mutation	  of	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serine	  to	  aspartic	  acid	  or	  threonine	  to	  glutamic	  acid	  mimics	  the	  negative	  charge	  that	  would	  be	  present	  from	  the	  addition	  of	  a	  phosphate	  group.	  This	  was	  first	  shown	  for	  the	  Simian	  Virus	  40	  T-­‐antigen	  (Schneider	  &	  Fanning	  1988).	  	  
1.9.	  Aims	  of	  thesis	  study	  
	  
	   The	  cyclin	  dependent	  kinase	  (CDK)	  Cdk1	  is	  known	  to	  have	  important	  roles	  in	  hyphal	  morphogenesis	  (Wang	  2009),	  which	  will	  be	  discussed	  in	  detail	  in	  Chapter	  3.	  Due	  to	  the	  importance	  of	  this	  kinase,	  the	  PhD	  project	  was	  designed	  to	  identify	  regulatory	  targets	  of	  Cdk1	  during	  hyphal	  growth.	  Initially	  bioinformatics	  was	  used	  to	  identify	  potential	  CDK	  targets.	  The	  phosphorylation	  states	  of	  the	  candidates	  were	  determined	  during	  yeast	  and	  hyphal	  growth.	  Candidate	  proteins	  that	  showed	  a	  differential	  phosphorylation	  pattern	  between	  yeast	  and	  hyphal	  growth	  were	  then	  studied	  further.	  	   The	  candidature	  of	  the	  PhD	  is	  split	  over	  two	  locations;	  with	  the	  initial	  investigation	  of	  potential	  CDK	  targets	  being	  carried	  out	  at	  the	  University	  of	  Sheffield.	  Further	  characterisation	  of	  differentially	  regulated	  potential	  CDK	  targets	  was	  then	  carried	  out	  at	  the	  Institute	  for	  Molecular	  and	  Cell	  Biology	  in	  Singapore.	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2	   	   	   	   	   	  	  	  	  	  	  	  	  	  Materials	  and	  Methods	  
	  
	  
2.1.	  C.	  albicans	  Growth	  Media	  
	  
Yeast	  Extract	  Peptone	  Dextrose	  (YEPD)	  	  1%	  w/v	  Bacto™-­‐Yeast	  Extract	  (BD	  Biosciences,	  USA),	  2%	  w/v	  Bacto™-­‐Peptone	  (BD	  Biosciences,	  USA),	  2%	  w/v	  D-­‐Glucose,	  80mg.	  l-­‐1	  Uridine.	  	  
	  
Yeast	  Extract	  Peptone	  Galactose	  (YPG)	  for	  expression	  from	  GAL1	  promoter	  1%	  w/v	  Bacto™-­‐Yeast	  Extract,	  2%	  w/v	  Bacto™-­‐Peptone,	  2%	  w/v	  Galactose,	  80mg.	  l-­‐1	  Uridine.	  	  	  
	  
Glucose	  Minimal	  Media	  (GMM)	  0.67%	  w/v	  Yeast	  Nitrogen	  Base	  (YNB)	  without	  Amino	  Acids	  (BD	  Biosciences,	  USA),	  2%	  w/v	  D-­‐glucose	  	  
	  
GMM	  Dropout	  Media	  for	  selection	  of	  prototrophic	  transformants	  0.67%	  w/v	  Yeast	  Nitrogen	  Base	  without	  Amino	  Acids,	  1.5%	  w/v	  Bacto™-­‐agar.	  Uridine,	  Arginine	  or	  Histidine	  were	  used	  at	  a	  final	  concentration	  of	  80mg.	  l-­‐1	  for	  auxotrophic	  strains.	  	  
Media	  for	  repression	  of	  the	  MET3	  Promoter	  YEPD	  or	  GMM	  media	  supplemented	  with	  10mM	  methionine	  and	  2mM	  cysteine.	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5-­‐Fluoroorotic	  acid	  media	  (5-­‐FOA)	  Agar	  0.67%	  Yeast	  Nitrogen	  Base	  without	  Amino	  Acids,	  2%	  Glucose,	  2%	  Bacto™-­‐Agar.	  A	  5-­‐FOA	  solution	  was	  added	  to	  the	  autoclaved	  mix	  to	  a	  final	  concentration	  of	  0.1%.	  Amino	  Acid	  supplements	  were	  added	  depending	  on	  the	  selection	  required.	  
	  
	  
2.2.	  E.	  coli	  culture	  media	  
	  
Luria-­‐Bertani	  (LB)	  1%	  w/v	  Bacto™-­‐tryptone	  (BD	  Biosciences,	  USA),	  0.5%	  w/v	  Bacto™-­‐Yeast	  Extract,	  1%	  w/v	  NaCl,	  pH	  7.0	  
	  
2TY	  	  1.1%	  w/v	  Bacto™-­‐tryptone,	  1%	  w/v	  Bacto™-­‐yeast	  extract,	  and	  0.5%	  w/v	  NaCl.	  
	  
	  
2.3.	  C.	  albicans	  culture	  conditions	  
	  
Yeast	  Morphology	  An	  overnight	  stationary	  phase	  culture	  was	  diluted	  to	  an	  OD600	  of	  0.8	  into	  YEPD	  or	  GMM	  at	  pH	  4.0	  and	  a	  temperature	  of	  30°C.	  The	  culture	  was	  then	  grown	  at	  30°C	  for	  the	  required	  amount	  of	  time.	  	  
Hyphal	  Morphology	  	  An	  overnight	  stationary	  phase	  culture	  was	  diluted	  to	  an	  OD600	  of	  0.8	  into	  YEPD	  or	  GMM	  at	  pH	  7.0	  and	  a	  temperature	  of	  37°C,	  along	  with	  the	  addition	  of	  20%	  v/v	  of	  Fetal	  calf	  serum.	  Cells	  were	  then	  grown	  at	  37°C	  for	  the	  required	  amount	  of	  time.	  	  	  
Elutriation	  	  An	  overnight	  stationary	  phase	  culture	  of	  C.	  albicans	  in	  YEPD	  was	  diluted	  1/10,000	  times	  into	  a	  litre	  of	  fresh	  YEPD	  media,	  and	  left	  to	  grow	  overnight	  at	  30°C.	  The	  OD600	  of	  the	  culture	  was	  measured,	  as	  to	  ensure	  that	  the	  culture	  was	  still	  in	  log	  phase	  growth	  the	  next	  morning.	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The	  elutriating	  rotor	  (Beckman	  JE	  5.0)	  was	  set	  up,	  and	  SDW	  was	  passed	  through	  at	  a	  flow	  rate	  of	  200mls/min;	  the	  rotor	  was	  turned	  to	  help	  facilitate	  the	  removal	  of	  air	  bubbles	  from	  the	  chamber.	  The	  centrifuge	  was	  set	  to	  1000rpm	  and	  then	  left	  to	  spin	  for	  a	  few	  minutes,	  until	  all	  air	  bubbles	  were	  out	  of	  the	  chamber	  and	  tubing.	  The	  speed	  was	  increased	  to	  4200rpm;	  and	  once	  settled,	  the	  flow	  rate	  set	  at	  60mls/min.	  The	  YEPD	  culture	  was	  gently	  sonicated	  and	  then	  added	  to	  the	  sample	  chamber	  via	  the	  input	  tube,	  ensuring	  that	  the	  pressure	  in	  the	  pipes	  did	  not	  go	  above	  10psi.	  After	  all	  the	  cells	  had	  entered	  the	  chamber,	  the	  input	  was	  switched	  back	  to	  SDW	  and	  left	  to	  flow	  through	  for	  5	  minutes.	  The	  centrifuge	  speed	  can	  then	  be	  decreased	  to	  4100rpm	  to	  allow	  cells	  to	  begin	  migration	  through	  the	  chamber.	  Once	  the	  output	  fractions	  show	  small	  un-­‐budded	  cells,	  these	  can	  be	  collected.	  The	  centrifuge	  speed	  was	  decreased	  100rpm	  at	  a	  time	  to	  a	  minimum	  of	  3800rpm,	  while	  constantly	  checking	  the	  fractions	  under	  the	  microscope	  to	  ensure	  small	  un-­‐budded	  cells	  were	  present.	  These	  cells	  were	  combined	  and	  then	  used	  directly	  in	  yeast	  and	  hyphal	  time-­‐course	  experiments.	  
	  
Inactivation	  of	  the	  Cdc28	  analogue	  sensitive	  allele	  with	  1NM-­‐PP1	  A	  15mM	  stock	  of	  1NM-­‐PP1	  (Calbiochem)	  was	  made	  up	  in	  Dimethylsulfoxide	  (DMSO)	  and	  added	  to	  the	  pre-­‐warmed	  culture	  media	  to	  a	  final	  concentration	  of	  30μM.	  	  
Repression	  of	  genes	  under	  the	  control	  of	  the	  tetracycline	  promoter	  Doxycycline-­‐HCl	  was	  added	  to	  YEPD	  media	  to	  a	  final	  concentration	  of	  20μg/ml.	  For	  efficient	  shutdown,	  overnight	  cultures	  were	  grown	  with	  doxycycline	  before	  re-­‐inoculation	  into	  fresh	  media	  containing	  doxycycline.	  	  	  	  
2.4.	  Microscopy	  	  
Microscope	  apparatus	  Microscopy	  was	  carried	  out	  using	  a	  Leica	  DMR	  microscope	  fitted	  with	  a	  Hamamatsu	  digital	  camera	  and	  interfaced	  with	  metamorph	  software	  (Molecular	  Devices);	  or	  with	  an	  Olympus	  Delta	  Vision	  Fluorescence	  Microscope	  (Applied	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precision).	  	  	  All	  images	  were	  taken	  at	  x100	  magnification	  unless	  otherwise	  stated.	  For	  fluorescence	  imaging	  the	  FITC	  channel	  (ex	  494nm,	  em	  518nm)	  was	  used	  for	  GFP	  signals,	  and	  the	  DAPI	  channel	  (ex	  358nm	  em	  461nm)	  was	  used	  for	  4',	  6-­‐Diamidino-­‐2-­‐Phenylindole,	  Dihydrochloride	  (DAPI)	  signals	  to	  visualize	  nuclear	  DNA.	  For	  M-­‐cherry	  epitope	  detection,	  an	  excitation	  of	  587nm	  and	  an	  absorbance	  of	  610nm	  was	  used.	  	  
Formaldehyde	  fixation	  of	  cells	  for	  microscopy	  Formaldehyde	  was	  added	  to	  a	  final	  concentration	  of	  1.05%;	  the	  sample	  was	  mixed	  by	  inversion	  and	  was	  left	  to	  incubate	  at	  room	  temperature	  for	  10minutes.	  Cells	  were	  pelleted	  by	  centrifugation	  at	  3000rpm	  for	  45seconds,	  and	  then	  re-­‐suspended	  in	  1xPBS.	  Fixed	  cells	  can	  then	  be	  stored	  at	  4°C.	  	  
	  
	  
Ethanol	  fixing	  of	  cells	  1ml	  of	  culture	  was	  pelleted	  by	  centrifugation	  at	  3000rpm	  for	  45s,	  and	  then	  re-­‐suspended	  in	  500μl	  of	  70%	  ethanol.	  Cells	  were	  stored	  at	  4°C	  until	  required.	  Before	  microscopy,	  cells	  were	  washed	  once	  with	  1xPBS	  and	  then	  re-­‐suspended	  in	  1xPBS.	  
	  
Pepsin	  treatment	  to	  separate	  clumped	  hyphae	  1ml	  of	  a	  fixed	  hyphal	  cells	  were	  pelleted	  by	  centrifugation	  at	  3000rpm	  for	  45s.	  Cells	  were	  then	  re-­‐suspended	  in	  500μl	  of	  pepsin	  solution	  (5mg/ml	  in	  55mM	  HCl)	  and	  mixed	  by	  pipetting.	  The	  samples	  were	  then	  incubated	  for	  30mins	  at	  37°C	  on	  a	  shaking	  platform.	  Cells	  were	  pelleted	  again	  as	  above	  and	  then	  re-­‐suspended	  in	  500μl	  of	  1xPBS.	  
	  
2.5.	  Molecular	  biology:	  DNA	  techniques	  	  
	  
Buffers	  and	  solutions	  	  
50x	  Tris-­‐Acetate	  EDTA	  (TAE)	  Buffer:	  	  24.2%	  w/v	  Tris-­‐base,	  5.71%	  v/v	  Acetic	  acid,	  0.05M	  EDTA	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10x	  Tris-­‐EDTA	  (TE)	  Buffer:	  100mM	  Tris-­‐HCl	  pH	  7.5,	  10mM	  EDTA	  
	  
Polymerase	  Chain	  Reaction	  (PCR)	  PCR	  fragments	  were	  generated	  from	  C.	  albicans	  genomic	  DNA	  or	  from	  pre-­‐existing	  vectors	  using	  the	  KOD	  Hot-­‐start	  Polymerase	  (Merck-­‐Novagen).	  50μl	  reactions	  contained	  the	  following:	  5μl	  10x	  KOD	  buffer,	  5μl	  dNTPs	  (2mM	  each),	  2μl	  Magnesium	  sulphate	  (25mM),	  0.5μl	  each	  primer	  from	  100μM	  stock	  and	  200ng	  genomic	  DNA	  or	  1ng	  plasmid	  DNA.	  The	  reaction	  was	  then	  made	  up	  to	  49μl	  before	  1μl	  KOD	  polymerase	  was	  added.	  PCR	  reaction	  conditions	  were	  as	  follows:	  	  
Step	   Temperature	   Time	   #	  Cycles	  Initial	  Denaturation	   94°C	   2mins	   1	  Denaturation	  	   94°C	   15secs	  
30	  Annealing	   Primer	  Dependent	   30secs	  Extension	   72°C	   20secs/Kb	  
	  
Purification	  of	  PCR	  products	  PCR	  products	  were	  purified	  either	  using	  the	  PCR	  Cleanup	  kit	  (QIAGEN)	  or	  by	  Ethanol-­‐Sodium	  acetate	  precipitation.	  For	  precipitation;	  1/10th	  volume	  of	  3M	  sodium	  acetate	  pH5.3	  was	  added	  to	  the	  sample,	  followed	  by	  2	  times	  the	  new	  volume	  of	  100%	  ethanol.	  Samples	  were	  then	  left	  at	  -­‐20°C	  for	  a	  minimum	  of	  1hr	  to	  allow	  the	  DNA	  to	  precipitate.	  
	  
DNA	  agarose	  gel	  electrophoresis	  PCR	  products,	  along	  with	  cut	  and	  uncut	  plasmid	  vectors,	  were	  run	  on	  a	  1%	  agarose	  TAE	  gel	  in	  order	  to	  separate	  DNA	  fragments	  by	  size.	  1%	  w/v	  agarose	  was	  dissolved	  in	  1xTAE	  buffer	  through	  gentle	  heating.	  When	  cooled	  sufficiently,	  0.05%	  v/v	  of	  ethidium	  bromide	  was	  added	  to	  the	  gel	  before	  it	  was	  poured	  into	  Bio-­‐Rad	  wide	  or	  mini	  sub	  cell	  apparatus,	  and	  the	  well	  comb	  added.	  Once	  set,	  gels	  were	  placed	  in	  the	  corresponding	  tanks	  and	  submerged	  with	  1xTAE	  buffer.	  Samples	  were	  combined	  with	  6xDNA	  loading	  dye	  to	  facilitate	  loading	  into	  the	  gel	  wells.	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DNA	  ladders,	  hyperladder-­‐1	  (Bioline)	  or	  NEB	  1Kb	  DNA	  Ladder,	  were	  used	  as	  size	  standards.	  Gels	  were	  run	  at	  constant	  volts	  between	  100-­‐140V.	  Visualisation	  of	  ethidium	  bromide	  intercalated	  DNA	  was	  carried	  out	  using	  a	  trans-­‐illuminator	  with	  attached	  camera.	  
	  
Restriction	  Endonuclease-­‐	  based	  cloning	  Purified	  PCR	  products	  (32μl)	  or	  plasmids	  containing	  inserts	  were	  digested	  in	  a	  total	  volume	  of	  40μl,	  and	  the	  final	  vector	  (23μl)	  was	  digested	  in	  a	  total	  volume	  of	  30μl.	  Digestions	  were	  carried	  out	  overnight	  at	  37°C	  using	  equal	  units	  of	  the	  required	  enzymes	  and	  appropriate	  buffers	  (New	  England	  Biolabs).	  Both	  digests	  were	  run	  on	  a	  DNA	  mini-­‐gel,	  with	  the	  appropriate	  fragments	  being	  cut	  out	  and	  purified	  using	  a	  QIAquick	  Gel	  Extraction	  Kit	  (QIAGEN).	  The	  eluted	  fragments	  were	  combined	  in	  a	  final	  volume	  of	  13μl	  to	  be	  used	  in	  ligation	  with	  1.5μl	  10x	  T4	  DNA	  ligation	  buffer	  and	  1μl	  T4	  DNA	  ligase	  (Fermentas).	  Ligations	  were	  carried	  out	  at	  room	  temperature	  for	  a	  minimum	  of	  45mins	  or	  overnight	  at	  4°C.	  1μl	  of	  the	  ligation	  reaction	  was	  then	  transformed	  in	  XL1-­‐Blue	  electrocompetent	  E.	  coli	  cells	  (Aligent	  Technologies)	  by	  electroporation	  at	  1.80V.	  Cells	  were	  plated	  out	  on	  LB-­‐ampicillin	  plates	  and	  left	  to	  incubate	  at	  37°C	  overnight.	  Colonies	  were	  selected	  for	  mini-­‐prep	  the	  following	  day	  and	  then	  checked	  by	  digestion,	  followed	  by	  sequencing.	  	  
Site-­‐Directed	  Mutagenesis	  Mutagenesis	  was	  carried	  out	  using	  either	  the	  Site-­‐Directed	  Mutagenesis	  kit	  (#200519)	  or	  Multi	  Site-­‐Directed	  Mutagenesis	  kit	  (#200514)	  from	  Aligent	  Biotechnologies,	  or	  by	  manual	  PCR	  mutagenesis.	  For	  the	  kits,	  mutagenesis	  was	  carried	  out	  as	  stated	  in	  the	  manufacturers	  instructions.	  	  	  
Skip-­‐PCR	  	  Skip-­‐PCR	  was	  used	  to	  remove	  the	  intron	  from	  the	  C-­‐terminal	  fragments	  that	  were	  expressed	  as	  a	  GST	  fusion	  protein	  for	  the	  kinase	  assay.	  Primers	  were	  designed	  to	  amplify	  the	  stretches	  of	  sequence	  adjacent	  to	  the	  sequence	  to	  be	  removed.	  The	  3’	  primer	  of	  the	  upstream	  fragment	  contained	  10bp	  of	  reverse	  sequence	  from	  the	  beginning	  of	  the	  downstream	  fragment;	  whereas	  the	  5’	  primer	  of	  the	  downstream	  fragment	  contained	  10bp	  of	  forward	  sequence	  from	  the	  end	  of	  the	  upstream	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fragment.	  Both	  fragments	  were	  then	  used	  as	  templates	  in	  another	  PCR	  reaction	  with	  the	  5’	  primer	  from	  the	  upstream	  fragment	  and	  the	  3’	  primer	  from	  the	  downstream	  fragment.	  This	  amplifies	  across	  the	  new	  template	  allowing	  generation	  of	  a	  fragment	  with	  the	  desired	  piece	  of	  sequence	  removed.	  	  
E.	  coli	  Heat-­‐shock	  transformation	  Chemically	  competent	  DH5α	  cells	  were	  thawed	  on	  ice	  and	  then	  left	  to	  incubate	  with	  1-­‐2μl	  of	  plasmid	  or	  ligation	  for	  15mins.	  Cells	  were	  then	  heat-­‐shocked	  by	  placing	  in	  a	  42°C	  waterbath	  for	  45sec.	  Cells	  could	  be	  plated	  straight	  out,	  or	  undergo	  a	  recovery	  step	  through	  addition	  of	  300μl	  2TY	  media	  and	  1hour	  incubation	  at	  37°C.	  After	  recovery	  different	  aliquots	  were	  plated	  out	  on	  2TY+Ampicillin	  agar	  in	  order	  to	  get	  single	  colonies	  from	  over-­‐night	  incubation	  at	  37°C.	  	  
E.	  coli	  Electroporation	  transformation	  Electrocompetent	  XL1-­‐Blue	  E.	  coli	  cells	  (Aligent	  Technologies)	  were	  thawed	  on	  ice.	  1μl	  of	  ligation	  or	  mutagenesis,	  or	  0.5μl	  of	  pure	  plasmid	  was	  added	  to	  a	  20μl	  aliquot	  of	  the	  cells.	  The	  cells	  were	  then	  transferred	  to	  an	  electrocuvette	  (Bio-­‐Rad)	  and	  pulsed	  once	  at	  180V.	  The	  cells	  were	  then	  plated	  out	  on	  LB	  plates	  with	  0.1mg/ml	  ampicillin	  and	  incubated	  as	  above.	  	  
Preparation	  of	  plasmid	  DNA	  from	  E.	  coli	  
E.	  coli	  were	  cultured	  in	  5-­‐10mls	  of	  LB-­‐Ampicillin	  media	  over-­‐night	  or	  in	  2TY	  media	  with	  0.1mg/ml	  ampicillin	  for	  4-­‐5hours.	  Cells	  were	  then	  lysed,	  and	  plasmid	  DNA	  purified	  using	  the	  QIAGEN	  plasmid	  mini	  kit	  (#12125).	  Final	  elution	  was	  carried	  out	  in	  50-­‐100μl	  SDW.	  	  
C.	  albicans	  genomic	  DNA	  isolation	  Purification	  of	  genomic	  DNA	  was	  carried	  out	  either	  with	  the	  Yeast	  Genomic	  DNA	  purification	  kit	  (Epicenter),	  or	  using	  the	  following	  protocol:	  1.5ml	  of	  an	  overnight	  culture	  was	  pelleted	  in	  a	  screw	  cap	  tube	  by	  a	  short	  spin	  at	  maximum	  speed,	  and	  then	  re-­‐suspended	  in	  250μl	  extraction	  buffer	  (0.01M	  Tris-­‐HCl	  pH	  8,	  1%	  w/v	  SDS	  0.1M	  NaCl	  and	  1mM	  EDTA).	  Equal	  volume	  of	  acid	  washed	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glass	  beads	  (0.4mm)	  were	  added	  to	  the	  cells.	  Samples	  were	  then	  vortexed	  at	  maximum	  speed	  for	  1min,	  before	  addition	  of	  150μl	  of	  1xTE	  buffer	  and	  300μl	  of	  Phenol:	  Chloroform:	  Isoamyl	  alcohol	  (PCI)	  (25:24:1).	  After	  vortexing	  for	  a	  further	  3mins,	  the	  samples	  were	  centrifuged	  at	  13,000rpm	  for	  5mins.	  The	  aqueous	  layer	  was	  then	  removed	  to	  a	  fresh	  tube,	  and	  an	  equal	  volume	  of	  PCI	  added	  followed	  by	  vortexing	  for	  1min	  to	  mix.	  Samples	  were	  centrifuged	  as	  above,	  with	  the	  aqueous	  layer	  of	  the	  supernatant	  again	  removed	  to	  a	  fresh	  tube.	  To	  this,	  1/10th	  volume	  of	  3M	  sodium	  acetate	  pH	  5.2	  was	  added,	  followed	  by	  2x	  the	  new	  volume	  of	  100%	  ethanol.	  Samples	  were	  placed	  at	  -­‐20°C	  for	  a	  minimum	  of	  1hour	  to	  allow	  the	  DNA	  to	  precipitate.	  The	  genomic	  DNA	  was	  pelleted	  by	  centrifugation	  at	  13,000rpm	  for	  30mins	  at	  4°C,	  and	  then	  washed	  twice	  with	  70%	  ethanol.	  The	  pellet	  was	  then	  dried	  in	  a	  sterile	  hood	  to	  remove	  remaining	  ethanol,	  before	  being	  re-­‐suspended	  in	  50μl	  of	  SDW.	  RNase	  treatment	  was	  carried	  out	  by	  the	  addition	  of	  1μl	  of	  10mg/ml	  RNase	  A,	  and	  the	  samples	  were	  incubated	  at	  37°C	  for	  30mins.	  After	  this,	  DNA	  was	  precipitated	  as	  above,	  and	  re-­‐suspended	  in	  a	  final	  volume	  of	  30μl.	  
	  
PCR	  to	  generate	  a	  transformation	  cassette.	  For	  initial	  C-­‐terminal	  GFP-­‐epitope	  tagging	  of	  proteins,	  transformation	  cassettes	  were	  used.	  For	  this	  the	  primers	  contained	  5’and	  3’	  homology	  to	  the	  region	  for	  targeted	  recombination	  in	  the	  C.	  
albicans	  genome,	  as	  well	  as	  plasmid	  specific	  sequences	  to	  allow	  amplification	  of	  a	  plasmid	  of	  GFP	  plus	  a	  terminator	  region	  and	  a	  selectable	  marker.	  To	  generate	  enough	  DNA	  cassettes	  for	  transformation,	  ten	  50μl	  reactions	  were	  carried	  out.	  Each	  of	  these	  contained:	  25μl	  Biomix-­‐red	  (Bioline),	  1μl	  plasmid	  DNA	  (diluted	  1/20	  from	  mini-­‐prep	  stock),	  2μl	  each	  primer	  from	  a	  5μM	  stock	  and	  20μl	  SDW.	  Reactions	  were	  carried	  out	  as	  follows:	  
Step	   Temperature	   Time	   #	  Cycles	  Initial	  Denaturation	   94°C	   2mins	   1	  Denaturation	   94°C	   30secs	  
35	  
Annealing	   Primer	  Dependent	   30secs	  Extension	   68°C	   1min/Kb	  Final	  Extension	   68°C	   10mins	   1	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  PCR	  reactions	  were	  then	  combined	  and	  the	  DNA	  precipitated	  using	  sodium	  acetate	  and	  ethanol.	  	  
C.	  albicans	  Transformation	  
Electroporation.	  Competent	  cells	  were	  prepared	  by	  taking	  a	  10ml	  overnight	  culture	  in	  YEPD,	  pelleted	  and	  washed	  twice	  with	  equal	  volumes	  of	  SDW.	  Cells	  were	  then	  re-­‐suspended	  in	  4ml	  1x	  Lithium	  Acetate-­‐TE	  (0.1M	  LiAc	  pH	  7.2,	  1xTE	  pH	  8.0)	  and	  incubated	  under	  gentle	  agitation	  at	  30°C	  for	  45mins.	  100μl	  1M	  DTT	  was	  then	  added	  to	  the	  cells	  and	  left	  to	  incubate	  for	  a	  further	  15min.	  Cells	  were	  washed	  twice	  with	  10ml	  cold	  SDW	  and	  once	  with	  2ml	  cold	  1M	  sorbitol.	  Cells	  were	  finally	  re-­‐suspended	  in	  2ml	  of	  1M	  sorbitol	  and	  kept	  at	  4°C	  until	  required	  (for	  up	  to	  2	  days).	  40μl	  of	  the	  competent	  cells	  were	  added	  to	  10μl	  of	  purified	  digested	  plasmid	  DNA,	  gently	  mixed	  and	  added	  to	  the	  cold	  electroporation	  cuvette.	  The	  cells	  were	  pulsed	  once	  at	  1.65V	  and	  then	  plated	  out	  on	  GMM	  agar	  with	  the	  appropriate	  selective	  supplements,	  then	  left	  to	  incubate	  at	  30°C	  for	  2	  days.	  	  
Fast	  Yeast-­‐Transformation.	  Rapid	  heat-­‐shock	  transformation	  of	  C.	  albicans	  was	  carried	  out	  using	  the	  Fast	  Yeast	  Transformation	  kit	  from	  G-­‐biosciences.	  	  	  
Overnight	  Heat-­‐shock	  transformation.	  A	  C.	  albicans	  overnight	  culture	  was	  re-­‐inoculated	  into	  50ml	  fresh	  YEPD	  to	  an	  OD600	  of	  0.2	  (~300μl),	  and	  then	  incubated	  with	  agitation	  at	  30ºC	  until	  the	  culture	  reached	  an	  OD600	  of	  0.6	  (~4hours).	  Cells	  were	  spun	  down	  at	  3000rpm	  for	  5min	  at	  room	  temperature.	  These	  were	  then	  washed	  with	  1ml	  of	  SDW	  and	  transferred	  to	  an	  eppendorf	  tube,	  where	  the	  cells	  were	  pelleted	  by	  a	  short	  spin.	  The	  cells	  were	  washed	  in	  1ml	  of	  transformation	  buffer	  (1xTE	  pH	  8.0,	  0.1M	  Lithium	  Acetate	  pH	  7.2	  (LiAc)),	  pelleted,	  and	  then	  re-­‐suspended	  in	  200μl	  transformation	  buffer.	  100μl	  of	  this	  solution	  was	  placed	  in	  transformation	  and	  control	  tubes;	  to	  which	  the	  following	  was	  added:	  36μl	  1M	  LiAc,	  30μl	  10xTE	  and	  10μl	  denatured	  salmon	  sperm	  DNA.	  To	  the	  transformation	  tube,	  100μl	  purified	  PCR	  product	  or	  30μl	  digested	  plasmid	  was	  added,	  and	  to	  the	  control	  tube	  100μl	  SDW	  was	  added.	  300μl	  60%	  PEG	  4000	  was	  then	  placed	  in	  each	  tube,	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and	  the	  contents	  mixed	  by	  gentle	  pipetting.	  The	  tubes	  were	  then	  placed	  in	  a	  30°C	  water-­‐bath	  overnight.	  	  	   The	  next	  day	  40μl	  DMSO	  was	  added	  to	  each	  tube,	  and	  placed	  at	  42°C	  for	  15min.	  After	  this,	  cells	  were	  pelleted	  by	  a	  30sec	  spin	  at	  up	  to	  8000rpm	  and	  then	  washed	  once	  with	  1ml	  SDW.	  Cells	  were	  then	  re-­‐suspended	  in	  200μl	  SDW,	  and	  2x110μl	  aliquots	  of	  the	  transformation	  were	  plated	  out	  on	  two	  GMM	  plates	  with	  appropriate	  selective	  markers.	  The	  whole	  of	  the	  control	  tube	  was	  plated	  out	  on	  a	  single	  plate.	  The	  plates	  were	  left	  at	  30°C	  for	  2days	  to	  allow	  colonies	  to	  grow.	  	  
C.	  albicans	  colony	  PCR.	  A	  10μl	  pipette	  tip	  was	  used	  to	  take	  a	  small	  amount	  of	  the	  colony,	  which	  was	  then	  re-­‐suspended	  in	  8.5μl	  SDW	  in	  a	  200μl	  PCR	  tube.	  The	  solution	  was	  then	  boiled	  at	  100°C	  for	  6mins,	  and	  then	  placed	  at	  -­‐80°C	  for	  a	  minimum	  of	  1hour.	  The	  solution	  was	  defrosted	  and	  used	  in	  a	  25μl	  PCR	  reaction	  containing	  12.5μl	  Biomix-­‐red	  (Bioline)	  and	  2μl	  of	  each	  checking	  primer	  from	  a	  5μM	  stock.	  Primers	  were	  designed	  to	  amplify	  a	  checking	  region	  of	  less	  than	  1kb.	  PCR	  conditions	  were	  as	  for	  transformation	  cassette	  generation,	  except	  that	  40	  cycles	  were	  carried	  out	  and	  the	  extension	  step	  was	  for	  a	  maximum	  of	  1min.	  	  	  
2.6.	  Molecular	  biology:	  	  RNA	  techniques	  
	  
Buffers	  and	  Solutions:	  
	  
DEPC	  treatment	  of	  solutions:	  Diethylpyrocarbonate	  (DEPC)	  was	  added	  to	  solutions	  to	  a	  final	  concentration	  of	  0.1%	  v/v.	  The	  containing	  bottles	  were	  then	  left	  at	  37°C	  overnight	  to	  allow	  RNase	  inactivation	  to	  occur,	  before	  autoclaving	  to	  break	  down	  the	  toxic	  DEPC.	  	  
10x	  Formaldehyde-­‐Agarose	  (FA)	  running	  buffer:	  200mM	  3-­‐[N-­‐morpholinopropanesulfonic	  acid	  (MOPS),	  50mM	  sodium	  acetate,	  10mM	  EDTA.	  The	  solution	  was	  brought	  to	  pH	  7.0	  with	  NaOH.	  When	  diluting	  to	  1x	  FA	  Buffer,	  0.02%	  v/v	  of	  37%	  formaldehyde	  was	  added.	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5x	  RNA	  loading	  dye:	  80μl	  of	  0.5M	  EDTA	  pH	  8.0,	  2ml	  100%	  glycerol,	  4ml	  10x	  FA	  buffer,	  720μl	  37%	  formaldehyde,	  3.084ml	  formamide	  and	  16μl	  saturated	  aqueous	  bromophenol	  blue	  solution.	  The	  loading	  dye	  was	  made	  up	  to	  10mls	  with	  DEPC	  treated	  SDW.	  	   	  
Isolation	  of	  total	  cell	  RNA	  from	  C.albicans	  A	  25ml	  culture	  was	  grown	  for	  3hours	  from	  a	  starting	  OD600	  of	  0.2.	  Cells	  were	  then	  harvested	  by	  centrifugation	  and	  washed	  once	  with	  DEPC-­‐treated	  SDW	  before	  the	  pellets	  were	  frozen	  at	  -­‐80°C.	  For	  the	  Microarray	  experiments,	  RNA	  was	  extracted	  using	  the	  RNeasy	  kit	  from	  QIAGEN	  following	  the	  manufacturers	  instructions	  for	  yeast	  cells.	  For	  Microarray	  analysis,	  RNA	  was	  eluted	  in	  88μl	  RNase	  free	  water	  before	  DNase	  treatment	  in	  at	  total	  volume	  of	  100μl	  with	  2μl	  of	  RNase	  free	  DNase	  1	  (Roche)	  at	  37°C	  for	  15min.	  Total	  RNA	  was	  then	  re-­‐purified	  using	  the	  RNeasy	  column	  with	  cleanup	  protocol.	  
	  
RNA	  Formaldehyde-­‐Agarose	  (FA)	  gel	  electrophoresis	  1.2g	  agarose	  was	  melted	  in	  80mls	  of	  RNase	  free	  (DEPC-­‐treated)	  water,	  before	  addition	  of	  10mls	  of	  10x	  FA	  running	  buffer.	  The	  gel	  was	  then	  cooled	  to	  65°C	  before	  5μl	  of	  ethidium	  bromide	  and	  1.8ml	  of	  37%	  formaldehyde	  was	  added	  before	  the	  gel	  was	  poured	  in	  a	  fume	  hood.	  The	  set	  gel	  was	  left	  to	  equilibrate	  in	  1x	  FA-­‐formaldehyde	  running	  buffer	  before	  samples	  were	  loaded.	  RNA	  samples	  were	  heated	  to	  65°C	  in	  RNA	  loading	  dye	  and	  then	  cooled	  for	  5mins	  on	  ice	  before	  running	  on	  the	  gel.	  The	  gel	  was	  run	  at	  90V	  for	  60min,	  and	  the	  RNA	  samples	  visualised	  on	  a	  transilluminator.	  
	  
Microarray	  experiments	  
C.	  albicans	  whole	  genome	  arrays	  were	  manufactured	  by	  Microarrays	  Inc.	  These	  contain	  the	  full	  ORF	  sequences	  from	  assembly	  19	  of	  C.	  albicans	  genome.	  Microarray	  hybridization	  experiments	  were	  carried	  out	  with	  the	  help	  of	  Vivien	  Koh	  of	  the	  microarray	  facility	  at	  Biopolis,	  Singapore.	  10μg	  total	  RNA	  from	  samples	  was	  given	  to	  the	  microarray	  facility,	  where	  all	  subsequent	  steps	  were	  carried	  out.	  Spreadsheets	  generated	  from	  these	  experiments	  were	  then	  analysed	  by	  Dr.	  Ian	  Sudbery	  using	  the	  Limma	  method	  to	  generate	  a	  list	  of	  genes	  with	  a	  two-­‐fold	  or	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greater	  significant	  (p=0.05)	  change	  in	  gene	  expression.	  Array	  data	  was	  then	  organized	  and	  analysed	  using	  Microsoft	  Excel.	  
	  
Reverse	  Transcription	  (RT)	  Prior	  to	  qPCR	  reactions	  0.5μg	  of	  total	  RNA	  was	  taken	  for	  cDNA	  synthesis.	  0.5μg	  of	  RNA	  was	  treated	  with	  DNase	  1	  (Roche)	  in	  a	  10μl	  reaction	  volume	  for	  30mins	  at	  37°C.	  	  To	  this	  reaction	  1.25μl	  oligo	  dT	  (100mM	  stock)	  was	  added	  along	  with	  1μl	  (10mM)	  dNTPs	  and	  0.75μl	  DEPC	  SDW.	  The	  reaction	  was	  then	  incubated	  at	  75°C	  for	  10mins	  to	  inactivate	  the	  DNase	  and	  denature	  the	  oligo	  dT	  primer.	  After	  this	  4μl	  Superscript	  III	  5x	  buffer	  was	  added	  along	  with	  1μl	  (100mM)	  DTT,	  1μl	  RNase	  inhibitors	  and	  1μl	  of	  the	  superscript	  III	  enzyme	  (Invitrogen).	  For	  each	  sample	  a	  negative	  RT	  reaction	  was	  carried	  out	  where	  everything	  was	  added	  except	  the	  RNase	  inhibitors	  and	  the	  reverse	  transcriptase	  enzyme.	  Reactions	  were	  placed	  in	  a	  PCR	  machine	  at	  25°C	  for	  5mins,	  followed	  by	  1hour	  at	  50°C	  and	  then	  finally	  15mins	  at	  70°C.	  30μl	  of	  SDW	  was	  then	  added	  to	  the	  reaction	  before	  40μl	  was	  removed	  and	  combined	  with	  an	  equal	  volume	  of	  SDW.	  This	  was	  done	  in	  order	  to	  dilute	  the	  sample	  for	  subsequent	  qPCR	  reactions.	  	  	  
qPCR	  reaction	  Primer	  pair	  stocks	  were	  made	  up	  to	  5μM	  for	  use	  in	  reactions.	  For	  each	  pair	  triplicate	  reactions	  were	  set	  up	  for	  both	  the	  positive	  and	  negative	  RT	  reactions.	  Each	  reaction	  contained	  the	  following:	  1μl	  (5μM)	  primer	  pair	  stock,	  3μl	  SDW,	  5μl	  2xSensiMix	  (Bioline)	  and	  1μl	  of	  the	  cDNA	  or	  negative	  RT	  reaction	  mix.	  A	  triplicate	  with	  no	  template	  control	  was	  also	  carried	  out	  for	  the	  primer	  pair,	  where	  the	  reaction	  contained	  everything	  except	  the	  1μl	  of	  RT	  reaction	  mix,	  which	  was	  substituted	  with	  water.	  This	  controls	  for	  any	  signal	  that	  the	  primers	  may	  generate	  in	  the	  absence	  of	  the	  template.	  Reactions	  were	  carried	  out	  as	  follows:	  
Step	   Temperature	   Time	   No.	  cycles	  
Initial	  Denaturation	   95°C	   10mins	   1	  Denaturation	   95°C	   30secs	   40	  Annealing	  	   58°C	   30secs	  Extension	   72°C	   30secs	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  The	  2xSensiMix	  contains	  the	  DNA	  intercalating	  dye	  SYBR	  green	  that	  preferentially	  binds	  to	  newly	  synthesised	  double	  stranded	  DNA.	  SYBR	  green	  is	  a	  fluorophore,	  absorbing	  blue	  light	  (497nm)	  and	  emitting	  green	  light	  (520nm).	  Thus	  the	  emission	  fluorescence	  can	  indicate	  the	  amount	  of	  double	  stranded	  DNA	  present,	  allowing	  DNA	  amplification	  during	  PCR	  to	  be	  followed	  in	  real-­‐time.	  To	  measure	  the	  amount	  of	  DNA	  present	  after	  each	  PCR	  cycle,	  the	  Rotor-­‐Gene	  6000	  system	  from	  QIAGEN	  was	  used.	  This	  provides	  a	  curved	  plot	  of	  the	  emission	  level	  over	  time,	  from	  which	  the	  ‘takeoff’	  value	  can	  be	  obtained.	  Samples	  with	  a	  higher	  template	  content	  to	  begin	  with	  will	  therefore	  ‘take-­‐off’	  earlier	  than	  those	  with	  less	  template,	  thus	  allowing	  the	  transcript	  levels	  to	  be	  compared	  across	  samples.	  	  
Normalisation	  of	  qPCR	  data	  To	  normalise	  the	  expression	  levels	  for	  the	  genes	  of	  interest,	  a	  ‘housekeeping’	  control	  gene	  was	  used,	  whose	  expression	  should	  be	  independent	  of	  the	  strain	  background	  the	  RNA	  was	  isolated	  from.	  Primers	  to	  the	  ADE2	  gene	  were	  used	  as	  the	  housekeeping	  control	  to	  normalise	  the	  expression	  levels	  of	  the	  experimental	  samples,	  controlling	  for	  possible	  differences	  in	  the	  amount	  of	  mRNA	  in	  the	  starting	  sample.	  This	  was	  done	  by	  subtracting	  the	  takeoff	  value	  for	  value	  for	  the	  gene	  of	  interest	  from	  that	  of	  ADE2,	  giving	  the	  value	  for	  ∆CT(ADE2-­‐GENE).	  This	  value	  was	  then	  used	  as	  the	  exponent	  to	  the	  experimentally	  derived	  amplification	  value,	  providing	  an	  approximate	  value	  for	  the	  amount	  of	  template	  cDNA	  present.	  This	  method	  makes	  the	  assumption	  that	  the	  amplification	  value	  for	  the	  control	  gene	  is	  the	  same	  as	  that	  of	  the	  gene	  to	  be	  experimentally	  tested.	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2.7.	  Molecular	  biology:	  protein	  biochemistry	  techniques	  
	  
Buffers	  and	  Solutions	  	  
	  
RIPA	  Lysis	  Buffer:	  50mM	  Tris-­‐HCl	  pH7.2,	  0.1%	  v/v	  Triton	  X-­‐100,	  0.1%	  w/v	  sodium	  deoxycholate,	  150mM	  NaCl	  
	  
SG	  Lysis	  Buffer:	  50mM	  Tris-­‐HCI	  [pH7.4],	  150mM	  KCI,	  1%	  NP-­‐40	  	  For	  lysis	  buffers,	  PhosSTOP	  Phosphatase	  Inhibitor	  Cocktail	  Tablets	  (Roche	  #04906837001)	  and	  cOmplete	  ULTRA	  Tablets,	  mini,	  EDTA-­‐free	  (Roche	  #05892791001)	  were	  added	  as	  required	  	  
6x	  Protein	  Loading	  Buffer:	  30%	  v/v	  glycerol,	  10%	  w/v	  SDS,	  9.3%	  w/v	  DTT,	  0.012%	  w/v	  bromophenol	  blue,	  50mM	  Tris-­‐HCl	  pH	  6.8	  
	  
2x	  Lamelli	  Loading	  dye:	  125mM	  Tris-­‐HCl	  [pH	  6.8],	  10%v/v	  glycerol,	  5%v/v	  β-­‐mercaptoethanol,	  2%w/v	  SDS0.015%v/v	  bromophenol	  blue	  
	  
SDS-­‐PAGE	  (Running)	  Buffer:	  125mM	  Tris-­‐base,	  460mM	  glycine,	  0.5%	  w/v	  SDS	  
	  
Tris-­‐Glycine	  (Transfer)	  Buffer:	  125mM	  Tris-­‐base,	  460mM	  glycine	  ,	  20%	  v/v	  methanol	  	  
	  
Tris	  Buffered	  Saline	  (TBS)	  Buffer:	  0.242%	  w/v	  Tris-­‐Base	  with	  0.8%w/v	  NaCl.	  The	  pH	  is	  then	  adjusted	  to	  7.6	  using	  HCl.	  	  
	  
Phosphate	  Buffered	  Saline	  (PBS)	  (10x):	  16g.l-­‐1	  NaCl,	  400mg.l-­‐1	  KCl,	  2.88g.l-­‐1	  Na2HPO4,	  480	  mg.l-­‐1	  KH2PO4	  adjusted	  to	  pH	  7.4.	  	  When	  TBS	  or	  PBS	  was	  used	  for	  blocking	  and	  washing	  solutions	  in	  western	  blotting,	  0.1%	  v/v	  Tween-­‐20	  was	  added.	  
	  
	  40	  	  
	  
Enhanced	  chemiluminesence	  (ECL)	  
	  
ECL	  1:	  100mM	  Tris-­‐HCl	  pH	  8.5,	  2.5mM	  Luminol	  (in	  DMSO)	  and	  0.4mM	  p-­‐Coumaric	  acid.	  
ECL	  2:	  100mM	  Tris-­‐HCl	  pH	  8.5,	  0.0006%	  v/v	  hydrogen	  peroxide	  Solutions	  were	  mixed	  in	  a	  1:1	  ratio	  and	  then	  incubated	  on	  the	  protein	  bound	  membrane.	  	  
Extraction	  of	  total	  cell	  protein	  from	  C.	  albicans	  A	  24	  or	  48hour	  culture	  was	  inoculated	  into	  fresh	  media	  to	  an	  OD600	  of	  0.8,	  and	  grown	  under	  yeast	  or	  hyphal	  inducing	  conditions.	  Cells	  were	  harvested	  by	  centrifugation	  at	  3500rpm	  for	  1min,	  and	  then	  washed	  with	  1ml	  of	  chilled	  SDW	  allowing	  transfer	  to	  a	  screw-­‐cap	  microfuge	  tube.	  The	  cells	  were	  then	  pelleted	  by	  short	  spin	  and	  snap	  frozen	  in	  liquid	  nitrogen	  or	  dry	  ice.	  The	  frozen	  pellets	  were	  weighed,	  with	  2-­‐3x	  the	  volume	  of	  RIPA	  including	  appropriate	  inhibitors	  added,	  along	  with	  1x	  volume	  of	  acid	  washed	  glass	  beads	  (0.4mm).	  Homogenization	  was	  carried	  out	  using	  the	  TOMY	  Microsmash	  system	  (TOMY,	  Japan),	  with	  3-­‐4x	  1min	  beating	  at	  5000rpm	  followed	  by	  a	  short	  spin	  at	  4°C.	  Alternatively;	  a	  Fast-­‐prep	  machine	  from	  MP	  Biomedical	  was	  used	  at	  4.5	  m/s	  for	  two	  bursts	  of	  30s;	  or	  3x30s	  bursts	  in	  a	  mini	  bead-­‐beater	  (Bio-­‐spec	  products).	  Glass	  beads	  and	  cell	  debris	  were	  removed	  by	  centrifugation	  at	  15,000rpm	  for	  10mins.	  The	  protein	  lysate	  can	  be	  removed	  for	  downstream	  applications	  or	  added	  to	  loading	  dye	  and	  boiled	  to	  run	  on	  a	  gel	  or	  store	  at	  -­‐80°C.	  	  
Bradford	  Protein	  Assay	  Protein	  standards	  were	  made	  at	  0.2,	  0.40,	  0.6,	  0.8	  and	  0.9mg/ml	  using	  Bovine	  Serum	  Albumin	  (BSA)	  in	  RIPA	  buffer	  with	  the	  necessary	  inhibitors.	  The	  Bio-­‐Rad	  protein	  assay	  reagent	  was	  diluted	  1:5	  to	  give	  a	  working	  solution.	  20μl	  of	  each	  standard	  were	  added	  to	  1ml	  of	  the	  reagent	  and	  the	  absorbance	  measured	  at	  A595,	  using	  20μl	  of	  RIPA	  buffer	  in	  1ml	  of	  reagent	  as	  a	  blank.	  The	  readings	  were	  used	  to	  plot	  a	  standard	  curve,	  from	  which	  the	  equation	  of	  the	  line	  was	  taken	  to	  calculate	  other	  protein	  concentrations	  from	  a	  given	  A595	  reading.	  Samples	  were	  diluted	  1:20	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before	  addition	  of	  reagent	  to	  ensure	  that	  a	  reading	  of	  less	  that	  OD596=1	  was	  present.	  	  
Lambda	  phosphatase	  treatment	  of	  proteins	  Dephosphorylation	  of	  proteins	  was	  carried	  out	  using	  Lambda	  Phosphatase	  (NEB	  #	  P0753).	  400	  units	  of	  lambda	  phosphatase	  were	  used	  for	  40μl	  10mg/ml	  lysate	  in	  a	  total	  reaction	  volume	  of	  50μl,	  including	  1mM	  MnCl2	  and	  1x	  PMP	  buffer.	  The	  reaction	  was	  carried	  out	  at	  30	  °C	  for	  1	  hour	  on	  a	  shaking	  platform	  set	  at	  200rpm.	  
	  
Immunoprecipitation	  (IP)	  of	  Epitope	  tagged	  proteins	  	  
	  
For	  Co-­‐Immunoprecipitation	  and	  Western	  blot	  analysis:	  1-­‐2mg	  of	  total	  cell	  extract	  was	  used	  at	  a	  final	  concentration	  of	  2mg/ml.	  To	  this	  20μg	  of	  agarose	  conjugated	  antibody	  or	  50μl	  of	  magnetic	  bead	  conjugated	  antibody	  (Miltenyi	  Biotec)	  was	  added.	  Incubation	  was	  carried	  out	  at	  4°C	  under	  gentle	  rotation	  for	  between	  30mins	  –	  2hours.	  For	  the	  magnetic	  beads,	  purification	  of	  the	  target	  protein	  was	  carried	  out	  using	  the	  magnetic	  column,	  following	  the	  manufacturers	  instructions.	  For	  agarose	  IPs,	  the	  beads	  were	  gently	  pelleted	  by	  short	  spin	  of	  <5000rpm	  at	  4°C.	  The	  beads	  were	  then	  washed	  3-­‐4	  times	  with	  10x	  bead	  volumes	  of	  RIPA	  lysis	  buffer.	  An	  equal	  volume	  of	  2x	  Lamelli	  loading	  dye	  was	  then	  added	  to	  the	  beads,	  which	  were	  subsequently	  boiled	  for	  5-­‐10mins	  to	  remove	  the	  bound	  protein.	  Samples	  could	  then	  be	  used	  directly	  in	  SDS-­‐PAGE,	  or	  stored	  at	  -­‐80°C	  for	  future	  use.	  	  
	  
Large	  scale	  IP	  to	  purify	  protein	  of	  interest	  for	  phospho-­‐peptide	  mapping.	  	  ~1g	  total	  cell	  lysate	  was	  obtained	  from	  ~40g	  (dry	  weight)	  of	  cells.	  The	  lysate	  was	  centrifuged	  for	  a	  further	  15mins	  at	  15,000rpm	  to	  ensure	  that	  all	  cellular	  debris	  was	  cleared.	  60μl	  Ez-­‐view	  anti-­‐HA	  agarose	  (Sigma-­‐Aldrich)	  was	  added	  to	  the	  lysate	  in	  a	  falcon	  tube	  and	  left	  to	  mix	  by	  rotation	  overnight	  at	  4°C.	  Pelleting	  and	  washing	  of	  the	  beads	  was	  carried	  out	  as	  above,	  ensuring	  at	  each	  step	  that	  as	  much	  of	  the	  agarose	  mix	  was	  obtained	  as	  possible.	  Beads	  were	  boiled	  for	  10mins	  in	  30μl	  2x	  Lamelli	  buffer	  and	  stored	  at	  -­‐80°C.	  Beads	  were	  then	  boiled	  for	  a	  second	  time	  before	  loading	  onto	  a	  SDS-­‐PAGE	  gel.	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Separation	  of	  proteins	  by	  SDS-­‐PAGE	  Proteins	  were	  separated	  according	  to	  their	  molecular	  weight	  using	  the	  Bio-­‐Rad®	  Protean	  II/III	  discontinuous	  electrophoresis	  system.	  Gels	  were	  run	  at	  a	  constant	  current	  of	  25	  milliamps	  (mA)	  and	  electric	  potential	  was	  limited	  to	  125V	  maximally.	  	  
	  
SDS-­‐PAGE	  resolving	  gel	  375mM	  Tris-­‐HCl	  pH	  8.8,	  0.1%	  w/v	  SDS,	  0.1%	  ammonium	  persulfate.	  	  50%	  Acrylamide:Bis-­‐acrylamide	  (37.5:1)	  was	  added	  to	  final	  concentrations	  of	  either	  6,	  7,	  8,	  10	  or	  12%.	  Gel	  solutions	  were	  made	  up	  to	  10ml	  with	  SDW	  and	  then	  0.0006	  %	  v/v	  Tetramethylethylenediamine	  (TEMED)	  was	  added	  to	  start	  the	  polymerization	  process.	  Gels	  were	  cast	  using	  1	  or	  1.5mm	  casting	  plates	  from	  Bio-­‐Rad.	  
	  
SDS-­‐PAGE	  stacking	  gel	  	  50mM	  Tris-­‐HCl	  pH	  6.8,	  0.1%	  w/v	  SDS,	  0.1%	  ammonium	  persulfate,	  5%	  37.5:1	  Acrylamide:Bis-­‐acrylamide.	  Gel	  solutions	  were	  made	  up	  to	  5mls	  with	  SDW	  and	  then	  0.001%	  v/v	  TEMED	  was	  added.	  10	  or	  15	  well	  stacking	  combs	  were	  then	  placed	  in	  the	  gel,	  which	  was	  left	  to	  set.	  	  
Staining	  of	  SDS-­‐PAGE	  Gels	  SDS-­‐PAGE	  gels	  were	  washed	  in	  SDW	  and	  then	  stained	  with	  InstantBlue™	  Coomassie	  stain	  (Expedeon	  Protein	  Solutions)	  under	  agitation	  for	  one	  hour.	  To	  remove	  background	  stain,	  the	  gel	  was	  then	  washed	  in	  SDW.	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Mass	  spectrometry	  for	  identification	  of	  gel	  bands	  Dehydrated	  bands	  from	  SDS-­‐PAGE	  gels	  were	  sent	  to	  the	  Center	  for	  Functional	  Genomics	  (CFG)	  at	  the	  University	  of	  Albany	  for	  identification	  (http://www.albany.edu/genomics/proteomics.html).	  	  
	  
Phospho-­‐peptide	  Mapping	  Phospho-­‐peptide	  mapping	  was	  carried	  out	  by	  the	  Proteomics	  facility	  at	  the	  IMCB	  in	  Singapore.	  IP	  samples	  were	  prepared	  as	  previously	  described	  to	  a	  final	  volume	  of	  50μl	  in	  protein	  loading	  dye.	  Samples	  were	  run	  on	  NuPAGE	  precast	  gels	  from	  Invitrogen	  before	  Colloidal	  Blue	  staining.	  Bands	  for	  Fkh2	  were	  removed	  and	  digested	  with	  trypsin	  before	  running	  on	  the	  LTQ	  Velos	  ETD	  machine	  (Thermo	  scientific).	  	  
Western	  blotting	  (transfer)	  to	  Nitrocellulose	  or	  PVDF	  membranes	  	  SDS-­‐PAGE	  gels	  were	  equilibrated	  in	  transfer	  buffer	  along	  with	  foam	  pads,	  filter	  paper	  and	  Nitrocellulose	  membrane	  all	  cut	  to	  the	  required	  size.	  For	  PVDF,	  the	  membrane	  was	  first	  soaked	  in	  methanol	  for	  1min	  and	  then	  equilibrated	  in	  transfer	  buffer	  for	  a	  minimum	  of	  5min.	  Transfer	  apparatus	  was	  set	  up	  as	  required	  for	  the	  Bio-­‐Rad	  Protean	  II	  system;	  an	  ice	  block	  was	  added	  and	  then	  the	  tank	  topped	  up	  with	  chilled	  transfer	  buffer.	  For	  one	  gel,	  transfer	  was	  carried	  out	  at	  220mA	  for	  2hours;	  and	  for	  2	  gels,	  300mA	  for	  3hours.	  All	  transfers	  were	  carried	  out	  at	  4°C	  to	  avoid	  over-­‐heating.	  
	  
Antibody	  blotting	  of	  membranes	  Membranes	  were	  placed	  in	  50ml	  tubes	  and	  blocked	  in	  10%	  milk	  powder	  in	  either	  TBS-­‐T	  (Nitrocellulose)	  or	  PBS-­‐T	  (PVDF)	  for	  an	  hour	  at	  room	  temperature,	  or	  overnight	  at	  4°C.	  The	  membranes	  were	  blotted	  with	  antibodies	  in	  5%	  BSA	  made	  up	  in	  either	  TBS-­‐T	  or	  PBS-­‐T	  for	  the	  required	  membrane.	  Antibody	  concentrations	  used	  are	  listed	  in	  section	  2.12.	  The	  membranes	  were	  incubated	  with	  primary	  antibodies	  for	  a	  minimum	  of	  1hour	  to	  overnight	  at	  4°C,	  with	  the	  membrane	  being	  washed	  3	  times	  for	  5mins	  in	  the	  correct	  buffer,	  before	  addition	  of	  the	  secondary	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antibody.	  The	  membrane	  was	  blotted	  with	  secondary	  antibodies	  for	  1-­‐3hours,	  again	  at	  4°C;	  and	  then	  washed	  4	  times	  as	  before.	  	  Alternatively;	  blocking	  and	  antibody	  blotting	  was	  carried	  out	  using	  a	  SNAP	  i.d.	  system	  (Millipore).	  A	  1%	  BSA	  in	  TBS-­‐T	  buffer	  was	  used	  for	  blocking	  and	  antibody	  incubation	  following	  the	  manufacturers	  instructions.	  	  For	  ECL	  detection	  of	  the	  antibody	  bound	  proteins,	  the	  above-­‐mentioned	  ECL	  reagents	  were	  mixed	  in	  equal	  quantities	  and	  incubated	  on	  the	  membrane	  for	  3min.	  Membranes	  were	  then	  either	  exposed	  to	  X-­‐ray	  films	  that	  were	  then	  developed,	  or	  developed	  using	  a	  Genegnome	  (Syngene)	  Chemiluminescence	  Imager.	  	  
Antibody	  stripping	  from	  membranes	  PVDF	  membranes	  were	  re-­‐hydrated	  and	  washed	  with	  TBS-­‐T	  twice	  before	  1hour	  incubation	  with	  10mls	  stripping	  buffer	  (2%	  SDS,	  62.5mM	  Tris-­‐HCl	  pH	  6.8,	  0.8%	  β-­‐mercaptoethanol)	  in	  a	  rolling	  falcon	  at	  room	  temperature.	  The	  blot	  was	  then	  washed	  sufficiently	  under	  the	  deionized	  water	  tap,	  before	  5x10min	  washes	  with	  TBS-­‐T.	  The	  membrane	  could	  then	  be	  re-­‐blocked	  for	  subsequent	  antibody	  probing.	  	  
Glutathione	  S-­‐Transferase	  (GST)	  fusion	  protein	  purification	  BL21	  E.	  coli	  strain	  were	  transformed	  with	  the	  pGEX-­‐4T1	  N-­‐terminal	  GST	  expression	  vector	  (GE	  Healthcare)	  containing	  the	  desired	  protein	  fragment.	  The	  E.	  
coli	  were	  cultured	  overnight	  in	  LB	  plus	  0.1mg/ml	  ampicillin	  at	  37°C	  and	  then	  diluted	  1:100	  into	  fresh	  media.	  Cells	  were	  grown	  to	  an	  OD600	  of	  0.7	  before	  the	  addition	  of	  isopropylthio-­‐β-­‐galactoside	  (IPTG)	  to	  a	  final	  concentration	  of	  1mM.	  The	  cultures	  were	  then	  grown	  for	  a	  further	  4hours	  before	  harvesting	  by	  centrifugation	  at	  4,500rpm	  for	  10mins.	  Cell	  pellets	  were	  washed	  twice	  in	  1xPBS	  and	  then	  snap	  frozen	  in	  liquid	  nitrogen.	  Pellets	  were	  re-­‐suspended	  in	  1xPBS	  with	  protease	  inhibitors	  before	  4	  rounds	  of	  sonication	  for	  30secs	  at	  maximum	  strength,	  with	  1	  min	  on	  ice	  in	  between.	  Triton	  X-­‐100	  was	  then	  added	  to	  the	  solution	  to	  a	  final	  concentration	  of	  1%,	  which	  was	  left	  to	  incubate	  for	  30mins	  at	  4°C.	  After	  this,	  the	  lysate	  was	  cleared	  by	  centrifugation	  at	  15,000rpm	  for	  30mins	  at	  4°C.	  During	  this	  time	  1μl	  of	  Glutathione	  sepharose	  4B	  beads(GE	  Healthcare)	  per	  ml	  of	  culture	  was	  taken	  and	  washed	  3	  times	  with	  cold	  PBS.	  The	  glutathione	  sepharose	  beads	  were	  added	  to	  the	  cleared	  lysate	  and	  then	  left	  to	  incubate	  for	  2hours-­‐overnight	  at	  4°C.	  
	  45	  	  




2x	  Kinase	  assay	  buffer:	  100mM	  Tris-­‐HCl	  pH7.5,	  2mM	  EGTA,	  0.02%	  v/v	  Tween-­‐20,	  2mM	  DTT,	  2mM	  β-­‐glycerophosphate,	  20mM	  magnesium	  chloride.	  	  Cells	  expressing	  an	  epitope	  tagged	  version	  of	  the	  required	  kinase	  were	  grown	  in	  the	  conditions	  where	  phosphorylation	  of	  the	  target	  protein	  is	  normally	  observed.	  The	  cells	  were	  then	  harvested	  and	  lysed	  in	  RIPA	  buffer,	  and	  2mg	  of	  total	  lysate	  was	  used	  to	  IP	  the	  kinase	  using	  an	  antibody	  to	  the	  epitope	  tag.	  	  The	  IP	  was	  washed	  3	  times	  with	  RIPA	  buffer	  (containing	  150mM	  NaCl),	  before	  being	  re-­‐suspended	  in	  25μl	  of	  2x	  kinase	  assay	  buffer.	  GST	  kinase	  substrates	  were	  diluted	  to	  1mg/ml	  and	  24μl	  was	  taken	  and	  added	  to	  the	  kinase	  reactions.	  For	  positive	  reactions	  1μl	  of	  ATP	  was	  added	  from	  a	  250mM	  stock	  to	  give	  a	  final	  concentration	  of	  5mM.	  For	  negative	  reactions,	  1μl	  of	  GST	  elution	  buffer	  was	  added.	  Reactions	  were	  incubated	  at	  30°C	  for	  1hour	  with	  gentle	  agitation.	  The	  beads	  were	  then	  pelleted	  and	  the	  reaction	  mixture	  removed	  and	  boiled	  in	  10μl	  6x	  protein	  loading	  dye.	  The	  beads	  were	  then	  re-­‐suspended	  in	  25μl	  RIPA	  buffer	  with	  5μl	  protein	  loading	  dye	  and	  boiled	  separately.	  15μl	  of	  the	  samples	  were	  run	  on	  a	  10%	  SDS-­‐PAGE	  gel	  and	  Western	  Blot	  was	  performed	  with	  an	  anti-­‐phosphoserine	  CDK	  antibody	  (Cell-­‐signalling	  technologies).	  Membranes	  were	  then	  stripped	  and	  re-­‐probed	  with	  an	  anti-­‐GST	  antibody	  (Santa-­‐Cruz).	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2.8.	  C.	  albicans	  strains	  used	  in	  this	  study	  
	  
Strain	   Genotype	   Source	  /	  Reference	  
BWP17	   	  ura3::λimm434/	  ura3::λimm434	  his1::hisG/	  his1::hisG	  arg4::hisG/arg4::hisG	  
	  
Wilson	  et	  al.,	  1999	  
FKH2-­‐YFP	  

















	  BWP17	  cdc28::HIS1/cdc28F80G:ARG4,	  
FKH2/FKH2/FKH2-­‐GFP:URA3	  
	  
Made	  from	  Sinha	  et	  al.	  2007	  
FKH2-­‐GFP	  in	  ccn1∆/∆	  




FKH2-­‐GFP	  in	  hgc1∆/∆	  




FKH2-­‐GFP	  in	  Cln3-­‐sd	  
	  BWP17	  Frt::cln3/ARG4:PMET3-­‐6Myc-­‐CLN3,	  
FKH2/FKH2/FKH2-­‐GFP:URA3	  
	  
Made	  from	  Zeng	  et	  al.	  2012	  
FKH2-­‐GFP	  in	  Clb2-­‐sd	  
	  BWP17	  clb2::HIS1/PMET3-­‐CLB2:URA3::clb2,	  
FKH2/FKH2/FKH2-­‐GFP:ARG4	  
	  
Made	  from	  Bensen	  et	  al.	  2005	  
FKH2-­‐GFP	  in	  Clb4-­‐sd	  
	   BWP17	  clb4::ARG4/PMET3-­‐CLB4:URA3::clb4,	  
FKH2/FKH2/FKH2-­‐GFP:HIS1	  
	  
Made	  from	  Bensen	  et	  al.	  2005	  
fkh2/FKH2	  
	  BWP17	  FKH2/fkh2::ARG4	  
 This	  Study	  




	  BWP17	  URAF::fkh2/fkh2::ARG4	  	   This	  Study	  
fkh2Δ/Δ	  (URA-­‐)	  
	  BWP17	  frt::fkh2/fkh2::ARG4	  	   This	  Study	  
fkh2/FKH2-­‐YFP	  


















	  BWP17	  frt::fkh2/fkh2::ARG4/fkh2(T7A,	  	  





	  BWP17	  frt::fkh2/fkh2::ARG4/fkh2(T7E,	  S503D,	  
S573D,	  T583E,	  S643D,	  S674D)-­‐GFP:URA3	  	   This	  Study	  
fkh2(15A)-­‐GFP	  
	  BWP17	  frt::fkh2/fkh2::ARG4/fkh2(T7A,	  	  
S503A,	  S573A,	  T583A,	  S643A,	  S674A,	  S14A,	  
T100A,	  S150A,	  S226A,	  T448A,	  T514A,	  S627A,	  
T638A,	  S656A)-­‐GFP:URA3	  	   This	  Study	  
fkh2(15E)-­‐GFP	  
	  BWP17	  frt::fkh2/fkh2::ARG4/fkh2(T7E,	  S503D,	  
S573D,	  T583E,	  S643D,	  S674D,	  S14D,	  T100E,	  
S150D,	  S226D,	  T448E,	  T514E,	  S627D,	  T638E,	  
S656D)-­‐GFP:URA3	  	   This	  Study	  
fkh2(11A)-­‐GFP	  
	  BWP17	  frt::fkh2/fkh2::ARG4/fkh2(S503A,	  
S573A,	  T583A,	  S643A,	  S674A,	  S226A,	  T448A,	  
T514A,	  S627A,	  T638A,	  S656A)-­‐GFP:URA3	  	   This	  Study	  
POB3-­‐HA,	  
fkh2∆/FKH2-­‐YFP	  
	  BWP17	  ARG4::fkh2/FKH2-­‐YFP:URA3,	  
POB3/POB3-­‐HA:HIS1	  	   This	  Study	  






	   BWP17	  frt::fkh2/fkh2::ARG4/fkh2(T7A,	  	  
S503A,	  S573A,	  T583A,	  S643A,	  S674A)-­‐




	  BWP17	  frt::fkh2/fkh2::ARG4/fkh2(T7A,	  	  
S503A,	  S573A,	  T583A,	  S643A,	  S674A)-­‐
GFP:URA3,	  POB3/POB3-­‐HA:HIS1	  	   This	  Study	  
GIN4-­‐6xMyc	   BWP17	  GIN4/GIN4-­‐6xMYC	   Li	  et	  al.	  2012	  	  
	  
	  







Source	  	  DH5α	   	  F-­‐,	  supE44,	  ΔlacU169	  (80lacZΔM15),	  hsdR17,	  recA1,	  endA1,	  gyrA96,	  thi-­‐1,	  relA1	   	  Delta	  Biotechnology	  	  	  XL1-­‐Blue	   	  recA1	  endA1	  gyrA96	  	  thi-­‐1	  hsdR17	  supE44	  relA1	  lac	  [F´	  proAB	  lacIqZΔM15	  Tn10	  (Tetr)].	   	  Aligent	  Technologies	  	  	  BL-­‐21	   	  E.	  coli	  B	  F-­‐,	  ompT,	  hsdS	  (rB	  -­‐,	  mB	  -­‐),	  gal,	  dcm	  	   	  G.E.	  Life	  Sciences	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2.10.	  Vectors	  used	  in	  this	  study	   	  
	  




FKH2-­‐6xMyc	  in	  CIP10U	  vector	  with	  XhoI-­‐6xMyc-­‐UTR-­‐PstI	  cut	  out	  and	  replaced	  with	  XhoI-­‐GFP-­‐UTR-­‐
PstI	  fragment	  	   This	  Study	  	  pCIP10U	  PFKH2-­‐
FKH2-­‐GFP	  H3ins	  	   pCIP10U	  PFKH2-­‐FKH2-­‐GFP	  vector	  with	  HindIII	  restriction	  site	  in	  FKH2	  promoter	   This	  Study	  
pCIP10U	  PFKH2-­‐
FKH2(6AMS)-­‐GFP	  
	  pCIP10U	  PFKH2-­‐FKH2-­‐GFP	  H3ins	  vector	  with	  fkh2	  mutations:	  S226A,	  S503A,	  T583A,	  S643A,	  S656A,	  S674A.	  	   This	  Study	  	  pCIP10U	  PFKH2-­‐
FKH2(6ACDK)-­‐GFP	  	  
pCIP10U	  PFKH2-­‐FKH2-­‐GFP	  H3ins	  vector	  with	  fkh2	  mutations:	  T7A,	  	  S503A,	  S573A,	  T583A,	  S643A,	  S674A.	   This	  Study	  	  pCIP10U	  PFKH2-­‐
FKH2(6ECDK)-­‐GFP	  	  
pCIP10U	  PFKH2-­‐FKH2-­‐GFP	  H3ins	  vector	  with	  fkh2	  mutations:	  T7E,	  S503D,	  S573D,	  T583E,	  S643D,	  S674D.	   This	  Study	  
pCIP10U	  PFKH2-­‐
FKH2(15A)-­‐GFP	  
	  pCIP10U	  PFKH2-­‐FKH2(6ACDK)-­‐GFP	  with	  further	  fkh2	  mutations:	  S14A,	  T100A,	  S150A,	  S226A,	  T448A,	  T514A,	  S627A,	  T638A,	  S656A.	  	   This	  Study	  
pCIP10U	  PFKH2-­‐
FKH2(15E)-­‐GFP	  




AscI-­‐PFKH2	  (HindIII	  ins)-­‐FKH2(1-­‐1278bp)-­‐XhoI	  fragment	  PCR	  amplified	  from	  pCIP10U	  PFKH2-­‐FKH2-­‐GFP	  H3ins	  and	  cloned	  into	  pCIP10U	  with	  GFP	  3’	  of	  XhoI	  cloning	  site.	  	  
This	  Study	  
	  pCIP10A	  PFKH2-­‐
FKH2-­‐GFP	  	   NotI-­‐URA3-­‐MluI	  fragment	  from	  pCIP10U	  PFKH2-­‐FKH2-­‐GFP	   This	  Study	  
	  50	  	  
	  pCIP10U	  
PFKH2(BamHI)FK
H2-­‐6xMyc	  	  	  




pCIP10U	  PFKH2(BamHI)FKH2-­‐6xMyc	  with	  FKH2	  promoter	  swapped	  with	  AscI-­‐PGAL1-­‐BamHI	  PCR	  fragment.	  	   This	  Study	  	  pCIP10U	  PGAL1-­‐
FKH2-­‐3xHA	  	  
pCIP10U	  PGAL1FKH2-­‐6xMyc	  with	  XhoI-­‐6xMyc-­‐UTR-­‐
PstI	  fragment	  replaced	  with	  XhoI-­‐3xHA-­‐UTR-­‐PstI	  fragment	   This	  Study	  	  pCIP10U	  PGAL1-­‐
FKH2-­‐GFP	  	   pCIP10U	  PGAL1-­‐FKH2-­‐3xHA	  with	  XhoI-­‐3xHA-­‐UTR-­‐PstI	  replaced	  with	  XhoI-­‐GFP-­‐UTR-­‐PstI	  fragment	   This	  Study	  	  pBKs	  FKH2	  URAF	  Del	  	  
KpnI-­‐FKH2(5’)-­‐XhoI	  and	  NotI-­‐FKH2(3’)-­‐SacII	  fragments	  cloned	  upstream	  and	  downstream	  respectively	  of	  C.	  albicans	  URA	  Flipper	  selectable	  marker	   This	  Study	  	  pBKs	  FKH2	  ARG4	  Del	  	   pBKs	  FKH2	  URAF	  Del	  with	  XhoI-­‐URAF-­‐NotI	  replaced	  with	  XhoI-­‐PARG4ARG4-­‐NotI	   This	  Study	  
	  
FKH2-­‐3xHA	  in	  pCIP10U	  	   kpnI-­‐FKH2(CT)-­‐XhoI	  fragment	  of	  FKH2	  cloned	  into	  pCIP10U	  with	  3xHA	  3’	  of	  XhoI	  cloning	  site	   This	  Study	  	  PGEX-­‐4T1	  	   N-­‐terminal	  fusion	  GST	  expression	  vector	  with	  multiple	  cloning	  site	  3’	  of	  GST	   G.E.	  Life	  Sciences	  	  GST-­‐FKH2(CT)	  	  
	  




BamHI-­‐FKH2(CT)6ACDK-­‐XhoI	  fragment	  generated	  by	  skip	  PCR	  from	  pCIP10U	  PFKH2-­‐fkh2(6ACDK)-­‐GFP	  to	  remove	  intron,	  cloned	  into	  pGEX-­‐4T1	  	   This	  Study	  	  pCIP10A	  POB3-­‐HA	  	   KpnI-­‐POB3(CT)-­‐XhoI	  fragment	  cloned	  upstream	  of	  HA	  epitope	  sequence	  in	  pCIP10A	  vector	   This	  Study	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  pCIP10A	  SRP1-­‐HA	  
	  	  	   KpnI-­‐SRP1(CT)-­‐XhoI	  fragment	  cloned	  upstream	  of	  HA	  epitope	  sequence	  in	  pCIP10A	  vector	   This	  Study	  	  pCIP10H	  POB3-­‐HA	  	  	   POB3-­‐HA	  in	  pCIP10A	  vector	  with	  the	  Candida	  selectable	  ARG4	  marker	  swapped	  to	  HIS1	   This	  Study	  	  pCIP10A	  CDC12-­‐MCherry	  	   kpnI-­‐CDC12(CT)-­‐XhoI	  fragment	  sub-­‐cloned	  into	  pCIP10A	  M-­‐cherry	  vector	   This	  Study	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Description	   Sequence	  (5’	  to	  3’)	  
19.1948	  Rev	  Check	  
	  3’	  Primer	  to	  check	  ORF19.1948	  N-­‐terminal	  GFP	  tag	  	   CCTCCATCTCCCCTGATGACG	  
19.1948-­‐S1	  Fwd	  
	  5’	  Primer	  for	  GFP	  tagging	  ORF19.1948	  at	  the	  N-­‐terminus	  	  
CCGAATAAACTCACTAAACTGACAGTGACAGTTTTAACTATACAAAGTTAAGGTTGCAAAAATTAACCCGAAGCTTCGTACGCTGCAGGTC	  
19.1948-­‐S2-­‐GFP	  Rev	  
	  3’	  Primer	  for	  GFP	  tagging	  ORF19.1948	  at	  the	  N-­‐terminus	  	  
GGTTAGATCTCGGATCTTTTTTATCGGTGTATTCATAGACACCATTGGATAATTTGTCGATGACTCCATAGCACCTGCGCCAGCCCCTGCGC	  
FKH2-­‐Fwd	  Check	  
	  5’	  Primer	  to	  check	  FKH2	  C-­‐terminal	  YFP	  tag	  	   GGGCGACCACAAGGCCAGCTAGG	  
FKH2-­‐URA	  Rev	   3’	  Primer	  for	  YFP	  tagging	  FKH2	  at	  the	  C-­‐terminus	  
	  CCTCTTATGTATGTAATTATTACGTATATACGTGTTATGTATCGTTCCTAAATCTACCTTTGTCAATGGTCTAGAAGGACCACCTTTGATTG	  	  
FKH2-­‐YFP	  Fwd	   5’	  Primer	  for	  YFP	  tagging	  Fkh2	  at	  the	  C-­‐terminus	  
	  CGAGAGAGGGAAAATGATGAAACCAATTCGCCATTTAAAAAAAAACAACGGACTGAAATGATTGATCTGGGTGGTGGTTCTAAAGGTGAAGAATTATT	  	  
FP3-­‐GFP	   	  5’	  Primer	  to	  check	  N-­‐terminal	  GFP	  tagging	  	   CTCCAATTGGCGATGGCCC	  
19.3469-­‐S1	  Fwd	  
	  5’	  Primer	  for	  GFP	  tagging	  Orf19.3469	  at	  the	  N-­‐terminus	  	  
GTTAGTAGTTAGTAGTAGTAGTGAGAGAGAGAGTGTGTGTGTGTGACACAAAATACAACTGACGCGATC	  GAAGCTTCGTACGCTGCAGGTC	  
19.3469-­‐S2-­‐GFP	  Rev	  
	  3’	  Primer	  for	  GFP	  tagging	  Orf19.3469	  at	  the	  N-­‐terminus	  	  
TTCAAGTTCTTCCTTTTTAAGTGGAGTCTTTGCCTTTGGTTGTCCATTATCAATTATCGTTGCTGACAT	  AGCACCTGCGCCAGCCCCTGCGC	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19.3469	  Rev	  Check	  
	  3’	  Primer	  to	  check	  Orf19.3469	  N-­‐terminal	  GFP	  tag	  	   GGACTATCTAGCATATCATCAGC	  
SFL1-­‐YFP	  Fwd	   5’	  Primer	  for	  YFP	  tagging	  SFL1	  at	  the	  C-­‐terminus	  
	  AATGATAATAAAAACGATAACGGTAATAGTGATGACAATGGGAACGATCATAAAAAGAGAAAATTAGAAGGTGGTGGTTCTAAAGGTGAAGAATTATT	  	  
SFL1-­‐URA	  Rev	   3’	  Primer	  for	  YFP	  tagging	  SFL1	  at	  the	  C-­‐terminus	  
	  GGCTTATTGATGAACGAACAATCAATCAGAGTTCGGTGCGCTTATTTACAATTTCTCGTGAGTAGACAGTCTAGAAGGACCACCTTTGATTG	  	  
SFL1	  Fwd	  Check	   	  5’	  Primer	  to	  check	  SFL1	  C-­‐terminal	  YFP	  tag	  	   GTCACCTGAGTAATAAATCGC	  
FKH2-­‐KpnI	  AF	   5’Primer	  to	  amplify	  5’	  region	  upstream	  of	  FKH2	   	  GGTACCCTTTATCAACCAATAACACAC	  	  
FKH2-­‐XhoI	  BR	   	  3’	  Primer	  to	  amplify	  5’	  region	  upstream	  of	  FKH2	  	   CTCGAGGTAAATCCTAGCAAAAAAATG	  
FKH2-­‐NotI	  CF	   5’Primer	  to	  amplify	  3’	  region	  downstream	  of	  FKH2	   GCGGCCGCCACTTCACTCACACAGATATA	  
FKH2-­‐SacII	  DR	   3’	  Primer	  to	  amplify	  3’	  region	  downstream	  of	  FKH2	   CCGCGGGGAATTTGATATATCATTGAA	  
T3	   5’	  Sequencing	  primer	  upstream	  of	  cloning	  sites	  in	  pCIP10	  and	  pBKs	   GCAATTAACCCTCACTAAAGG	  	  
T7	   3’	  Sequencing	  primer	  downstream	  of	  cloning	  sites	  in	  pCIP10	  and	  pBKs	   TAATACGACTCACTATAGGG	  	  
FKH2	  Del	  Chk	  Fwd	   5’	  Primer	  for	  checking	  FKH2	  deletions	   GAACAAAAAATTAAGACAGAAC	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URAF	  Del	  Rev	  Chk	   3’	  primer	  for	  checking	  URA	  flipper	  deletions	   CGGAAATCTATTGTTGTTGTCAC	  	  
ARG4	  Del	  Rev	  Chk	   3’	  primer	  for	  checking	  ARG4	  cassette	  deletions	   GAAATGACTGAATTATGTCGGTC	  	  
FKH2+5’	  AscI	  Fwd	   5’	  Primer	  to	  amplify	  FKH2	  and	  600bp	  of	  its	  promoter	   GGCGCGCCCAGCACTTTTGATCATTCACG	  	  
FKH2	  XhoI	  Rev	   3’	  Primer	  to	  amplify	  FKH2	   CTCGAGCAGATCAATCATTTCAGTCCG	  	  
FKH2	  Fwd	  Seq	  1	   FKH2	  sequencing	  primer,	  binds	  in	  promoter	   CAA	  CCA	  ATA	  ACA	  CAC	  TTT	  TGA	  TTC	  	  
FKH2	  Fwd	  Seq	  2	   FKH2	  sequencing	  primer	   CAG	  GAT	  ATG	  ATA	  AAT	  GCA	  GTG	  G	  	  
FKH2	  Fwd	  Seq	  3	   FKH2	  sequencing	  primer	   GAA	  CAA	  ACG	  AAT	  TTC	  AAG	  TGG	  	  
FKH2	  Fwd	  Seq	  4	   FKH2	  sequencing	  primer	   CTC	  AGC	  AAC	  AAA	  AAC	  AAC	  AAC	  	  
FKH2	  (Pro)	  
HindIII	  insertion	   Mutagenic	  primer	  for	  HindIII	  mutation	  in	  FKH2	  Promoter	   AATTGGAAGCAAAAGTAAGAA	  	  AAGCTT	  	  TCTTTATCCTGTTTTTTTTTA	  
FKH2	  T7A	   Mutagenic	  primer	  to	  mutate	  T7	  to	  A	  in	  Fkh2	   ATG	  TCA	  GCA	  CAA	  TTT	  ATC	  GCA	  CCG	  AAA	  AAG	  CGT	  CCC	  
FKH2	  T7E	   Mutagenic	  primer	  to	  mutate	  T7	  to	  E	  in	  Fkh2	   CGA	  TTA	  TTT	  ACA	  AAT	  GTC	  AGC	  ACA	  ATT	  TAT	  CGA	  GCC	  GAA	  AAA	  GCG	  TCC	  CCA	  CTC	  AC	  
FKH2	  S14A	   Mutagenic	  primer	  to	  mutate	  T14	  to	  A	  in	  Fkh2	   CCGAAAAAGCGTCCCCACGCACCACTAGATAGTAATGAATTACTTC	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FKH2	  S14D	   Mutagenic	  primer	  to	  mutate	  T14	  to	  D	  in	  Fkh2	   CCGAAAAAGCGTCCCCACGATCCACTAGATAGTAATGAATTACTTC	  	  
FKH2	  T100A	   Mutagenic	  primer	  to	  mutate	  T100	  to	  A	  in	  Fkh2	   CCAGTAATACTAATATAACTGCACCTTTAATAGATATTGACTTGGG	  	  
FKH2	  T100E	   Mutagenic	  primer	  to	  mutate	  T100	  to	  E	  in	  Fkh2	   CCAGTAATACTAATATAACTGAACCTTTAATAGATATTGACTTGGG	  	  
FKH2	  S150A	   Mutagenic	  primer	  to	  mutate	  S150	  to	  A	  in	  Fkh2	   GTCAAAAAGTTAATGTTGATGCACCAAATGTTAATGCATTACATTC	  	  
FKH2	  S150D	   Mutagenic	  primer	  to	  mutate	  S150	  to	  D	  in	  Fkh2	   GTCAAAAAGTTAATGTTGATGATCCAAATGTTAATGCATTACATTC	  	  
FKH2	  S226A	   Mutagenic	  primer	  to	  mutate	  S226	  to	  A	  in	  Fkh2	   GATAAAGCTCATCTAACTCATGCCCCTTCATCTATTTCAGCAAACTCG	  	  
FKH2	  S226D	   Mutagenic	  primer	  to	  mutate	  S226	  to	  D	  in	  Fkh2	   GATAAAGCTCATCTAACTCATGACCCTTCATCTATTTCAGCAAACTCG	  	  
FKH2	  T448A	   Mutagenic	  primer	  to	  mutate	  T448	  to	  A	  in	  Fkh2	   CAAATAGCGATCGTCGTTATGCACCATACCAACAACTGCAAAACCC	  	  
FKH2	  T448E	   Mutagenic	  primer	  to	  mutate	  T448	  to	  E	  in	  Fkh2	   CAAATAGCGATCGTCGTTATGAACCATACCAACAACTGCAAAACCC	  	  
FKH2	  S503A	   Mutagenic	  primer	  to	  mutate	  S503	  to	  A	  in	  Fkh2	   CAT	  TAA	  AAC	  CGA	  GCC	  CAG	  TGC	  TCC	  AAA	  AAG	  AAA	  TCCA	  TCT	  
FKH2	  S503D	   Mutagenic	  primer	  to	  mutate	  S503	  to	  D	  in	  Fkh2	   CTG	  AGT	  AAC	  ATT	  AAA	  ACC	  GAG	  CCC	  AGT	  GAT	  CCA	  AAA	  AGA	  AAT	  CCA	  TCT	  A	  
FKH2	  T514A	   Mutagenic	  primer	  to	  mutate	  T514	  to	  A	  in	  Fkh2	   ATCCATCTATTTCTAACAACGCACCAAAGATGGCTAAAGGCACAGG	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FKH2	  T514E	   Mutagenic	  primer	  to	  mutate	  T514	  to	  E	  in	  Fkh2	   ATCCATCTATTTCTAACAACGAACCAAAGATGGCTAAAGGCACAGG	  	  
FKH2	  S572A	   Mutagenic	  primer	  to	  mutate	  S572	  to	  A	  in	  Fkh2	   GAG	  ACA	  TTG	  GAT	  TAA	  ACT	  TTG	  CCG	  CTC	  CCA	  AAA	  AGA	  TAA	  CTG	  CTT	  TAG	  
FKH2	  S572D	   Mutagenic	  primer	  to	  mutate	  S572	  to	  D	  in	  Fkh2	   GGA	  GAC	  ATT	  GGA	  TTA	  AAC	  TTT	  GCC	  GAT	  CCC	  AAA	  AAG	  ATA	  ACT	  GCT	  TTA	  GA	  
FKH2	  T583A	   Mutagenic	  primer	  to	  mutate	  T583	  to	  A	  in	  Fkh2	   AGA	  TAA	  CTG	  CTT	  TAG	  AAG	  CCT	  ATG	  CGC	  CGG	  AAA	  GAG	  
FKH2	  T583E	   Mutagenic	  primer	  to	  mutate	  T583	  to	  E	  in	  Fkh2	   CCA	  AAA	  AGA	  TAA	  CTG	  CTT	  TAG	  AAG	  CCT	  ATG	  AGC	  CGG	  AAA	  GAG	  GTT	  C	  
FKH2	  S627A	  and	  T638A	  	   Mutagenic	  primer	  to	  mutate	  S627	  and	  T638	  to	  A	  in	  Fkh2	  
CCAAATACAAATCAATCGGCACCGGCATTTTGGAATTTTGTTCAATTTAGTGCACCTAATGGACAA	  	  
FKH2	  S627D	  and	  T638E	  	   Mutagenic	  primer	  to	  mutate	  S627	  and	  T638	  to	  D	  and	  E	  respectively	  in	  Fkh2	  
CCAAATACAAATCAATCGGATCCGGCATTTTGGAATTTTGTTCAATTTAGTGAACCTAATGGACAA	  	  
FKH2	  S643A	   Mutagenic	  primer	  to	  mutate	  S643	  to	  A	  in	  Fkh2	   TTT	  GTT	  CAA	  TTT	  AGT	  ACA	  CCT	  AAT	  GGA	  CAA	  GCA	  CCA	  GTA	  AGA	  AAA	  AG	  
FKH2	  S643D	   Mutagenic	  primer	  to	  mutate	  S643	  to	  D	  in	  Fkh2	   TTT	  GTT	  CAA	  TTT	  AGT	  ACA	  CCT	  AAT	  GGA	  CAA	  GAT	  CCA	  GTA	  AGA	  AAA	  AGT	  AGT	  GAA	  GAA	  GTA	  
FKH2	  S656A	   Mutagenic	  primer	  to	  mutate	  S656	  to	  A	  in	  Fkh2	   GTGAAGAAGTAGGGAATAATGCTCCTACATTGAATAGAAAAATAAA	  	  
FKH2	  S656D	   Mutagenic	  primer	  to	  mutate	  S656	  to	  D	  in	  Fkh2	   GTGAAGAAGTAGGGAATAATGATCCTACATTGAATAGAAAAATAAA	  	  
FKH2	  S674A	   Mutagenic	  primer	  to	  mutate	  S674	  to	  A	  in	  Fkh2	   AGC	  GAG	  AGA	  GGG	  AAA	  ATG	  ATG	  AAA	  CCA	  ATG	  CGC	  CAT	  TTA	  AAA	  AAA	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FKH2	  S674D	   Mutagenic	  primer	  to	  mutate	  S674	  to	  D	  in	  Fkh2	   AAA	  AAT	  AAA	  GCG	  AGA	  GAG	  GGA	  AAA	  TGA	  TGA	  AAC	  CAA	  TGA	  TCC	  ATT	  TAA	  AAA	  AAA	  ACA	  ACG	  GAC	  
FKH2(1-­‐426)	  
XhoI	  Rev	   Reverse	  primer	  to	  truncate	  Fkh2	  to	  residue	  426	   CCG	  CTCGAG	  GGTTTGCATGGGATTAGAAGG	  	  
PFKH2	  BamHI	  insertion	   Mutagenic	  primer	  to	  introduce	  BamHI	  restriction	  site	  upstream	  of	  FKH2	  in	  vector	  for	  promoter	  swap	  
TTTTAGTCATTTTTTTGCTA	  GGAT	  CC	  ACGATTATTTACAAATGTCA	  
AscI-­‐PGAL1	  Fwd	   5’	  Primer	  to	  amplify	  the	  GAL1	  promoter	   TTGGCGCGCCGTTTAAGTTTTTATTATTATGAGTTG	  	  
BamHI-­‐PGAL1	  Rev	   3’	  Primer	  to	  amplify	  the	  GAL1	  promoter	   CGCGGATCCGGTATAACTCTTTCTTATAAAAATCG	  
POB3(CT)-­‐
KpnI	  Fwd	   5’	  primer	  to	  amplify	  Pob3(CT)	   CGG	  GGTACC	  GCAGTAGTCAACGAAACTAGTGC	  	  
POB3(CT)-­‐
XhoI	  Rev	   3’	  primer	  to	  amplify	  Pob3(CT)	   CCG	  CTCGAG	  ATTCTTGGCCTTTTTCTTAGG	  	  
SRP1(CT)-­‐
KpnI	  Fwd	   5’	  primer	  to	  amplify	  Srp1(CT)	   CGG	  GGTACC	  GTGACTCTTCTGACAATCGAGAC	  	  
SRP1(CT)-­‐
XhoI	  Rev	   3’	  primer	  to	  amplify	  Srp1(CT)	   CCG	  CTCGAG	  AAACTGAAAGTTCTGTTGTTGTTG	  	  
FKH2(CT)A	  Fwd-­‐BamHI	   5’	  primer	  for	  FKH2(CT)	  skip	  PCR	  upstream	  fragment	   CGC	  GGATCC	  CCTTCTAATCCCATGCAAACC	  	  
FKH2(CT)B	  Rev	   3’	  primer	  for	  FKH2(CT)	  skip	  PCR	  upstream	  fragment	  with	  overlap	   TCTGTTGATACTGTGCCTTTAGCCATCTTTG	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FKH2(CT)C	  Fwd	   5’	  primer	  for	  FKH2(CT)	  skip	  PCR	  downstream	  fragment	   AAAGGCACAGTATCAACAGAAAGCCATTCGAG	  	  
ADE2q-­‐F1	   5’	  Primer	  for	  amplification	  of	  ADE2	  in	  qPCR	  reactions	   AAGGAATCTCCATTGGTGGG	  	  
ADE2q-­‐R1	   3’	  Primer	  for	  amplification	  of	  ADE2	  in	  qPCR	  reactions	   GGCCGCCACCATACCTGGCA	  	  
HGC1q-­‐F1	   5’	  Primer	  for	  amplification	  of	  HGC1	  in	  qPCR	  reactions	   AATATGCAACCACCACCACC	  	  
HGC1q-­‐R1	   3’	  Primer	  for	  the	  amplification	  of	  HGC1	  in	  qPCR	  reactions	   GAAACAGCACGAGAACCAGC	  	  
KIP4q-­‐F1	   5’	  Primer	  for	  amplification	  of	  KIP4	  in	  qPCR	  reactions	   TACTGGGTTTGGAGGTGGAC	  	  
KIP4q-­‐R1	   3’	  Primer	  for	  amplification	  of	  KIP4	  in	  qPCR	  reactions	   TTGCTGTTGTTGATGCTGCT	  	  
SAP4q-­‐F1	   5’	  Primer	  for	  amplification	  of	  SAP4	  in	  qPCR	  reactions	   TGGTGGTATTGACAAGGCCA	  	  
SAP4q-­‐R1	   3’	  Primer	  for	  amplification	  of	  SAP4	  in	  qPCR	  reactions	   ACACCAGCGTTGACATTGAC	  	  
CHT2q-­‐F1	   5’	  Primer	  for	  amplification	  of	  CHT2	  in	  qPCR	  reactions	   ACAAATGTGTTGCCACTCCA	  	  
CHT2qR1	   3’	  Primer	  for	  amplification	  of	  CHT2	  in	  qPCR	  reactions	   GGCTTTTGGTTTTTGAGCAG	  	  
ECE1q-­‐F1	   5’	  Primer	  for	  amplification	  of	  ECE1	  in	  qPCR	  reactions	   TCTCAAGCTGCCATCATCC	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ECE1q-­‐R1	   3’	  Primer	  for	  amplification	  of	  ECE1	  in	  qPCR	  reactions	   TTGTGGAATGTTGCCAAGAA	  	  	  	  













	  	  Mouse,	  anti-­‐GFP,	  monoclonal	  
	  1°	  antibody	  for	  detection/immunoprecipitation	  of	  GFP	  tagged	  proteins	  	  
	  1:3000	   	  Roche	  	  
	  Mouse,	  anti-­‐Myc,	  monoclonal	  
	  1°	  antibody	  for	  detection/immunoprecipitation	  of	  Myc	  tagged	  proteins	   	  1:1000	  
	  Bioserv	  or	  Roche	  	  	  Mouse,	  anti-­‐HA	  monoclonal	  
	  1°	  antibody	  for	  detection/immunoprecipitation	  of	  HA	  tagged	  proteins	   	  1:1000	  
	  Bioserv	  or	  Santa	  Cruz	  	  	  Rabbit,	  anti-­‐GST	  monoclonal	  
	  1°	  antibody	  for	  detection/immunoprecipitation	  of	  GST	  tagged	  proteins	   	  1:5000	  
	  Santa	  Cruz	  Biotech	  	  	  Mouse,	  anti-­‐PSTAIRE	  monoclonal	  
	  1°	  antibody	  for	  the	  detection	  of	  Cyclin	  Dependent	  Kinases	  through	  their	  conserved	  PSTAIRE	  motif	  	  
	  1:10,000	   	  Sigma	  	  
	  Rabbit,	  anti-­‐Cdc11	  polyclonal	  
	  1°	  antibody	  for	  the	  detection	  of	  Cdc11	  (raised	  against	  S.	  cerevisiae	  Cdc11)	  	   	  1:5000	  
	  Santa	  Cruz	  Biotech	  	  Rabbit,	  anti-­‐Phosphoserine	  CDK	  polyclonal	  
	  1°	  antibody	  for	  the	  detection	  of	  phosphorylated	  serines	  in	  CDK	  consensus	  motifs	  	  
	  1:2000	   	  Cell-­‐signaling	  	  Rabbit	  anti-­‐Phosphoserine	  CDK/MAPK	  polyclonal	  	  
	  1°	  antibody	  for	  the	  detection	  of	  phosphorylated	  serines	  in	  CDK/MAPK	  (SP)	  target	  motifs	   	  1:2000	  
	  Cell	  Signaling	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  Goat,	  anti-­‐mouse-­‐HRP	  Polyclonal	  
	  2°	  antibody	  to	  mouse	  primary	  antibodies	  conjugated	  to	  horse	  radish	  peroxidase	  	  
	  1:1000-­‐1:10,000	   	  Dako	  	  Goat,	  anti-­‐Rabbit-­‐HRP	  Polyclonal	  
	  2°	  antibody	  to	  rabbit	  primary	  antibodies	  conjugated	  to	  horse	  radish	  peroxidase	  	  
	  1:5000-­‐1:10,000	   	  Dako	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3	   	  	  	  	  	  	  	  	   	   Cyclin-­‐Dependent	  Kinase	  Targets	  	  Initial	  screen	  of	  potential	  CDK	  targets	  in	  C.	  albicans	  	  
3.1.	  Introduction	  	   Cyclin-­‐dependent	  kinases	  (CDKs)	  are	  heterodimeric	  protein	  kinases	  that	  require	  the	  binding	  of	  a	  cyclin	  subunit	  for	  their	  activity	  and	  specificity.	  Originally	  discovered	  through	  genetic	  studies	  in	  yeast	  (Nurse	  &	  Thuriaux	  1980;	  Hartwell	  et	  al.	  1974)	  and	  biochemical	  studies	  in	  sea	  urchins	  (Evans	  et	  al.	  1983),	  the	  cyclin-­‐CDK	  module	  has	  been	  found	  to	  be	  ubiquitous	  in	  eukaryotes,	  with	  many	  organisms	  possessing	  multiple	  CDKs	  involved	  in	  diverse	  cellular	  processes	  (Enserink	  &	  Kolodner	  2010).	  CDKs	  phosphorylate	  serine	  or	  threonine	  residues	  N-­‐terminal	  to	  a	  proline	  residue	  (S/T-­‐P	  minimal	  motif),	  with	  a	  preference	  for	  the	  basic	  residues	  arginine	  or	  lysine	  C-­‐terminal	  to	  the	  phosphorylation	  site	  (S/T-­‐P-­‐x-­‐K/R	  consensus	  motif)	  (Nigg	  1993).	  However	  recent	  in	  vitro	  evidence	  suggests	  that	  CDKs	  may	  also	  be	  able	  to	  phosphorylate	  other	  sites	  (Egelhofer	  et	  al.	  2008).	  Generally,	  CDK	  target	  proteins	  contain	  clusters	  of	  minimal	  and	  consensus	  motifs	  located	  in	  regions	  of	  intrinsic	  disorder,	  often	  referred	  to	  as	  low	  complexity	  regions.	  From	  this	  point	  on	  CDK	  function	  and	  regulation	  will	  be	  given	  in	  the	  context	  of	  the	  extensively	  studied	  
S.	  cerevisiae	  Cdk1.	  	  
3.1.1.	  Cdk1	  
	   Genetic	  screens	  in	  S.	  cerevisiae	  and	  S.	  pombe	  first	  identified	  the	  mitotic	  CDK;	  an	  essential	  gene	  whose	  temperature-­‐sensitive	  conditional	  mutants	  could	  not	  progress	  through	  mitotic	  cell	  division	  (Hartwell	  et	  al.	  1974;	  Nurse	  &	  Thuriaux	  1980).	  Originally	  known	  as	  Cdc2+	  in	  S.	  pombe	  and	  CDC28	  in	  S.	  cerevisiae,	  the	  mitotic	  CDK	  in	  all	  eukaryotes	  is	  now	  referred	  to	  as	  CDK1.	  Cdk1	  has	  been	  extensively	  studied	  in	  yeast	  and	  higher	  eukaryote	  models.	  It	  is	  the	  primary	  CDK	  controlling	  progress	  through	  all	  stages	  of	  cell	  division	  in	  yeast,	  and	  has	  been	  shown	  sufficient	  to	  drive	  the	  mammalian	  cell	  cycle	  on	  its	  own	  (Santamaría	  et	  al.	  2007).	  Cyclins	  were	  
	  62	  	  
initially	  discovered	  through	  radiolabelling,	  as	  proteins	  that	  showed	  expression	  and	  degradation	  in	  synchrony	  with	  embryonic	  division	  in	  sea	  urchins	  (Evans	  et	  al.	  1983).	  It	  has	  since	  been	  discovered	  that	  generally	  each	  CDK	  associates	  with	  multiple	  cyclin	  subunits	  to	  provide	  functional	  diversity;	  and	  in	  the	  case	  of	  Cdk1,	  the	  cyclin	  association	  and	  subsequent	  degradation	  acts	  to	  control	  passage	  through	  different	  stages	  of	  the	  cell	  cycle.	  S.	  cerevisiae	  has	  nine	  cyclins	  that	  periodically	  interact	  with	  Cdk1.	  Three	  of	  these	  are	  G1	  cyclins	  (Cln1-­‐3),	  which	  control	  progression	  through	  G1	  and	  entry	  into	  S-­‐phase	  of	  the	  cell	  cycle.	  Cln3	  regulates	  the	  SBF	  (Swi4	  cell-­‐cycle	  box	  binding	  factor)	  and	  MBF	  (Mlu1	  cell-­‐cycle	  box	  binding	  factor)	  transcription	  factors	  controlling	  the	  transcriptional	  programs	  for	  START	  (entry	  into	  S-­‐phase)	  (Dirick	  et	  al.	  1995).	  Cln1	  and	  Cln2	  are	  expressed	  at	  START,	  being	  required	  for	  spindle	  pole	  body	  duplication	  (Haase	  et	  al.	  2001)	  and	  initiation	  of	  polarised	  bud	  growth	  (Cvrcková	  &	  Nasmyth	  1993).	  Of	  the	  six	  B-­‐type	  cyclins,	  Clb5	  and	  Clb6	  are	  the	  first	  to	  be	  expressed,	  being	  active	  in	  G1	  to	  aid	  the	  initiation	  of	  S-­‐phase	  (Schwob	  et	  al.	  1994),	  after	  which	  Clb6	  is	  degraded	  (Jackson	  et	  al.	  2006).	  Clb5	  then	  goes	  on	  to	  regulate	  DNA	  replication	  during	  S-­‐phase.	  (Donaldson	  et	  al.	  1998).	  Clb3	  and	  Clb4	  are	  expressed	  in	  S-­‐phase	  to	  further	  coordinate	  DNA	  replication,	  and	  to	  assemble	  the	  spindle	  for	  the	  subsequent	  mitosis	  (Richardson	  et	  al.	  1992).	  Clb1	  and	  Clb2	  are	  the	  last	  to	  be	  expressed,	  being	  induced	  during	  the	  G2/M	  transition	  to	  control	  the	  polarised	  to	  isotropic	  growth	  switch	  and	  events	  up	  until	  the	  end	  of	  mitosis	  where	  they	  are	  then	  degraded	  (Lew	  &	  Reed	  1993).	  In	  addition	  to	  activation	  through	  cyclin	  binding,	  CDKs	  are	  also	  regulated	  by	  cyclin-­‐dependent	  kinase	  inhibitors	  (CKIs),	  and	  by	  cyclin-­‐dependent	  kinase	  activating	  kinases	  (CAKs).	  S.	  cerevisiae	  has	  two	  CKIs,	  Far1	  and	  Sic1.	  Far1	  is	  generally	  involved	  in	  Cdk1	  inhibition	  mediated	  by	  pheromone	  signalling	  as	  part	  of	  the	  mating	  response	  (Chang	  &	  Herskowitz	  1990);	  whereas	  Sic1	  is	  expressed	  in	  late	  M/G1	  phases	  (Knapp	  et	  al.	  1996)	  and	  prevents	  S-­‐phase	  entry	  through	  inhibition	  of	  Cdk1-­‐Clb	  complexes	  (Schwob	  et	  al.	  1994).	  This	  inhibition	  is	  relieved	  when	  Cdk1-­‐Cln	  complexes	  increase	  above	  a	  threshold	  level,	  phosphorylating	  Sic1	  for	  Skp-­‐Cullin-­‐Fbox	  (SCF)-­‐mediated	  degradation	  (Schneider	  et	  al.	  1996).	  The	  CAK,	  Cak1,	  activates	  Cdk1	  through	  phosphorylation	  of	  T169	  on	  the	  T-­‐loop,	  causing	  readjustment	  to	  increase	  cyclin	  binding	  affinity	  (Kaldis	  et	  al.	  1996).	  Cdk1	  also	  undergoes	  inhibitory	  phosphorylation	  at	  Y19	  through	  the	  action	  of	  the	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morphogenesis	  checkpoint	  kinase	  Swe1,	  preventing	  mitosis	  occurring	  before	  the	  cell	  is	  ready	  (Booher	  et	  al.	  1993).	  This	  phosphorylation	  is	  reversed	  by	  the	  phosphatase	  Mih1	  (Russell	  et	  al.	  1989).	  Acetylation	  has	  also	  been	  shown	  to	  be	  required	  for	  correct	  Cdk1	  function	  (Choudhary	  et	  al.	  2009).	  
	  
3.1.2.	  The	  role	  of	  Cdk1	  in	  morphogenesis	  
	   As	  mentioned	  previously,	  Cdk1	  controls	  timely	  progression	  through	  the	  mitotic	  cell	  cycle,	  linking	  morphogenesis	  to	  the	  onset	  of	  DNA	  replication,	  and	  then	  nuclear	  division	  with	  cytokinesis	  and	  cell	  separation.	  Regulation	  of	  Cdk1	  activity	  ensures	  that	  each	  of	  these	  processes	  occurs	  at	  specific	  cell	  cycle	  stages,	  and	  that	  the	  cycle	  proceeds	  uni-­‐directionally.	  	   Cdk1-­‐Cln	  complexes	  bring	  about	  the	  initiation	  of	  polarised	  growth	  at	  the	  start	  of	  the	  cell	  cycle.	  Cdk1-­‐Cln2	  phosphorylates	  the	  CDK	  inhibitor	  Far1	  causing	  it	  to	  be	  degraded	  (Henchoz	  et	  al.	  1997),	  and	  thus	  the	  release	  of	  Cdc24,	  which	  Far1	  had	  been	  sequestering	  in	  the	  nucleus	  (Shimada	  et	  al.	  2000).	  Cdc24,	  the	  GEF	  of	  Cdc42,	  then	  localises	  to	  the	  bud	  site	  causing	  activation	  of	  Cdc42	  to	  allow	  polarisation	  of	  the	  actin	  cytoskeleton	  to	  commence	  (Park	  &	  Bi	  2007).	  Cdk1-­‐Cln	  phosphorylation	  of	  the	  Cdc24	  associated	  proteins,	  Boi1	  and	  Boi2,	  has	  been	  shown	  to	  be	  necessary	  for	  their	  correct	  bud	  neck	  localisation	  (McCusker	  et	  al.	  2007).	  	   Cdk1,	  in	  conjunction	  with	  the	  CDK	  Pho85,	  has	  been	  shown	  to	  provide	  inhibitory	  phosphorylation	  of	  the	  Cdc42	  GAP	  Rga2	  during	  G1	  phase,	  preventing	  aberrant	  Cdc42	  activation	  and	  untimely	  bud	  formation	  (Fig.	  3.1.1)	  (Sopko	  et	  al.	  2007).	  A	  similar	  mechanism	  has	  also	  been	  observed	  for	  other	  GAPs,	  Bem2	  and	  Bem3,	  which	  are	  also	  involved	  in	  morphogenesis	  (Fig.	  3.1.1.)	  (Knaus	  et	  al.	  2007).	  	   After	  initiation	  of	  morphogenesis	  Cdk1	  regulates	  cell	  growth	  up	  until	  the	  point	  of	  division.	  In	  order	  for	  cell	  growth	  to	  occur,	  more	  membrane	  lipids	  are	  required	  along	  with	  remodelling	  of	  the	  cell	  wall.	  Cdk1	  directly	  phosphorylates	  the	  triglycerol	  lipase	  Tgl4	  to	  stimulate	  the	  breakdown	  of	  triglycerols	  into	  fatty	  acids	  and	  diacylglycerol	  precursors	  for	  membrane	  lipids	  (Kurat	  et	  al.	  2009).	  Tus1,	  a	  GEF	  for	  the	  GTPase	  Rho1	  involved	  in	  the	  cell	  wall	  integrity	  pathway,	  is	  also	  a	  target	  of	  Cdk1	  for	  activation	  at	  the	  G1/S	  transition	  (Fig.	  3.1.1)	  (Kono	  et	  al.	  2008);	  thus	  linking	  Cdk1	  to	  the	  maintenance	  of	  the	  cell	  wall.	  Cdk1	  also	  retains	  the	  chitin	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synthase	  Chs2	  in	  the	  endoplasmic	  reticulum	  via	  phosphorylation	  that	  is	  reversed	  at	  upon	  mitotic	  cyclin	  destruction	  at	  the	  end	  of	  mitosis	  (Teh	  et	  al.	  2009),	  allowing	  transport	  to	  the	  Golgi,	  and	  on	  to	  the	  bud	  neck	  for	  cell	  separation	  to	  occur.	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  
	  
Fig.	  3.1.1.	  Roles	  of	  Cdk1	  during	  bud	  morphogenesis	  in	  S.	  cerevisiae.	  Modified	  from	  Enserink	  and	  Kolodner	  2010.	  	   Cdk1	  has	  recently	  been	  shown	  to	  regulate	  the	  exocyst	  complex,	  involved	  in	  the	  fusion	  of	  secretory	  vesicles	  with	  the	  plasma	  membrane	  at	  sites	  of	  polarised	  growth.	  This	  occurs	  through	  inhibitory	  phosphorylation	  of	  the	  Exo84	  subunit.	  Cdk1-­‐Clb2	  phosphorylates	  Exo84	  during	  mitosis	  to	  destabilise	  the	  exocyst	  and	  thus	  stop	  cell	  surface	  expansion	  while	  division	  is	  occurring	  (Luo	  et	  al.	  2013).	  	   Cdk1	  is	  required	  for	  the	  polarised	  to	  isotropic	  bud	  growth	  switch;	  yet	  the	  precise	  role	  of	  Cdk1	  in	  this	  process	  remains	  elusive.	  Cdk1-­‐Clb2	  can	  negatively	  regulate	  the	  transcription	  of	  the	  Cln	  cyclins	  required	  for	  polarised	  bud	  growth	  (Amon	  et	  al.	  1993);	  but	  it	  is	  also	  possible	  that	  Cdk1	  can	  regulate	  the	  phospholipid	  flippases	  (Ubersax	  et	  al.	  2003),	  which	  are	  known	  to	  be	  important	  for	  the	  isotropic	  switch	  (Saito	  et	  al.	  2007).	  	   Cdk1	  can	  also	  control	  morphogenesis	  through	  regulation	  of	  septin	  subunits.	  Cdk1-­‐Cln	  has	  been	  shown	  to	  phosphorylate	  the	  septins	  Cdc3	  and	  Shs1.	  
Enserink and Kolodner Cell Division 2010, 5:11
http://www.celldiv.com/content/5/1/11
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these phosphorylations were required for the function of
Boi1 and Boi2.
Hydr lysis of GTP to GDP by Cdc42 is stimulated by
the GAPs Rga1, Rga2, Bem2 and Bem3, and cycling
between t e GDP-bo nd s ate and the GTP-bound state
is important for the function of Cdc42, since Cdc42
mutants that are locked in either the GDP-bound or the
GTP-bound form display similar phenotypes [190]. Inter-
estingly, Rga2 was recently shown to be directly phospho-
rylated by Cdk1 and Pho85 during G1 [16,191], which is
thought to inhibit its activity, thus restricting activation
of Cdc42 and preventing preliminary bud formation dur-
ing G1 phase [191]. Furthermore, Bem2 and Bem3 are
also phosphorylated and thereby inhibited by Cln-Cdk1
[192]. Therefore, during G1 phase, when Cdk1 is inactive,
hypophosphorylated (i.e. active) Rga2, Bem2 and Bem3
keep Cdc42 in an inactive state, thus preventing cell
polarization and bud formation during this phase of the
cell cycle. Once the cell passes Start, Cdk1 r motes bu
formation by stimulating Cdc42 activity in several ways:
(i) by degrading Far1, thus releasing Cdc24 from the
nucleus; (ii) by promoting the activity of Boi1 and Boi2,
which help maintain a polarized state; and (iii) by inhibit-
ing the activity of the Cdc42-GAPs Rga2, Bem2 and
Bem3.
Once cell polarity is established, vesicles are trans-
ported along the actin cables towards the site of bud
growth. Among other things, these vesicles mediate the
transport of factors involved in cell wall synthesis, and
fusion of these vesicles with the pl sma membrane pro-
vides the membrane material that supports surface
growth of th  cell membrane. Continuo s fusion of t e
Figure 2 Cdk1 and control of bud morphogenesis. Landmark proteins select the bud site, which is followed by recruitment and activation of Bud1, 
which in turn recruits and activates the small GTPase Cdc42. Cdk1 reinforces activation of Cdc42 by inhibiting the activity of the GAPs Bem2/3 and 
Rga2, and by phosphorylating the a aptor proteins Bem1 and Boi1/2. Cdk1 may also activate Cdc42 by phosphorylating the GEF Cdc24. GTP-bound 
Cdc42 then recruits Cla4, which mediates polarization of the actin cytoskeleton, which is required for bud growth. In addition, Cdk1 promotes the 
activity of the small GTPase Rho1 by inhibiting Bem2 and by activating the GEF Tus1, which supports bud growth. The septins Shs1 and Cdc3 are also 
phosphorylated by Cdk1, which may affect the mobility of Cdc3, while phosphorylation of Shs1 may affect the activity of Cdk1 by negative feedback 
in a later stage of the cell cycle. See text for details.
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Phosphorylation	  of	  Shs1	  is	  required	  for	  the	  recruitment	  of	  the	  septin	  associated	  kinase	  Gin4	  (Egelhofer	  et	  al.	  2008),	  whereas	  phosphorylation	  of	  Cdc3	  is	  required	  for	  disassembly	  of	  the	  old	  septin	  during	  the	  G1	  phase	  of	  the	  cell	  cycle	  (Tang	  &	  Reed	  2002).	  Cdk1	  dependent	  control	  of	  the	  septins	  has	  been	  shown	  to	  be	  very	  important	  in	  C.	  albicans	  and	  will	  be	  covered	  below.	  	  
3.1.3.	  The	  role	  of	  Cdk1	  in	  C.	  albicans	  morphogenesis	  	  
	  
C.	  albicans	  Cdk1	  has	  conserved	  roles	  in	  regulating	  morphogenesis	  and	  cell	  cycle	  progression	  as	  in	  related	  yeast	  species.	  However	  it	  also	  has	  been	  shown	  to	  be	  a	  key	  regulator	  of	  the	  specialised	  yeast-­‐to-­‐hyphal	  transition	  observed	  in	  C.	  
albicans.	  Inhibition	  of	  an	  analogue	  sensitive	  version	  of	  CaCdk1	  (F85G)	  with	  the	  1NM-­‐PP1	  ATP	  analogue	  causes	  defects	  in	  hyphal	  development.	  Hyphal-­‐like	  germ	  tubes	  are	  formed,	  but	  these	  cannot	  be	  maintained	  –	  leading	  to	  the	  formation	  of	  short,	  kinked	  projections	  that	  cannot	  polarise	  further	  (Fig.	  3.1.2)	  (Bishop	  et	  al.	  2010).	  	  	   	   	  	  	  	  	  	  
	  
Fig.	  3.1.2.	  Inhibition	  of	  Cdk1	  during	  hyphal	  growth	  in	  C.	  albicans.	  Taken	  from	  Bishop	  et	  al.	  2010.	  Cdc28(WT)	  or	  Cdc28as	  cells	  were	  incubated	  with	  30μm	  1NM-­‐PP1	  for	  2hrs.	  	   The	  C.	  albicans	  genome	  encodes	  only	  two	  G1	  cyclins	  (CCN1	  and	  CLN3),	  and	  two	  G2	  cyclins	  (CLB2	  and	  CLB4),	  along	  with	  a	  novel	  hyphal-­‐specific	  cyclin	  HGC1	  (Zheng	  et	  al.	  2004).	  CLN3	  is	  an	  essential	  gene,	  required	  for	  both	  yeast	  and	  hyphal	  morphogenesis	  (Chapa	  et	  al.	  2005).	  Depletion	  of	  CLN3	  using	  a	  regulatable	  promoter	  results	  in	  large	  unbudded	  cells	  that	  eventually	  form	  hyphal-­‐like	  filaments	  as	  a	  terminal	  phenotype.	  Shut-­‐down	  of	  CLN3	  expression	  on	  hyphal	  
normal hyphal growth, and that this phosphorylation is
directly or indirectly dependent on the activity of Cdc28. To
investigate whether the Spitzenko¨rper formed in the absence
of Sec2, we used the Spitzenko¨rper marker FM4-64. When
Cdc28 was inhibited in a cdc28-1as strain, FM4-64 no longer
localized to an apical spot, as it did in a wild-type strain
(Figure 5E). Quantitation of this experiment showed that in
the wild-type strain 30/42 hyphae displayed an apical spot,
whereas only 4/66 hyphae examined formed a spot when
Cdc28 was inhibited. Thus, when phosphorylation of Sec2 to
the Spitzenko¨rper is prevented by inhibition of Cdc28, the
Spitzenko¨rper does not form.
Hyphal growth requires the cyclins Hgc1 and Ccn1. Hgc1
is homologous to S. cerevisiae Cln1/2. It is specifically
Sec2-YFP + 30µm 1NM PP1
120 min
cdc28∆ /cdc28-as1 Sec2-YFP
+ 30µm 1NM PP1 120 min
cdc28∆ /cdc28-as1 Sec2 S584E
+ 30µm 1NM PP1 120 min
Sec2-YFP + FM464 cdc28∆/cdc281as +
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Figure 5 Sec2 phosphorylation and localization is Cdc28 dependent. (A) When Cdc28-1as is inhibited, Sec2-YFP shows the yeast, but not the
hyphal pattern of phosphorylation upon hyphal induction. Stationary phase cells were size fractionated by elutriation and induced to form
hyphae. Samples were collected after 180min. (B–D) Sec2 localization and hyphal formation is inhibited by 1NM-PP1 in cells expressing only
Cdc28-1as. Stationary phase cdc28-1as/cdc28D SEC2-YFP; CDC28/CDC28 SEC2-YFP or cdc28D/cdc28-as1 SEC2 S584E cells were induced to form
hyphae in the presence of 30 mM 1NM-PP1 on the surface of agarose in concavity microscope slides and incubated in parallel at 381C on a
microscope stage heated by a temperature hood. (B) The same representative cdc28-1as/cdc28D SEC2-YFP cell imaged after 60 and 120min as
indicated. (C) 60min after induction, 10 cdc28-1as/cdc28D SEC2-YFP cells were selected, their morphology and pattern of Sec2-YFP localization
recorded at intervals. The duration of the Spitzenko¨rper or crescent pattern localization pattern is graphically represented by black bars or grey
bars, respectively. Cessation of any apical localization is shown by the termination of the grey bars. (D) After 120min, representative fields of
cells of each genotype were recorded. Solid arrows show the presence of a Spitzenko¨rper, an example, highlighted by the black arrowhead, is
enlarged in inset of the left panel. Barbed arrows in the middle panel show cells, which cannot be recorded in a single focal plane because the
hypha has grown into the agarose substratum. In these cells, care was taken to examine them by using an extended focal range to verify the
absence of any apical Sec2-YFP localization. (E) Inhibition of Cdc28 1as by 1NM PP1 prevents Spitzenko¨rper formation. Spitzenko¨rper was
visualized by uptake of FM4-64, 90min after hyphal induction. Scale bars: panel B, 1mm; panel D, E, 5mm; inset 1mm.
Phosphorylation of C. albicans Sec2 by Cdc28
A Bishop et al
The EMBO Journal VOL 29 | NO 17 | 2010 &2010 European Molecular Biology Organization2936
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induction	  produces	  kinked	  hyphae	  with	  swollen	  tips,	  demonstrating	  that	  it	  may	  have	  a	  role	  in	  hyphal	  as	  well	  as	  yeast	  morphogenesis.	  CCN1	  is	  not	  essential	  for	  viability;	  however	  it	  is	  required	  for	  maintaining	  hyphal	  growth	  (Loeb,	  Sepulveda-­‐Becerra,	  et	  al.	  1999),	  appearing	  earlier	  in	  hyphae	  and	  persisting	  for	  longer	  (Bensen	  et	  al.	  2005).	  The	  essential	  G2	  cyclin	  Clb2	  is	  required	  for	  mitotic	  exit,	  and	  along	  with	  the	  non-­‐essential	  Clb4,	  negatively	  regulates	  pseudohyphal	  growth.	  In	  true	  hyphae	  cells	  G2	  cyclin	  accumulation	  is	  delayed,	  with	  premature	  activation	  resulting	  in	  the	  production	  of	  shorter	  and	  wider	  germ	  tubes	  (Bensen	  et	  al.	  2005).	  Clb4	  has	  been	  shown	  to	  be	  the	  S-­‐phase	  cyclin,	  carrying	  functional	  homology	  to	  S.	  cerevisiae	  Clb5/6	  (Ofir	  &	  Kornitzer	  2010).	  The	  hyphal	  specific	  cyclin	  Hgc1	  is	  non-­‐essential,	  but	  is	  required	  for	  true	  hyphal	  formation	  and	  for	  virulence	  in	  murine	  infection	  models	  (Zheng	  et	  al.	  2004).	  Currently	  it	  has	  not	  been	  shown	  if	  HGC1	  undergoes	  cell	  cycle	  specific	  expression,	  which	  would	  be	  a	  likely	  reason	  for	  the	  observation	  that	  hyphal	  formation	  is	  not	  dependent	  on	  the	  cell	  cycle	  stage.	  Regulation	  of	  HGC1	  expression	  occurs	  via	  the	  cAMP-­‐PKA	  pathway	  and	  the	  transcriptional	  repressors	  Nrg1	  and	  Tup1	  (García-­‐Sánchez	  et	  al.	  2005).	  Since	  the	  discovery	  of	  Hgc1,	  there	  has	  been	  much	  interest	  in	  the	  roles	  of	  Cdk1-­‐Hgc1	  and	  other	  cyclins	  in	  hyphal	  morphogenesis.	  A	  number	  of	  studies	  have	  highlighted	  the	  specific	  roles	  of	  Cdk1	  in	  this	  process	  (Fig.	  3.1.3.).	  Cdk1-­‐Hgc1	  has	  been	  shown	  to	  phosphorylate	  Rga2,	  the	  GAP	  for	  Cdc42,	  during	  hyphal	  growth	  (Zheng	  et	  al.	  2007).	  This	  phosphorylation	  excludes	  Rga2	  from	  hyphal	  tips,	  allowing	  a	  higher	  concentration	  of	  active	  Cdc42	  at	  sites	  of	  polarised	  growth,	  promoting	  germ	  tube	  formation	  and	  extension.	  The	  septin	  subunit	  Cdc11	  is	  phosphorylated	  during	  hyphal	  growth;	  first	  by	  Cdk1-­‐Ccn1,	  and	  then	  this	  phosphorylation	  is	  maintained	  by	  Cdk1-­‐Hgc1	  (Sinha	  et	  al.	  2007).	  The	  septin	  ring	  is	  also	  thought	  to	  be	  regulated	  by	  Hgc1	  through	  the	  Sep7	  subunit	  to	  control	  septin	  dynamics	  (González-­‐Novo	  et	  al.	  2008).	  Vesicle	  transport	  in	  hyphae	  is	  regulated	  through	  Hgc1	  dependent	  phosphorylation	  of	  Sec2,	  the	  Guanine	  nucleotide	  exchange	  factor	  (GEF)	  for	  the	  Sec4	  GTPase	  (Bishop	  et	  al.	  2010).	  Phosphorylation	  of	  Efg1	  by	  Cdk1-­‐Hgc1	  during	  hyphal	  growth	  has	  been	  shown	  to	  repress	  Ace2	  target	  genes,	  thus	  preventing	  cell	  separation	  from	  occurring	  (Wang	  et	  al.	  2009).	  Further	  to	  this,	  HGC1	  is	  required	  to	  block	  the	  localisation	  of	  Cdc14	  to	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Fig.	  3.1.3.	  Roles	  of	  Cdk1-­‐Hgc1/Ccn1	  in	  C.	  albicans	  hyphal	  growth.	  Modified	  from	  Wang.	  2009.	  	  
 	  
3.2.	  Results	  
	   Initially,	  bioinformatic	  analysis	  was	  carried	  out	  in	  order	  to	  select	  potential	  CDK	  targets.	  Proteins	  containing	  the	  perfect	  CDK	  consensus	  site	  (S/TPxK/R)	  were	  searched	  for	  using	  the	  pattern-­‐matching	  program	  on	  the	  Candida	  Genome	  Database	  (CGD)	  (http://www.candidagenome.org/cgi-­‐bin/PATMATCH/nph-­‐patmatch).	  From	  this	  a	  list	  was	  produced	  of	  1482	  proteins,	  ranked	  in	  order	  of	  the	  highest	  number	  of	  consensus	  sites	  per	  protein	  (See	  supplementary	  CD).	  This	  gave	  many	  proteins	  that	  are	  known	  Cdk1	  targets	  in	  the	  related	  S.	  cerevisiae,	  demonstrating	  that	  this	  is	  a	  reliable	  method	  for	  identifying	  potential	  targets.	  From	  this	  list,	  four	  proteins	  were	  chosen	  for	  further	  study	  and	  validation.	  Proteins	  were	  chosen	  based	  on	  the	  criteria	  of	  a	  known	  or	  expected	  role	  in	  filamentous	  growth	  and	  a	  high	  number	  of	  consensus	  CDK	  sites.	  The	  proteins	  selected	  were	  two	  transcription	  factors	  known	  to	  have	  a	  role	  in	  C.	  albicans	  morphogenesis;	  Sfl1	  and	  
(WJ Li, Y Wang, unpublished results), but the signifi-
cance remains to be investigated.
Many other conditions that interfere with the cell cycle
can cause cell elongation in C. albicans. Some are
mediated by well-defined checkpoint pathways
[15!,57!!], while others are not [9–11,58–61]. Great chal-
lenges lie ahead in establishing the pathways linking the
events that disturb the cell cycle with the polarity
machinery.
Conclusion
In the past few years, exciting advances have been
achieved in understanding how CDKs control morpho-
genesis in fungi by establishing concrete links between
CDKs and some key components of the polarity machin-
ery. One conserved mechanism has emerged that CDKs
promote polarized growth through inhibitory phosphoryl-
ation of Cdc42 GAPs, although the specific mechanisms
of inhibition vary. In C. albicans, evolution of the hyphal-
specific Cdc28Hgc1 provides a mechanism to ensure the
continuous, cell-cycle-independent hyphal growth. The
identification of a Cdc42 GAP, two septins and the
transcription factor Efg1 as the substrates of Cdc28Hgc1
has revealed molecular events crucial for establishing and
maintaining hyphal development (Figure 2). The phos-
phorylation of Cdc11 by Cdc28Ccn1 immediately after
hyphal induction indicates that certain modifications of
the polarity machinery occur before the expression of
hyphal-specific genes. Past efforts on the identification of
hypha-specific genes have produced few genes important
for hyphal growth. Perhaps it is time to shift our focus to
post-transcriptional and post-translational levels to
unearth mechanisms underlying the yeast-hyphal
decision in fungi. To this end, endeavors in identifying
substrates of CDKs have proved to be productive in
yielding mechanistic insights.
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Fkh2;	  along	  with	  two	  un-­‐annotated	  open	  reading	  frames,	  Orf19.3469	  and	  Orf19.1948,	  which	  contain	  nine	  and	  six	  CDK	  consensus	  sites	  respectively.	  To	  study	  these	  proteins	  further,	  the	  domain	  architecture	  around	  the	  potential	  phosphorylation	  sites	  was	  worked	  out	  using	  the	  SMART	  programme	  at	  EMBL	  (http://smart.embl-­‐heidelberg.de).	  	  To	  study	  the	  proteins	  in	  vivo	  C-­‐terminal	  GFP/YFP	  fusions	  were	  made,	  allowing	  detection	  of	  phosphorylation	  statuses	  through	  band	  retardation	  on	  1D	  SDS-­‐PAGE	  combined	  with	  Western	  blotting	  and	  antibody	  detection.	  The	  use	  of	  a	  fluorophore	  tag	  also	  allows	  visualisation	  of	  the	  proteins	  subcellular	  localisation	  where	  possible.	  	  	  
3.2.1.	  Orf19.3469	  
	  
3.2.1.1.	  Introduction	  	   Orf19.3469	  is	  currently	  uncharacterised	  in	  C.	  albicans;	  however	  it	  shows	  weak	  homology	  to	  S.	  cerevisiae	  Stb1	  (e-­‐value	  1.6	  x	  10-­‐4),	  a	  Swi6	  binding	  protein	  which	  has	  a	  role	  in	  regulating	  MBF	  but	  not	  SBF	  dependent	  transcription	  at	  START	  in	  the	  cell	  cycle	  (Costanzo	  et	  al.	  2003).	  ScStb1	  has	  previously	  been	  shown	  to	  be	  an	  
in	  vitro	  regulatory	  target	  for	  Cdk1-­‐Cln	  phosphorylation	  (Ho	  et	  al.	  1999).	  Microarray	  experiments	  in	  C.	  albicans	  have	  recently	  shown	  that	  the	  ORF19.3469	  mRNA	  transcript	  is	  up-­‐regulated	  during	  biofilm	  development	  (Nobile	  et	  al.	  2012),	  suggesting	  it	  may	  be	  important	  for	  morphogenesis	  and	  pathogenesis.	  The	  transcript	  has	  also	  been	  shown	  to	  be	  up-­‐regulated	  on	  deletion	  of	  the	  adenylate	  cyclase	  CYR1,	  a	  key	  up-­‐stream	  component	  of	  the	  cAMP-­‐PKA	  pathway	  involved	  in	  hyphal	  morphogenesis	  (Harcus	  et	  al.	  2004).	  Orf19.3469	  contains	  nine	  consensus	  CDK	  sites,	  two	  of	  which	  are	  conserved	  with	  ScStb1,	  along	  with	  seventeen	  minimal	  sites,	  many	  of	  which	  are	  clustered	  around	  low	  complexity	  –	  disordered	  regions,	  which	  as	  previously	  mentioned	  is	  indicative	  of	  a	  true	  CDK	  target.	  (Fig.	  3.2.1.)	  	  	  	  	  	  	  


















Fig.	  3.2.1.	  Domain	  structure	  of	  Orf19.3469,	  including	  potential	  CDK	  phosphorylation	  sites.	  Scale	  bar	  
represents	  amino	  acids	  in	  the	  primary	  sequence.	   
	  
	  
3.2.1.2.	  C-­‐terminal	  tagging	  of	  Orf19.3469	  with	  GFP 
	  	  	   A	  PCR	  cassette	  was	  generated	  from	  the	  pFA-­‐GFP-­‐URA3	  plasmid	  using	  a	  5’-­‐3’	  primer	  with	  69bp	  of	  homology	  to	  the	  3’	  region	  of	  ORF19.3469,	  excluding	  the	  stop	  codon,	  along	  with	  the	  plasmid	  specific	  S1	  sequence.	  The	  3’-­‐5’	  primer	  contained	  the	  plasmid	  specific	  S2	  sequence	  followed	  by	  69bp	  of	  reverse	  complemented	  homology	  to	  a	  region	  a	  few	  hundred	  base-­‐pairs	  (bp)	  downstream	  of	  the	  gene	  (Fig.	  3.2.2.	  3.2.3A).	  The	  cassette	  was	  transformed	  using	  the	  overnight	  transformation	  protocol;	  the	  transformant	  colonies	  were	  first	  checked	  by	  PCR	  (Fig.	  3.2.3B)	  and	  then	  Western	  blot	  (Fig.	  3.2.3C).	  This	  method	  was	  used	  to	  tag	  and	  check	  all	  of	  the	  other	  target	  proteins.	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Fig.	  3.2.2.	  Schematic	  of	  C-­‐terminal	  PCR	  cassette	  epitope	  tagging.	  The	  forward	  amplification	  primer	  is	  
identical	  to	  the	  last	  69bp	  of	  the	  gene	  of	  interest	  not	  including	  the	  stop	  codon,	  followed	  by	  the	  5’	  	  (S1)	  
sequence	  for	  amplification	  of	  GFP	  from	  the	  plasmid.	  The	  reverse	  primer	  contains	  69bp	  of	  identity	  to	  a	  
region	  downstream	  of	  the	  gene,	  oriented	  for	  the	  3’-­‐5’	  strand,	  followed	  by	  a	  plasmid	  specific	  sequence	  to	  
allow	  amplification	  from	  the	  selectable	  marker	  back	  towards	  the	  GFP	  tag	  (S2).	  	  Once	  generated	  by	  PCR,	  
the	  cassette	  is	  transformed	  into	  C.	  albicans,	  with	  recombination	  occurring	  between	  the	  identical	  
sequences	  present	  in	  the	  PCR	  cassette	  and	  at	  the	  gene	  of	  interest’s	  locus.	  Correct	  genomic	  integration	  
yields	  a	  gene	  fusion	  product	  where	  the	  gene-­‐GFP	  sequence	  is	  transcribed	  as	  one	  mRNA,	  terminating	  at	  
the	  GAL4	  terminator	  integrated	  from	  the	  cassette.	  This	  mRNA	  will	  then	  be	  translated	  into	  the	  desired	  C-­‐
terminal	  GFP	  fusion	  protein. 	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3.2.1.3.	  Orf19.3469	  phosphorylation	  during	  yeast	  and	  Hyphal	  growth	  














































































Fig.	  3.2.4.	  Orf19.3469	  phosphorylation	  during	  yeast	  and	  hyphal	  growth.	  	  (A)	  Yeast	  and	  hyphal	  
phosphorylation	  time-­‐courses.	  Samples	  were	  harvested	  for	  protein	  extraction	  at	  the	  shown	  time-­‐points	  
and	  50μg	  total	  cell	  lysate	  was	  run	  on	  a	  10%	  SDS-­‐PAGE	  gel.	  Western	  blots	  were	  probed	  with	  an	  αGFP	  
antibody	  to	  detect	  Orf19.3469-­‐GFP	  and	  αPSTAIRE	  to	  detect	  CDK	  levels,	  confirming	  equal	  loading.	  	  (B)	  
Comparison	  of	  yeast	  and	  hyphal	  phosphorylation,	  confirmed	  by	  lambda	  phosphatase	  (λppase)	  
treatment. 
	  
3.2.2.	  Orf19.1948	  	  
3.2.2.1.	  Introduction	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seven	  minimal	  CDK	  sites	  in	  the	  protein,	  mainly	  located	  around	  the	  N-­‐terminus	  (Fig.	  3.2.5.).	  	  	  	  	  	  	  	  	  	  
Fig.	  3.2.5.	  Domain	  structure	  of	  Orf19.1948,	  including	  potential	  CDK	  phosphorylation	  sites.	  Scale	  bar	  
represents	  amino	  acids	  in	  the	  primary	  sequence. 	  	  
3.2.2.2.	  Orf19.1948	  phosphorylation	  during	  yeast	  and	  hyphal	  growth	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Fig.	  3.2.6.	  Phosphorylation	  of	  Orf19.1948	  during	  yeast	  and	  hyphal	  growth.	  (A)	  Yeast	  and	  hyphal	  
phosphorylation	  time-­‐courses.	  Cells	  were	  harvested	  for	  protein	  extraction	  at	  the	  shown	  time-­‐points.	  
50μg	  of	  protein	  from	  each	  time-­‐point	  was	  run	  on	  a	  10%	  SDS-­‐PAGE	  gel.	  Western	  blotting	  was	  carried	  out	  
with	  an	  αGFP	  antibody	  to	  detect	  Orf19.1948-­‐GFP	  and	  αPSTAIRE	  to	  detect	  CDKs	  as	  a	  loading	  control.	  (B)	  
Comparison	  of	  yeast	  and	  hyphal	  phosphorylation	  and	  confirmation	  by	  lambda	  phosphatase	  (λppase)	  
treatment. 
	  
3.2.2.3.	  Localisation	  of	  Orf19.1948	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Fig	  .3.2.7.	  Orf19.1948-­‐GFP	  localisation	  during	  yeast	  and	  hyphal	  growth.	  Images	  were	  taken	  from	  log-­‐






	   Sfl1	  is	  a	  heat-­‐shock	  domain-­‐containing	  transcription	  factor,	  which	  has	  been	  shown	  to	  negatively	  regulate	  hyphal	  growth	  (Bauer	  &	  Wendland	  2007),	  with	  deletion	  of	  SFL1	  resulting	  in	  a	  constitutively	  filamentous	  phenotype	  (Fig.	  3.2.8.).	  It	  acts	  as	  part	  of	  the	  Ssn6-­‐Tup1	  complex	  to	  decrease	  expression	  of	  certain	  hyphal	  specific	  genes	  such	  as	  HWP1,	  and	  is	  believed	  to	  work	  antagonistically	  with	  the	  positive	  hyphal	  regulator	  Flo8	  (Li	  et	  al.	  2007).	  Further	  to	  its	  role	  as	  a	  negative	  regulator,	  CaSfl1	  has	  also	  been	  shown	  to	  up-­‐regulate	  the	  expression	  of	  the	  heat	  shock	  proteins	  Hsp30	  and	  Hsp90	  (Zhang	  et	  al.	  2008).	  Recently	  the	  roles	  of	  Sfl1	  as	  an	  activator	  and	  a	  repressor	  have	  been	  confirmed	  (Znaidi	  et	  al.	  2013).	  Sfl1	  can	  up-­‐regulate	  the	  expression	  of	  genes	  required	  for	  growth	  in	  the	  yeast	  morphology,	  as	  well	  as	  negatively	  regulating	  genes,	  such	  as	  UME6,	  required	  for	  hyphal	  growth.	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Fig.3.2.8.	  sfl1∆/∆	  constitutive	  filamentation	  phenotype.	  Taken	  from,	  with	  permission,	  from	  Li.	  et	  al	  
2007 	   	  	  	   	  	  	  	  
	  
Fig.	  3.2.9.	  Domain	  structure	  of	  C.	  albicans	  Sfl1,	  including	  potential	  CDK	  phosphorylation	  sites.	  Sfl1	  
contains	  an	  N-­‐terminal	  Heat	  Shock	  Factor	  (HSF)	  DNA	  binding	  domain.	  Scale	  bar	  represents	  amino	  acids	  
in	  the	  primary	  sequence. 
 
	  
3.2.3.2.	  Sfl1	  phosphorylation	  during	  yeast	  and	  hyphal	  growth	  
	   Sfl1-­‐YFP	  shows	  a	  similar	  pattern	  of	  1D-­‐PAGE	  mobility	  during	  both	  yeast	  and	  hyphal	  growth.	  After	  around	  120mins	  post	  induction,	  a	  second,	  more	  retarded	  form	  of	  Sfl1-­‐YFP	  appears	  on	  a	  1D	  SDS-­‐PAGE	  Western	  blot	  during	  both	  yeast	  and	  hyphal	  growth	  (Fig.	  3.2.10A.).	  Phosphatase	  (λppase)	  treatment	  of	  a	  120mins	  sample	  from	  both	  yeast	  and	  hyphae	  caused	  this	  more	  retarded	  form	  to	  disappear,	  demonstrating	  that	  it	  is	  indeed	  phosphorylation	  that	  is	  occurring	  (Fig.	  3.2.10B.).	  Sfl1	  appears	  as	  two	  isoforms	  of	  slightly	  different	  molecular	  weights	  on	  a	  1D	  SDS-­‐PAGE	  Western	  blot.	  This	  could	  be	  due	  to	  different	  isoforms	  of	  Sfl1	  being	  present,	  or	  a	  breakdown	  product	  of	  the	  full-­‐length	  Sfl1.	  






















Fig.	  3.2.10.	  Sfl1	  Phosphorylation	  during	  yeast	  and	  hyphal	  growth.	  (A)	  Yeast	  and	  hyphal	  time-­‐course	  
experiments.	  Protein	  extracts	  were	  taken	  from	  cells	  at	  the	  specified	  time-­‐points	  and	  50μg	  was	  run	  on	  a	  
7%	  SDS-­‐PAGE	  gel.	  (B)	  Comparison	  of	  Sfl1	  phosphorylation	  between	  yeast	  and	  hyphal	  growth,	  including	  
phosphatase	  (λppase)	  treatment	  to	  confirm	  phosphorylation.	   
	  
	  
3.2.3.2	  Sfl1	  Localisation	  












































Fig.	  3.2.11.	  Sfl1-­‐YFP	  localisation	  during	  yeast	  and	  hyphal	  growth.	  Images	  were	  taken	  from	  log	  phase	  






































Fig.	  3.2.12.	  fkh2∆/∆	  yeast	  and	  hyphal	  phenotypes.	  Taken,	  with	  permission,	  from	  Bensen.	  et	  al	  2002.	  (A)	  
fkh2∆/∆	  is	  constitutively	  pseudohyphal	  when	  grown	  under	  yeast	  inducing	  conditions.	  (B)	  fkh2∆/∆	  








Fig.	  3.2.13.	  Domain	  structure	  of	  C.	  albicans	  Fkh2	  including	  potential	  CDK	  phosphorylation	  sites.	  Fkh2	  
contains	  an	  N-­‐terminal	  Fork-­‐head	  DNA	  binding	  domain,	  along	  with	  a	  Fork	  Head	  Associated	  (FHA)	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3.2.4.2.	  Fkh2	  phosphorylation	  during	  yeast	  and	  hyphal	  growth	  















Fig.	  3.2.14.	  Fkh2	  phosphorylation	  during	  yeast	  and	  hyphal	  growth.	  (A)	  Yeast	  and	  hyphal	  time-­‐course	  
experiments.	  Protein	  extracts	  were	  taken	  from	  cells	  at	  the	  specified	  time-­‐points	  and	  50μg	  was	  run	  on	  a	  
7%	  SDS-­‐PAGE	  gel.	  (B)	  Confirmation	  of	  phosphorylation	  at	  the	  specified	  time-­‐points	  by	  lambda	  
phosphatase	  (λppase)	  treatment. 
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3.4.2.3.	  Fkh2	  Localisation	  















Fig.	  3.2.15.	  Fkh2-­‐GFP	  localisation	  during	  yeast	  and	  hyphal	  growth.	  Images	  were	  taken	  from	  log	  phase	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3.3.1.	  Orf19.3469	  
	   Orf19.3469	  is	  phosphorylated	  after	  60mins	  during	  yeast	  growth	  (Fig.	  3.2.4.),	  with	  the	  phosphorylation	  being	  maintained	  up	  to	  the	  observed	  three	  hours.	  The	  phosphorylation	  also	  appears	  to	  coincide	  with	  an	  increase	  in	  the	  level	  of	  Orf19.3469.	  These	  results	  suggest	  that	  Orf19.3469	  may	  have	  a	  role	  in	  the	  later	  stages	  of	  yeast	  growth,	  after	  the	  initiation	  of	  the	  cell	  cycle.	  In	  hyphae	  a	  similar	  pattern	  of	  phosphorylation	  was	  observed;	  however	  it	  was	  difficult	  to	  ascertain,	  as	  levels	  of	  Orf19.3469	  were	  much	  lower	  during	  hyphal	  compared	  to	  yeast	  growth	  (Fig.	  3.2.4.).	  This	  may	  mean	  that	  less	  Orf19.3469	  is	  required	  during	  hyphal	  growth.	  In	  S.	  cerevisiae	  the	  un-­‐phosphorylated	  form	  of	  Stb1	  is	  thought	  to	  bind	  Swi6	  during	  the	  G1	  phase	  of	  the	  cell	  cycle	  (Ho	  et	  al.	  1999;	  Costanzo	  et	  al.	  2003),	  possibly	  negatively	  regulating	  MBF	  and	  SBF	  transcription	  through	  the	  Sin3	  Histone	  deacetylase	  complex	  (HDAC)	  (de	  Bruin	  et	  al.	  2008).	  These	  data	  correlate	  with	  the	  observed	  phosphorylation	  of	  Orf19.3469	  during	  yeast	  growth,	  as	  after	  60mins	  into	  yeast	  growth	  it	  would	  be	  expected	  that	  most	  cells	  would	  have	  passed	  START	  in	  the	  cell	  cycle.	  Therefore	  it	  can	  be	  speculated	  that	  Orf19.3469	  is	  indeed	  the	  homologue	  of	  ScStb1,	  and	  that	  the	  observed	  phosphorylation	  is	  required	  to	  relieve	  repression	  of	  transcriptional	  programs	  to	  enter	  the	  cell	  cycle.	  To	  further	  investigate	  this	  in	  C.	  
albicans,	  time-­‐course	  experiments	  could	  be	  repeated	  with	  synchronised	  cells	  to	  determine	  whether	  the	  phosphorylation	  is	  cell	  cycle	  dependent.	  Also,	  interactions	  with	  Swi6	  and	  Sin3	  homologues	  in	  C.	  albicans	  could	  be	  followed	  during	  such	  time-­‐courses,	  and	  phosphorylation	  blocked/phosphomimetic	  mutants	  of	  Orf19.3469	  could	  be	  used	  to	  see	  if	  they	  affect	  such	  interactions	  and	  the	  timing	  of	  START.	  
	  
3.3.2.	  Orf19.1948	  
	   Orf19.1948	  is	  only	  detected	  after	  90mins	  into	  both	  yeast	  and	  hyphal	  growth,	  which	  is	  concurrent	  with	  the	  presence	  of	  a	  more	  retarded	  phospho-­‐isoform	  of	  the	  protein	  on	  1D	  SDS-­‐PAGE	  (Fig.	  3.2.6.).	  This	  suggests	  a	  later	  role	  for	  Orf19.1948	  in	  the	  yeast	  and	  hyphal	  growth	  programs	  or	  cell	  cycles.	  This	  could	  be	  further	  investigated	  by	  synchronising	  the	  cells	  before	  carrying	  out	  time-­‐course	  experiments,	  in	  order	  to	  see	  if	  there	  are	  fluctuations	  in	  Orf19.1948	  expression	  and	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phosphorylation	  in	  conjunction	  with	  cell	  cycle	  progression.	  Orf19.1948	  shows	  much	  lower	  expression	  levels	  during	  hyphal	  growth	  (Fig.	  3.2.6.),	  suggesting	  a	  likely	  yeast	  growth-­‐specific	  role.	  	  
3.3.3.	  Sfl1	  	   Sfl1	  is	  appears	  as	  two	  isoforms	  when	  run	  on	  a	  1D	  SDS-­‐PAGE	  (Fig.	  3.2.10.).	  Assuming	  that	  there	  are	  not	  due	  to	  breakdown	  occurring,	  this	  suggests	  the	  presence	  of	  different	  forms	  of	  Sfl1	  that	  may	  differ	  in	  function.	  SFL1	  does	  not	  contain	  any	  introns,	  and	  therefore	  the	  different	  isoforms	  cannot	  be	  due	  to	  alternative	  splicing	  occurring.	  Sfl1	  is	  not	  expressed	  in	  stationary	  phase	  cells	  (Fig.	  3.2.10A.),	  suggesting	  a	  role	  only	  during	  the	  resumption	  of	  growth,	  from	  when	  the	  level	  of	  Sfl1	  remains	  constant.	  Phosphorylation	  of	  Sfl1	  occurs	  during	  the	  later	  stages	  of	  yeast	  and	  hyphal	  growth	  (Fig.	  3.2.10.),	  suggesting	  there	  may	  be	  a	  function	  independent	  of	  its	  known	  role	  in	  the	  repression	  of	  hyphal	  growth.	  This	  function	  could	  be	  investigated	  by	  using	  mass	  spectrometry	  to	  determine	  the	  sites	  in	  Sfl1	  that	  are	  phosphorylated	  at	  120mins	  into	  yeast	  and	  hyphal	  growth.	  These	  sites	  could	  then	  be	  mutated	  to	  non-­‐phosphorylatable	  alanine	  or	  phosphomimetic	  glutamic/aspartic	  acid	  residues,	  and	  the	  phenotypic	  consequences	  observed.	  We	  have	  also	  confirmed	  the	  observations	  of	  Li	  et	  al	  2007,	  showing	  that	  Sfl1	  is	  a	  nuclear	  protein	  (Fig.	  3.2.11.).	  	  
3.3.4.	  Fkh2	  	   Fkh2	  is	  the	  only	  protein	  in	  this	  study	  to	  show	  a	  clear	  difference	  in	  phosphorylation	  between	  yeast	  and	  hyphal	  growth	  (Fig.	  3.2.14).	  During	  yeast	  growth	  Fkh2	  shows	  a	  similar	  phosphorylation	  pattern	  to	  that	  observed	  in	  S.	  
cerevisiae,	  where	  phosphorylation	  occurs	  after	  START	  in	  order	  to	  control	  progression	  through	  the	  G2/M	  phase	  boundary	  (Pic-­‐Taylor	  et	  al.	  2004).	  This	  will	  be	  confirmed	  by	  using	  synchronous	  cells	  obtained	  through	  centrifugal	  elutriation.	  During	  hyphal	  growth	  Fkh2	  shows	  a	  highly	  unexpected	  pattern	  of	  phosphorylation	  that	  is	  considerably	  different	  from	  that	  observed	  during	  yeast	  growth.	  Fkh2	  is	  phosphorylated	  20min	  after	  hyphal	  induction,	  and	  only	  remains	  so	  for	  the	  first	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60min.	  This	  suggests	  a	  function	  that	  is	  independent	  of	  that	  observed	  during	  yeast	  growth	  in	  related	  organisms.	  Due	  to	  the	  timing	  of	  the	  phosphorylation,	  it	  is	  likely	  that	  it	  is	  required	  for	  the	  initiation	  of	  hyphal	  growth,	  or	  in	  preparation	  for	  later	  events	  that	  occur	  during	  hyphal	  growth.	  The	  fact	  that	  Fkh2	  is	  localised	  to	  the	  nucleus	  in	  both	  yeast	  and	  hyphae,	  suggests	  the	  function	  in	  hyphal	  growth	  is	  likely	  to	  depend	  on	  Fkh2’s	  activity	  as	  a	  transcriptional	  regulator.	  To	  investigate	  this	  further,	  the	  phosphorylation	  sites	  on	  Fkh2	  can	  be	  determined	  and	  phosphomimetic	  and	  phosphorylation-­‐blocked	  mutants	  can	  be	  made	  as	  mentioned	  above.	  Such	  mutants	  can	  then	  be	  used	  to	  observe	  the	  phenotypic	  effects	  of	  the	  phosphorylation,	  and	  to	  test	  whether	  they	  affect	  Fkh2-­‐dependent	  transcriptional	  programs.	  	  
3.3.5.	  Conclusions	  	   Due	  to	  the	  clear	  differences	  in	  phosphorylation	  of	  Fkh2	  between	  yeast	  and	  hyphal	  growth,	  further	  work	  will	  be	  carried	  out	  to	  elucidate	  the	  function	  of	  the	  early	  phosphorylation	  of	  Fkh2.	  We	  will	  attempt	  to	  determine	  whether,	  as	  expected,	  Cdk1	  is	  responsible	  for	  the	  observed	  phosphorylation,	  and	  the	  physiological	  consequences	  that	  this	  phosphorylation	  has.	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4	  	   	   	   	  	   	   	  	  	  	  Fkh2	  Phosho-­‐regulation	  	  
4.1	  Introduction	  
	  
4.1.1.	  Fork-­‐head	  transcription	  factors	  
	   Fork-­‐head	  (Fkh)	  transcription	  factors	  are	  a	  family	  of	  proteins	  containing	  the	  Fork-­‐head	  box,	  winged	  helix,	  DNA-­‐binding	  domain.	  Fork-­‐head	  transcription	  factors	  were	  initially	  discovered	  through	  forward	  genetic	  studies	  in	  Drosophila	  
melanogaster	  (Weigel	  et	  al.	  1989).	  Mutants	  were	  isolated	  in	  which	  two-­‐spiked	  head	  structures	  were	  formed	  in	  the	  embryo,	  and	  were	  found	  to	  be	  defective	  in	  anterior	  and	  posterior	  gut	  formation.	  	  The	  Fork-­‐head	  (Fkh)	  gene	  responsible	  for	  this	  phenotype	  was	  then	  cloned	  through	  chromosome	  walking.	  Further	  investigation	  of	  the	  Fkh	  protein	  revealed	  nuclear	  localisation,	  suggesting	  a	  role	  in	  transcription	  of	  other	  genes.	  However	  the	  Fkh	  protein	  lacked	  discernable	  domains	  that,	  at	  the	  time,	  were	  expected	  in	  transcription	  factors.	  Later	  it	  was	  discovered	  that	  a	  110	  amino	  acid	  domain	  present	  in	  the	  Fkh	  protein	  was	  conserved	  with	  mammalian	  HNF-­‐3	  transcription	  factors,	  thus	  defining	  a	  novel	  transcription	  factor	  family	  (Weigel	  &	  Jäckle	  1990).	  Structural	  studies	  of	  DNA	  bound	  HNF-­‐3	  showed	  that	  the	  fork	  head	  domain	  consists	  of	  three	  alpha	  helices	  in	  a	  helix-­‐turn-­‐helix	  motif,	  flanked	  by	  two	  large	  loops	  referred	  to	  as	  wings	  (Clark	  et	  al.	  1993).	  Thus	  the	  domain	  was	  named	  the	  winged	  helix	  DNA	  binding	  domain.	  	  	   Since	  the	  initial	  discovery	  of	  D.	  melanogaster	  Fork-­‐head,	  many	  winged	  helix	  DNA-­‐binding	  transcription	  factors	  have	  been	  discovered	  in	  organisms	  from	  yeast	  to	  humans.	  In	  multicellular	  organisms	  the	  abundance	  of	  Fork-­‐head	  transcription	  factors	  and	  a	  high	  variation	  in	  function	  has	  lead	  to	  new	  nomenclature	  rules	  being	  agreed	  upon.	  Such	  transcription	  factors	  in	  higher	  organisms	  are	  now	  referred	  to	  as	  Fork-­‐head	  box	  (FOX)	  transcription	  factors,	  and	  are	  assigned	  a	  letter	  based	  on	  their	  class,	  and	  then	  a	  number	  within	  the	  particular	  class	  (Kaestner	  et	  al.	  2000).	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4.1.2.	  Fork-­‐head	  transcription	  factors	  in	  morphogenesis	  and	  cell	  cycle	  
progression	  	   The	  initial	  work	  on	  Fork-­‐head	  transcription	  factors	  was	  carried	  out	  in	  multicellular	  eukaryote	  systems;	  however	  the	  roles	  of	  Fork-­‐head	  transcription	  factors	  in	  cell	  cycle	  progression	  and	  morphogenesis	  have	  been	  best	  studied	  in	  yeast	  models.	  In	  S.	  cerevisiae	  there	  are	  four	  Fork-­‐head	  transcription	  factors:	  Fkh1,	  Fkh2,	  Hcm1	  and	  Fhl1.	  Of	  these,	  three	  are	  involved	  in	  cell	  cycle	  progression	  (Fkh1,	  Fkh2	  and	  Hcm1)	  (Murakami	  et	  al.	  2010),	  whereas	  Fhl1	  is	  required	  for	  the	  transcription	  of	  ribosomal	  protein	  genes	  (Martin	  et	  al.	  2004).	  	   HCM1	  is	  expressed	  during	  G1/S	  phase	  and	  is	  required	  for	  the	  expression	  of	  Fkh1/2,	  along	  with	  other	  S-­‐phase-­‐specific	  genes	  necessary	  for	  budding	  and	  chromosome	  segregation	  (Pramila	  et	  al.	  2006).	  	  Fkh1/2	  are	  required	  for	  the	  correct	  timing	  of	  CLB2	  cluster	  gene	  expression	  and	  maintenance	  of	  a	  correct	  yeast	  morphology	  (Zhu	  et	  al.	  2000;	  Pic	  et	  al.	  2000)	  (Fig.	  4.1.1.).	  Further	  elucidation	  of	  this	  regulatory	  mechanism	  revealed	  that	  Fkh1	  and	  Fkh2	  have	  opposing	  roles	  in	  
CLB2	  cluster	  gene	  expression	  (Hollenhorst	  et	  al.	  2000).	  	  Deletion	  of	  FKH1	  brings	  about	  earlier	  expression	  of	  CLB2	  cluster	  genes	  and	  increases	  the	  rate	  of	  progression	  through	  S	  and	  G2	  phases	  of	  the	  cell	  cycle.	  This	  suggests	  a	  negative	  role	  in	  regulating	  CLB2	  cluster	  genes	  during	  G1/S,	  which	  is	  supported	  by	  the	  observation	  that	  Fkh1	  along	  with	  the	  chromatin-­‐remodeling	  enzyme	  Isw1	  can	  repress	  expression	  during	  G2/M	  phases	  of	  the	  cell	  cycle	  (Sherriff	  et	  al.	  2007).	  Deletion	  of	  FKH2	  results	  in	  slower	  progression	  through	  the	  cell	  cycle	  in	  ordinance	  with	  reduced	  CLB2	  cluster	  expression.	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Fig.	  4.1.1.	  Fork-­‐head	  transcription	  factor	  deletion	  phenotypes	  in	  S.	  cerevisiae.	  Taken	  from	  Pic	  et	   al	   2000.	   	  A)	   Wild	   type	  W303	   cells	  B)	   fkh1∆	   cells	  C)	   fkh2∆	   cells	  D)	   fkh1∆fkh2∆	   cells	   showing	  altered	  morphology	  and	  cell	  separation	  defects	  	   Activation	  of	  the	  CLB2	  cluster	  requires	  a	  protein	  complex	  formed	  of	  Mcm1,	  Fkh2	  and	  its	  co-­‐activator	  Ndd1,	  which	  assembles	  in	  the	  upstream	  promoter	  sequences	  of	  CLB2	  cluster	  genes	  (Fig.4.1.2.)	  (Pic	  et	  al.	  2000;	  Koranda	  et	  al.	  2000).	  Fkh1	  can	  bind	  to	  CLB2	  cluster	  promoters	  in	  vitro,	  but	  not	  in	  vivo	  as	  it	  cannot	  interact	  with	  Mcm1	  to	  activate	  transcription	  (Hollenhorst	  et	  al.	  2001).	  Mcm1	  present	  in	  up-­‐stream	  promoters	  recruits	  Fkh2	  through	  DNA	  bending	  (Lim	  et	  al.	  2003),	  with	  Fkh2	  binding	  through	  a	  region	  N-­‐terminal	  to	  its	  DNA	  binding	  domain	  (Boros	  et	  al.	  2003).	  Fkh2	  competes	  with	  the	  Yox1	  repressor	  for	  binding	  to	  a	  hydrophobic	  pocket	  on	  Mcm1	  (Darieva	  et	  al.	  2010).	  Fkh2	  is	  phosphorylated	  by	  Cdk1-­‐Clb5	  during	  S-­‐phase	  to	  relieve	  repression	  at	  CLB2	  cluster	  promoters	  (Pic-­‐Taylor	  et	  al.	  2004),	  likely	  mediated	  by	  Fkh2	  and	  Isw2	  during	  the	  G1	  phase	  of	  the	  cell	  cycle	  (Sherriff	  et	  al.	  2007).	  Ndd1	  is	  thought	  to	  undergo	  inhibitory	  phosphorylation	  by	  protein	  kinase	  C	  early	  during	  G1/S	  (Darieva	  et	  al.	  2012),	  but	  is	  later	  phosphorylated	  at	  threonine	  319	  by	  Cdk1-­‐Clb2	  during	  the	  G2	  cell	  cycle	  phase,	  triggering	  Ndd1	  to	  bind	  the	  FHA	  domain	  of	  Fkh2	  (Reynolds	  et	  al.	  2003;	  Darieva	  et	  al.	  2003)	  to	  activate	  transcription.	  Phosphorylation	  of	  Ndd1	  by	  Cdc5	  further	  activates	  CLB2	  cluster	  expression,	  of	  which	  CDC5	  is	  a	  member,	  therefore	  providing	  positive	  feedback	  (Darieva	  et	  al.	  2006).	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the	  G1/S	  transition	  in	  cell	  cycle	  through	  targeting	  the	  Jnk1	  kinase	  required	  for	  the	  transition	  (Wang	  et	  al.	  2008).	  FOXM1	  is	  phosphorylated	  in	  its	  C-­‐terminal	  domain	  by	  Cdk2-­‐CyclinA	  during	  S/G2	  phases,	  relieving	  inhibition	  by	  FOXM1’s	  N-­‐terminal	  domain	  (Laoukili	  et	  al.	  2008).	  This	  also	  allows	  the	  Polo	  kinase	  Plk1	  to	  bind	  and	  further	  phosphorylate	  the	  C-­‐terminal	  domain,	  fully	  activating	  FOXM1’s	  transcriptional	  ability	  (Fu	  et	  al.	  2008).	  Again	  this	  provides	  a	  positive	  feedback	  circuit,	  as	  Plk1	  is	  transcriptionally	  regulated	  by	  FOXM1.	  	  
4.1.3.	  Candida	  albicans	  Fkh2	  
	  
C.	  albicans	  	  FKH2	  was	  discovered	  through	  homology	  searching	  with	  the	  related	  yeast	  S.	  cerevisiae	  (Bensen	  et	  al.	  2002).	  It	  is	  the	  single	  homologue	  of	  FKH1	  and	  FKH2	  from	  S.	  cerevisiae,	  but	  shares	  highest	  homology	  in	  its	  Fork-­‐head	  DNA	  binding	  domain	  with	  ScFkh2	  (Fig.4.1.3.).	  Due	  to	  this	  high	  similarity	  it	  is	  thought	  that	  CaFKH2	  shares	  the	  conserved	  role	  in	  cell	  cycle	  progression	  with	  ScFKH1	  and	  
ScFKH2.	  This	  was	  shown	  by	  the	  fact	  that	  CaFKH2	  will	  rescue	  the	  morphological	  defect	  phenotype	  of	  the	  S.	  cerevisiae	  fkh1∆,	  fkh2∆	  mutant.	  The	  Fkh2	  minimal	  DNA	  binding	  motif	  (AAACAAA)	  has	  also	  been	  shown	  associated	  with	  genes	  transcribed	  during	  S-­‐phase	  of	  the	  cell	  cycle	  (Côte	  et	  al.	  2009).	  A	  subset	  of	  such	  genes	  expressed	  from	  S	  to	  G2	  phases	  may	  have	  an	  involvement	  in	  hyphal	  growth	  (Gordân	  et	  al.	  2012).	  It	  has	  been	  shown	  that	  CaFkh2	  is	  a	  nuclear	  protein,	  and	  that	  deletion	  results	  in	  morphogenetic	  defects,	  such	  as	  constitutive	  pseudohyphal	  growth	  along	  with	  cell	  separation	  defects.	  Microarray	  analysis	  of	  319	  ORFs	  in	  a	  fkh2∆/∆	  mutant	  showed	  that	  some	  cell	  cycle	  and	  hyphal	  specific	  genes	  have	  their	  expression	  down-­‐regulated	  in	  the	  absence	  of	  FKH2	  (Fig.4.1.4A-­‐C).	  It	  was	  confirmed	  by	  northern	  analysis	  that	  Fkh2	  regulates	  HWP1,	  ECE1	  and	  CLB4	  mRNA	  levels	  (Fig.4.1.4D.).	  
FKH2	  has	  also	  been	  shown	  to	  be	  up-­‐regulated	  in	  a	  reconstituted	  oral	  epithelium	  model	  of	  infection	  (Zakikhany	  et	  al.	  2007),	  suggesting	  a	  possible	  role	  in	  virulence.	  Recently	  it	  has	  been	  shown	  that	  overexpression	  of	  FKH2	  leads	  to	  filamentous	  growth	  on	  both	  solid	  and	  liquid	  media	  (Chauvel	  et	  al.	  2012);	  however	  how	  increased	  levels	  of	  Fkh2	  causes	  filamentation	  has	  not	  been	  explored.	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Fig.	  4.1.3.	  Schematic	  comparing	  CaFkh2	  homology	  with	  ScFkh1	  and	  ScFkh2.	  Taken,	  with	  permission,	  from	  Bensen	  et	  al	  2002.	  CaFkh2	  shares	  homology	  to	  ScFkh1/2,	  but	  is	  most	  similar	  to	  
ScFkh2	  in	  the	  Fork-­‐head	  DNA	  binding	  domain.	  Fractions	  represent	  the	  number	  of	  residues	  that	  are	  similar	  in	  each	  domain.	  	  	  
	  	  	  	  	  	  	  
	  
Fig.	  4.1.4.	  Transcriptional	  effects	  of	  knocking	  out	  FKH2	  in	  C.	  albicans.	  Taken	  from	  Bensen	  et	  al.	  	  2002.	  Transcriptional	  array	  of	  319	  C.	  albicans	  open	  reading	  frames.	  1)	  FKH2/FKH2	  3hour	  hyphae	  vs.	  FKH2/FKH2	  3hour	  yeast	  2)	  fkh2∆/∆	  3hour	  hyphae	  vs.	  FKH2/FKH2	  3hour	  hyphae	  3)	  fkh2∆/∆	  yeast	  vs.	  FKH2/FKH2	  yeast.	  A)	  Genes	  with	  increased	  expression	  during	  hyphal	  growth	  in	  
FKH2/FKH2	  but	  not	  in	  fkh2∆/∆.	  B)	  Genes	  with	  expression	  down-­‐regulated	  in	  fkh2∆/∆	  compared	  with	  FKH2/FKH2	  during	  yeast	  growth.	  C)	  Genes	  with	  expression	  up-­‐regulated	  in	  fkh2∆/∆	  cells	  compared	  with	  FKH2/FKH2	  during	  yeast	  growth.	  D)	  Northern	  blot	  confirmation	  that	  CLB4	  mRNA	  levels	  increase	  during	  yeast	  growth	  on	  deletion	  of	  FKH2,	  and	  that	  ECE1	  and	  HWP1	  mRNA	  levels	  during	  hyphal	  growth	  decrease	  upon	  deletion	  of	  FKH2.	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  Results	  	  






















Fig.	  4.2.1.	  Fkh2	  undergoes	  cell	  cycle-­‐dependent	  phosphorylation	  during	  synchronous	  yeast	  
growth.	  FKH2/FKH2-­‐YFP	  G1	  cells	  were	  obtained	  by	  elutriation	  from	  a	  log	  phase	  yeast	  culture	  and	  then	  re-­‐inoculated	  into	  yeast	  growth	  conditions.	  Samples	  were	  taken	  for	  Western	  blot	  and	  microscopy	  at	  the	  shown	  time-­‐points.	  50μg	  of	  protein	  extract	  was	  run	  on	  a	  7%	  SDS-­‐PAGE	  gel,	  and	  an	  αGFP	  antibody	  was	  used	  to	  detect	  Fkh2	  after	  Western	  blotting.	  Small	  and	  large	  bud	  growth	  was	  used	  to	  follow	  yeast	  growth	  phases,	  and	  DAPI	  was	  used	  as	  a	  nuclear	  marker	  to	  observe	  when	  nuclear	  division	  was	  occurring.	  Values	  for	  each	  time-­‐point	  are	  the	  average	  of	  50	  separate	  cells.	  	  	  
4.2.2.	  Fkh2	  is	  phosphorylated	  independently	  of	  the	  cell	  cycle	  on	  hyphal	  
induction	  
	  	   During	  synchronous	  hyphal	  growth,	  Fkh2	  is	  phosphorylated	  by	  20mins	  post	  induction	  and	  remains	  so	  up	  until	  around	  60min	  post	  induction.	  This	  observed	  phosphorylation	  does	  not	  appear	  to	  return	  later	  on	  in	  hyphal	  growth	  (Fig.	  4.2.2.).	  The	  hyphal	  phosphorylation	  coincides	  with	  highly	  polarised	  growth	  while	  the	  germ	  tube	  is	  being	  formed,	  and	  then	  disappears	  once	  all	  cells	  in	  the	  population	  have	  produced	  a	  germ	  tube.	  In	  this	  strain	  the	  septin	  Cdc12	  was	  C-­‐terminally	  tagged	  with	  mCherry,	  allowing	  visualization	  of	  septin	  ring	  formation,	  which	  can	  be	  used	  as	  a	  marker	  of	  cell	  cycle	  progression	  past	  START	  (Cid	  et	  al.	  2001;	  Bensen	  et	  al.	  2005).	  From	  this	  it	  can	  be	  seen	  that	  formation	  of	  the	  hyphal	  septin	  ring	  only	  occurs	  after	  Fkh2	  has	  been	  phosphorylated	  and	  subsequently	  dephosphorylated.	  This	  suggests	  that	  the	  hyphal	  phosphorylation	  of	  Fkh2	  occurs	  before	  the	  beginning	  of	  the	  cell	  cycle,	  and	  is	  therefore	  independent	  of	  cell	  cycle	  progression.	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Fig.	  4.2.2.	  Fkh2	  is	  phosphorylated	  early	  after	  hyphal	  induction,	  independent	  of	  cell	  cycle	  
stage.	  FKH2/FKH2-­‐YFP	  G1	  cells	  were	  obtained	  from	  a	  log	  phase	  culture	  through	  elutriation	  and	  then	  re-­‐inoculated	  into	  hyphal	  inducing	  conditions.	  Samples	  were	  taken	  at	  the	  shown	  time-­‐points	  for	  microscopy	  and	  protein	  extraction.	  50μg	  of	  protein	  extract	  from	  each	  time-­‐point	  was	  run	  on	  a	  7%	  SDS-­‐PAGE	  gel,	  and	  an	  αGFP	  antibody	  was	  used	  to	  detect	  Fkh2-­‐GFP	  on	  the	  subsequent	  Western	  blot.	  Samples	  were	  re-­‐run	  on	  a	  10%	  SDS-­‐PAGE	  gel	  for	  an	  αPSTAIRE	  loading	  control	  Western	  blot.	  Hyphal	  growth	  was	  followed	  by	  microscopy	  using	  DAPI	  as	  a	  marker	  for	  the	  nucleus	  and	  Cdc12-­‐mCherry	  to	  mark	  the	  septin	  ring.	  Each	  time-­‐point	  contains	  average	  values	  for	  50	  cells.	  
	  
	  
4.2.3.	  Determining	  the	  residues	  phosphorylated	  on	  Fkh2	  after	  hyphal	  
induction	  
	   To	  determine	  which	  sites	  on	  Fkh2	  are	  phosphorylated	  early	  on	  in	  hyphal	  growth,	  phospho-­‐peptide	  mapping	  was	  carried	  out.	  The	  C-­‐terminal	  fragment	  of	  the	  
FKH2	  gene	  was	  cloned	  into	  a	  vector	  with	  the	  Hemagglutinin	  epitope	  (HA)	  and	  a	  
URA3	  selectable	  marker	  3’	  of	  the	  cloning	  site.	  This	  vector	  was	  then	  digested	  with	  
NcoI	  to	  cut	  it	  once	  and	  allow	  integration	  through	  recombination	  with	  a	  copy	  of	  
FKH2	  in	  the	  genome.	  This	  strain	  was	  confirmed	  by	  previously	  mentioned	  techniques.	  	  	   The	  FKH2-­‐HA	  strain	  was	  used	  to	  immunoprecipitate	  (IP)	  Fkh2-­‐HA	  from	  a	  5L	  culture,	  grown	  for	  40mins	  in	  hyphal	  inducing	  conditions.	  The	  purified	  Fkh2-­‐HA	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was	  eluted	  from	  the	  beads	  and	  run	  on	  a	  gel,	  before	  Coomassie	  staining	  and	  excision	  of	  the	  band	  that	  corresponded	  to	  Fkh2-­‐HA	  (Fig.	  4.2.3A).	  The	  band	  was	  digested	  and	  then	  run	  on	  the	  mass	  spectrometer.	  The	  results	  from	  the	  phospho-­‐peptide	  mapping	  show	  that	  Fkh2	  is	  phosphorylated	  at	  this	  time-­‐point,	  and	  that	  some	  of	  the	  phosphorylation	  occurs	  at	  CDK	  consensus	  phosphorylation	  motifs	  (Fig.	  4.2.3B-­‐C).	  	   To	  support	  the	  observation	  that	  Fkh2	  is	  phosphorylated	  at	  CDK	  consensus	  and	  minimal	  sites	  on	  hyphal	  induction,	  the	  phosphorylation	  status	  of	  Fkh2	  was	  investigated	  with	  an	  antibody	  (αPSER)	  that	  recognises	  phosphorylated	  serines	  in	  CDK	  consensus	  and	  minimal	  sites	  (Fig.	  4.2.4A.).	  Fkh2-­‐YFP	  was	  IP’d	  from	  cultures	  40min	  after	  hyphal	  induction.	  Samples	  underwent	  SDS-­‐PAGE	  gel	  separation	  and	  the	  subsequent	  Western	  blot	  was	  probed	  with	  the	  above-­‐mentioned	  phospho-­‐specific	  antibody.	  Fkh2	  is	  indeed	  phosphorylated	  at	  CDK	  sites	  containing	  serine	  upon	  hyphal	  induction,	  supporting	  the	  previous	  phospho-­‐peptide	  mapping	  data	  (Fig.	  4.2.3.).	  This	  experiments	  was	  also	  carried	  out	  for	  Fkh2	  during	  yeast	  growth	  conditions	  (120mins)	  using	  cells	  expressing	  a	  6xMyc	  C-­‐terminally	  tagged	  Fkh2	  (Fig.	  4.2.4B.).	  For	  this	  experiment	  an	  antibody	  (αPSER(CDK))	  that	  detects	  phosphorylation	  only	  at	  serine	  residues	  in	  CDK	  consensus	  sites	  was	  used.	  This	  showed	  that	  Fkh2	  is	  phosphorylated	  at	  serine	  residues	  in	  CDK	  sites	  during	  yeast	  growth.	  Gin4-­‐6Myc	  has	  previously	  been	  shown	  to	  be	  phosphorylated	  at	  CDK	  sites	  during	  yeast	  growth	  using	  this	  antibody	  (Li	  et	  al.	  2012),	  and	  was	  therefore	  used	  as	  a	  positive	  control	  (Fig.	  4.2.4B).	  An	  IP	  from	  a	  log	  phase	  BWP17	  culture	  was	  used	  as	  a	  negative	  control	  for	  non-­‐specific	  binding	  of	  the	  phospho-­‐antibody	  on	  the	  western	  blot	  (Fig.	  4.2.4B).	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Fig.	  4.2.3.	  Investigating	  Fkh2	  early	  hyphal	  phosphorylation	  by	  mass-­‐spectrometry	  phospho-­‐
peptide	  mapping.	  A).	  Coomassie	  stained	  gel	  of	  Fkh2-­‐HA	  IP	  for	  phospho-­‐peptide	  mapping	  –	  values	  represent	  kDa	  molecular	  weight	  markers.	  B)	  Table	  of	  residues	  phosphorylated	  and	  peptide	  hits.	  Phosphorylated	  residues	  in	  the	  peptide	  are	  coloured	  red.	  C)	  Results	  from	  phospho-­‐peptide	  mapping.	  	  Red	  –	  significant	  hit,	  Grey	  –	  possible	  phosphorylation	  site,	  Green	  –	  either	  site	  is	  phosphorylated.	  	  D)	  Schematic	  of	  Fkh2	  phosphorylation	  sites	  observed	  from	  biological	  replicates	  of	  Fkh2-­‐3HA	  expressing	  cells	  grown	  for	  40mins	  under	  hyphal	  induction	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Fig.	  4.2.4.	  Investigating	  Fkh2	  phosphorylation	  with	  phospho-­‐specific	  antibodies.	  A)	  Fkh2-­‐YFP	  was	  IP’d	  from	  expressing	  cells	  40mins	  after	  hyphal	  induction.	  After	  Western	  blotting	  the	  membrane	  was	  probed	  with	  an	  αPhosphoserine	  CDK/MAPK	  (S/P	  site)	  antibody	  (αPSER)	  (Cell	  Signaling).	  The	  membrane	  was	  then	  stripped	  and	  re-­‐probed	  with	  an	  αGFP	  antibody	  (Roche).	  B)	  Fkh2-­‐6xMyc	  was	  IP’d	  from	  expressing	  cells	  at	  120mins	  after	  re-­‐inoculation	  into	  yeast	  growth	  conditions.	  After	  Western	  blotting	  the	  membrane	  was	  probed	  with	  an	  αPhosphoserine	  CDK	  (SPxR/K	  site)	  antibody	  (αPSER(CDK))	  (Cell	  Signaling);	  then	  stripped	  and	  re-­‐probed	  with	  an	  αMyc	  antibody.	  Between	  carrying	  out	  these	  experiments	  the	  αPhosphoserine	  CDK	  (SPxR/K	  site)	  antibody	  was	  discontinued	  by	  Cell	  Signaling.	  
	  
4.2.4.	  Mutagenesis	  studies	  of	  Fkh2	  phosphorylation	  	   In	  order	  to	  further	  understand	  the	  phospho-­‐regulation	  of	  Fkh2,	  the	  phosphorylation	  sites	  were	  mutated.	  From	  this,	  the	  sites	  that	  are	  phosphorylated	  could	  be	  confirmed,	  along	  with	  the	  physiological	  consequences	  of	  these	  mutations,	  which	  will	  be	  covered	  later.	  	  
4.2.4.1	  Construction	  of	  a	  fkh2Δ/Δ	  strain	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selectable	  auxotrophic	  marker	  (Fig.	  4.2.5A).	  A	  500bp	  5’	  upstream	  fragment	  of	  
FKH2	  was	  amplified	  with	  a	  5’	  KpnI	  and	  3’	  XhoI	  restriction	  site	  (Fig.	  4.2.5B).	  This	  was	  cloned	  into	  the	  pBluescript	  (pBks)	  vector	  upstream	  of	  the	  ARG4	  gene	  and	  its	  promoter	  from	  C.	  albicans	  (Fig.	  4.2.5C).	  A	  400bp	  downstream	  fragment	  of	  FKH2	  with	  5’	  NotI	  and	  3’	  SacII	  sites	  was	  then	  cloned	  in	  downstream	  of	  the	  ARG4	  gene	  (Fig.	  4.2.5B-­‐C).	  This	  vector	  was	  then	  sequenced	  to	  check	  that	  the	  FKH2	  up	  and	  down-­‐stream	  sequences	  were	  correct,	  and	  did	  not	  contain	  mutations.	  To	  transform	  the	  FKH2	  5’-­‐ARG4-­‐FKH2	  3’	  fragment	  it	  was	  cut	  from	  the	  vector	  with	  KpnI	  and	  SacII.	  This	  then	  recombined	  with	  the	  homologous	  sequences	  in	  the	  genome,	  removing	  one	  allele	  of	  FKH2	  and	  replacing	  it	  with	  the	  ARG4	  selectable	  marker,	  allowing	  selection	  of	  ARG4+	  correct	  transformants.	  These	  transformant	  colonies	  were	  then	  checked	  by	  PCR	  to	  determine	  that	  the	  knockout	  cassette	  had	  inserted	  into	  the	  correct	  locus	  (Fig.	  4.2.5D).	  	  	   In	  order	  to	  knockout	  the	  second	  allele	  of	  FKH2,	  the	  selectable	  marker	  in	  the	  knockout	  vector	  was	  replaced	  with	  a	  different	  selectable	  marker.	  The	  PARG4-­‐ARG4	  marker	  was	  cut	  out	  of	  the	  vector	  with	  XhoI	  and	  NotI,	  and	  replaced	  with	  the	  URA-­‐Flipper	  (URAF)	  marker	  that	  had	  been	  cut	  out	  of	  a	  pBks	  vector	  (Hickman	  et	  al.	  2013)	  with	  the	  same	  restriction	  sites.	  Once	  generated,	  this	  vector	  was	  transformed	  into	  the	  fkh2/FKH2	  strain.	  Homozygous	  deletion	  colonies	  were	  selected	  for	  as	  being	  prototrophic	  for	  both	  arginine	  and	  uridine.	  These	  were	  then	  confirmed	  by	  PCR	  to	  determine	  correct	  genomic	  integration	  (Fig.	  4.2.5D).	  	  Using	  the	  URAF	  selectable	  marker	  allows	  excision	  of	  the	  URA3	  marker,	  so	  that	  it	  can	  be	  recycled	  to	  carry	  out	  other	  transformations	  into	  the	  strain.	  The	  URA-­‐Flipper	  contains	  the	  FLP	  recombinase	  under	  the	  control	  of	  the	  SAP2	  promoter,	  which	  is	  induced	  under	  conditions	  where	  protein	  is	  the	  sole	  nitrogen	  source.	  A	  
fkh2Δ/∆	  URA3+	  colony	  was	  grown	  overnight	  in	  yeast	  carbon	  base-­‐BSA	  to	  activate	  the	  SAP2	  promoter.	  The	  expressed	  FLP	  recombinase	  then	  excises	  the	  URA3	  cassette	  by	  recombining	  the	  two	  FRT	  sites	  either	  side	  of	  the	  cassette.	  ura3-­‐	  colonies	  were	  then	  selected	  for	  by	  plating	  out	  the	  culture	  onto	  5-­‐FOA	  agar.	  Correct	  colonies	  were	  confirmed	  by	  PCR	  to	  show	  that	  the	  URAF	  marker	  was	  no	  longer	  present	  (Fig.	  4.2.5E).	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   The	  fkh2∆/Δ	  strain	  shows	  the	  same	  phenotype	  as	  previously	  noted	  by	  Bensen	  et	  al	  2002,	  further	  confirming	  that	  both	  copies	  of	  FKH2	  have	  been	  knocked	  out	  (Fig.	  4.2.5F).	  	  	  
	  
	  
Fig.	  4.2.5.	  Construction	  of	  a	  fkh2∆/∆	  strain.	  A)	  Diagram	  of	  pBluescript	  (pBKs)	  vector	  containing	  
FKH2	  ARG4	  deletion	  cassette	  (PARG4	  is	  the	  ARG4	  promoter	  region),	  and	  the	  URA3-­‐Flipper	  deletion	  cassette	  (PSAP2	  is	  the	  SAP2	  promoter	  region).	  B)	  KpnI-­‐FKH2	  5’-­‐XhoI	  and	  NotI-­‐FKH2	  3’-­‐SacII	  PCR	  fragments.	  C)	  Confirmation	  of	  integration	  of	  each	  FKH2	  fragment	  into	  the	  pBKs	  vector	  by	  digesting	  with	  the	  same	  enzymes	  used	  to	  integrate.	  D)	  PCR	  to	  check	  integration	  of	  the	  deletion	  cassettes	  at	  the	  correct	  genomic	  locus	  in	  C.	  albicans,	  using	  FKH2	  Del	  Chk	  Fwd	  and	  either	  URAF	  or	  ARG4	  Del	  Rev	  Chk	  primers.	  E)	  PCR	  to	  check	  that	  the	  URA3	  gene	  has	  been	  excised	  from	  the	  FKH2	  genomic	  locus,	  using	  FKH2-­‐kpn1	  AF	  and	  FKH2-­‐SacII	  DR.	  The	  URA+	  fkh2∆/∆	  strain	  was	  used	  as	  the	  negative	  control.	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4.2.4.2.	  Cloning	  of	  FKH2	  	  
	   In	  order	  to	  introduce	  mutations	  at	  the	  phosphorylation	  sites	  in	  Fkh2,	  the	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Fig.4.2.6.	  Construction	  of	  a	  FKH2-­‐GFP	  vector	  for	  phosphorylation	  site	  mutagenesis.	  A)	  Diagram	  of	  the	  PFKH2-­‐FKH2-­‐GFP	  pCIP10	  URA3	  vector,	  showing	  inserted	  HindIII	  restriction	  site	  B)	  PCR	  fragment	  amplified	  of	  AscI-­‐PFKH2-­‐FKH2-­‐XhoI	  fragment.	  C)	  AscI/XhoI	  digests	  of	  plasmids	  from	  transformant	  colonies	  after	  ligation.	  D)	  HindIII	  digests	  to	  check	  mutagenesis	  to	  add	  a	  HindIII	  restriction	  site	  into	  the	  FKH2	  promoter,	  with	  correct	  plasmids	  being	  present	  as	  only	  a	  single	  band.	  
	  
4.2.4.3.	  Mutation	  of	  sites	  from	  Phospho-­‐peptide	  mapping	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   When	  comparing	  this	  mutant	  (Fkh2(6AMS))	  with	  wild-­‐type	  Fkh2	  tagged	  with	  GFP,	  it	  can	  be	  observed	  that	  there	  is	  no	  difference	  in	  the	  phosphorylation	  level	  during	  yeast	  growth	  or	  on	  hyphal	  induction	  (Fig.	  4.2.7A).	  The	  upper	  band	  corresponding	  to	  the	  phosphorylated	  isoform	  of	  Fkh2	  is	  still	  present	  when	  analysed	  by	  SDS-­‐PAGE	  followed	  by	  αGFP	  Western	  blotting.	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig.	  4.2.7.	  Mutational	  analysis	  of	  Fkh2	  phosphorylation.	  A)	  fkh2(6AMS)-­‐GFP	  and	  FKH2/FKH2-­‐YFP	  cells	  were	  grown	  for	  120mins	  as	  yeast	  and	  40mins	  as	  hyphae;	  50μg	  protein	  extract	  from	  these	  cells	  was	  run	  on	  a	  7%	  SDS-­‐PAGE	  gel	  to	  separate	  phospho-­‐isoforms	  and	  the	  subsequent	  Western	  blot	  was	  probed	  with	  αGFP	  	  B)	  fkh2(6ACDK)-­‐GFP	  and	  fkh2(6ECDK)-­‐GFP	  	  were	  grown	  as	  above	  with	  the	  
FKH2/FKH2-­‐YFP	  strain,	  and	  the	  protein	  extracted	  for	  αGFP	  Western	  blotting	  as	  before.	  Samples	  were	  re-­‐run	  on	  a	  10%	  SDS-­‐PAGE	  gel	  that	  was	  then	  Western	  blotted	  and	  probed	  with	  αPSTAIRE	  as	  a	  control	  for	  equal	  loading.	  	  
4.2.4.4.	  Mutation	  of	  CDK	  consensus	  sites	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phosphorylation	  at	  the	  CDK	  sites	  prevents	  Fkh2	  from	  being	  phosphorylated	  on	  hyphal	  induction	  (Fig.	  4.2.7B),	  demonstrating	  that	  these	  are	  the	  sites	  that	  are	  phosphorylated	  on	  hyphal	  induction.	  However	  there	  still	  appears	  to	  be	  a	  partial	  band-­‐shift	  during	  yeast	  growth,	  suggesting	  that	  there	  are	  other	  sites	  that	  are	  phosphorylated	  during	  yeast	  growth.	  The	  fkh2(6ECDK)-­‐GFP	  strain	  mimicking	  phosphorylation	  still	  shows	  a	  band	  shift	  on	  hyphal	  induction	  and	  during	  yeast	  growth.	  	  	  
4.2.4.5.	  Mutation	  of	  CDK	  consensus	  and	  minimal	  sites	  
	  	   In	  addition	  to	  mutating	  the	  CDK	  consensus	  sites,	  the	  nine	  minimal	  (S/TP)	  sites	  were	  also	  mutated	  to	  either	  block	  or	  mimic	  phosphorylation.	  	  This	  generated	  
fkh2(15A)-­‐GFP	  and	  fkh2(15E)-­‐GFP	  plasmids	  that	  were	  integrated	  back	  into	  the	  
fkh2∆/∆	  strain	  and	  checked	  as	  previously	  mentioned.	  Along	  with	  this	  the	  eleven	  CDK	  consensus	  and	  minimal	  sites	  C-­‐terminal	  to	  the	  DNA	  binding	  domain	  were	  mutated	  to	  alanine,	  allowing	  confirmation	  that	  the	  phosphorylation	  of	  Fkh2	  occurs	  in	  its	  C-­‐terminal	  domain.	  The	  plasmid	  for	  this	  strain	  was	  generated	  by	  making	  use	  of	  two	  internal	  KpnI	  sites	  in	  the	  FKH2	  sequence.	  The	  fkh2(15A)-­‐GFP	  and	  the	  FKH2-­‐
GFP	  plasmids	  were	  digested	  with	  Kpn1	  and	  XhoI	  to	  release	  two	  C-­‐terminal	  fragments	  from	  each	  vector.	  The	  two	  fragments	  containing	  the	  phosphorylation	  blocking	  mutations	  were	  cloned	  back	  into	  the	  wild-­‐type	  vector,	  generating	  a	  construct	  in	  which	  all	  the	  C-­‐terminal	  CDK	  sites	  of	  Fkh2	  had	  alanine	  mutations.	  Correct	  orientation	  of	  integration	  of	  the	  DNA	  fragments	  containing	  mutations	  was	  confirmed	  by	  sequencing.	  This	  plasmid	  was	  again	  integrated	  back	  into	  the	  fkh2∆/∆	  strain	  at	  the	  FKH2	  promoter.	  	   The	  Fkh2(15A)-­‐GFP	  did	  not	  show	  phosphorylation	  upon	  hyphal	  induction	  or	  during	  yeast	  growth	  (Fig.	  4.2.8.).	  	  This	  confirms	  the	  result	  observed	  with	  the	  
fkh2(6A)-­‐GFP	  strain	  during	  hyphal	  growth,	  and	  demonstrates	  that	  there	  are	  indeed	  other	  residues	  on	  Fkh2	  that	  are	  phosphorylated	  during	  yeast	  growth.	  The	  
Fkh2(15E)-­‐GFP	  protein	  shows	  a	  band-­‐shift	  during	  both	  yeast	  and	  hyphal	  growth,	  similar	  to	  that	  observed	  with	  the	  Fkh2(6ECDK)-­‐GFP	  protein	  (Fig.	  4.2.8.).	  The	  
fkh2(11A)-­‐GFP	  strain	  shows	  a	  loss	  of	  phosphorylation	  on	  hyphal	  induction	  and	  during	  yeast	  growth	  (Fig.	  4.2.8.).	  This	  demonstrates	  that	  the	  CDK	  sites	  in	  the	  C-­‐
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Fig.	  4.2.8.	  Comparison	  of	  Fkh2	  Phospho-­‐mutants.	  A)	  Phosphorylation	  mutants	  isolated	  from	  cells	  after	  120min	  yeast	  growth.	  B)	  Phosphorylation	  mutants	  isolated	  from	  cells	  40min	  after	  hyphal	  induction.	  Gels	  were	  run	  and	  Western	  blotting	  carried	  out	  as	  previously	  described.	  Samples	  were	  re-­‐run	  and	  blots	  probed	  with	  αPSTAIRE	  to	  confirm	  equal	  loading.	  
	  
	  
4.2.4.6.	  Fkh2	  C-­‐terminal	  truncation	  (fkh2	  1-­‐426)	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back	  into	  the	  fkh2∆/∆	  strain	  showed	  nearly	  a	  full	  rescue	  of	  the	  phenotype	  (Fig.	  5.1.7.).	  	  	   The	  phosphorylation	  status	  of	  this	  strain	  was	  tested	  on	  hyphal	  induction	  and	  during	  yeast	  growth	  (Fig.	  4.2.9.).	  Due	  to	  the	  difference	  in	  molecular	  weight	  of	  






Fig.	  4.2.9.	  Truncation	  of	  Fkh2	  affects	  its	  phosphorylation	  status.	  fkh2(1-­‐426)-­‐GFP	  cells	  were	  grown	  under	  yeast	  or	  hyphal	  inducing	  conditions	  as	  previously	  described.	  50μg	  samples	  were	  run	  on	  SDS-­‐PAGE	  and	  Western	  blotted;	  the	  blot	  was	  probed	  with	  αGFP	  to	  detect	  if	  a	  band-­‐shift	  was	  present.	  Phosphatase	  (λppase)	  treatment	  was	  used	  to	  confirm	  that	  no	  phospho-­‐band	  shift	  was	  observed.	  A	  separate	  αPSTAIRE	  was	  again	  used	  as	  a	  loading	  control.	  	  
	  
	  
4.2.5.	  Determining	  if	  Cdk1	  is	  responsible	  for	  Fkh2	  phosphorylation	  	   Due	  to	  phosphorylation	  of	  Fkh2	  occurring	  in	  CDK	  consensus	  motifs,	  it	  was	  then	  sought	  to	  determine	  if,	  as	  expected,	  Cdk1	  is	  responsible	  for	  the	  observed	  phosphorylation	  	   	  
4.2.5.1	  Cdk1	  can	  phosphorylate	  Fkh2	  in	  vitro	  
	  	   To	  determine	  whether	  Cdk1	  can	  directly	  phosphorylate	  Fkh2,	  an	  in	  vitro	  kinase	  assay	  was	  carried	  out.	  Initially	  the	  DNA	  sequence	  of	  the	  C-­‐terminal	  region	  of	  Fkh2	  was	  amplified	  from	  the	  wild-­‐type	  and	  fkh2(6ACDK)-­‐GFP	  vectors	  and	  cloned	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into	  the	  N-­‐terminal	  GST	  expression	  vector	  pGEX-­‐4T1.	  Due	  to	  the	  intron	  present	  in	  the	  3’	  region	  of	  the	  FKH2	  gene,	  skip	  PCR	  was	  used	  to	  amplify	  only	  the	  coding	  sequence,	  as	  the	  intron	  cannot	  be	  spliced	  out	  in	  E.	  coli	  and	  would	  therefore	  prevent	  expression	  of	  the	  C-­‐terminal	  fragment.	  The	  GST-­‐Fkh2	  C-­‐terminal	  (CT)	  fragment	  plasmids	  were	  transformed	  into	  BL21,	  allowing	  expression	  and	  purification	  of	  the	  GST-­‐Fkh2(CT)	  fragment	  (Fig.4.2.10.).	  	  	  
	  	  
Fig.	  4.2.10.	  Purification	  of	  GST-­‐Fkh2(CT)	  from	  E.	  coli.	  800ml	  BL21	  E.coli	  containing	  the	  GST-­‐
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Fig.	  4.2.11.	  Cdk1	  can	  phosphorylate	  the	  C-­‐terminus	  of	  Fkh2	  in	  vitro.	  GST-­‐Fkh2(CT)	  WT	  and	  6ACDK	  purified	  from	  E.	  coli	  were	  used	  in	  the	  reactions.	  A	  BWP17	  negative	  IP	  and	  a	  sample	  without	  ATP	  were	  used	  as	  negative	  controls.	  Samples	  were	  run	  on	  a	  10%	  SDS-­‐PAGE	  gel	  and	  the	  subsequent	  Western	  blot	  blotted	  first	  with	  αPhosphoserine-­‐CDK	  (αPSER(CDK))	  (Cell	  Signaling)	  and	  then	  stripped	  and	  re-­‐probed	  with	  αGST	  as	  a	  loading	  control.	  	  	  
	  
4.2.5.2.	  Inhibition	  of	  analogue-­‐sensitive	  Cdk1	  does	  not	  prevent	  Fkh2	  
phosphorylation	  
	   To	  determine	  whether	  the	  observed	  in	  vitro	  phosphorylation	  of	  Fkh2	  occurs	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no	  loss	  of	  Fkh2-­‐GFP	  band-­‐shift	  on	  hyphal	  induction	  or	  during	  yeast	  growth	  (Fig.	  4.2.12A).	  To	  show	  that	  the	  1NM-­‐PP1	  analogue	  was	  working,	  an	  aliquot	  of	  the	  cells	  was	  kept	  growing	  under	  hyphal-­‐inducing	  conditions,	  so	  that	  the	  phenotype	  could	  be	  observed.	  Indeed	  the	  correct	  phenotype	  was	  observed	  for	  inhibition	  of	  Cdk1	  (Fig.	  4.2.12B),	  suggesting	  that	  Cdk1	  does	  not	  phosphorylate	  Fkh2	  in	  vivo.	  This	  experiment	  was	  repeated	  more	  than	  10	  times,	  varying	  the	  conditions,	  but	  still	  showing	  the	  same	  result.	  Interestingly	  the	  αPSTAIRE	  loading	  control	  appears	  as	  two	  bands	  in	  the	  analogue-­‐sensitive	  strain.	  This	  strain	  only	  has	  one	  allele	  of	  CDK1,	  suggesting	  that	  the	  other	  allele	  of	  CDK1	  produces	  a	  protein	  product	  of	  a	  different	  size.	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig.	  4.2.12.	  Inhibiting	  Cdk1	  does	  not	  affect	  Fkh2	  phosphorylation.	  Aliquots	  of	  cdk1-­‐as/FKH2-­‐GFP	  cells	  
were	  taken	  and	  treated	  for	  30mins	  with	  either	  DMSO	  or	  30μM	  of	  1NM-­‐PP1	  ATP	  analogue	  (Merck)	  
dissolved	  in	  DMSO.	  These	  aliquots	  were	  re-­‐inoculated	  into	  yeast	  or	  hyphal	  growth	  conditions	  and	  grown	  
for	  120mins	  or	  40mins	  respectively.	  Samples	  were	  compared	  with	  a	  FKH2/FKH2-­‐YFP	  strain.	  A)	  50μg	  of	  
total	  cell	  lysate	  was	  run	  on	  a	  7%	  SDS-­‐PAGE	  gel,	  with	  the	  Western	  blot	  being	  probed	  with	  αGFP	  to	  detect	  
the	  Fkh2-­‐GFP	  band-­‐shift.	  A	  separate	  αPSTAIRE	  blot	  was	  used	  as	  a	  loading	  control.	  A	  sample	  from	  the	  
1NM-­‐PP1	  treated	  cells	  was	  kept	  for	  microscopy	  to	  confirm	  the	  kinase	  was	  inhibited 
	  
4.2.5.3.	  Fkh2	  phosphorylation	  in	  Cdk1	  cyclin	  knockout	  strains 



















	  108	  	  
	   In	  the	  ccn1∆	  strain,	  Fkh2-­‐GFP	  still	  shows	  a	  band-­‐shift	  on	  hyphal	  induction	  and	  during	  yeast	  growth	  (Fig.	  4.2.13.)..	  Knockout	  of	  HGC1	  or	  shutdown	  of	  CLN3	  with	  the	  MET3	  promoter	  does	  not	  affect	  Fkh2’s	  phosphorylation	  status	  in	  yeast	  or	  hyphae	  (Fig.	  4.2.13.);	  however,	  Fkh2	  appears	  more	  stable	  in	  the	  hgc1∆/∆	  strain..	  















Fig.	  4.2.13.	  Investigating	  Fkh2	  phosphorylation	  in	  Cdk1	  cyclin	  knockouts/shutdown	  strains.	  All	  strains	  were	  grown	  up	  overnight	  in	  YEPD	  to	  allow	  partial	  shutdown	  of	  the	  MET3	  promoter.	  For	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4.2.5.4.	  Investingating	  if	  Fkh2	  and	  Cdk1	  physically	  interact	  








Fig.	  4.2.14.	  Examining	  if	  Fkh2	  and	  Cdk1	  physically	  interact.	  Fkh2-­‐YFP	  was	  IP’d	  from	  2mg	  of	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4.2.6.	  Other	  kinases	  that	  may	  phosphorylate	  Fkh2	  	  
	  Due	  to	  the	  observation	  that	  loss	  of	  Cdk1	  activity	  does	  not	  prevent	  Fkh2	  phosphorylation,	  other	  kinases	  that	  could	  carry	  out	  the	  phosphorylation	  were	  sought.	  These	  were	  chosen	  on	  the	  basis	  that	  they	  would	  be	  able	  to	  at	  least	  phosphorylate	  CDK	  minimal	  motifs	  (S/TP).	  
	  
4.2.6.1	  Deletion	  of	  CRK1	  does	  not	  affect	  Fkh2	  phosphorylation	  	  











Fig.	  4.2.15.	  Investigating	  if	  other	  kinases	  phosphorylate	  Fkh2.	  Kinase	  knockout	  strains	  
crk1∆/∆,	  hog1∆/∆	  and	  ssn3∆/∆	  were	  used,	  along	  with	  an	  analogue	  sensitive	  Tpk1	  strain	  in	  which	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4.2.6.2.	  Deletion	  of	  HOG1	  does	  not	  affect	  Fkh2	  phosphorylation	  	  
	  	   To	  determine	  whether	  stress-­‐activated	  protein	  kinase	  Hog1	  is	  responsible	  for	  the	  phosphorylation	  of	  Fkh2;	  Fkh2	  was	  C-­‐terminally	  tagged	  with	  GFP	  in	  a	  
hog1∆/∆	  strain.	  The	  phosphorylation	  state	  of	  Fkh2-­‐GFP	  in	  this	  strain	  was	  then	  compared	  with	  Fkh2-­‐GFP	  in	  BWP17.	  	  Fkh2-­‐GFP	  in	  hog1∆	  still	  appears	  as	  two	  bands	  when	  analysed	  by	  1D	  SDS-­‐PAGE	  with	  an	  αGFP	  Western	  blot	  (Fig.	  4.2.15).	  This	  shows	  that	  in	  the	  absence	  of	  HOG1,	  Fkh2	  can	  still	  be	  phosphorylated	  upon	  hyphal	  induction	  and	  during	  yeast	  growth,	  and	  thus	  Hog1	  is	  not	  responsible	  for	  phosphorylation	  of	  Fkh2.	  Interestingly,	  there	  appears	  to	  be	  more	  Fkh2	  present	  in	  the	  hog1∆/∆	  mutant,	  suggesting	  that	  Fkh2	  may	  be	  more	  stable	  or	  higher	  expressed	  when	  HOG1	  is	  knocked	  out.	  	  	  
4.2.6.3.	  Inhibiting	  cAMP-­‐dependent	  protein	  kinases	  does	  not	  affect	  Fkh2	  
phosphorylation	  
	   The	  cAMP-­‐dependent	  protein	  kinases	  Tpk1	  and	  Tpk2	  are	  key	  components	  of	  the	  hyphal	  morphogenesis	  program	  (Bockmühl	  et	  al.	  2001).	  It	  is	  thought	  that	  they	  are	  partially	  redundant,	  as	  deletion	  of	  either	  one	  separately	  does	  not	  affect	  viability,	  however,	  deletion	  of	  both	  is	  lethal.	  Due	  to	  this	  a	  strain	  has	  been	  constructed	  where	  TPK2	  has	  been	  knocked	  out,	  and	  TPK1	  mutated	  in	  order	  to	  make	  it	  sensitive	  to	  the	  1NM-­‐PP1	  ATP	  analogue	  (Bockmühl	  et	  al.	  2001).	  Fkh2	  was	  GFP	  tagged	  C-­‐terminally	  in	  this	  strain	  to	  allow	  the	  phosphorylation	  status	  to	  be	  detected	  through	  a	  band-­‐shift	  on	  a	  1D	  SDS-­‐PAGE	  gel.	  No	  loss	  of	  Fkh2-­‐GFP	  phosphorylation	  could	  be	  detected	  on	  addition	  of	  1NM-­‐PP1	  during	  yeast	  growth	  or	  on	  hyphal	  induction	  (Fig.	  4.2.15.).	  	  
4.2.6.4.	  Deletion	  of	  SSN3	  does	  not	  affect	  Fkh2	  phosphorylation	  
	  	   Ssn3	  is	  the	  homologue	  of	  Cdk8,	  which	  in	  S.	  pombe	  has	  been	  shown	  to	  be	  required	  for	  phosphorylation	  of	  Fkh2	  (Szilagyi	  et	  al.	  2012).	  CaSsn3	  has	  recently	  been	  shown	  to	  phosphorylate	  the	  transcription	  factor	  Sef1	  as	  a	  requirement	  for	  virulence	  (Chen	  &	  Noble	  2012).	  The	  ssn3∆/∆	  strain	  from	  this	  study	  was	  obtained	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and	  then	  transformed	  to	  C-­‐terminally	  tag	  Fkh2	  with	  GFP.	  	  This	  strain	  was	  tested	  as	  previously	  to	  determine	  the	  phosphorylation	  status	  on	  hyphal	  induction	  and	  during	  yeast	  growth.	  No	  loss	  of	  Fkh2-­‐GFP	  phosphorylation	  could	  be	  detected	  in	  this	  strain	  (Fig.	  4.2.15.).	  	  
4.2.6.5.	  Repression	  of	  the	  CDK	  PHO85	  does	  not	  affect	  Fkh2	  phosphorylation	  	  	  	   Pho85	  is	  a	  CDK	  that	  has	  been	  shown	  to	  work	  in	  partial	  redundancy	  with	  Cdk1	  in	  S.	  cerevisiae,	  phosphorylating	  substrates	  such	  as	  Rga2	  (Sopko	  et	  al.	  2007).	  Recently	  it	  has	  been	  shown	  that	  Pho85	  is	  required	  for	  temperature	  dependent	  filamentation	  in	  C.	  albicans	  (Shapiro	  et	  al.	  2012).	  This	  evidence	  suggests	  that	  Pho85	  could	  be	  responsible	  for	  phosphorylation	  of	  Fkh2	  on	  hyphal	  induction.	  The	  

























4.3.1.	  Fkh2	  is	  differentially	  phosphorylated	  between	  yeast	  and	  hyphal	  
growth	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synchronise	  the	  cells,	  which	  arrests	  large	  G1	  cells	  just	  prior	  to	  START	  (Hartwell	  et	  al.	  1974).	  Using	  elutriation	  is	  the	  only	  method	  for	  synchronisation	  in	  C.	  albicans,	  but	  this	  selects	  for	  small	  G1	  cells	  that	  still	  have	  to	  grow	  before	  entry	  into	  START,	  allowing	  better	  observation	  of	  events	  that	  occur	  during	  G1.	  The	  timing	  of	  the	  phosphorylation	  in	  C.	  albicans	  yeasts	  suggests	  that	  Fkh2	  is	  phosphorylated	  after	  the	  cell	  has	  passed	  START,	  as	  the	  cells	  already	  have	  small	  buds	  forming	  (Fig.	  4.2.1.).	  In	  the	  synchronous	  yeast	  time-­‐course	  in	  C.	  albicans	  Fkh2	  also	  undergoes	  short	  periods	  of	  de-­‐phosphorylation	  at	  120	  and	  200mins	  (Fig.	  4.2.1.),	  both	  of	  which	  occur	  when	  most	  cells	  are	  bi-­‐nucleate	  having	  just	  undergone	  nuclear	  division.	  This	  suggests	  that	  Fkh2	  is	  dephosphorylated	  at	  the	  end	  of	  mitosis,	  possibly	  by	  the	  Cdc14	  phosphatase	  as	  part	  of	  resetting	  the	  cell	  to	  a	  G1	  state	  (Rock	  &	  Amon	  2009).	  	  	   During	  hyphal	  growth	  Fkh2-­‐GFP	  is	  phosphorylated	  from	  20-­‐60mins	  post	  induction,	  with	  the	  phosphorylation	  peaking	  at	  40mins	  (Fig.	  4.2.2.).	  By	  this	  time	  nearly	  100%	  of	  the	  cells	  have	  formed	  a	  hyphal	  germ	  tube,	  suggesting	  that	  the	  phosphorylation	  may	  have	  a	  role	  in	  this	  process.	  With	  the	  peak	  in	  phosphorylation	  the	  level	  of	  Fkh2	  is	  also	  greater,	  suggesting	  that	  Fkh2	  phosphorylation	  may	  have	  a	  role	  in	  controlling	  its	  own	  expression.	  It	  is	  likely	  that	  the	  phosphorylation	  is	  occurring	  before	  the	  beginning	  of	  the	  cell	  cycle,	  as	  marked	  by	  the	  formation	  of	  a	  septin	  ring	  (Fig.	  4.2.1.).	  In	  yeast	  cells	  START	  occurs	  just	  prior	  to	  bud	  emergence,	  so	  this	  can	  be	  used	  as	  a	  marker	  for	  the	  beginning	  of	  the	  cell	  cycle	  (Hartwell	  et	  al.	  1974;	  Hazan	  et	  al.	  2002).	  However	  this	  is	  not	  the	  case	  in	  hyphae,	  with	  germ	  tubes	  forming	  before	  the	  beginning	  of	  the	  cell	  cycle	  (Hazan	  et	  al.	  2002).	  Therefore	  the	  formation	  of	  the	  septin	  ring	  was	  used	  as	  marker	  for	  the	  beginning	  of	  the	  cell	  cycle,	  as	  it	  has	  be	  shown	  to	  be	  during	  yeast	  growth	  (Cid	  et	  al.	  2001;	  Finley	  &	  Berman	  2005).	  After	  60mins	  into	  hyphal	  growth	  Fkh2	  is	  dephosphorylated	  and	  appears	  to	  remain	  so,	  at	  least	  up	  until	  the	  end	  of	  nuclear	  division,	  as	  was	  tested	  (Fig.	  4.2.2.).	  Looking	  at	  the	  timing	  of	  this	  de-­‐phosphorylation	  and	  comparing	  that	  with	  Cdc14	  hyphal	  expression	  (Clemente-­‐Blanco	  et	  al.	  2006),	  it	  is	  unlikely	  that	  Cdc14	  could	  be	  involved	  in	  this	  process.	  If	  the	  phosphorylation	  of	  Fkh2	  is	  unlinked	  from	  the	  cell	  cycle	  in	  hyphae,	  it	  suggests	  a	  role	  for	  Fkh2	  that	  is	  independent	  of	  its	  expected	  role	  inferred	  from	  S.	  
cerevisiae	  (Zhu	  et	  al.	  2000).	  Due	  to	  the	  phosphorylation	  in	  both	  yeast	  and	  hyphae	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occurring	  during	  polarised	  growth	  phases	  (Fig.	  4.2.1-­‐2.)	  it	  could	  be	  speculated	  that	  the	  physiological	  function	  of	  the	  phosphorylation	  is	  to	  regulate	  polarised	  growth.	  However	  this	  phosphorylation	  event	  occurring	  early	  on	  hyphal	  induction	  may	  be	  required	  later	  for	  cell	  cycle	  progression.	  	  
	  
4.3.2.	  Fkh2	  is	  phosphorylated	  at	  CDK	  consensus	  sites	  on	  hyphal	  induction	  
	   Phospho-­‐peptide	  mapping	  of	  Fkh2	  40mins	  after	  hyphal	  induction	  showed	  that	  phosphorylation	  is	  occurring	  at	  CDK	  sites	  (Fig.	  4.2.3.).	  This	  follows	  the	  prediction	  from	  studies	  in	  other	  eukaryotes,	  that	  Fkh2	  is	  targeted	  by	  CDK	  dependent	  phosphorylation	  (Pic-­‐Taylor	  et	  al.	  2004;	  Szilagyi	  et	  al.	  2012;	  Murakami	  et	  al.	  2010).	  Mutation	  of	  the	  serine/threonine	  in	  sites	  detected	  by	  phospho-­‐peptide	  mapping	  to	  alanine	  did	  not	  affect	  Fkh2	  phosphorylation	  (Fig.	  4.2.7A);	  however	  mutation	  of	  all	  the	  CDK	  consensus	  sites	  to	  the	  phosphorylation-­‐blocked	  alanine	  did	  prevent	  Fkh2	  phosphorylation	  on	  hyphal	  induction	  (Fig.	  4.2.7B).	  This	  means	  that	  some	  of	  the	  CDK	  consensus	  phosphorylation	  sites	  weren’t	  detected	  by	  the	  phospho-­‐peptide	  mapping.	  A	  likely	  reason	  for	  this	  is	  due	  to	  the	  fact	  that	  the	  protein	  was	  only	  cleaved	  with	  trypsin	  prior	  to	  running	  in	  the	  mass-­‐spectrometer.	  Trypsin	  preferentially	  cleaves	  proteins	  after	  arginine	  and	  lysine	  residues	  (Keil	  1992),	  such	  as	  found	  in	  CDK	  consensus	  motifs	  (S/PxR/K).	  Therefore	  it	  is	  likely	  that	  tryptic	  cleavage	  occurred	  in	  phosphorylated	  CDK	  motifs,	  and	  therefore	  the	  phosphorylated	  serine	  or	  threonine	  wouldn’t	  be	  present	  on	  one	  of	  the	  peptides.	  	  	   Mutation	  of	  the	  six	  CDK	  consensus	  sites	  in	  Fkh2	  to	  alanine	  appears	  to	  affect	  the	  protein	  level	  (Fig.	  4.2.7B.	  4.2.8B),	  as	  well	  as	  the	  phosphorylation	  shift.	  This	  could	  be	  due	  to	  the	  absence	  of	  phosphorylation	  making	  Fkh2	  unstable,	  or	  preventing	  Fkh2	  from	  positively	  reinforcing	  its	  own	  expression.	  The	  glutamic	  or	  aspartic	  acid	  substitutions	  at	  these	  sites	  give	  increased	  levels	  of	  Fkh2	  compared	  with	  both	  the	  A	  mutant	  and	  the	  wild-­‐type	  strain	  (Fig.	  4.2.7-­‐8.).	  Also	  the	  peak	  in	  Fkh2	  phosphorylation	  occurs	  coincidental	  with	  peak	  protein	  level	  (Fig.	  4.2.1-­‐2.).	  These	  observations	  suggest	  that	  phosphorylation	  of	  Fkh2	  may	  reinforce	  its	  own	  expression.	  	   Mutation	  of	  the	  six	  consensus	  sites	  to	  phosphomimetic	  glutamic	  or	  aspartic	  acid	  still	  produced	  two	  bands	  for	  Fkh2	  on	  a	  1D	  SDS-­‐PAGE	  gel	  (Fig.	  4.2.7-­‐8.).	  It	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would	  be	  expected	  that	  this	  change	  in	  the	  molecular	  weight,	  and	  charge	  of	  the	  protein,	  would	  cause	  the	  whole	  protein	  to	  run	  at	  the	  same	  level	  as	  the	  upper	  band	  of	  the	  wild-­‐type	  phosphorylated	  form.	  However	  as	  observed	  this	  is	  not	  the	  case,	  suggesting	  that	  the	  CDK	  phosphorylation	  may	  prime	  further	  phosphorylation	  or	  other	  post-­‐translational	  modifications	  to	  occur.	  	   Mutating	  the	  CDK	  minimal	  and	  consensus	  sites	  to	  A	  or	  E/D	  showed	  the	  same	  band-­‐shift	  patterns	  observed	  for	  the	  consensus	  site	  mutants	  only	  (Fig.	  4.2.8.).	  This	  was	  also	  the	  case	  for	  the	  fkh2(11A)	  mutant	  with	  all	  the	  minimal	  and	  consensus	  CDK	  sites	  C-­‐terminal	  to	  the	  DNA	  binding	  domain	  mutated	  to	  A	  (Fig.	  4.2.8.).	  Interestingly,	  the	  protein	  levels	  were	  greater	  for	  the	  15A	  and	  11A	  mutants	  compared	  with	  the	  6ACDK	  mutant	  (Fig.	  4.2.8.).	  Assuming	  that	  all	  these	  sites	  can	  be	  phosphorylated,	  this	  would	  suggest	  that	  a	  partial	  alteration	  of	  regulation	  is	  more	  severe	  than	  a	  complete	  loss	  of	  possible	  regulation.	  Another	  reason	  could	  be	  that	  these	  mutants	  have	  activated	  an	  alternative	  pathway	  that	  could	  regulate	  FKH2	  independently	  of	  Fkh2	  itself.	  	   The	  C-­‐terminal	  truncation	  of	  Fkh2	  (1-­‐426)	  and	  mutation	  of	  the	  CDK	  sites	  in	  the	  C-­‐terminus	  of	  the	  protein	  (11A)	  both	  cause	  loss	  of	  phosphorylation	  (Fig.	  4.2.8-­‐9.).	  This	  implies	  that	  it	  is	  the	  C-­‐terminus	  of	  Fkh2	  that	  is	  targeted	  for	  phosphorylation.	  This	  is	  as	  would	  be	  expected	  due	  to	  the	  clustering	  of	  CDK	  consensus	  and	  minimal	  sites	  within	  disordered	  C-­‐terminus	  of	  Fkh2.	  
	  
4.3.3.	  Difficulties	  in	  determining	  the	  kinase	  responsible	  for	  Fkh2	  
phosphorylation	  
	   It	  was	  expected	  that	  Fkh2	  is	  a	  substrate	  of	  a	  CDK,	  and	  that	  it	  was	  Cdk1	  that	  carried	  out	  the	  phosphorylation.	  This	  is	  due	  to	  the	  cluster	  of	  CDK	  consensus	  sites	  in	  the	  C-­‐terminus	  of	  the	  protein	  located	  in	  an	  intrinsically	  disordered	  region,	  and	  the	  fact	  that	  homologues	  of	  Fkh2	  in	  related	  organisms	  are	  CDK	  substrates.	  	  	   In	  vitro	  experiments	  confirmed	  that	  Cdk1	  could	  phosphorylate	  the	  C-­‐terminus	  of	  Fkh2	  (Fig.	  4.2.11.).	  However	  this	  does	  not	  appear	  to	  occur	  in	  vivo,	  as	  inhibition	  of	  Cdk1	  (Fig.	  4.2.12.)	  or	  deletion/repression	  of	  the	  associated	  cyclins	  (Fig.	  4.2.13.)	  has	  no	  effect	  on	  Fkh2	  phosphorylation.	  This	  is	  also	  supported	  by	  the	  fact	  that	  an	  interaction	  between	  Fkh2	  and	  CDKs	  could	  not	  be	  detected	  (Fig.	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4.2.14.).	  The	  in	  vitro	  phosphorylation	  data	  cannot	  be	  taken	  as	  enough	  to	  confirm	  that	  Fkh2	  is	  a	  Cdk1	  target,	  as	  the	  conditions	  for	  the	  assay	  are	  very	  different	  from	  those	  found	  in	  vivo.	  The	  fact	  that	  the	  C-­‐terminus	  of	  Fkh2	  has	  the	  target	  phosphorylation	  motifs	  for	  CDKs,	  along	  with	  the	  high	  concentrations	  of	  kinase,	  substrate	  and	  ATP	  will	  favor	  phosphorylation	  occurring.	  	  	   As	  Cdk1	  could	  not	  be	  shown	  to	  be	  responsible	  for	  Fkh2	  phosphorylation,	  a	  series	  of	  other	  kinases	  were	  tested.	  These	  were	  selected	  based	  on	  the	  likelihood	  that	  they	  would	  phosphorylate	  CDK	  consensus	  motifs.	  Neither	  Ssn3,	  Crk1,	  Tpk1/Tpk2	  nor	  Hog1	  could	  be	  seen	  to	  be	  responsible	  for	  the	  phosphorylation	  of	  Fkh2	  (Fig.	  4.2.15.).	  The	  only	  other	  CDK	  in	  C.	  albicans	  with	  a	  full	  PSTAIRE	  motif	  is	  Pho85.	  However	  testing	  this	  kinase	  has	  proved	  difficult,	  as	  the	  tetracycline	  promoter	  strain	  did	  not	  allow	  complete	  depletion	  of	  Pho85	  on	  addition	  of	  doxycycline	  (Fig.	  4.2.16.).	  On	  repression	  of	  Pho85	  there	  was	  no	  change	  observed	  in	  the	  level	  of	  Fkh2	  phosphorylation	  in	  yeast	  or	  hyphae;	  and	  conversely,	  over-­‐expression	  of	  Pho85	  by	  not	  repressing	  the	  tetracycline	  promoter	  did	  not	  cause	  any	  increase	  in	  Fkh2	  phosphorylation,	  with	  Fkh2	  remaining	  dephosphorylated	  in	  stationary	  phase	  (Fig.	  4.2.16.).	  These	  results	  would	  suggest	  that	  Pho85	  is	  not	  responsible	  for	  the	  phosphorylation	  of	  Fkh2.	  There	  is	  however	  a	  possibility	  that	  Pho85	  and	  Cdk1	  could	  be	  acting	  redundantly,	  but	  as	  yet	  it	  has	  not	  been	  possible	  to	  generate	  a	  strain	  in	  which	  both	  of	  these	  kinases	  are	  inhibited	  in	  order	  to	  test	  this.	  	   The	  data	  above	  suggest	  that	  Fkh2’s	  phospho-­‐regulation	  is	  not	  conserved	  from	  that	  observed	  in	  related	  yeast	  species.	  There	  are	  many	  other	  kinases	  that	  could	  be	  tested,	  some	  of	  which	  knockout	  mutants	  are	  available	  for.	  However	  this	  has	  not	  currently	  been	  possible.	  A	  BLAST	  search	  of	  the	  CDK	  PSTAIRE	  motif	  (EGVPSTAIREISLLKE)	  against	  the	  Candida	  genome	  found	  Orf19.1619	  to	  have	  78.6%	  identity.	  This	  protein	  is	  a	  possible	  homologue	  of	  S.	  cerevisiae	  CTK1,	  which	  has	  been	  shown	  to	  be	  a	  kinase	  subunit	  of	  RNA	  polymerase	  II	  (Lee	  &	  Greenleaf	  1991).	  	  Orf19.1619	  would	  be	  a	  good	  starting	  point	  for	  further	  investigation	  into	  the	  kinase	  responsible	  for	  phosphorylation	  of	  Fkh2.	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5	  	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  Fkh2	  Mutants	  	  
In	  the	  previous	  chapter	  the	  phospho-­‐regulation	  of	  Fkh2	  was	  investigated.	  Although	  the	  kinase	  that	  phosphorylates	  Fkh2	  remains	  unidentified,	  the	  sites	  that	  are	  phosphorylated	  upon	  hyphal	  induction	  are	  now	  known.	  Using	  the	  mutants	  generated	  in	  the	  previous	  chapter	  the	  effect	  of	  Fkh2	  phosphorylation	  can	  be	  dissected.	  These	  mutants	  allow	  the	  observation	  of	  the	  phenotypic	  consequences	  of	  Fkh2	  not	  being	  phosphorylated	  (6ACDK),	  and	  mimicking	  constitutive	  phosphorylation	  (6ECDK).	  Due	  to	  differential	  phosphorylation	  of	  Fkh2	  in	  hyphae	  compared	  to	  yeast,	  it	  is	  of	  interest	  to	  look	  at	  how	  this	  phosphorylation	  affects	  hyphal	  formation	  and	  maintenance.	  The	  phenotypic	  consequences	  of	  the	  phosphorylation	  can	  be	  compared	  with	  the	  phenotype	  of	  other	  Fkh2	  mutants,	  such	  as	  that	  of	  the	  fkh2∆/∆	  strain	  (Bensen	  et	  al.	  2002)	  and	  the	  FKH2	  overexpression	  strain	  (Chauvel	  et	  al.	  2012).	  In	  addition,	  further	  investigation	  into	  the	  above	  mentioned	  mutants	  could	  be	  carried	  out.	  	   	  
5.1	  Morphological	  consequences	  of	  Fkh2	  phosphorylation	  	  
5.1.1.	  Blocking	  of	  Fkh2	  phosphorylation	  affects	  yeast	  cell	  shape	  






































Fig.	  5.1.1.	  Phenotypes	  of	  Fkh2	  phospho-­‐mutants	  during	  yeast	  growth.	  A)	  100x	  DIC	  microscope	  images	  of	  the	  fkh2/FKH2,	  fkh2(6ACDK)	  and	  fkh2(6ECDK)	  strains.	  Scale	  bars	  represent	  5μm.	  B)	  Quantitation	  of	  the	  cell	  volume	  for	  each	  of	  the	  mutants	  (n=50). 
	  
	  
5.1.2.	  Blocking	  Fkh2	  phosphorylation	  results	  in	  altered	  hyphal	  morphology	  
and	  prevents	  maintenance	  of	  invasive	  filamentous	  growth.	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strain	  has	  a	  similar	  morphology	  to	  the	  wild-­‐type	  strain.	  The	  fkh2(6ACDK)	  strain	  can	  begin	  to	  form	  hyphae	  normally;	  however,	  constrictions	  form	  at	  the	  tips	  later	  in	  hyphal	  growth	  (Fig.	  5.1.2A.).	  Quantitation	  shows	  that	  more	  than	  half	  of	  the	  
fkh2(6ACDK)	  hyphae	  contain	  constrictions	  (Fig.	  5.1.2C.)	  This	  suggests	  that	  the	  cells	  are	  failing	  to	  maintain	  polarisation,	  possibly	  starting	  to	  revert	  back	  to	  the	  yeast	  morphology.	  This	  is	  supported	  by	  the	  observed	  branching	  in	  the	  fkh2(6ACDK)	  strain	  (Fig.	  5.1.2C.).	  The	  phosphorylation	  status	  of	  Fkh2	  does	  not	  appear	  to	  affect	  the	  rate	  of	  hyphal	  growth,	  as	  after	  5	  hours	  the	  mutant	  and	  wild-­‐type	  Fkh2	  hyphae	  are	  of	  similar	  length	  (Fig.	  5.1.2B.).	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20%	  serum	  to	  induce	  hyphal	  formation.	  BWP17,	  FKH2/FKH2-­‐YFP	  and	  fkh2/FKH2-­‐
YFP	  strains	  were	  used	  as	  controls	  to	  ensure	  that	  any	  observed	  phenotypes	  were	  not	  due	  to	  haploinsufficiency	  or	  the	  GFP	  tag	  affecting	  Fkh2	  function.	  	  The	  
FKH2/FKH2-­‐YFP	  and	  fkh2/FKH2-­‐YFP	  strains	  showed	  the	  same	  filamentation	  ability	  as	  BWP17,	  and	  when	  the	  surface	  colony	  was	  washed	  away	  extensive	  invasion	  of	  the	  underlying	  agar	  could	  be	  seen.	  This	  implies	  that	  the	  fkh2/FKH2	  strain	  is	  haplosufficient,	  and	  that	  tagging	  Fkh2	  with	  GFP	  does	  not	  impair	  its	  function.	  The	  
fkh2(6ACDK)	  strain	  formed	  smooth	  surface	  colonies	  on	  the	  serum	  agar	  that	  could	  easily	  be	  washed	  away,	  showing	  limited	  invasion	  of	  the	  agar	  substratum.	  The	  















Fig.	  5.1.3.	  Invasive	  ability	  of	  Fkh2	  phospho-­‐mutants	  on	  solid	  media.	  Overnight	  cultures	  were	  diluted	  to	  
an	  OD600	  of	  1.0	  before	  10	  fold	  serial	  dilutions	  were	  spotted	  onto	  YEPD	  agar	  with	  20%	  serum.	  Plates	  were	  
incubated	  at	  37°C	  for	  5	  days.	  Surface	  colonies	  were	  washed	  off	  using	  deionised	  water.	  
	  
	  
5.1.3.	  The	  phosphorylation	  status	  of	  Fkh2	  does	  not	  affect	  its	  localisation	  
	  	   One	  way	  in	  which	  phosphorylation	  can	  affect	  protein	  function	  is	  to	  control	  subcellular	  localisation.	  It	  is	  known	  that	  Fkh2	  normally	  localises	  to	  the	  distinct	  spot	  of	  the	  nucleus	  (Bensen	  et	  al.	  2002);	  therefore	  the	  localisation	  of	  the	  phospho-­‐
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mutants	  was	  observed	  using	  their	  C-­‐terminal	  GFP	  tag.	  Yeast	  cells	  were	  grown	  for	  microscopy	  as	  previously	  stated,	  with	  Fkh2	  localisation	  subsequently	  observed	  by	  fluorescence	  microscopy	  (Fig.	  5.1.4.).	  The	  GFP	  signal	  from	  the	  Fkh2	  6ACDK	  and	  6ECDK	  proteins	  is	  still	  primarily	  focused	  to	  a	  distinct	  area,	  similar	  to	  wild-­‐type	  Fkh2	  and	  consistent	  with	  a	  nuclear	  localisation.	  DAPI	  staining	  would	  have	  confirmed	  nuclear	  localisation;	  however,	  the	  vector-­‐shield	  DNA	  stain	  used	  at	  the	  time	  fixed	  the	  cells	  causing	  a	  loss	  of	  the	  Fkh2-­‐GFP	  signal,	  and	  therefore	  could	  not	  be	  used.	  	   To	  observe	  the	  Fkh2	  phosphorylation	  site	  mutant’s	  localisation	  during	  hyphal	  growth,	  liquid	  hyphal	  cultures	  were	  induced	  as	  previously	  described.	  These	  cultures	  were	  grown	  for	  5	  hours	  so	  that	  the	  morphological	  abnormalities	  of	  the	  




Fig.	  5.1.4.	  Localisation	  of	  Fkh2	  CDK	  consensus	  site	  mutants	  during	  yeast	  and	  hyphal	  growth.	  	  Cells	  
were	  grown	  in	  yeast	  or	  hyphal	  growth	  conditions	  for	  the	  times	  shown.	  20%	  serum	  was	  used	  for	  the	  
hyphal	  induction	  after	  filtering	  with	  an	  Amicon	  3K	  column.	  DIC	  and	  GFP	  images	  were	  taken	  at	  x100	  
magnification	  with	  a	  Leica	  DMR	  microscope. 
	  
5.1.4.	  Phenotypes	  of	  other	  Fkh2	  phosphorylation	  mutants.	  
	   In	  addition	  to	  the	  CDK	  consensus	  site	  mutants,	  other	  phospho-­‐mutants	  were	  generated	  in	  order	  to	  confirm	  the	  phosphorylation	  sites	  on	  Fkh2.	  With	  these	  mutants	  it	  was	  of	  interest	  to	  see	  the	  phenotypic	  effects	  during	  yeast	  and	  hyphal	  
FKH2%YFP( )h2(6ACDK)%GFP( )h2(6ECDK)%GFP(
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growth,	  and	  to	  compare	  these	  with	  the	  phenotypes	  of	  the	  other	  CDK	  consensus	  site	  mutants.	  	  
	  
5.1.4.1.	  Mutation	  of	  CDK	  consensus	  and	  minimal	  sites	  










Fig.	  5.1.5.	  Phenotypes	  and	  localisation	  of	  Fkh2	  CDK	  consensus	  and	  minimal	  site	  mutants	  during	  yeast	  
and	  hyphal	  growth.	  Cells	  were	  grown	  in	  yeast	  or	  hyphal	  growth	  conditions	  for	  the	  times	  shown.	  20%	  
serum	  was	  used	  for	  the	  hyphal	  induction	  after	  filtering	  with	  an	  Amicon	  3K	  column	  to	  remove	  factors	  



























Fig.	  5.1.6.	  Invasive	  ability	  of	  other	  Fkh2	  phosphorylation	  mutants	  on	  solid	  media.	  Strains	  were	  serially	  
diluted	  onto	  solid	  YEPD	  media	  with	  20%	  serum,	  and	  then	  incubated	  for	  5	  days	  at	  37°C.	  Surface	  colonies	  
were	  photographed	  before	  being	  washed	  away	  to	  reveal	  the	  extent	  of	  agar	  invasion. 
	  
5.1.4.2.	  Mutation	  of	  sites	  detected	  by	  phospho-­‐peptide	  mapping	  








Fig.	  5.1.7.	  Phenotypes	  and	  localisation	  of	  other	  Fkh2	  phosphorylation	  mutants	  during	  yeast	  and	  
hyphal	  growth.	  Cells	  were	  grown	  in	  yeast	  or	  hyphal	  inducing	  conditions	  for	  the	  times	  shown.	  20%	  serum	  
was	  used	  for	  the	  hyphal	  induction	  after	  filtering	  with	  an	  Amicon	  3K	  column.	  DIC	  and	  GFP	  images	  were	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5.1.4.3.	  Mutation	  of	  Fkh2	  C-­‐terminal	  CDK	  consensus	  and	  minimal	  sites	  
	   The	  fkh2(11A)	  mutant	  is	  blocked	  for	  phosphorylation	  at	  all	  CDK	  sites	  C-­‐terminal	  to	  the	  DNA	  binding	  domain.	  This	  mutant	  shows	  loss	  of	  the	  associated	  phospho-­‐band-­‐shifts,	  confirming	  that	  phosphorylation	  of	  Fkh2	  occurs	  in	  its	  C-­‐terminus	  (Fig.	  4.2.8.).	  The	  fkh2(11A)	  strain	  grows	  normally	  as	  yeast,	  but	  has	  quite	  profound	  defects	  in	  hyphal	  maintenance,	  shown	  by	  swelling	  at	  the	  hyphal	  tips	  (Fig.	  5.1.7.).	  fkh2(11A)	  maintained	  normal	  distinct	  localisation	  during	  yeast	  and	  hyphal	  growth,	  confirming	  that	  the	  absence	  of	  phosphorylation	  does	  no	  affect	  its	  localisation.	  	  
	  
5.1.4.4.	  Truncation	  of	  Fkh2’s	  C-­‐terminus	  (1-­‐426)	  
	   Truncation	  of	  the	  C-­‐terminus	  of	  Fkh2	  prevents	  phosphorylation	  of	  Fkh2	  occurring	  during	  both	  yeast	  and	  hyphal	  growth.	  fkh2(1-­‐426)	  yeast	  cells	  grow	  normally,	  but	  some	  hyphal	  cells	  again	  show	  constrictions	  near	  the	  tip	  (Fig.	  5.1.7.).	  Truncation	  of	  Fkh2	  causes	  minor	  filamentation	  defects	  on	  solid	  YEPD	  serum	  media,	  with	  only	  partial	  invasion	  of	  the	  agar	  substratum	  (Fig.	  5.1.6.).	  	  
	  
	  
5.2	  Fkh2-­‐dependent	  regulation	  of	  transcriptional	  programs.	  	   Mutation	  of	  the	  phosphorylation	  sites	  in	  Fkh2	  is	  shown	  above	  to	  affect	  the	  long-­‐term	  maintenance	  of	  invasive	  filamentous	  growth.	  As	  previously	  mentioned,	  Fkh2	  and	  its	  homologues	  are	  known	  transcriptional	  regulators;	  suggesting	  a	  hypothesis	  that	  the	  observed	  fkh2(6ACDK)	  phenotype	  is	  due	  to	  an	  altered	  hyphal	  transcriptional	  program.	  Previous	  microarray	  analysis	  with	  the	  fkh2∆/∆	  strain	  showed	  the	  hyphal	  expression-­‐specific	  genes	  ECE1	  and	  HYR1	  are	  down-­‐regulated	  in	  the	  absence	  of	  FKH2	  (Bensen	  et	  al.	  2002).	  However	  this	  study	  used	  a	  limited	  array,	  only	  containing	  probes	  for	  319	  out	  of	  6525	  C.	  albicans	  ORFs,	  and	  therefore	  is	  likely	  to	  have	  under-­‐represented	  the	  transcriptional	  role	  of	  Fkh2.	  To	  investigate	  the	  role	  of	  Fkh2	  and	  its	  phospho-­‐regulation	  in	  yeast	  and	  hyphal	  growth,	  complete	  arrays	  were	  carried	  out	  as	  listed	  below:	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A) fkh2∆/∆	  (Experimental)	  vs.	  BWP17	  (Control):	  3hours	  yeast	  growth	  in	  YEPD	  (Fig.	  5.2.6.)	  	  
B) fkh2(6ACDK)	  (Experimental)	  vs.	  FKH2/FKH2-­‐YFP	  (Control):	  3hours	  yeast	  growth	  in	  YEPD	  (Fig.5.2.7)	  	  	  
C) fkh2∆/∆	  (Experimental)	  vs.	  BWP17	  (Control):	  3hours	  hyphal	  growth	  in	  YEPD	  plus	  20%	  serum	  (Fig.	  5.2.2.)	  	  
D) fkh2(6ACDK)	  (Experimental)	  vs.	  FKH2/FKH2-­‐YFP	  (Control):	  3hours	  hyphal	  growth	  in	  YEPD	  plus	  20%	  serum.	  (Fig.	  5.2.3)	  	  
E) PGAL1-­‐FKH2-­‐GFP	  (Experimental)	  vs.	  FKH2/FKH2-­‐YFP	  (control):	  3hours	  yeast	  growth	  in	  YEPG.	  The	  results	  of	  this	  array	  will	  be	  presented	  in	  a	  separate	  section	  below	  (Fig.	  5.4.5).	  	  	  	   For	  the	  fkh2(6ACDK)	  array	  experiments	  the	  correct	  control	  strain	  to	  have	  used	  would	  be	  fkh2/FKH2-­‐YFP,	  as	  this	  would	  negate	  any	  possible	  effects	  due	  to	  haploinsufficiency;	  however	  this	  strain	  was	  not	  available	  at	  the	  time	  the	  arrays	  were	  carried	  out,	  therefore	  the	  FKH2/FKH2-­‐YFP	  strain	  was	  used.	  However	  as	  shown	  below,	  qPCR	  experiments	  using	  the	  fkh2/FKH2-­‐YFP	  strain	  confirmed	  the	  main	  conclusions	  of	  the	  microarray	  (Fig.	  5.2.5.).	  Total	  RNA	  was	  isolated	  from	  each	  of	  the	  strains	  after	  the	  allotted	  time,	  with	  the	  quality	  being	  confirmed	  by	  formaldehyde	  agarose	  electrophoresis	  (Fig.	  5.2.1.).	  	  These	  samples	  were	  then	  sent	  to	  the	  microarray	  facility	  at	  Biopolis	  shared	  facilities	  for	  further	  processing	  by	  Dr.	  Vivien	  Koh.	  Here	  samples	  were	  reverse	  transcribed	  and	  Cy3	  (Control)	  or	  Cy5	  (Experimental)	  dyes	  added,	  before	  hybridisation	  to	  the	  arrays	  and	  subsequent	  scanning.	  Each	  of	  the	  five	  arrays	  was	  carried	  out	  twice	  with	  the	  initial	  data	  being	  provided	  in	  excel	  spreadsheets.	  These	  data	  were	  then	  combined	  for	  each	  sample	  by	  Dr.	  Ian	  Sudbery,	  and	  filtered	  for	  genes	  with	  a	  greater	  than	  two-­‐fold	  change	  in	  expression	  between	  the	  control	  and	  experimental	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samples,	  resulting	  in	  a	  false	  discovery	  rate	  of	  less	  than	  5%.	  The	  filtered	  data,	  of	  genes	  with	  significant	  expression	  changes,	  were	  then	  combined	  into	  one	  excel	  spreadsheet,	  allowing	  the	  comparison	  of	  each	  gene	  across	  all	  five	  arrays	  (See	  included	  CD).	  This	  spreadsheet	  has	  been	  sorted	  into	  five	  separate	  sheets;	  where	  each	  sheet	  shows	  up	  to	  the	  top	  50	  genes	  down	  or-­‐up-­‐regulated	  in	  each	  mutant	  strain	  compared	  with	  the	  control	  (Fig.	  5.2-­‐3,	  5.2.6-­‐7,	  5.4.5.).	  Also	  included	  in	  the	  spreadsheet	  are	  the	  presence	  of	  Fkh2	  consensus	  ((G/A)TAAA(C/T)AAA)	  or	  minimal	  (AAA(C/T)AAA)	  DNA	  binding	  sites	  (Gordân	  et	  al.	  2012)	  in	  the	  1kb	  upstream	  of	  the	  gene;	  found	  using	  the	  pattern	  matching	  program	  on	  the	  Candida	  genome	  Database	  http://www.candidagenome.org/cgi-­‐bin/PATMATCH/nph-­‐patmatch.	  As	  a	  standard	  up	  to	  12.7%	  of	  genes	  in	  the	  Candida	  genome	  contain	  a	  Fkh2	  consensus	  binding	  site	  in	  the	  1kb	  of	  upstream	  sequence,	  and	  up	  to	  61.6%	  of	  genes	  contain	  a	  minimal	  site.	  There	  is	  only	  a	  slight	  enrichment	  of	  consensus	  Fkh2	  binding	  sites	  in	  the	  combined	  microarray	  data	  set	  (15.47%	  genes	  –	  22%	  increase);	  however	  there	  is	  a	  greater	  enrichment	  of	  Fkh2	  minimal	  binding	  sites	  (83.5%	  genes	  –	  35%	  increase).	  Therefore	  this	  method	  can	  provide	  an	  indication	  of	  regulation	  by	  Fkh2,	  but	  will	  need	  to	  be	  confirmed	  by	  further	  in	  vivo	  experiments.	  Additional	  analysis	  of	  genes	  with	  a	  greater	  than	  two-­‐fold	  change	  in	  expression	  between	  the	  control	  and	  experimental	  samples	  was	  carried	  out	  using	  the	  Gene	  Ontology	  (GO)	  process	  slim	  mapper	  http://www.candidagenome.org/cgi-­‐bin/GO/goTermMapper,	  or,	  where	  possible,	  GO	  process	  term	  finder	  http://www.candidagenome.org/cgi-­‐bin/GO/goTermFinder	  on	  the	  Candida	  genome	  database.	  Values	  from	  these	  tables	  are	  referenced	  in	  the	  results	  sections	  and	  full	  tables	  can	  be	  found	  in	  excel	  spreadsheets	  on	  the	  supplementary	  CD.	  The	  GO	  process	  slim	  mapper	  lists	  all	  of	  the	  process	  categories	  that	  any	  of	  the	  genes	  in	  the	  set	  fall	  into,	  and	  will	  list	  categories	  for	  all	  of	  the	  genes;	  whereas	  the	  GO	  process	  term	  finder	  identifies	  GO	  categories	  for	  which	  the	  given	  gene	  set	  shows	  significant	  enrichment.	  Sets	  of	  up	  or	  down-­‐regulated	  genes	  from	  different	  arrays	  were	  compared	  using	  the	  list	  comparer	  from	  the	  Whitehead	  Institute	  at	  MIT	  http://jura.wi.mit.edu/bioc/tools/compare.php.	  These	  are	  presented	  in	  the	  Venn	  diagrams	  to	  allow	  visual	  comparison	  between	  samples	  (Fig.	  5.2.4,	  5.2.8-­‐9).	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Fig.	  5.2.1.	  Determination	  of	  RNA	  quality	  from	  Fkh2	  mutant	  strains	  before	  microarrays.	  RNA	  samples	  
were	  isolated	  from	  cultures	  grown	  for	  3hours	  in	  rich	  media	  for	  the	  listed	  conditions.	  5μl	  of	  total	  RNA	  
from	  each	  samples	  was	  run	  on	  a	  1.2%	  formaldehyde-­‐agarose	  gel,	  stained	  with	  ethidium	  bromide.	  Values	  
along	  the	  left	  hand	  side	  represent	  DNA	  ladder	  molecular	  weight	  values	  in	  kb.	   	  The	  five	  microarray	  experiments	  generated	  extensive	  data	  on	  Fkh2’s	  possible	  functions	  during	  both	  yeast	  and	  hyphal	  growth.	  This	  will	  be	  covered	  in	  two	  sections:	  firstly	  data	  will	  be	  presented	  and	  discussed	  on	  the	  role	  of	  Fkh2	  and	  its	  phospho-­‐regulation	  during	  invasive	  hyphal	  growth.	  This	  will	  be	  followed	  by	  a	  more	  detailed	  analysis,	  with	  presentation	  of	  the	  expression	  data	  from	  yeast	  growth,	  and	  further	  mining	  of	  both	  the	  yeast	  and	  hyphal	  expression	  data	  to	  try	  and	  elucidate	  other	  possible	  biological	  roles	  for	  Fkh2	  in	  C.	  albicans.	  	  
	  
	  
5.2.1.	  Overview:	  regulation	  of	  C.	  albicans	  virulence	  factor	  expression	  during	  
filamentous	  invasive	  growth	  through	  phosphorylation	  of	  Fkh2	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Fig.	  5.2.2.	  Genes	  down	  or	  up-­‐regulated	  in	  the	  absence	  of	  FKH2	  during	  hyphal	  growth.	  Excel	  
spreadsheet	  sorted	  for	  genes	  with	  reduced	  or	  increased	  expression	  in	  array	  C.	  Displayed	  are	  the	  top	  50	  
genes	  showing	  reduced/increased	  expression,	  along	  with	  the	  presence/absence	  of	  Fkh2	  binding	  sites	  in	  




A B C D E Consensus
ULP2 !4 !20 !11 !18 0 ULP2 ULP2 ULP2
SCW11 !19 0 !9 0 !4 #N/A #N/A
FGR41 !5 0 !8 0 !4 FGR41 FGR41
HYR1 !3 0 !8 !3 0 HYR1 #N/A
PGA10 4 0 !7 0 0 #N/A #N/A
orf19.5390 !6 0 !6 0 4 orf19.5390 #N/A
SAP6 0 0 !5 !6 0 SAP6 #N/A
CHT2 !2 0 !5 !7 0 CHT2 CHT2
orf19.2019 0 0 !5 0 0 orf19.2019 orf19.2019
PGA34 0 0 !5 !3 0 PGA34 PGA34 PGA34
ERG1 !2 0 !5 0 0 ERG1 ERG1
ERG26 !2 0 !5 0 0 #N/A ERG26
SAP4 0 0 !4 !6 0 SAP4 #N/A
ATO2 !4 0 !4 0 0 ATO2 #N/A ATO2
HGT6 0 0 !4 !2 0 HGT6 HGT6
CRH11 0 0 !4 !2 0 CRH11 CRH11 CRH11
FKH2 !6 !2 !4 0 5 FKH2 FKH2 FKH2
orf19.1562 !3 0 !4 !2 !2 #N/A orf19.1562
ERG11 !2 0 !4 0 0 ERG11 ERG11
orf19.1964 0 0 !4 0 0 #N/A #N/A
orf19.2890 0 0 !4 0 0 #N/A #N/A
tS(CGA)1 0 !2 !4 !3 0 #N/A #N/A
KAR2 5 2 !4 0 0 #N/A #N/A
orf19.7043 0 0 !4 0 0 #N/A orf19.7043
UPC2 0 0 !4 0 0 #N/A UPC2
PHM7 0 !2 !4 0 0 PHM7 PHM7
orf19.1272 !3 0 !4 0 0 #N/A orf19.1272
MET15 0 0 !4 0 0 #N/A MET15
PGA38 !4 0 !4 0 !3 #N/A #N/A
orf19.210 !2 0 !4 0 0 orf19.210 #N/A
orf19.281 0 0 !4 0 0 orf19.281 orf19.281 orf19.281
orf19.3132 !3 0 !3 0 0 #N/A #N/A
AGO1 !2 !2 !3 !3 0 AGO1 #N/A
CGT1 0 0 !3 0 0 CGT1 #N/A
orf19.3655 0 0 !3 0 0 #N/A #N/A
GIT2 0 0 !3 !2 0 GIT2 GIT2 GIT2
orf19.3051 0 0 !3 !2 0 orf19.3051 orf19.3051 #N/A
orf19.4013 0 0 !3 0 0 orf19.4013 #N/A orf19.4013
ERG10 0 0 !3 !8 0 #N/A #N/A
FRP1 0 0 !3 0 0 FRP1 #N/A
PGA7 2 !2 !3 0 0 #N/A #N/A
orf19.3393 !2 0 !3 0 0 #N/A #N/A
CHT3 !6 0 !3 0 !6 CHT3 CHT3
NOC4 !4 0 !3 0 2 #N/A NOC4
SNO1 0 0 !3 0 0 SNO1 #N/A
RBT5 6 0 !3 0 0 RBT5 #N/A
PGA6 0 0 !3 0 0 #N/A PGA6
orf19.693 4 0 !3 0 4 #N/A orf19.693
MET14 !3 0 !3 0 0 #N/A MET14
orf19.2167 !2 0 !3 0 0 #N/A orf19.2167









A B C D E
WH11 65 0 19 0 6
KAR5 7 0 9 5 0
orf19.1991 4 0 9 0 3
orf19.4216 9 0 9 4 0
NTH1 5 2 7 0 0
HSP21 3 0 7 2 0
orf19.1363 8 0 7 0 2
DAG7 0 0 6 0 0
orf19.7306 6 0 6 0 3
REP1 5 0 6 0 0
PGA13 14 +2 6 0 3
ALS2 8 +2 6 0 2
UGA6 0 0 5 0 0
PUS4 6 0 5 0 0
orf19.3921 0 0 5 0 0
orf19.5735.3 0 0 5 0 0
SAP8 0 0 5 0 0
STE4 3 0 5 0 0
CSH1 14 0 5 2 4
ARG4 3 4 5 5 0
orf19.7310 6 0 5 0 0
HAK1 0 4 5 0 0
orf19.4172 0 0 5 0 0
orf19.3556 0 0 4 0 0
IFA14 2 0 4 0 0
orf19.7487 0 0 4 0 0
orf19.3748 0 0 4 0 0
CAN1 2 0 4 0 2
orf19.1534 0 0 4 0 0
CEK2 5 0 4 3 0
orf19.1658 0 0 4 0 0
UGA3 2 0 4 0 0
orf19.2537 0 0 4 0 0
orf19.2631 +2 0 4 0 0
ZCF6 0 +3 4 0 0
orf19.2846 5 0 4 0 0
CLB4 2 2 4 3 0
orf19.4570 3 0 4 0 0
PDE1 2 0 4 2 0
orf19.654 0 0 4 0 0
PRM9 0 3 4 2 0
RBF1 9 0 4 0 2
orf19.6873.1 0 0 4 0 0
orf19.1533 0 0 4 0 0
orf19.1862 9 0 4 0 5
orf19.1179 0 5 4 0 0
TLO34 4 0 4 0 +2
orf19.4043 3 0 4 0 0
orf19.1034 0 0 3 0 0
orf19.5572 0 0 3 0 0
EBP1 6 0 3 0 0




Fig.	  5.2.3.	  Genes	  down	  or	  up-­‐regulated	  on	  blocking	  Fkh2	  phosphorylation	  during	  hyphal	  growth.	  Excel	  
spreadsheet	  sorted	  for	  genes	  with	  increased	  or	  decreased	  expression	  in	  array	  D.	  Displayed	  are	  the	  top	  
50	  genes	  down/up-­‐regulated	  during	  hyphal	  growth	  in	  the	  absence	  of	  Fkh2	  phosphorylation,	  with	  the	  
presence	  or	  absence	  of	  a	  Fkh2	  DNA	  binding	  site	  in	  the	  1kb	  upstream	  of	  the	  gene.	   	  	  
A B C D E Consensus
RHR2 0 2 0 #20 0 RHR2 RHR2
ULP2 #4 #20 #11 #18 0 ULP2 ULP2 ULP2
DUR35 0 0 0 #11 0 #N/A DUR35
orf19.6754 0 0 0 #8 0 orf19.6754 orf19.6754
ERG10 0 0 #3 #8 0 #N/A #N/A
ECE1 0 0 #3 #7 0 ECE1 #N/A ECE1
CHT2 #2 0 #5 #7 0 CHT2 CHT2
SAP6 0 0 #5 #6 0 SAP6 #N/A
SAP4 0 0 #4 #6 0 SAP4 #N/A
FRE10 0 #2 0 #5 0 #N/A #N/A
PDC12 0 0 #2 #5 0 #N/A #N/A
HGC1 0 0 0 #4 4 HGC1 #N/A
MAK21 0 0 0 #4 0 MAK21 MAK21 MAK21
POL93 0 0 0 #4 0 #N/A POL93
SAP5 0 0 0 #3 0 SAP5 #N/A
orf19.4414 0 0 0 #3 0 #N/A #N/A
tS(CGA)1 0 #2 #4 #3 0 #N/A #N/A
orf19.4194 3 0 0 #3 0 #N/A #N/A
orf19.6741 #3 0 #2 #3 0 orf19.6741 orf19.6741
GRX1 0 0 0 #3 0 GRX1 #N/A GRX1
orf19.2322.3 0 0 0 #3 0 #N/A #N/A
orf19.6501 0 0 0 #3 0 #N/A #N/A
GPX2 2 0 0 #3 0 #N/A #N/A
ECM331 5 0 #3 #3 2 #N/A ECM331
ADE5,7 0 0 #2 #3 0 ADE5,7 ADE5,7
AGO1 #2 #2 #3 #3 0 AGO1 #N/A
HYR1 #3 0 #8 #3 0 HYR1 #N/A
KIP4 0 0 #3 #3 0 KIP4 KIP4 #N/A
GOR1 0 0 0 #3 4 GOR1 #N/A
orf19.6079 0 0 0 #3 0 orf19.6079 #N/A
MAL2 0 0 #3 #3 0 #N/A MAL2
GDH3 #4 #5 0 #3 0 #N/A #N/A
PGA34 0 0 #5 #3 0 PGA34 PGA34 PGA34
orf19.4450.1 0 0 #2 #3 0 #N/A #N/A
orf19.715 4 0 0 #3 0 #N/A orf19.715
DEF1 0 #6 0 #3 3 DEF1 #N/A
orf19.178 3 0 0 #3 2 #N/A orf19.178
RPS19A 0 0 0 #2 3 #N/A #N/A
GIT2 0 0 #3 #2 0 GIT2 GIT2 GIT2
orf19.3128 0 0 #3 #2 0 orf19.3128 #N/A
MSB2 0 0 0 #2 0 MSB2 #N/A
TRY6 0 0 0 #2 0 #N/A #N/A
YVC1 0 0 #3 #2 0 #N/A YVC1
SEO1 0 0 #3 #2 0 #N/A SEO1
PGA50 0 0 0 #2 0 PGA50 PGA50
ARO9 0 0 #3 #2 3 ARO9 ARO9 #N/A
orf19.3325 0 0 #2 #2 0 #N/A #N/A
orf19.2210 0 0 #3 #2 0 orf19.2210 orf19.2210 orf19.2210
orf19.6118 0 0 0 #2 0 orf19.6118 orf19.6118 orf19.6118
orf19.334 0 0 #2 #2 0 orf19.334 orf19.334
CDC4 0 0 0 #2 0 #N/A CDC4
A B C D E Consensus
PWP1 0 0 0 25 0 PWP1 #N/A PWP1
tR(CCG)1 0 2 0 7 5 #N/A #N/A
KAR5 7 0 9 5 0 #N/A KAR5
ARG4 3 4 5 5 0 #N/A ARG4
TLO4 0 0 0 4 0 TLO4 #N/A
tL(CAA)1 0 0 0 4 0 #N/A #N/A
orf19.5842 0 0 0 4 0 #N/A #N/A
tP(UGG)1 0 2 0 4 4 #N/A #N/A
orf19.1189 0 0 2 4 0 orf19.1189 orf19.1189
VPS35 0 0 0 4 0 VPS35 #N/A
tP(AGG)1 0 5 0 4 5 #N/A #N/A
orf19.5264 0 0 0 4 0 #N/A #N/A
orf19.4216 9 0 9 4 0 orf19.4216 #N/A orf19.4216
orf19.3517 0 0 0 3 0 orf19.3517 #N/A orf19.3517
tP(UGG)4 0 0 0 3 3 #N/A #N/A
orf19.588 0 0 0 3 0 #N/A #N/A
ZCF5 0 0 0 3 0 #N/A ZCF5
orf19.4703 0 0 0 3 2 orf19.4703 orf19.4703 orf19.4703
orf19.6487 0 0 0 3 6 orf19.6487 orf19.6487
POT1H2 0 0 0 3 0 #N/A POT1@2
RAD6 0 0 2 3 0 #N/A #N/A
tW(CCA)1 0 0 0 3 3 #N/A #N/A
HGT18 2 0 0 3 0 HGT18 #N/A
tA(AGC)1 0 0 0 3 3 #N/A #N/A
IFG3 0 0 0 3 0 #N/A #N/A
tV(AAC)6 0 0 0 3 3 #N/A #N/A
PIN4 0 0 0 3 0 PIN4 PIN4 PIN4
CLB4 2 2 4 3 0 CLB4 #N/A
tN(GUU)1 0 0 0 3 0 #N/A #N/A
tV(AAC)1 0 0 0 3 2 #N/A #N/A
tY(GUA)1 0 0 0 3 3 #N/A #N/A
COF1 0 0 0 3 2 COF1 #N/A
FGR42 0 0 0 3 0 FGR42 #N/A FGR42
GSC1 0 2 0 3 0 GSC1 #N/A
CEK2 5 0 4 3 0 #N/A CEK2
orf19.3607 0 0 2 3 0 orf19.3607 #N/A
orf19.652 0 0 0 3 0 #N/A #N/A
MAM33 0 0 2 2 0 #N/A MAM33
HHT2 0 3 0 2 2 HHT2 #N/A
tI(AAU)1 0 0 0 2 0 #N/A #N/A
orf19.6264.4 0 0 0 2 2 orf19.6264.4 orf19.6264.4 orf19.6264.4
CIS2 0 0 0 2 0 CIS2 CIS2
CAG1 5 5 3 2 0 CAG1 #N/A
tY(GUA)4 0 0 0 2 2 #N/A #N/A
orf19.1208 0 2 0 2 0 #N/A #N/A
CTA26 0 0 2 2 0 CTA26 #N/A
orf19.7602 0 0 0 2 0 #N/A #N/A
orf19.5727 0 0 0 2 0 #N/A orf19.5727
orf19.4346 0 0 0 2 0 orf19.4346 #N/A
orf19.7203 0 0 0 2 0 orf19.7203 orf19.7203 #N/A
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Fig.	  5.2.4.	  Venn	  diagrams	  comparing	  genes	  with	  altered	  expression	  during	  hyphal	  growth	  in	  the	  
fkh2∆/∆	  and	  fkh2(6ACDK)	  strains.	  A)	  Genes	  down-­‐regulated	  during	  hyphal	  growth	  B)	  Genes	  up-­‐regulated	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filamentous	  growth	  (14.9%),	  biofilm	  formation	  (12.2%)	  and	  pathogenesis	  (8.1%)	  compared	  with	  the	  fkh2∆/∆	  strain.	  GO	  term	  analysis	  of	  the	  fkh2∆/∆	  down	  regulated	  gene	  set	  shows	  that	  in	  addition	  to	  hyphal	  specific	  genes,	  genes	  involved	  in	  a	  wide	  range	  of	  cell	  functions	  are	  significantly	  affected.	  Indeed,	  in	  the	  fkh2∆/∆	  gene	  set	  the	  only	  GO	  term	  associated	  with	  hyphal	  growth	  is	  “response	  to	  a	  biotic	  substance”	  (See	  GO	  term	  spreadsheet)	  which	  refers	  to	  a	  response	  to	  serum	  (Inglis	  et	  al.	  2013).	  In	  terms	  of	  significance	  this	  is	  ranked	  18	  out	  of	  21	  terms	  identified.	  In	  contrast,	  the	  GO	  term	  analysis	  of	  the	  fkh2(6ACDK)	  data	  shows	  that	  the	  processes	  significantly	  affected	  are	  almost	  exclusively	  associated	  with	  functions	  such	  as	  adhesion,	  biofilm	  formation,	  interaction	  with	  the	  host	  and	  immune	  system	  response.	  Also,	  in	  the	  
fkh2(6ACDK)	  strain	  the	  hyphal	  specific	  cyclin	  HGC1	  shows	  reduced	  expression	  during	  hyphal	  growth,	  which	  is	  not	  the	  case	  in	  the	  fkh2∆/∆	  strain	  (Fig.	  5.2.2).	  The	  above	  results	  indicate	  that	  the	  hyphal	  phosphorylation	  of	  Fkh2	  may	  be	  specifically	  required	  for	  the	  expression	  of	  pathogenesis	  genes	  in	  C.	  albicans.	  	  To	  further	  differentiate	  between	  the	  effect	  of	  loss	  of	  FKH2	  and	  blocking	  Fkh2	  phosphorylation,	  GO	  term-­‐finder/slim-­‐mapper	  process	  analysis	  was	  carried	  out	  separately	  for	  genes	  down-­‐regulated	  only	  in	  the	  fkh2∆/∆	  (fkh2∆/∆-­‐only),	  for	  genes	  only	  down	  regulated	  in	  the	  fkh2(6ACDK)	  (fkh2(6ACDK)-­‐only)	  strain,	  and	  for	  genes	  that	  are	  down-­‐regulated	  in	  both	  strains.	  Interestingly	  GO	  slim	  analysis	  showed	  that	  GO	  terms	  for	  pathogenesis,	  interspecies	  interaction	  and	  biofilm	  formation	  show	  strong	  representation	  in	  the	  fkh2(6ACDK)-­‐only	  group,	  and	  the	  set	  of	  genes	  down-­‐regulated	  in	  both	  strains,	  but	  not	  in	  the	  fkh2∆/∆-­‐only	  gene	  set	  (Table	  5.1.).	  This	  is	  further	  supported	  using	  the	  GO	  term-­‐mapper	  analysis,	  which	  only	  shows	  significant	  enrichment	  of	  genes	  involved	  in	  host	  interaction	  and	  pathogenesis	  in	  the	  fkh2(6ACDK)-­‐only	  (Table	  5.2)	  and	  down-­‐regulated	  in	  both	  strains	  gene	  sets	  (Table	  5.3),	  but	  not	  in	  the	  fkh2∆/∆-­‐only	  gene	  set	  (Table	  5.4).	  Thus,	  Fkh2	  phosphorylation	  is	  required	  to	  specifically	  activate	  a	  subset	  of	  genes	  that	  are	  associated	  with	  invasion,	  biofilm	  formation,	  host-­‐pathogen	  interaction	  and	  commensalism.	  For	  genes	  that	  are	  down-­‐regulated	  in	  both	  fkh2∆/∆	  and	  
fkh2(6ACDK)	  strains,	  further	  down-­‐regulation	  is	  generally	  observed	  in	  the	  
fkh2(6ACDK)	  strain	  compared	  to	  the	  fkh2∆/∆	  strain.	  Thus,	  lack	  of	  Fkh2	  phosphorylation	  specifically	  changes	  the	  properties	  of	  Fkh2	  rather	  than	  simply	  impairing	  its	  function.	  A	  hypothesis	  that	  would	  explain	  why	  there	  is	  greater	  loss	  of	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gene	  function	  with	  loss	  of	  the	  Fkh2	  phosphorylation	  sites	  compared	  to	  the	  absence	  of	  FKH2	  is	  that	  the	  phosphorylation	  changes	  the	  action	  of	  Fkh2	  from	  a	  repressor	  to	  an	  inducer	  of	  gene	  expression.	  	  	   	  	  	  	  	  	  	  
	  
Table.	  5.1.	  Comparison	  of	  GO	  slim	  process	  terms	  associated	  with	  virulence	  for	  genes	  down-­‐
regulated	  during	  hyphal	  growth	  in	  the	  fkh2∆/∆-­‐only,	  fkh2(6ACDK)-­‐only	  and	  in	  both	  strains.	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4.50% 0.40% 4.84E805 0.00% ERG24:ERG6:ARE2:NCP1:ERG26:UPC2:ERG1:ERG2:
ERG11
ergosterol+metabolic+process 4.50% 0.40% 4.84E805 0.00% ERG24:ERG6:ARE2:NCP1:ERG26:UPC2:ERG1:ERG2:
ERG11
sterol+metabolic+process 5.00% 0.60% 8.31E805 0.00% ERG24:ERG6:orf19.2050:ARE2:NCP1:ERG26:UPC2:
ERG1:ERG2:ERG11
















4.00% 0.40% 0.00038 0.00% ERG24:ERG6:NCP1:ERG26:UPC2:ERG1:ERG2:ERG1
1
sterol+biosynthetic+process 4.00% 0.40% 0.00103 0.00% ERG24:ERG6:NCP1:ERG26:UPC2:ERG1:ERG2:ERG1
1





























5.50% 1.00% 0.00409 0.00% ERG24:ERG6:NCP1:PDC11:ERG26:SNO1:UPC2:PSD
2:ERG1:ERG2:ERG11

















7.00% 1.70% 0.00658 0.00% ERG24:ERG6:orf19.2050:orf19.21:ARE2:NCP1:PDC
11:ERG26:SNO1:UPC2:PSD2:ERG1:ERG2:ERG11
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Tables.	  5.2-­‐4.	  GO	  term	  finder	  analysis	  for	  down-­‐regulated	  gene	  sets.	  5.2)	  Genes	  down	  regulated	  in	  fkh2(6ACDK)-­‐only	  set	  during	  hyphal	  growth.	  5.3)	  Gene	  that	  shown	  down-­‐regulation	  in	  both	  the	  fkh2∆/∆	  and	  fkh2(6ACDK)	  strains	  during	  hyphal	  growth.	  5.4)	  Genes	  that	  are	  only	  down-­‐regulated	  in	  the	  fkh2∆/∆	  -­‐only	  set	  during	  hyphal	  growth.	  	  
5.2.2.	  Confirming	  Fkh2’s	  phosphorylation-­‐dependent	  regulation	  of	  genes	  for	  
filamentous	  invasive	  growth.	  	  
	   It	  was	  shown	  that	  a	  number	  of	  hyphal	  specific	  genes	  are	  down-­‐regulated	  in	  the	  absence	  of	  Fkh2	  phosphorylation.	  However	  as	  previously	  mentioned	  the	  
FKH2/FKH2-­‐YFP	  control	  strain	  used	  was	  not	  the	  most	  appropriate,	  as	  the	  results	  observed	  may	  be	  due	  to	  haploinsufficiency	  of	  the	  fkh2/fkh2(6ACDK)	  strain.	  Also,	  only	  the	  fkh2(6ACDK)	  phosphorylation	  mutant	  strain	  was	  used	  in	  the	  microarray,	  therefore	  the	  transcriptional	  effect	  of	  the	  phosphomimetic	  fkh2(6ECDK)	  mutant	  


















































lipid'biosynthetic'process 7.50% 2.30% 0.03891 0.06% CDS1:ERG24:ERG6:SPT23:NCP1:ERG26:EHT1:SCS7:
UPC2:PSD2:ERG1:orf19.4240:FAS2:ERG2:ERG11
cellular'metal'ion'homeostasis 5.50% 1.40% 0.06429 0.12% VMA5:SPF1:orf19.3132:VCX1:FET34:orf19.4240:CT
R2:orf19.55:FRP1:RBT5:PGA10
metal'ion'homeostasis 5.50% 1.40% 0.09637 0.24% VMA5:SPF1:orf19.3132:VCX1:FET34:orf19.4240:CT
R2:orf19.55:FRP1:RBT5:PGA10
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remains	  unknown.	  To	  investigate	  both	  of	  these	  problems,	  and	  to	  confirm	  the	  results	  observed	  in	  the	  above	  microarrays,	  the	  expression	  of	  the	  hyphal-­‐specific	  genes	  ECE1,	  KIP4,	  HGC1,	  SAP4	  and	  CHT2	  was	  determined	  in	  the	  fkh2/FKH2-­‐YFP,	  
fkh2(6ACDK)	  and	  fkh2(6ECDK)	  strains	  using	  quantitative	  PCR	  (qPCR).	  	  	   For	  the	  experiment,	  cells	  were	  grown	  in	  hyphal-­‐inducing	  conditions	  as	  previously	  described.	  Total	  RNA	  was	  then	  isolated	  from	  the	  strains	  and	  reverse	  transcribed	  to	  cDNA,	  from	  which	  qPCR	  was	  carried	  out	  using	  primer	  pairs	  specific	  to	  each	  of	  the	  genes	  in	  question.	  Expression	  levels	  were	  normalised	  against	  the	  expression	  of	  the	  housekeeping	  gene	  ADE2.	  For	  each	  strain	  two	  biological	  replicates	  were	  carried	  out,	  with	  three	  technical	  replicates	  of	  each	  primer	  pair.	  The	  normalised	  threshold	  CT	  values	  for	  each	  gene	  in	  the	  respective	  strains	  were	  combined,	  being	  used	  as	  the	  exponent	  to	  the	  experimentally	  derived	  amplification	  value	  for	  the	  primer	  pair.	  This	  gives	  a	  value	  for	  the	  amount	  of	  the	  target	  gene	  transcript	  present	  in	  the	  total	  starting	  RNA	  from	  the	  different	  strains.	  These	  values	  are	  shown	  for	  each	  strain	  in	  Figure	  5.2.5A,	  allowing	  comparison	  of	  the	  amount	  of	  each	  transcript	  in	  the	  mutant	  and	  wild-­‐type	  strains.	  	  	   The	  normalised	  transcript	  levels	  in	  the	  phosphorylation	  mutants	  and	  wild-­‐type	  fkh2/FKH2-­‐YFP	  strain	  were	  then	  further	  compared	  using	  the	  ∆∆CT	  method	  as	  described	  in	  the	  materials	  and	  methods.	  These	  results	  are	  shown	  in	  Figure	  5.2.5B.	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Fig.	  5.2.5.	  qPCR	  confirmation	  of	  genes	  that	  with	  altered	  expression	  in	  the	  Fkh2	  phosphorylation	  
mutants.	  RNA	  was	  isolated	  from	  fkh2/FKH2-­‐YFP,	  fkh2	  (6ACDK)	  and	  fkh2(6ECDK)	  strains	  after	  3hours	  of	  
hyphal	  growth.	  A)	  Graph	  showing	  amplification	  of	  the	  target	  transcripts	  in	  the	  wild-­‐type	  Fkh2	  strain	  and	  
the	  phospho-­‐mutants.	  B)	  ∆∆CT	  analysis	  of	  transcript	  expression	  in	  the	  Fkh2	  phosphorylation	  mutants,	  
showing	  the	  relative	  level	  of	  each	  transcript	  compared	  to	  the	  wild-­‐type	  Fkh2	  strain.	  Results	  are	  from	  
two	  biological	  replicate	  experiments,	  each	  with	  three	  technical	  replicates.	  Error	  bars	  represent	  1	  
standard	  deviation.	   	  	   All	  of	  the	  invasive	  filamentation-­‐specific	  genes	  show	  a	  reduction	  in	  expression	  in	  the	  fkh2(6ACDK)-­‐GFP	  strain	  compared	  with	  the	  fkh2/FKH2-­‐YFP	  strain,	  with	  transcripts	  being	  present	  at	  less	  than	  half	  the	  wild-­‐type	  level	  in	  the	  phosphorylation	  blocked	  mutant.	  ECE1,	  KIP4	  and	  SAP4	  show	  expression	  levels	  that	  are	  similar	  to	  wild-­‐type	  in	  the	  fkh2(6ECDK)-­‐GFP	  strain	  (Fig.	  5.14B.).	  However	  HGC1	  and	  CHT2	  show	  reduced	  levels	  of	  expression	  in	  the	  phosphomimetic	  strain	  compared	  with	  the	  fkh2/FKH2-­‐YFP	  strain.	  The	  CHT2	  transcript	  also	  appears	  to	  be	  less	  abundant	  in	  the	  phosphomimetic	  Fkh2	  strain	  than	  in	  the	  phosphorylation	  blocked	  strain	  (Fig.	  5.14B.).	  This	  is	  not	  the	  case	  for	  the	  other	  genes,	  all	  of	  which	  show	  a	  higher	  transcript	  abundance	  in	  the	  fkh2(6ECDK)-­‐GFP	  strain	  compared	  to	  the	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5.2.3.	  Detailed	  analysis	  of	  the	  microarray	  results:	  FKH2	  deletion	  alters	  gene	  
expression	  during	  yeast	  growth	  	  
5.2.3.1	  Genes	  down-­‐regulated	  during	  yeast	  growth	  upon	  FKH2	  deletion	  	  GO	  slim	  process	  analysis	  was	  carried	  out	  for	  genes	  that	  are	  at	  least	  two-­‐fold	  down-­‐regulated	  in	  fkh2∆/∆	  yeast.	  The	  largest	  category,	  as	  for	  most	  of	  the	  arrays,	  is	  for	  genes	  whose	  biological	  function	  is	  unknown	  (25.8%).	  This	  is	  due	  to	  the	  limited	  annotation	  of	  the	  C.	  albicans	  genome,	  especially	  for	  genes	  of	  which	  no	  known	  S.	  
cerevisiae	  homologue	  exists.	  Therefore	  it	  is	  likely	  that	  the	  percentage	  values	  for	  each	  category	  under-­‐represent	  the	  actual	  number	  of	  genes	  present	  in	  the	  category.	  	  The	  best-­‐represented	  annotated	  categories	  are:	  regulation	  of	  biological	  processes	  (23.8%),	  transport	  (17.2%),	  and	  response	  to	  chemical	  stimulus	  (15.9%).	  Genes	  involved	  in	  cell-­‐cycle	  progression	  show	  lower	  than	  expected	  representation	  at	  8.6%;	  however	  a	  number	  of	  genes	  involved	  in	  stress	  response	  (15.9%)	  are	  down-­‐regulated,	  suggesting	  some	  relation	  to	  the	  function	  of	  S.	  cerevisiae	  FKH1	  and	  FKH2	  in	  regulating	  stress	  response	  (Postnikoff	  et	  al.	  2012).	  The	  cell	  wall	  proteins	  RBE1,	  SCW11,	  FGR41,	  HYR1,	  RHD3	  and	  PGA53	  all	  show	  down-­‐regulation	  in	  the	  absence	  of	  FKH2	  (Fig.	  5.2.6.).	  However	  this	  may	  be	  an	  indirect	  effect	  as	  EFG1	  is	  also	  down-­‐regulated,	  which	  is	  known	  to	  regulate	  the	  expression	  of	  cell	  wall	  proteins	  (Sohn	  et	  al.	  2003).	  The	  failure	  of	  fkh2∆/∆	  yeast	  cells	  to	  separate	  could	  be	  attributed	  to	  reduced	  expression	  of	  the	  cytokinetic	  protein	  HOF1,	  and	  the	  chitinases	  CHT2/3.	  FKH2	  has	  previously	  been	  shown	  to	  regulate	  histone	  genes	  in	  C.	  albicans	  (Bensen	  et	  al.	  2002),	  which	  is	  confirmed	  by	  the	  observed	  down-­‐regulation	  of	  the	  histone	  H2A	  HTA2,	  and	  the	  histone	  acetyl	  transferase	  TRA1.	  Evidence	  for	  the	  role	  of	  FKH2	  in	  cell	  cycle	  regulation	  can	  be	  taken	  from	  decreased	  expression	  of	  the	  Cdk1	  tyrosine	  phosphatase	  MIH1,	  the	  orthologue	  of	  the	  kinetochore	  component	  ScSPC42,	  ORF19.1484;	  and	  ULP2,	  a	  SUMO	  deconjugating	  enzyme	  with	  roles	  in	  transcription	  and	  DNA	  replication	  (Huaping	  et	  al.	  2007)	  (Fig.	  5.6.2.).	  ULP2	  is	  shown	  to	  be	  down-­‐regulated	  under	  all	  conditions	  tested	  except	  FKH2	  over-­‐expression,	  strongly	  suggesting	  positive	  regulation	  by	  Fkh2.	  This	  is	  supported	  by	  the	  presence	  of	  a	  Fkh2	  consensus	  binding	  site	  in	  the	  1kb	  upstream	  of	  the	  ULP2	  coding	  sequence.	  	  Another	  interesting	  gene	  that	  shows	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reduced	  expression	  in	  most	  of	  the	  Fkh2	  mutants	  is	  for	  the	  putative	  argonaute	  protein	  AGO1,	  which	  again	  contains	  a	  Fkh2	  minimal	  binding	  motif	  in	  its	  promoter.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  
Fig.	  5.2.6.	  Genes	  down	  or	  up-­‐regulated	  in	  the	  absence	  of	  FKH2	  during	  yeast	  growth.	  Excel	  spreadsheet	  
sorted	  for	  genes	  showing	  decreased/increased	  expression	  in	  array	  A.	  Displayed	  are	  the	  top	  50	  genes	  
down-­‐regulated	  during	  yeast	  growth	  on	  deletion	  of	  FKH2,	  included	  with	  the	  presence	  or	  absence	  of	  a	  
Fkh2	  binding	  site	  in	  the	  1kb	  upstream	  of	  the	  gene.	   
	  
	  
A B C D E Consensus
orf19.1484 !26 0 0 0 0 orf19.1484 orf19.1484 #N/A
SCW11 !19 0 !9 0 !4 #N/A #N/A
MIS12 !9 0 0 0 0 MIS12 #N/A
TIF4631 !9 0 !2 0 0 #N/A #N/A
orf19.8 !9 0 0 0 0 orf19.8 orf19.8 orf19.8
AOX1 !8 0 !2 0 0 AOX1 #N/A
orf19.4995 !8 0 0 0 0 #N/A #N/A
MSO1 !8 0 0 0 0 #N/A MSO1
RBE1 !8 0 0 0 !4 RBE1 RBE1
orf19.1258 !7 0 0 0 2 orf19.1258 #N/A
orf19.5971 !7 0 0 0 0 #N/A #N/A
orf19.2813 !6 0 0 0 0 #N/A #N/A
CHT3 !6 0 !3 0 !6 CHT3 CHT3
orf19.5390 !6 0 !6 0 4 orf19.5390 #N/A
NUP !6 !3 0 0 0 NUP NUP #N/A
FKH2 !6 !2 !4 0 5 FKH2 FKH2 FKH2
FGR41 !5 0 !8 0 !4 FGR41 FGR41
orf19.6083 !5 0 0 0 0 orf19.6083 orf19.6083
CPA1 !5 0 0 0 0 CPA1 CPA1 CPA1
ULP2 !4 !20 !11 !18 0 ULP2 ULP2 ULP2
PNC1 !4 0 0 0 0 #N/A #N/A
GDH3 !4 !5 0 !3 0 #N/A #N/A
NOC4 !4 0 !3 0 2 #N/A NOC4
PGA38 !4 0 !4 0 !3 #N/A #N/A
orf19.2778 !4 0 0 0 0 orf19.2778 #N/A
TAR1 !4 0 !3 0 0 #N/A #N/A
NDT80 !4 0 0 0 0 #N/A NDT80
ATO2 !4 0 !4 0 0 ATO2 #N/A ATO2
orf19.6586 !4 0 0 0 0 #N/A #N/A
orf19.5231 !4 0 0 0 0 orf19.5231 #N/A orf19.5231
orf19.6741 !3 0 !2 !3 0 orf19.6741 orf19.6741
orf19.2018 !3 !2 0 0 0 #N/A #N/A
orf19.6805 !3 !3 0 0 0 #N/A #N/A
orf19.1647 !3 0 0 0 0 #N/A orf19.1647
PEX8 !3 0 0 0 0 #N/A #N/A
orf19.3124 !3 0 0 0 0 orf19.3124 #N/A
orf19.5043 !3 0 0 0 0 #N/A #N/A
GPR1 !3 0 0 0 0 GPR1 GPR1
STP4 !3 0 0 0 0 STP4 #N/A
ERG6 !3 0 !3 0 0 #N/A #N/A
MET14 !3 0 !3 0 0 #N/A MET14
orf19.6476 !3 !3 0 0 0 orf19.6476 #N/A
orf19.5223 !3 2 0 0 0 orf19.5223 #N/A
orf19.2887 !3 0 !2 0 0 #N/A #N/A
OPT1 !3 !4 0 0 0 OPT1 OPT1
HXT5 !3 0 0 0 0 HXT5 HXT5 #N/A
orf19.1651 !3 0 3 2 0 orf19.1651 #N/A
HSX11 !3 0 0 0 0 HSX11 HSX11
orf19.2197 !3 0 0 0 0 orf19.2197 #N/A
orf19.35 !3 0 0 0 0 orf19.35 orf19.35 #N/A
PHO4 !3 0 0 0 0 #N/A #N/A
A B C D E Consensus
WH11 65 0 19 0 6 WH11 WH11
RBR1 25 2 2 0 5 RBR1 RBR1 #N/A
FGR624 16 0 /2 0 0 FGR6/4 #N/A
RNR22 15 0 0 0 0 RNR22 RNR22 RNR22
CSH1 14 0 5 2 4 #N/A #N/A
PGA13 14 /2 6 0 3 #N/A PGA13
orf19.915 12 0 0 0 3 orf19.915 orf19.915 orf19.915
ALS1 10 0 0 0 0 #N/A #N/A
orf19.1276 10 0 0 0 0 #N/A #N/A
RBF1 9 0 4 0 2 RBF1 #N/A
orf19.1862 9 0 4 0 5 orf19.1862 #N/A
orf19.4216 9 0 9 4 0 orf19.4216 #N/A orf19.4216
ALS2 8 /2 6 0 2 #N/A #N/A
orf19.1363 8 0 7 0 2 orf19.1363 orf19.1363 orf19.1363
DDR48 8 0 /2 0 0 DDR48 DDR48 DDR48
HSP70 8 0 0 2 2 HSP70 HSP70
orf19.711 7 2 3 2 0 orf19.711 orf19.711 orf19.711
KAR5 7 0 9 5 0 #N/A KAR5
PSA2 7 0 0 0 0 PSA2 #N/A PSA2
orf19.4195 7 0 0 0 0 #N/A #N/A
PUS4 6 0 5 0 0 #N/A #N/A
orf19.1210 6 0 0 0 0 #N/A #N/A
orf19.7310 6 0 5 0 0 #N/A orf19.7310
IHD1 6 0 0 0 0 IHD1 IHD1 IHD1
orf19.251 6 0 0 0 4 #N/A #N/A
FRS1 6 0 /2 0 0 #N/A #N/A
FDH1 6 0 2 0 0 FDH1 #N/A
MUM2 6 3 3 2 0 MUM2 #N/A
orf19.6608 6 0 0 0 0 orf19.6608 #N/A orf19.6608
EBP1 6 0 3 0 0 EBP1 EBP1
RBT5 6 0 /3 0 0 RBT5 #N/A
orf19.7306 6 0 6 0 3 #N/A #N/A
orf19.1535 6 0 0 0 0 #N/A #N/A
orf19.5592 5 0 0 0 0 orf19.5592 orf19.5592
orf19.1460 5 0 /2 0 0 #N/A orf19.1460
orf19.2846 5 0 4 0 0 orf19.2846 #N/A orf19.2846
orf19.3114 5 0 0 0 0 #N/A #N/A
KAR2 5 2 /4 0 0 #N/A #N/A
orf19.3581 5 0 0 0 0 orf19.3581 orf19.3581
GPD2 5 0 2 0 0 GPD2 GPD2
AQY1 5 0 2 0 /3 #N/A #N/A
ASR1 5 0 0 0 3 #N/A #N/A
orf19.5569 5 0 0 2 2 orf19.5569 #N/A
REP1 5 0 6 0 0 REP1 REP1
CAG1 5 5 3 2 0 CAG1 #N/A
CEK2 5 0 4 3 0 #N/A CEK2
ECM331 5 0 /3 /3 2 #N/A ECM331
ALS9 5 0 3 0 0 ALS9 #N/A
NTH1 5 2 7 0 0 NTH1 #N/A
GRP2 5 0 0 0 2 #N/A #N/A
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5.2.3.2.	  Genes	  up-­‐regulated	  during	  yeast	  growth	  upon	  FKH2	  deletion	  	   For	  genes	  with	  increased	  expression	  in	  the	  fkh2∆/∆	  mutant	  during	  yeast	  growth	  the	  GO	  analysis	  shows	  similar	  representation	  to	  that	  observed	  for	  down-­‐regulated	  genes.	  This	  includes	  strong	  representation	  of	  the	  GO	  categories:	  regulation	  of	  biological	  processes	  (18.2%),	  response	  to	  stress	  (15.1%),	  and	  response	  to	  chemical	  stimulus	  (14.7%);	  showing	  that	  Fkh2	  can	  differentially	  regulate	  subsets	  of	  genes	  involved	  in	  a	  similar	  process.	  The	  Cdk1	  B-­‐type	  cyclin	  
CLB4	  is	  up-­‐regulated,	  confirming	  the	  results	  of	  Bensen	  et	  al,	  and	  serving	  as	  a	  positive	  control	  to	  show	  that	  the	  microarray	  experiments	  are	  working	  correctly.	  	  A	  number	  of	  adhesin	  genes	  (ALS1,	  ALS2	  and	  ALS9)	  are	  up-­‐regulated	  during	  yeast	  growth	  (Fig.	  5.2.6.),	  suggesting	  an	  explanation	  for	  the	  observed	  clumping	  phenotype.	  There	  is	  also	  up-­‐regulation	  of	  a	  subset	  of	  stress	  response	  genes;	  combating	  problems	  such	  as:	  genotoxic	  stress	  (RAD51	  and	  DAP1),	  heat	  stress	  (HSP21,	  HSP31	  and	  HSP70)	  and	  reactive	  oxygen	  species	  (SOD4	  and	  SOD5).	  However	  this	  up-­‐regulation	  may	  be	  indirect;	  being	  due	  to	  the	  decreased	  fitness	  of	  the	  fkh2∆/∆	  strain,	  rather	  than	  loss	  of	  direct	  repression	  from	  Fkh2.	  HSP21,	  HSP70,	  
RAD51	  and	  SOD4/5	  all	  contain	  a	  minimal	  Fkh2	  binding	  motif	  in	  their	  1kb	  of	  upstream	  sequence,	  suggesting	  that	  they	  may	  indeed	  be	  negatively	  regulated	  by	  Fkh2	  in	  vivo.	  Interestingly	  -­‐	  the	  pheromone	  response	  MAPK	  pathway	  components	  
STE4	  and	  CEK2	  are	  also	  up-­‐regulated	  in	  this	  mutant.	  Increased	  expression	  of	  the	  cAMP	  phosphodiesterase	  PDE1	  could	  explain	  the	  difficulty	  of	  the	  fkh2∆/∆	  strain	  to	  respond	  to	  hyphal	  inducing	  signals,	  preventing	  the	  level	  of	  cAMP	  reaching	  that	  required	  for	  activation	  of	  the	  PKA	  pathway.	  PDE1	  is	  also	  shown	  to	  be	  up-­‐regulated	  in	  other	  Fkh2	  mutant	  arrays	  during	  hyphal	  growth	  (Fig.	  5.2.2.)	  	  
5.2.4.	  Blocking	  Fkh2	  phosphorylation	  affects	  gene	  expression	  during	  yeast	  
growth	  
	  	   Compared	  with	  the	  fkh2∆/∆	  mutant	  the	  transcriptional	  changes	  observed	  in	  the	  fkh2(6ACDK)	  mutant	  are	  not	  as	  extensive;	  with	  only	  44	  genes	  being	  down	  and	  76	  genes	  up-­‐regulated,	  compared	  with	  the	  151	  down	  and	  292	  genes	  up-­‐regulated	  during	  yeast	  growth	  in	  the	  fkh2∆/∆	  mutant.	  Of	  the	  genes	  that	  are	  down-­‐regulated,	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Figure	  5.2.7.	  Venn	  diagrams	  comparing	  genes	  with	  altered	  expression	  during	  yeast	  growth	  in	  the	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5.2.4.1.	  Genes	  down-­‐regulated	  during	  yeast	  growth	  on	  blocking	  Fkh2	  
phosphorylation	  	  	   The	  majority	  of	  down-­‐regulated	  genes	  fall	  into	  similar	  GO	  slim	  process	  categories	  as	  for	  the	  fkh2∆/∆	  strain;	  with	  most	  genes	  being	  involved	  in:	  regulation	  of	  biological	  processes	  (25%),	  transport	  (20.5%),	  filamentous	  growth	  (20.5%),	  stress	  response	  (18.2%),	  chemical	  response	  (11.4%)	  or	  cell	  cycle	  regulation	  (9.4%).	  The	  FKH2	  transcript	  itself	  is	  down-­‐regulated	  (Fig.	  5.2.8.),	  supporting	  the	  idea	  that	  phosphorylation	  of	  Fkh2	  may	  positively	  reinforce	  its	  own	  expression.	  	  A	  number	  of	  cell	  surface	  protein	  genes	  (PGA7,	  PGA13,	  PGA25	  and	  PGA56)	  and	  genes	  involved	  in	  mineral	  acquisition	  (ZRT2,	  FRE10,	  ORF19.4459)	  are	  also	  down-­‐regulated.	  Other	  interesting	  genes	  with	  reduced	  expression	  are:	  the	  mRNA	  binding	  protein	  She3,	  the	  MAPK	  Cek1	  and	  the	  RNA	  Polymerase	  II	  regulator	  Def1	  (Fig.	  5.2.8.).	  	  	  
5.2.4.2.	  Genes	  up-­‐regulated	  during	  yeast	  growth	  on	  blocking	  of	  Fkh2	  
phosphorylation.	  
	   GO	  slim	  mapping	  process	  analysis	  again	  shows	  strong	  representation	  of	  the	  groups:	  regulation	  of	  biological	  processes	  (26.3%),	  transport	  (15.8%),	  stress	  (13.2%)	  and	  chemical	  stimulus	  response	  (11.8%).	  However,	  there	  is	  increased	  representation	  for	  genes	  involved	  in	  carbohydrate	  metabolism	  (11.8%)	  and	  cell	  cycle	  regulation	  (11.8%).	  CLB4	  is	  again	  shown	  to	  be	  up-­‐regulated,	  suggesting	  that	  Fkh2	  phosphorylation	  may	  be	  required	  to	  negatively	  regulate	  CLB4	  expression	  during	  the	  cell	  cycle.	  A	  number	  of	  genes	  involved	  in	  DNA	  maintenance	  and	  regulation	  are	  up-­‐regulated;	  these	  include:	  the	  endonuclease	  SPO11,	  involved	  in	  recombination	  during	  the	  parasexual	  cycle;	  the	  histone	  H3	  HHT2,	  and	  ORF19.7420,	  which	  is	  thought	  to	  be	  involved	  in	  the	  regulation	  of	  RNA	  polymerase	  II.	  There	  is	  also	  an	  increased	  transcript	  level	  of	  the	  adenylyl	  cyclase	  CYR1,	  implying	  that	  there	  may	  be	  higher	  levels	  of	  intracellular	  cAMP	  in	  the	  fkh2(6ACDK)	  strain.	  Consistent	  with	  this	  hypothesis,	  PDE1	  does	  not	  show	  up-­‐regulation	  in	  fkh2(6ACDK)	  during	  yeast	  growth,	  which	  would	  be	  required	  to	  negatively	  regulate	  cAMP	  levels	  (Fig.	  5.2.8.).	  	  





























Fig.	  5.2.8.	  Genes	  down	  or	  up-­‐regulated	  on	  blocking	  Fkh2	  phosphorylation	  during	  yeast	  growth.	  Excel	  
spreadsheet	  sorted	  for	  genes	  with	  reduced	  expression	  in	  array	  B.	  Displayed	  are	  the	  44	  down-­‐regulated	  
genes	  on	  blocking	  Fkh2	  phosphorylation	  during	  yeast	  growth	  and	  the	  top	  50	  up-­‐regulated	  genes,	  
included	  with	  the	  presence	  or	  absence	  of	  a	  Fkh2	  binding	  site	  in	  the	  1kb	  upstream	  of	  the	  gene. 	  	  
	  	  
A B C D E Consensus A B C D E Consensus
ULP2 !4 !20 !11 !18 0 ULP2 ULP2 ULP2 orf19.6061 0 8 0 0 0 orf19.6061 #N/A
orf19.1117 0 !9 0 0 0 #N/A orf19.1117 ROT2 0 7 0 0 0 #N/A ROT2
ZRT2 !2 !6 0 0 0 #N/A #N/A orf19.4088 0 7 0 0 0 #N/A #N/A
DEF1 0 !6 0 !3 3 DEF1 #N/A orf19.1144 0 6 0 0 0 #N/A #N/A
GDH3 !4 !5 0 !3 0 #N/A #N/A CAG1 5 5 3 2 0 CAG1 #N/A
orf19.4459 0 !4 0 !2 0 #N/A orf19.4459 tP(AGG)1 0 5 0 4 5 #N/A #N/A
SHE3 0 !4 0 0 0 SHE3 SHE3 orf19.1179 0 5 4 0 0 #N/A #N/A
OPT1 !3 !4 0 0 0 OPT1 OPT1 ARG4 3 4 5 5 0 #N/A ARG4
GST3 3 !3 0 0 2 GST3 GST3 orf19.5863 0 4 0 0 0 orf19.5863 orf19.5863 orf19.5863
orf19.6476 !3 !3 0 0 0 orf19.6476 #N/A orf19.3151 0 4 0 0 0 #N/A #N/A
orf19.7225 0 !3 0 0 0 orf19.7225 #N/A PGA26 4 4 0 0 0 PGA26 #N/A
NUP !6 !3 0 0 0 NUP NUP #N/A HAK1 0 4 5 0 0 HAK1 HAK1
CEK1 0 !3 !3 0 0 #N/A #N/A orf19.1368 0 3 0 0 0 #N/A orf19.1368
ZCF6 0 !3 4 0 0 ZCF6 ZCF6 ZCF6 PRC3 0 3 0 0 0 #N/A PRC3
orf19.4090.1 0 !3 0 0 0 #N/A #N/A MUM2 6 3 3 2 0 MUM2 #N/A
orf19.6805 !3 !3 0 0 0 #N/A #N/A PGA39 0 3 0 0 0 PGA39 PGA39 #N/A
PHO84 0 !3 0 0 0 #N/A PHO84 CYR1 0 3 0 0 0 CYR1 #N/A
NDH51 0 !3 0 0 0 NDH51 #N/A orf19.7296 0 3 0 0 0 #N/A orf19.7296
SOD2 0 !2 0 0 0 #N/A #N/A orf19.4316 0 3 0 0 0 #N/A #N/A
orf19.4847 0 !2 0 0 0 #N/A #N/A orf19.351 0 3 0 0 0 #N/A orf19.351
PGA25 0 !2 0 0 !2 PGA25 PGA25 #N/A orf19.7555 4 3 0 0 0 orf19.7555 orf19.7555 orf19.7555
PGA7 2 !2 !3 0 0 #N/A #N/A RHD3 !2 3 0 2 3 RHD3 RHD3 RHD3
PHM7 0 !2 !4 0 0 PHM7 PHM7 DUG3 0 3 0 0 0 #N/A #N/A
AGO1 !2 !2 !3 !3 0 AGO1 #N/A SPO11 0 3 0 0 0 SPO11 SPO11
FKH2 !6 !2 !4 0 5 FKH2 FKH2 FKH2 HHT2 0 3 0 2 2 HHT2 #N/A
orf19.3335 0 !2 0 0 0 orf19.3335 #N/A orf19.3335 SLF1 0 3 0 0 0 SLF1 SLF1 SLF1
tS(CGA)1 0 !2 !4 !3 0 #N/A #N/A ARV1 0 3 0 0 0 #N/A ARV1
orf19.4246 0 !2 !2 0 0 #N/A #N/A orf19.2071 0 3 0 0 0 orf19.2071 orf19.2071
ALS2 8 !2 6 0 2 #N/A #N/A orf19.7420 0 3 0 0 0 orf19.7420 orf19.7420
FRE10 0 !2 0 !5 0 #N/A #N/A orf19.1353 0 3 0 0 0 orf19.1353 orf19.1353 orf19.1353
orf19.1236 !2 !2 !3 0 0 orf19.1236 orf19.1236 #N/A OPT4 0 3 0 0 0 #N/A #N/A
orf19.3793 0 !2 0 0 0 #N/A #N/A PRM9 0 3 4 2 0 #N/A #N/A
orf19.5267 !3 !2 0 0 !5 orf19.5267 #N/A orf19.5267 orf19.27 !3 3 0 0 0 orf19.27 #N/A
FOX2 0 !2 0 0 0 FOX2 #N/A orf19.4031 0 2 0 0 0 orf19.4031 #N/A
DLD1 0 !2 0 0 0 #N/A #N/A RET2 0 2 0 0 0 #N/A RET2
GCV2 !2 !2 !3 0 0 GCV2 #N/A orf19.5139 0 2 0 0 0 orf19.5139 orf19.5139
PGA56 0 !2 0 0 0 PGA56 PGA56 #N/A GSC1 0 2 0 3 0 GSC1 #N/A
NUP60 !3 !2 0 0 0 NUP60 NUP60 RPS10 2 2 3 0 0 #N/A #N/A
SIM1 0 !2 0 0 0 SIM1 #N/A SIM1 orf19.4030 0 2 2 0 0 #N/A #N/A
PGA13 14 !2 6 0 3 #N/A PGA13 PEX4 2 2 0 0 0 PEX4 #N/A
orf19.2018 !3 !2 0 0 0 #N/A #N/A orf19.4690 4 2 0 0 0 #N/A #N/A
RPL82 !3 !2 0 0 0 #N/A #N/A NTH1 5 2 7 0 0 NTH1 #N/A
orf19.1831 0 !2 0 0 0 #N/A #N/A ADH1 0 2 0 0 0 ADH1 ADH1
orf19.6319 0 !2 0 0 0 #N/A #N/A tR(CCG)1 0 2 0 7 5 #N/A #N/A
RHR2 0 2 0 !20 0 RHR2 RHR2
PIKA 2 2 0 0 0 #N/A #N/A
CLB4 2 2 4 3 0 CLB4 #N/A
orf19.711 7 2 3 2 0 orf19.711 orf19.711 orf19.711
GDH2 0 2 0 0 0 #N/A GDH2
orf19.7200 4 2 2 0 0 #N/A #N/A
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5.2.5.	  FKH2	  Deletion	  alters	  hyphal	  transcriptional	  programs.	  




























Figure	  5.2.9.	  Venn	  diagrams	  comparing	  genes	  with	  altered	  expression	  in	  the	  fkh2∆/∆	  strain	  during	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5.2.5.1.	  Genes	  down	  regulated	  during	  hyphal	  growth	  upon	  FKH2	  deletion	  	  GO	  slim	  process	  analysis	  shows	  that	  one-­‐quarter	  (25.4%)	  of	  down-­‐regulated	  genes	  are	  of	  unknown	  function.	  Response	  to	  stress	  shows	  strong	  representation	  (20.8%),	  possibly	  related	  to	  inability	  to	  react	  to	  the	  change	  in	  temperature	  and	  the	  increased	  stresses	  hyphal	  growth	  puts	  on	  the	  cell.	  The	  other	  main	  GO	  categories	  represented	  are:	  transport	  (20.3%),	  regulation	  of	  biological	  processes	  (18.6%),	  response	  to	  chemical	  stimulus	  (15.3%),	  and	  organelle	  organization	  (14%).	  	  The	  RAS1	  GTPase,	  that	  regulates	  the	  cAMP-­‐PKA	  and	  MAPK	  pathways,	  shows	  reduced	  expression,	  as	  again	  does	  the	  CEK1	  MAPK	  (Fig.	  5.2.2.).	  This	  suggests	  a	  possible	  inability	  to	  activate	  the	  transcription	  factor	  Cph1	  that	  is	  required	  for	  filamentation	  on	  solid	  media	  (Liu	  et	  al.	  1994).	  The	  promoters	  of	  RAS1	  and	  CEK1	  both	  contain	  a	  Fkh2	  minimal	  binding	  site,	  suggesting	  possible	  direct	  regulation.	  As	  shown	  for	  the	  other	  arrays	  there	  is	  strong	  representation	  of	  cell	  wall/GPI	  anchored	  proteins,	  such	  as:	  RBT5,	  HYR1,	  PGA10,	  SCW11,	  FGR41,	  PGA34	  and	  PGA6	  (Fig.	  5.2.2.).	  The	  polarity	  regulating	  proteins	  SEC3	  and	  BUD2	  show	  a	  reduction	  in	  expression,	  indicating	  a	  possible	  reason	  for	  the	  inability	  of	  the	  
fkh2∆/∆	  strain	  to	  form	  highly	  polarised	  true	  hyphae.	  Other	  groups	  of	  genes	  that	  are	  down-­‐regulated	  are	  those	  for	  iron	  acquisition/utilization	  (FET34,	  FTH1	  and	  FRP1),	  and	  histone	  regulation	  (SET3,	  RPD3	  and	  HTA2).	  
	  
5.2.5.2.	  Genes	  up-­‐regulated	  during	  hyphal	  growth	  upon	  FKH2	  deletion	  	   GO	  slim	  process	  analysis	  of	  genes	  up-­‐regulated	  during	  hyphal	  growth	  in	  the	  absence	  of	  FKH2	  shows	  a	  similar	  pattern	  as	  seen	  for	  the	  previous	  arrays,	  with	  regulation	  of	  biological	  processes	  (23.8%)	  being	  the	  largest	  group	  of	  genes	  with	  a	  known	  function.	  Interestingly,	  the	  next	  best-­‐represented	  group	  is	  for	  genes	  involved	  in	  filamentous	  growth	  (15.1%).	  Response	  to	  stress	  (13.5%),	  chemical	  stimulus	  response	  (12.3%),	  transport	  (11.9%),	  RNA	  metabolism	  (11.1%)	  and	  cell	  cycle	  (10.7%)	  groups	  all	  show	  similar	  levels	  of	  representation.	  	  The	  hyphal	  repressor	  SFL1,	  along	  with	  the	  Tup1	  co-­‐repressor	  MIG1,	  is	  up-­‐regulated	  (Fig.	  5.2.2.);	  possibly	  as	  a	  cause	  or	  consequence	  of	  the	  inability	  to	  form	  true	  hyphae.	  The	  cytokinetic	  kinase	  DBF2,	  and	  phosphatase	  CDC14	  also	  show	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increased	  expression	  during	  hyphal	  growth	  in	  the	  absence	  of	  FKH2.	  As	  does	  MLC1	  (Fig.	  5.2.2.),	  a	  component	  of	  both	  the	  actomyosin	  ring	  for	  cytokinesis,	  and	  the	  actomyosin	  based	  polarised	  secretion	  system	  in	  filamentous	  growth.	  Again	  components	  of	  the	  mating	  response	  pathway	  (CAG1,	  STE2,	  SET4	  and	  CEK2)	  and	  genes	  involved	  in	  DNA	  damage	  response	  (RAD51,	  RAD5	  and	  RFX1)	  have	  increased	  expression	  on	  FKH2	  deletion.	  The	  Cdk1	  cyclins	  CLN3	  and	  CLB4	  both	  show	  up-­‐regulation,	  further	  supporting	  a	  role	  for	  Fkh2	  in	  cell	  cycle	  regulation.	  A	  kinase	  related	  protein	  that	  shows	  increased	  expression	  in	  the	  absence	  of	  FKH2	  is	  SOK1,	  which	  is	  known	  to	  be	  involved	  in	  biofilm	  formation	  and	  hyphal	  development	  (Nobile	  et	  al.	  2012).	  	  
5.2.6.	  Further	  transcriptional	  investigation	  of	  blocking	  Fkh2	  
































Figure	  5.2.10.	  Venn	  diagrams	  comparing	  genes	  with	  altered	  expression	  in	  the	  fkh2(6ACDK)	  strain	  during	  
yeast	  and	  hyphal	  growth.	  A)	  Genes	  that	  are	  down-­‐regulated	  in	  the	  fkh2(6ACDK)	  strain.	  B)	  Genes	  that	  are	  
up-­‐regulated	  in	  the	  fkh2(6ACDK)	  strain.	  
	  
	  
5.2.6.1.	  Genes	  down-­‐regulated	  during	  hyphal	  growth	  on	  blocking	  Fkh2	  



























































































	  148	  	  
	   CDC4,	  a	  component	  of	  ubiquitin	  ligase	  Skip-­‐Cullin-­‐Fbox	  (SCF)	  complex,	  shows	  reduced	  expression	  in	  fkh2(6ACDK)	  hyphae,	  but	  not	  in	  the	  other	  mutants	  and	  conditions	  tested	  (Fig.	  5.2.3.).	  The	  SCF	  complex	  has	  a	  known	  role	  in	  hyphal	  morphogenesis	  (Atir-­‐Lande	  et	  al.	  2005),	  so	  it	  is	  of	  interest	  that	  it	  may	  be	  positively	  regulated	  by	  Fkh2.	  	   Another	  gene	  that	  shows	  reduced	  expression	  is	  for	  the	  MSB2	  cell	  wall	  sensor	  that	  is	  upstream	  of	  the	  Cek1-­‐MAPK	  pathway	  (Román,	  Cottier,	  et	  al.	  2009)	  (Fig.	  5.2.3.),	  further	  highlighting	  the	  role	  of	  Fkh2	  in	  the	  regulation	  of	  this	  pathway.	  
	  
5.2.6.2.	  Genes	  up-­‐regulated	  during	  hyphal	  growth	  on	  blocking	  Fkh2	  
phosphorylation	  	  	   GO	  slim	  analysis	  of	  genes	  with	  increased	  (≥2	  fold)	  expression	  in	  fkh2(6ACDK)	  hyphae	  shows	  different	  GO	  term	  representations	  compared	  with	  other	  arrays.	  The	  largest	  category	  is	  for	  genes	  involved	  in	  translation	  (22%),	  with	  many	  genes	  for	  transfer	  RNAs	  (tRNAs)	  being	  up-­‐regulated.	  Regulation	  of	  biological	  processes	  (20.9%)	  and	  response	  to	  stress	  (15.4%)	  again	  show	  strong	  representation.	  Other	  GO	  slim	  terms	  that	  the	  up-­‐regulated	  genes	  sort	  into	  are	  for:	  organelle	  organization	  (18.7%),	  cell	  cycle	  regulation	  (14.3%),	  biological	  processes	  (18.7%),	  filamentous	  growth	  (13.2%)	  and	  transport	  (12.1%).	  This	  provides	  further	  evidence	  supporting	  the	  cell	  cycle	  regulatory	  role	  of	  Fkh2,	  as	  well	  as	  presenting	  a	  possibly	  different	  role	  for	  Fkh2	  in	  regulating	  genes	  for	  organelle	  organization.	  	  Of	  the	  up-­‐regulated	  genes,	  CLB4	  and	  PDE1	  are	  known	  to	  be	  negative	  regulators	  of	  filamentation	  (Bensen	  et	  al.	  2005;	  Wilson	  et	  al.	  2010).	  The	  gene	  with	  the	  greatest	  increase	  in	  expression	  in	  fkh2(6ACDK)	  hyphae	  is	  for	  the	  putative	  RNA	  processing	  protein	  PWP1	  (Fig.	  5.2.3.).	  Interestingly	  PWP1	  does	  not	  show	  any	  changes	  in	  expression	  in	  the	  other	  mutants	  and	  conditions	  tested.	  DNA	  damage	  response	  genes	  RAD6	  and	  PIN4	  show	  up-­‐regulation,	  along	  with	  genes	  for	  the	  heat	  shock	  proteins:	  Hsp21,	  Hsp60	  and	  Hsp70	  (Fig.	  5.2.3.).	  The	  H3	  histone	  HHT2	  shows	  increased	  expression,	  as	  is	  also	  the	  case	  in	  the	  fkh2(6ACDK)	  strain	  during	  yeast	  growth.	  	  This	  suggests	  that	  the	  phosphorylation	  of	  Fkh2	  may	  be	  important	  for	  
HHT2	  expression.	  The	  Cdk1	  phosphatase,	  MIH1,	  is	  up-­‐regulated	  in	  the	  fkh2(6ACDK)	  strain	  during	  hyphal	  growth,	  but	  interestingly	  is	  down-­‐regulated	  during	  yeast	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growth	  in	  the	  absence	  of	  FKH2	  (Fig.	  5.2.3.).	  The	  MAPK	  CEK2	  is	  again	  up-­‐regulated,	  as	  it	  is	  in	  the	  absence	  of	  FKH2	  in	  both	  yeast	  and	  hyphae	  (Fig.	  5.2.3.).	  
	  
5.3.	  Searching	  for	  interacting	  partners	  of	  Fkh2	  	   In	  order	  to	  try	  and	  determine	  the	  possibly	  cell	  cycle-­‐independent	  functions	  of	  Fkh2	  early	  after	  hyphal	  induction,	  the	  proteins	  that	  interact	  with	  Fkh2	  at	  this	  time	  were	  sought	  after.	  	  	  	  
5.3.1.	  Mass-­‐Spectromic	  identification	  of	  Fkh2	  interacting	  partners	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Fig.	  5.3.1.	  Novel	  interacting	  partners	  of	  Fkh2	  early	  in	  hyphal	  growth.	  Samples	  were	  grown	  for	  40mins	  
post	  hyphal	  induction	  when	  Fkh2	  is	  known	  to	  be	  phosphorylated	  A)	  Coomassie	  stained	  gel	  of	  Fkh2-­‐6Myc	  
immunoprecipitation	  (IP	  αMyc)	  including	  total	  lysate	  of	  starting	  material	  (0)	  and	  elution	  from	  washes	  of	  
the	  IP	  (1-­‐4).	  B)	  Cut-­‐out	  of	  the	  IP	  lane	  from	  the	  gel	  showing	  the	  proteins	  that	  were	  identified	  by	  mass-­‐
spectrometry	  peptide	  identification.	  C)	  CoIP	  confirming	  Fkh2’s	  interaction	  with	  Pob3,	  but	  not	  Srp1..	   
	  
	  
5.3.2.	  Pob3	  physically	  interacts	  with	  Fkh2	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bands	  could	  be	  detected	  corresponding	  to	  both	  Pob3-­‐HA	  and	  Srp1-­‐HA.	  	  However	  only	  the	  Pob3	  interaction	  could	  be	  seen	  as	  specific	  under	  the	  conditions	  tested,	  with	  a	  band	  for	  Srp1	  also	  being	  present	  in	  the	  negative	  αGFP	  IP	  from	  a	  strain	  that	  only	  has	  Srp1	  tagged	  with	  HA.	  	  	  
5.3.4.	  Fkh2’s	  interaction	  with	  Pob3	  is	  dependent	  on	  Fkh2’s	  phosphorylation	  
status.	  
	  	   As	  it	  is	  known	  in	  S.	  cerevisiae	  that	  phosphorylation	  of	  Fkh2	  is	  required	  to	  mediate	  interaction	  with	  Ndd1	  (Pic-­‐Taylor	  et	  al.	  2004),	  an	  experiment	  was	  carried	  out	  to	  determine	  whether	  phosphorylation	  of	  CaFkh2	  affected	  its	  interaction	  with	  the	  chromatin	  modifier	  Pob3.	  Pob3	  was	  C-­‐terminally	  tagged	  with	  HA	  in	  the	  
fkh2/FKH2-­‐YFP,	  fkh2(6ACDK)-­‐GFP	  and	  fkh2(6ECDK)-­‐GFP	  strains.	  Fkh2-­‐YFP/GFP	  was	  then	  IP’d	  from	  each	  of	  these	  strains	  grown	  for	  40mins	  post	  hyphal	  induction.	  The	  presence	  of	  Pob3-­‐HA	  was	  detected	  by	  running	  the	  IP	  samples	  on	  a	  gel	  and	  probing	  the	  subsequent	  Western	  blot	  with	  an	  αHA	  antibody	  (Fig.	  5.3.2.).	  The	  blot	  was	  then	  stripped	  and	  re-­‐probed	  with	  an	  αGFP	  antibody	  to	  confirm	  IP	  of	  Fkh2.	  Pob3-­‐HA	  could	  be	  detected	  associated	  with	  both	  the	  wild-­‐type	  and	  phosphomimetic	  forms	  of	  Fkh2,	  but	  not	  the	  phosphorylation	  blocked	  form	  of	  Fkh2.	  Thus,	  the	  phosphorylation	  status	  of	  Fkh2	  appears	  to	  affect	  its	  interaction	  with	  Pob3	  on	  hyphal	  induction.	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Fig.	  5.3.2.	  Investigating	  the	  effect	  of	  Fkh2	  phosphorylation	  on	  its	  interaction	  with	  Pob3.	  αGFP	  IP	  of	  
wild-­‐type	  Fkh2-­‐YFP	  and	  the	  fkh2(6ACDK)/(6ECDK)-­‐GFP	  proteins	  in	  strains	  where	  Pob3	  is	  tagged	  with	  HA.	  
The	  presence	  of	  co-­‐precipitating	  Pob3	  was	  determined	  by	  αHA	  Western	  blot.	  αGFP	  Western	  blot	  was	  
used	  as	  a	  loading	  control	  for	  the	  αGFP	  IP.	  Lysates	  confirm	  strain	  identity	  and	  quality	  of	  
immunoprecipitation. 	  
5.4.	  FKH2	  Over-­‐expression	  	  	  
5.4.1.	  Over-­‐expression	  strategy	  	  
	   Initially	  over-­‐expression	  of	  FKH2	  was	  sought	  in	  order	  to	  obtain	  a	  sufficient	  amount	  of	  the	  protein	  product	  for	  phospho-­‐peptide	  mapping.	  In	  order	  to	  do	  this,	  a	  
PGAL1-­‐FKH2-­‐3HA	  vector	  was	  constructed.	  	  Firstly	  a	  BamHI	  restriction	  site	  was	  introduced	  between	  the	  end	  of	  the	  
FKH2	  promoter	  and	  beginning	  of	  the	  FKH2	  gene	  in	  pCIP10U	  PFKH2-­‐FKH2-­‐6xMYC.	  This	  allowed	  the	  native	  promoter	  sequence	  to	  be	  cut	  out	  with	  AscI/BamHI,	  and	  then	  replaced	  with	  an	  AscI-­‐PCaGAL1-­‐BamHI	  fragment	  generated	  by	  PCR	  from	  BWP17	  genomic	  DNA.	  Correct	  insertion	  of	  the	  fragment	  was	  checked	  by	  AscI/BamHI	  restriction	  digest,	  before	  sequencing	  of	  newly	  amplified	  promoter	  region.	  	  After	  this	  the	  6xMYC	  epitope	  tag	  in	  the	  vector	  was	  swapped	  for	  a	  HA	  tag	  through	  
XhoI/PstI	  sub-­‐cloning	  from	  another	  pCIP10	  vector.	  This	  was	  again	  checked	  through	  restriction	  digest.	  The	  pCIP10U	  PGAL1-­‐FKH2-­‐HA	  vector	  was	  integrated	  through	  digesting	  with	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Fig.	  5.4.1.	  FKH2	  overnight	  over-­‐expression	  phenotype.	  FKH2/FKH2-­‐HA	  and	  PGAL1-­‐FKH2-­‐HA	  strains	  were	  




5.4.2.	  Comparison	  of	  Fkh2	  expression	  levels	  upon	  over-­‐expression	  	   	  Comparison	  of	  the	  PGAL1-­‐FKH2-­‐HA	  strain	  with	  the	  FKH2/FKH2-­‐HA	  strain	  was	  not	  possible	  due	  to	  the	  number	  of	  copies	  of	  HA	  present	  in	  the	  tag.	  The	  wild-­‐type	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Fig.	  5.4.2.	  Confirmation	  of	  Fkh2	  over-­‐expression.	  FKH2/FKH2-­‐YFP	  and	  PGAL1-­‐FKH2-­‐GFP	  strains	  were	  re-­‐
inoculated	  into	  YEPD	  or	  YEPG	  at	  30°C	  and	  grown	  for	  3hours.	  50μg	  of	  total	  lysate	  from	  the	  samples	  was	  
run	  on	  a	  10%	  SDS-­‐PAGE	  gel,	  which	  was	  subsequently	  Western	  blotted.	  The	  blot	  was	  probed	  with	  αGFP	  
to	  detect	  Fkh2-­‐YFP/GFP	  and	  αPSTAIRE	  as	  a	  loading	  standard. 
	  
	  
5.4.3.	  FKH2	  over-­‐expression	  causes	  filamentation	  under	  yeast	  growth	  
conditions	  	   	  






























Fig.	  5.4.3.	  FKH2	  over-­‐expression	  causes	  filamentation	  on	  solid	  media	  under	  yeast	  growth	  conditions.	  
PGAL1-­‐FKH2-­‐GFP	  and	  FKH2/FKH2-­‐YFP	  overnight	  cultures	  were	  diluted	  to	  an	  OD600	  of	  1.0	  before	  10	  fold	  
serial	  dilutions	  were	  carried	  out.	  2μl	  of	  each	  dilution	  was	  spotted	  and	  dried	  onto	  a	  YEPG	  agar	  plate,	  and	  
then	  left	  to	  grow	  at	  30°C	  for	  5	  days.	  Surface	  colonies	  were	  imaged	  and	  then	  washed	  away	  with	  
deionised	  water. 
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Fig.	  5.4.4.	  	  FKH2	  over-­‐expression	  phenotype	  after	  re-­‐inoculation	  from	  stationary	  phase	  into	  yeast	  
growth	  conditions.	  FKH2/FKH2-­‐YFP	  and	  PGAL1-­‐FKH2-­‐GFP	  strains	  were	  grown	  for	  5	  hours	  in	  glucose	  or	  
galactose	  to	  repress	  or	  induce	  the	  GAL1	  promoter	  respectively.	  	  Microscope	  images	  were	  taken	  with	  an	  
Olympus	  Delta	  Vision	  fluorescence	  microscope	  (Applied	  Precision)	  Scale	  bars	  in	  bottom	  right	  hand	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5.4.5.	  Microarray	  analysis	  of	  FKH2	  over-­‐expression	  
	  
	   	  
	  
Fig.	  5.4.5.	  Genes	  down	  or	  up-­‐regulated	  on	  over-­‐expression	  of	  FKH2.	  Excel	  spreadsheet	  sorted	  for	  genes	  
with	  decreased/increased	  expression	  in	  array	  E.	  Displayed	  are	  the	  top	  50	  down	  or	  up-­‐regulated	  genes	  




A B C D E Consensus
orf19.3158 0 0 0 0 "15 #N/A #N/A
orf19.4315 0 0 0 0 "13 #N/A #N/A
CHT3 "6 0 "3 0 "6 CHT3 CHT3
RAD54 0 0 0 0 "5 #N/A #N/A
orf19.5267 "3 "2 0 0 "5 orf19.5267 #N/A orf19.5267
HSP31 2 0 0 0 "5 #N/A #N/A
SCW11 "19 0 "9 0 "4 #N/A #N/A
FGR41 "5 0 "8 0 "4 FGR41 FGR41
orf19.6628 0 0 0 0 "4 #N/A #N/A
RBE1 "8 0 0 0 "4 RBE1 RBE1
orf19.389 0 0 2 0 "3 orf19.389 #N/A
PGA38 "4 0 "4 0 "3 #N/A #N/A
PRI2 0 0 0 0 "3 #N/A #N/A
TLO5 0 0 0 0 "3 TLO5 #N/A TLO5
SWE1 0 0 0 0 "3 SWE1 SWE1 #N/A
orf19.1507 0 0 0 0 "3 orf19.1507 #N/A
ENG1 "2 0 0 0 "3 ENG1 ENG1 ENG1
AQY1 5 0 2 0 "3 #N/A #N/A
DSE1 "2 0 0 0 "3 #N/A DSE1
orf19.1107 0 0 0 0 "3 #N/A orf19.1107
orf19.7502 3 0 3 0 "3 #N/A orf19.7502
orf19.6786 0 0 0 0 "3 #N/A orf19.6786
HTA3 0 0 0 0 "3 HTA3 #N/A
orf19.5051 0 0 0 0 "3 orf19.5051 orf19.5051 #N/A
SOU2 0 0 0 0 "3 #N/A #N/A
orf19.1774 0 0 0 0 "3 orf19.1774 orf19.1774 orf19.1774
orf19.6789 0 0 0 0 "3 orf19.6789 orf19.6789 orf19.6789
orf19.6742 0 0 0 0 "3 orf19.6742 #N/A
orf19.2519 0 0 0 0 "3 orf19.2519 #N/A orf19.2519
orf19.668 0 0 0 0 "3 #N/A #N/A
PHO113 0 0 0 0 "2 PHO113 PHO113
orf19.1277 "3 0 "2 "2 "2 #N/A orf19.1277
orf19.4557 0 0 0 0 "2 orf19.4557 #N/A
ROB1 0 0 0 0 "2 #N/A ROB1
orf19.2285 0 0 0 0 "2 orf19.2285 #N/A
orf19.239 0 0 0 0 "2 orf19.239 #N/A
PEX3 0 0 2 0 "2 #N/A PEX3
CTA9 0 0 0 0 "2 CTA9 CTA9
CSA2 0 0 0 0 "2 #N/A #N/A
PGA25 0 "2 0 0 "2 PGA25 PGA25 #N/A
DAM1 0 0 0 0 "2 DAM1 DAM1 #N/A
PGA53 "2 0 0 0 "2 PGA53 #N/A
orf19.1562 "3 0 "4 "2 "2 #N/A orf19.1562
orf19.5518 0 0 0 0 "2 orf19.5518 orf19.5518 orf19.5518
orf19.4435 0 0 0 0 "2 orf19.4435 #N/A
orf19.1508 0 0 0 0 "2 orf19.1508 orf19.1508
orf19.3302 0 0 0 0 "2 #N/A #N/A
orf19.3148 0 0 0 0 "2 orf19.3148 orf19.3148
CYC1 0 0 0 0 "2 CYC1 #N/A
RHD1 0 0 2 0 "2 RHD1 #N/A
orf19.5040 0 0 0 0 "2 #N/A #N/A
A B C D E Consensus
orf19.3499 0 0 "2 0 20 orf19.3499 orf19.3499 #N/A
orf19.319 0 2 0 0 12 orf19.319 orf19.319 orf19.319
orf19.7091 0 2 0 0 11 #N/A #N/A
ARG1 3 0 0 0 7 #N/A #N/A
orf19.48 4 0 "3 0 7 orf19.48 #N/A
WH11 65 0 19 0 6 WH11 WH11
orf19.6487 0 0 0 3 6 orf19.6487 orf19.6487
FKH2 "6 "2 "4 0 5 FKH2 FKH2 FKH2
tR(CCG)1 0 2 0 7 5 #N/A #N/A
tA(UGC)2 0 0 0 0 5 #N/A #N/A
RBR1 25 2 2 0 5 RBR1 RBR1 #N/A
orf19.1862 9 0 4 0 5 orf19.1862 #N/A
tP(AGG)1 0 5 0 4 5 #N/A #N/A
orf19.5390 "6 0 "6 0 4 orf19.5390 #N/A
orf19.693 4 0 "3 0 4 #N/A orf19.693
tP(UGG)1 0 2 0 4 4 #N/A #N/A
CSH1 14 0 5 2 4 #N/A #N/A
tT(UGU)2 0 0 0 0 4 #N/A #N/A
HGC1 0 0 0 "4 4 HGC1 #N/A
SMC1 0 0 0 0 4 SMC1 SMC1 SMC1
tQ(UUG)1 0 0 0 2 4 #N/A #N/A
EXG2 0 0 0 0 4 EXG2 EXG2
GOR1 0 0 0 "3 4 GOR1 #N/A
orf19.251 6 0 0 0 4 #N/A #N/A
orf19.6148 3 0 0 "2 3 orf19.6148 #N/A
orf19.5140 4 0 2 0 3 #N/A orf19.5140
RBT1 0 0 0 0 3 RBT1 RBT1 RBT1
ARG3 0 0 0 0 3 ARG3 #N/A
orf19.513 0 0 0 0 3 orf19.513 orf19.513
orf19.1096 2 0 0 0 3 #N/A #N/A
BMT3 0 0 0 0 3 #N/A BMT3
RIB1 0 0 0 0 3 RIB1 RIB1
SSU1 0 0 0 0 3 SSU1 SSU1
RPS19A 0 0 0 "2 3 #N/A #N/A
ASR1 5 0 0 0 3 #N/A #N/A
RFX2 2 0 "2 "2 3 RFX2 RFX2 RFX2
orf19.1991 4 0 9 0 3 orf19.1991 orf19.1991
tC(GCA)1 3 0 0 0 3 #N/A #N/A
orf19.5514 0 0 0 0 3 #N/A orf19.5514
tT(UGU)1 0 0 0 0 3 #N/A #N/A
tA(AGC)1 0 0 0 3 3 #N/A #N/A
CPA2 0 0 0 0 3 #N/A #N/A
SOD5 2 0 0 0 3 SOD5 #N/A
PGA13 14 "2 6 0 3 #N/A PGA13
tP(UGG)4 0 0 0 3 3 #N/A #N/A
tV(AAC)6 0 0 0 3 3 #N/A #N/A
RNR3 0 0 0 0 3 RNR3 RNR3
orf19.7306 6 0 6 0 3 #N/A #N/A
orf19.6864 0 0 0 0 3 #N/A #N/A
DLH1 2 0 0 0 3 #N/A #N/A
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5.4.5.1.	  Genes	  down-­‐regulated	  upon	  FKH2	  over-­‐expression	  
	  
	   The	  GO	  slim	  process	  terms	  for	  genes	  with	  ≥2-­‐fold	  down-­‐regulation	  on	  FKH2	  over-­‐expression	  follow	  a	  similar	  pattern	  as	  previously	  observed.	  The	  best-­‐represented	  slim	  terms	  are	  for	  genes	  involved	  in:	  biological	  processes	  (38.7%),	  regulation	  of	  biological	  processes	  (25.3%),	  organelle	  organization,	  cell	  cycle	  regulation	  (21.3%),	  and	  response	  to	  stress	  (18.7%).	  This	  further	  supports	  a	  role	  for	  Fkh2	  in	  regulation	  of	  these	  processes.	  However	  these	  may	  be	  pleiotropic	  effects	  that	  are	  due	  to	  the	  severe,	  terminal	  phenotype	  associated	  with	  FKH2	  over-­‐expression.	  A	  number	  of	  genes	  involved	  in	  cytokinesis	  show	  reduced	  expression	  (Fig.	  5.4.5.),	  providing	  an	  explanation	  for	  why	  the	  cells	  fail	  to	  separate.	  These	  include	  genes	  for	  the	  mitotic	  exit	  phosphatase	  Cdc14	  and	  the	  septin	  associated	  kinase	  Gin4,	  along	  with	  genes	  for	  mother-­‐daughter	  cell	  separation	  such	  as	  ENG1,	  
CHT3	  and	  the	  essential	  DSE1	  (Fig.	  5.4.5.).	  Deletion	  of	  GIN4	  has	  previously	  been	  shown	  to	  be	  associated	  with	  constitutive	  filamentation	  (Wightman	  et	  al.	  2004),	  and	  therefore	  reduced	  expression	  of	  GIN4	  may	  contribute	  to	  the	  observed	  filamentation	  phenotype.	  Genes	  for	  two	  essential	  subunits	  of	  the	  Dam1	  complex,	  
ASK1	  and	  DAM1	  (Thakur	  &	  Sanyal	  2011),	  also	  show	  reduced	  expression	  (Fig.	  5.4.5.).	  The	  down-­‐regulation	  of	  these	  genes	  provides	  a	  possible	  mechanism	  for	  the	  observed	  cell	  cycle	  arrest	  phenotype	  on	  FKH2	  over-­‐expression.	  In	  addition	  to	  this	  the	  morphogenesis	  checkpoint	  gene	  SWE1	  is	  also	  down-­‐regulated	  (Fig.	  5.4.5.),	  suggesting	  the	  inability	  to	  activate	  this	  checkpoint.	  
	  
5.4.5.2.	  Genes	  up-­‐regulated	  upon	  FKH2	  over-­‐expression	  
	  	   FKH2	  is,	  as	  expected,	  up-­‐regulated	  on	  FKH2	  over-­‐expression,	  being	  present	  at	  five-­‐fold	  the	  basal	  level	  (Fig.	  5.4.5.).	  This	  further	  confirms	  that	  the	  over-­‐expression	  strategy	  is	  working.	  GO	  slim	  mapping	  analysis	  follows	  a	  similar	  theme	  as	  observed	  in	  the	  other	  array	  experiments;	  however	  there	  is	  an	  increased	  amount	  of	  genes	  up-­‐regulated	  for	  which	  the	  biological	  function	  is	  unknown	  (28.9%).	  As	  observed	  for	  the	  fkh2(6ACDK)	  strain	  under	  hyphal	  inducing	  conditions,	  a	  number	  of	  genes	  involved	  in	  translation	  (16.9%)	  are	  up-­‐regulated,	  with	  many	  of	  these	  encoding	  tRNAs.	  Stress	  response	  genes	  show	  good	  GO	  term	  representation	  (12%).	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These	  include	  the	  heat-­‐shock	  genes	  ASR1	  and	  HSP70,	  the	  DNA	  damage	  response	  genes	  RFX2,	  SMC1,	  and	  DLH1,	  and	  the	  peroxide	  stress	  combating	  superoxide	  dismutase	  SOD5	  (Fig.	  5.4.5.).	  This	  shows	  that	  the	  cells	  are	  undergoing	  a	  number	  of	  different	  stresses	  that	  they	  need	  to	  combat.	  The	  hyphal	  specific	  cyclin	  HGC1	  shows	  up-­‐regulation	  on	  FKH2	  over-­‐expression	  (Fig.	  5.4.5.),	  and	  could	  be	  a	  positive	  regulator	  of	  the	  observed	  filamentation	  phenotype.	  	  Indeed	  –	  overexpression	  of	  G1	  cyclins	  in	  S.	  cerevisiae	  leads	  to	  hyperpolarized	  growth	  (Loeb,	  Kerentseva,	  et	  al.	  1999).	  Interestingly	  the	  telomere-­‐associated	  genes	  TLO1,	  TLO7	  and	  TLO9	  also	  show	  increased	  expression	  (Fig.	  5.4.5.).	  	  
	  
5.5.	  Discussion	  	  
	  
	  
5.5.1.	  Fkh2	  phosphorylation	  affects	  yeast	  and	  hyphal	  morphologies	  
	  
	   In	  the	  previous	  chapter	  Fkh2	  phosphorylation	  site	  mutants	  were	  made,	  showing	  that	  Fkh2	  is	  phosphorylated	  in	  CDK	  consensus	  phosphorylation	  motifs	  during	  yeast	  and	  hyphal	  growth.	  Phenotypic	  observation	  of	  these	  mutants	  showed	  that	  phosphorylation	  of	  Fkh2	  is	  a	  requirement	  for	  correct	  yeast	  and	  hyphal	  morphologies.	  Blocking	  phosphorylation	  at	  CDK	  consensus	  sites	  on	  Fkh2	  gives	  yeast	  cells	  that	  are	  enlarged	  and	  show	  slight	  elongation	  (Fig.	  5.1.1).	  However	  during	  hyphal	  growth	  the	  loss	  of	  Fkh2	  phosphorylation	  is	  more	  profound,	  with	  cells	  failing	  to	  maintain	  filamentous	  invasive	  growth	  (Fig.	  5.1.2-­‐3.).	  Further	  mutants	  generated	  for	  CDK	  consensus	  and	  minimal	  sites,	  along	  with	  truncation	  of	  the	  phosphorylation	  sites,	  confirmed	  the	  observed	  filamentation	  defects	  (Fig.	  5.1.5-­‐7.).	  Phosphomimetic	  mutants	  of	  Fkh2	  grew	  normally	  as	  yeast	  (Fig.	  5.1.1.)	  and	  were	  still	  able	  to	  filament	  in	  liquid	  and	  on	  solid	  media	  (Fig.	  5.1.2-­‐3,	  Fig.	  5.1.5-­‐6.).	  Previously	  it	  was	  shown	  that	  FKH2	  is	  required	  for	  both	  yeast	  and	  true	  hyphal	  morphogenesis	  (Bensen	  et	  al.	  2002).	  These	  results	  support	  this	  observation;	  although,	  blocking	  Fkh2	  phosphorylation	  does	  not	  give	  as	  severe	  a	  phenotype	  as	  deletion	  of	  FKH2,	  suggesting	  that	  Fkh2	  has	  phosphorylation	  dependent	  and	  independent	  functions.	  In	  the	  aforementioned	  study	  it	  was	  shown	  that	  Fkh2	  localises	  to	  the	  nucleus.	  This	  distinct	  localisation	  has	  been	  confirmed	  (Fig.	  3.2.14.),	  and	  shown	  not	  to	  be	  dependent	  of	  the	  phosphorylation	  status	  of	  Fkh2	  (Fig.	  5.1.4-­‐5,	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Fig.	  5.1.7).	  These	  results	  above	  suggest	  that	  the	  early	  phosphorylation	  of	  Fkh2	  is	  a	  requirement	  for	  the	  long-­‐term	  maintenance	  of	  hyphal	  growth;	  however	  they	  do	  not	  indicate	  the	  mechanism	  by	  which	  this	  is	  achieved.	  
	  
5.5.2.	  Fkh2	  and	  transcriptional	  programs	  
	   Fkh2	  and	  its	  homologues	  are	  known	  transcriptional	  regulators	  (Bensen	  et	  al.	  2002;	  Zhu	  et	  al.	  2000),	  suggesting	  that	  the	  observed	  mutant	  phenotypes	  may	  be	  due	  to	  transcriptional	  changes	  in	  these	  strains.	  Due	  to	  the	  limited	  coverage	  of	  previous	  fkh2∆/∆	  array	  data	  (Bensen	  et	  al.	  2002),	  this	  was	  repeated	  using	  probes	  covering	  every	  C.	  albicans	  ORF	  (Fig.	  5.2.2-­‐3,	  5.2.6,	  5.2.8.).	  	  Ideally	  a	  global	  Chromatin	  Immunoprecipitation	  (ChIP)	  analysis	  should	  have	  been	  carried	  out	  together	  with	  the	  microarrays	  using	  the	  same	  samples;	  as	  this	  would	  provide	  information	  of	  whether	  Fkh2	  can	  directly	  regulate	  genes	  showing	  altered	  levels	  of	  expression	  in	  the	  Fkh2	  mutants.	  However	  performing	  ChIP	  with	  Fkh2	  has	  proved	  difficult;	  therefore	  we	  only	  have	  the	  presence	  of	  a	  predicted	  Fkh2	  binding	  site	  upstream	  of	  the	  gene	  as	  an	  indication	  of	  whether	  it	  is	  an	  in	  vivo	  regulatory	  target.	  All	  the	  genes	  of	  interest	  mentioned	  in	  the	  results	  section	  are	  combined	  in	  Fig.	  5.5.1.	  	  
	  	  	  	  
Fig.	  5.5.1.	  Combined	  genes	  of	  interest	  across	  all	  arrays.	  Genes	  of	  interest	  selected	  from	  the	  excel	  
spreadsheet	  along	  with	  their	  expression	  data	  across	  all	  five	  arrays,	  and	  information	  on	  the	  presence	  or	  









A B C D E
ULP2 !4 !20 !11 !18 0 ULP2 ULP2 ULP2
AGO1 !2 !2 !3 !3 0 AGO1 #N/A
CDC4 0 0 0 !2 0 #N/A CDC4
CEK1 0 !3 !3 0 0 #N/A #N/A
ECE1 0 0 !3 !7 0 ECE1 #N/A ECE1
SAP4 0 0 !4 !6 0 SAP4 #N/A
SAP5 0 0 0 !3 0 SAP5 #N/A
SAP6 0 0 !5 !6 0 SAP6 #N/A
HGC1 0 0 0 !4 4 HGC1 #N/A
CHT2 !2 0 !5 !7 0 CHT2 CHT2
KIP4 0 0 !3 !3 0 KIP4 KIP4 #N/A
RFX2 2 0 !2 !2 3 RFX2 RFX2 RFX2
SEC14 0 0 0 !2 0 #N/A #N/A
PGA34 0 0 !5 !3 0 PGA34 PGA34 PGA34
HYR1 !3 0 !8 !3 0 HYR1 #N/A
PGA50 0 0 0 !2 0 PGA50 PGA50
ALG1 0 0 !3 !2 0 #N/A #N/A
CSA1 0 0 !2 !2 0 #N/A #N/A
MSB2 0 0 0 !2 0 MSB2 #N/A
A B C D E
RAD6 0 0 2 3 0 #N/A #N/A
CLB4 2 2 4 3 0 CLB4 #N/A
PDE1 2 0 4 2 0 #N/A PDE1
RHD3 02 3 0 2 3 RHD3 RHD3 RHD3
MIH1 02 0 0 2 0 MIH1 MIH1
CEK2 5 0 4 3 0 #N/A CEK2
CYR1 0 3 0 0 0 CYR1 #N/A
HSP21 3 0 7 2 0 #N/A HSP21
HSP60 0 0 0 2 0 #N/A HSP60
HSP70 8 0 0 2 2 HSP70 HSP70
CAG1 5 5 3 2 0 CAG1 #N/A
ZCF5 0 0 0 3 0 #N/A ZCF5
GSC1 0 2 0 3 0 GSC1 #N/A
FKH2 06 02 04 0 5 FKH2 FKH2 FKH2
DAM1 0 0 0 0 02 DAM1 DAM1 #N/A
ASK1 0 0 0 0 02 #N/A #N/A
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5.2.2.1.	  Fkh2	  phosphorylation	  is	  required	  to	  regulate	  genes	  for	  filamentous	  
invasive	  growth	  and	  pathogenesis.	  
	  
	   Previously	  it	  has	  been	  shown	  that	  FKH2	  is	  required	  for	  the	  expression	  of	  the	  hyphal-­‐specific	  genes	  ECE1,	  HYR1	  and	  HWP1	  (Bensen	  et	  al.	  2002).	  In	  the	  above	  results	  it	  is	  shown	  that	  along	  with	  ECE1	  and	  HYR1,	  FKH2	  is	  required	  for	  the	  expression	  of	  the	  hyphal	  expression	  specific	  genes	  SAP4,	  SAP6,	  KIP4	  and	  CHT2	  (Fig.	  5.2.2.).	  Further	  to	  this,	  these	  genes	  are	  also	  down-­‐regulated	  in	  the	  absence	  of	  Fkh2	  phosphorylation	  (Fig.	  5.2.3.),	  and	  show	  further	  down-­‐regulation	  than	  is	  observed	  in	  the	  fkh2∆/∆	  strain	  (Fig.	  5.5.1.).	  Comparing	  genes	  down-­‐regulated	  between	  the	  
fkh2∆/∆	  and	  fkh2(6ACDK)	  strains	  shows	  that:	  genes	  down-­‐regulated	  in	  fkh2(6ACDK)-­‐only	  and	  in	  both	  fkh2∆/∆	  and	  fkh2(6ACDK)	  strains	  are	  primarily	  involved	  in	  pathogenic	  processes,	  such	  as	  host	  interaction	  and	  biofilm	  formation	  (Tables.	  5.1-­‐4).	  This	  indicates	  that	  loss	  of	  Fkh2	  phosphorylation	  has	  a	  more	  dominant	  effect	  on	  the	  expression	  of	  invasive	  growth	  and	  pathogenesis	  related	  genes	  than	  FKH2	  deletion,	  highlighting	  the	  importance	  of	  Fkh2	  phosphorylation	  in	  the	  C.	  albicans	  pathogenesis	  program.	  All	  of	  the	  above	  mentioned	  hyphal	  specific	  genes	  contain	  a	  Fkh2	  minimal	  binding	  motif	  in	  their	  promoter,	  suggesting	  that	  they	  may	  be	  true	  regulatory	  targets	  of	  Fkh2.	  	  The	  hyphal	  specific	  Cdk1	  cyclin	  HGC1	  shows	  reduced	  expression	  in	  the	  
fkh2(6ACDK)	  strain,	  but	  not	  in	  the	  fkh2∆/∆	  strain	  (Fig.	  5.5.1.),	  suggesting	  that	  HGC1	  regulation	  is	  dependent	  on	  Fkh2	  phosphorylation.	  This	  observation	  fits	  well	  with	  the	  early	  hyphal	  timing	  of	  Fhk2	  phosphorylation	  (Fig.	  4.2.2.),	  which	  would	  cause	  up-­‐regulation	  of	  HGC1	  to	  orchestrate	  many	  processes	  required	  for	  hyphal	  development	  (Wang	  2009).	  Hgc1	  is	  known	  to	  be	  required	  for	  maintenance	  of	  hyphal	  growth	  (Sinha	  et	  al.	  2007),	  and	  its	  reduced	  expression	  in	  fkh2(6ACDK)	  hyphae	  suggests	  a	  reason	  for	  the	  strain’s	  inability	  to	  maintain	  filamentation.	  A	  problem	  with	  this	  hypothesis	  is	  that	  HGC1	  only	  shows	  half	  the	  level	  of	  wild-­‐type	  expression	  in	  the	  fkh2(6ECDK)	  strain	  (Fig.	  5.14B.).	  However	  Fkh2	  is	  only	  phosphorylated	  for	  a	  short	  period	  on	  hyphal	  induction	  and	  then	  remains	  dephosphorylated.	  It	  maybe	  that	  maintaining	  Fkh2	  in	  a	  phosphorylated	  state	  causes	  reduced	  expression	  of	  genes	  that	  are	  up-­‐regulated	  early	  in	  hyphal	  growth.	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It	  would	  be	  of	  interest	  to	  over-­‐express	  HGC1	  in	  the	  fkh2(6ACDK)	  strain	  to	  see	  if	  this	  restores	  the	  ability	  to	  maintain	  filamentous	  growth.	  	  	   In	  the	  qPCR	  experiments	  the	  results	  from	  the	  microarrays	  were	  confirmed	  (Fig.	  5.2.5.),	  showing	  that	  the	  use	  of	  the	  fkh2/FKH2	  was	  acceptable	  for	  the	  microarrays.	  The	  results	  showed	  that	  SAP4,	  KIP4	  and	  ECE1	  transcript	  levels	  in	  the	  
fkh2(6ECDK)	  strain	  are	  virtually	  that	  of	  	  their	  wild-­‐type	  level	  in	  hyphal	  growth	  (Fig.	  5.2.5B.),	  allowing	  the	  assumption	  that	  their	  regulation	  depends	  on	  Fkh2’s	  phosphorylation	  status.	  However,	  this	  is	  not	  the	  case	  for	  CHT2,	  which	  shows	  further	  decreased	  expression	  in	  the	  fkh2(6ECDK)	  strain	  compared	  with	  the	  
fkh2(6ACDK)	  strain	  (Fig.	  5.2.5B.).	  This	  could	  be	  due	  to	  the	  correct	  phospho-­‐regulation	  of	  Fkh2	  being	  required	  for	  CHT2	  expression,	  and	  Fkh2	  being	  locked	  in	  either	  a	  phosphorylated	  or	  dephosphorylated	  state	  preventing	  this.	  	  The	  known	  virulence	  factors	  ECE1	  and	  SAP4-­‐6	  show	  decreased	  expression	  on	  blocking	  Fkh2	  phosphorylation,	  implying	  that	  the	  fkh2(6ACDK)	  strain	  	  may	  show	  reduced	  virulence,	  as	  is	  the	  case	  for	  the	  fkh2∆/∆	  strain.	  Further	  to	  this,	  GO	  analysis	  implies	  that	  expression	  of	  genes	  required	  for	  pathogenesis	  is	  a	  phosphorylation	  dependent	  function	  of	  Fkh2	  (Tables	  5.1-­‐4.).	  The	  virulence	  of	  the	  Fkh2	  phosphorylation	  mutants	  is	  currently	  under	  investigation	  through	  collaboration	  with	  Dr.	  Julian	  Naglik’s	  group	  at	  Kings	  College	  London.	  As	  the	  fkh2(6ACDK)	  strain	  does	  not	  show	  a	  reduction	  in	  adhesin	  gene	  expression,	  it	  should	  still	  be	  able	  to	  bind	  epithelial	  cells.	  Therefore	  this	  will	  allow	  observation	  of	  virulence	  requirements	  post	  host	  cell	  adhesion.	  A	  role	  for	  Fkh2	  in	  pathogenesis	  can	  also	  be	  implied	  by	  the	  observation	  that	  FKH2	  is	  up-­‐regulated	  in	  a	  reconstituted	  human	  oral	  epithelium	  model	  of	  infection	  (Zakikhany	  et	  al.	  2007).	  	   Along	  with	  the	  down-­‐regulated	  genes	  in	  the	  fkh2(6ACDK)	  strain	  that	  are	  required	  for	  filamentous	  growth,	  there	  is	  also	  increased	  expression	  of	  negative	  regulators	  of	  filamentation	  (Fig.	  5.5.1.):	  CLB4,	  RAD6	  and	  PDE1	  (Bensen	  et	  al.	  2005;	  Leng	  et	  al.	  2000;	  Wilson	  et	  al.	  2010).	  This	  further	  explains	  the	  inability	  of	  the	  
fkh2(6ACDK)	  strain	  to	  maintain	  filamentous	  growth.	  And	  suggests	  that	  one	  possible	  role	  of	  Fkh2	  during	  hyphal	  growth	  is	  to	  repress	  negative	  regulators	  of	  filamentation.	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5.5.2.2.	  Other	  roles	  of	  Fkh2	  in	  the	  regulation	  of	  transcriptional	  programs	  	   	  	  Deletion	  of	  FKH2	  causes	  drastic	  transcriptional	  changes,	  with	  443	  genes	  in	  yeast	  and	  488	  genes	  in	  hyphal	  growth	  showing	  a	  greater	  than	  two-­‐fold	  change	  in	  expression	  (Fig.	  5.2.9.).	  Such	  changes	  can	  account	  for	  the	  severe	  phenotype	  observed	  in	  the	  fkh2∆/∆	  strain;	  however	  some	  changes	  may	  be	  pleiotropic	  in	  response	  to	  the	  deleterious	  phenotype	  of	  fkh2∆/∆,	  such	  as	  the	  common	  up-­‐regulation	  of	  stress	  response	  genes	  (See	  GO	  spreadsheets).	  Deletion	  of	  FKH2	  has	  a	  greater	  positive	  effect	  on	  gene	  transcription	  during	  yeast	  growth,	  but	  a	  more	  negative	  effect	  during	  hyphal	  growth	  (Fig.	  5.2.9.).	  This	  implies	  that	  Fkh2	  may	  act	  primarily	  as	  a	  repressor	  during	  yeast	  growth,	  and	  as	  a	  transcriptional	  activator	  during	  hyphal	  growth.	  Very	  few	  cell	  cycle	  regulated	  transcripts	  show	  changes	  in	  expression	  in	  the	  arrays	  A-­‐D;	  likely	  due	  to	  the	  experimental	  design.	  Zhu	  et	  al.	  found	  in	  S.	  cerevisiae	  that	  differential	  regulation	  of	  the	  CLB2	  cluster	  was	  only	  observed	  in	  synchronous	  fkh1∆/fkh2∆	  cells,	  and	  not	  in	  asynchronous	  cultures	  (Zhu	  et	  al.	  2000).	  Such	  an	  experiment	  was	  not	  possible	  with	  C.	  albicans	  fkh2∆/∆	  cells,	  as	  the	  constitutively	  pseudohyphal	  phenotype	  meant	  that	  elutriation	  was	  not	  possible,	  and	  no	  means	  of	  chemical	  synchronisation	  exists	  for	  white	  phase	  C.	  albicans	  cells.	  Such	  an	  experiment	  may	  however	  be	  possible	  using	  a	  heterozygous	  FKH2	  strain	  under	  the	  control	  of	  a	  regulatable	  promoter.	  The	  experiments	  were	  therefore	  carried	  out	  using	  the	  same	  design	  as	  for	  Bensen	  et	  al.,	  allowing	  comparison	  of	  the	  results	  between	  the	  two	  studies.	  	  Throughout	  the	  fkh2∆/∆	  and	  fkh2(6ACDK)	  arrays	  there	  are	  emerging	  patterns.	  Stress	  response	  genes	  show	  altered	  regulation	  in	  absence	  of	  FKH2	  and	  when	  Fkh2	  phosphorylation	  is	  blocked.	  Genes	  for	  heat,	  reactive	  oxygen	  and	  genotoxic	  stress	  show	  a	  general	  up-­‐regulation	  in	  both	  yeast	  and	  hyphae	  (See	  GO	  spreadsheets).	  This	  suggests	  that	  Fkh2	  may	  have	  a	  role	  in	  the	  negative	  regulation,	  or	  possible	  fine-­‐tuning	  of	  stress	  responses.	  This	  could	  be	  tested	  further	  by	  looking	  at	  responses	  of	  the	  Fkh2	  mutant	  to:	  further	  elevated	  temperatures	  above	  37°C,	  exposure	  to	  hydrogen	  peroxide,	  and	  exposure	  to	  DNA	  damaging	  agents	  such	  as	  Methyl	  methanesulfonate.	  	  	   Components	  of	  the	  mating	  response	  MAPK	  pathway	  and	  the	  cAMP-­‐PKA	  pathway	  show	  altered	  regulation	  in	  the	  Fkh2	  mutants.	  RAS1,	  an	  upstream	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component	  of	  both	  the	  MAPK	  and	  PKA	  pathways,	  is	  down-­‐regulated	  in	  fkh2∆/∆	  hyphae	  (Fig.	  5.5.1.).	  This	  provides	  a	  good	  explanation	  for	  the	  inability	  of	  fkh2∆/∆	  cells	  to	  properly	  respond	  to	  hyphal	  inducing	  signals.	  The	  cAMP	  phosphodiesterase	  
PDE1	  shows	  increased	  expression	  under	  all	  conditions	  except	  fkh2(6ACDK)	  yeast	  growth	  (Fig.	  5.5.1.);	  under	  which	  the	  adenylyl	  cyclase	  CYR1	  is	  up-­‐regulated	  (Fig.	  5.5.1.).	  This	  suggests	  that	  Fkh2	  can	  regulate	  cellular	  cAMP	  levels,	  but	  that	  in	  yeast	  this	  regulation	  is	  independent	  of	  Fkh2’s	  phosphorylation	  status.	  The	  MAPKs	  Cek1	  and	  Cek2	  appeared	  to	  be	  differentially	  regulated	  by	  Fkh2;	  with	  CEK1	  being	  down-­‐regulated	  in	  fkh2∆/∆	  hyphae	  and	  fkh2(6ACDK)	  yeast	  cells,	  whereas	  CEK2	  is	  up-­‐regulated	  under	  all	  conditions	  except	  fkh2(6ACDK)	  yeast	  growth	  and	  FKH2	  over-­‐expression	  (Fig.	  5.5.1.).	  It	  is	  interesting	  that	  these	  kinases,	  that	  are	  thought	  to	  be	  partially	  redundant	  (Chen	  et	  al.	  2002),	  may	  be	  differentially	  regulated.	  The	  cell	  wall	  sensor	  for	  the	  MAPK	  pathway,	  MSB2,	  shows	  decreased	  expression	  in	  fkh2(6ACDK)	  hyphae	  (Fig.	  5.5.1.),	  implying	  that	  Fkh2	  phosphorylation	  is	  required	  for	  its	  expression.	  This	  presents	  an	  interesting	  idea	  for	  a	  model	  in	  which	  the	  Cek1	  MAPK	  could	  phosphorylate	  Fkh2,	  activating	  it	  for	  increased	  expression	  of	  the	  MSB2	  sensor	  to	  allow	  further	  activation	  of	  the	  MAPK	  pathway	  in	  a	  positive	  feedback	  loop.	  Evidence	  for	  this	  comes	  from	  the	  stabilization	  of	  Fkh2	  and	  prominent	  phosphorylation	  in	  a	  hog1∆/∆	  strain.	  Hog1	  is	  thought	  to	  negatively	  regulate	  Cek1	  (Eisman	  et	  al.	  2006);	  and	  therefore	  loss	  of	  Hog1	  repression	  would	  result	  in	  a	  highly	  active	  Cek1	  that	  could	  phosphorylate	  and	  stabilise	  Fkh2.	  Also	  secreted	  aspartyl	  proteases,	  which	  we	  have	  shown	  to	  be	  regulated	  by	  Fkh2	  (Fig.	  5.5.1.),	  are	  required	  for	  Msb2	  cleavage	  to	  activate	  Cek1	  MAPK	  signaling	  (Puri	  et	  al.	  2012);	  thus	  providing	  another	  possible	  level	  of	  positive	  feedback.	  Therefore	  it	  would	  be	  of	  interest	  to	  test	  whether	  Cek1	  is	  responsible	  for	  Fkh2	  phosphorylation	  
in	  vivo.	  
	  
5.5.3.	  Novel	  Interacting	  Partners	  of	  Fkh2	  
	  
	   Currently	  no	  interaction	  data	  is	  available	  for	  CaFkh2,	  therefore	  possible	  interactors	  can	  only	  be	  inferred	  from	  what	  is	  known	  in	  S.	  cerevisiae.	  However,	  due	  to	  the	  proposed	  cell	  cycle	  independent	  role	  of	  Fkh2	  in	  hyphal	  growth,	  it	  is	  likely	  that	  different	  interactions	  would	  be	  involved.	  This	  was	  shown	  to	  be	  true,	  as	  early	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in	  hyphal	  growth	  Fkh2	  was	  found	  to	  be	  complexed	  with	  the	  chromatin	  modifier	  Pob3	  (Fig.	  5.3.1.),	  which	  is	  known	  to	  be	  involved	  in	  transcription	  and	  DNA	  replication	  (Schlesinger	  &	  Formosa	  2000),	  and	  deletion	  of	  which	  is	  known	  to	  affect	  filamentous	  growth	  (Uhl	  et	  al.	  2003).	  The	  observation	  that	  Fkh2	  interacts	  with	  a	  chromatin	  modifier	  early	  on	  hyphal	  induction	  suggests	  that	  transcriptional	  changes	  dependent	  on	  Fkh2	  may	  occur	  via	  an	  epigenetic	  mechanism.	  This	  correlates	  well	  with	  previous	  report	  that	  proposes	  an	  early	  window	  of	  epigenetic	  changes	  on	  hyphal	  induction,	  which	  are	  required	  for	  long	  term	  maintenance	  of	  hyphal	  growth	  (Lu	  et	  al.	  2011).	  	  Due	  to	  the	  early	  hyphal	  phosphorylation	  of	  Fkh2	  occurring	  within	  this	  window,	  it	  can	  be	  speculated	  that	  Fkh2	  is	  phosphorylated	  in	  order	  to	  interact	  with	  Pob3,	  epigenetically	  activating	  genes	  that	  are	  required	  to	  maintain	  filamentation.	  This	  is	  indeed	  the	  case,	  as	  the	  interaction	  only	  appears	  to	  be	  maintained	  when	  Fkh2	  is	  in	  a	  phosphorylated	  state	  (Fig.	  5.3.2.).	  
	  
5.5.4.	  FKH2	  over-­‐expression	  causes	  cell	  cycle	  arrest	  filamentation	  
	  
	   Expression	  of	  FKH2	  under	  the	  GAL1	  promoter	  gives	  a	  five-­‐fold	  increase	  in	  
FKH2	  levels	  (Fig.	  5.4.5.	  5.5.1.),	  causing	  cells	  to	  filament	  under	  yeast	  growth	  conditions	  on	  solid	  and	  in	  liquid	  media	  (Fig.	  5.4.1.	  5.4.3-­‐4.).	  These	  filaments	  resemble	  those	  formed	  on	  cell	  cycle	  arrest	  (Bachewich	  et	  al.	  2005).	  A	  number	  of	  genes	  required	  for	  cell	  cycle	  progression	  and	  cytokinesis	  are	  down-­‐regulated	  in	  this	  strain	  (Fig.	  5.4.5),	  possibly	  as	  a	  cause	  or	  effect	  of	  the	  observed	  phenotype.	  Two	  essential	  genes	  that	  are	  down-­‐regulated	  are	  for	  the	  Dam1	  and	  Ask1	  components	  of	  the	  Dam1	  complex	  (Fig.	  5.4.5.),	  required	  for	  spindle	  attachment	  to	  kinetochores	  (Thakur	  &	  Sanyal	  2011).	  Failure	  of	  this	  event	  to	  happen	  would	  likely	  activate	  the	  spindle	  checkpoint,	  leading	  to	  the	  observed	  cell	  cycle	  arrest	  filamentation	  (Berman	  2006).	  To	  confirm	  whether	  Fkh2	  regulates	  these	  genes	  directly	  ChIP	  experiments	  could	  be	  carried	  out.	  Previous	  microarray	  analysis	  of	  chemical	  and	  CDC5	  depletion	  cell	  cycle	  arrest	  did	  not	  show	  DAM1	  and	  ASK1	  to	  be	  down-­‐regulated	  (Bachewich	  et	  al.	  2005),	  suggesting	  that	  their	  reduced	  expression	  is	  Fkh2	  dependent.	  	   The	  hyphal	  specific	  cyclin	  HGC1	  is	  up-­‐regulated	  on	  FKH2	  over-­‐expression	  (Fig.	  5.4.5.),	  but	  has	  also	  previously	  been	  shown	  to	  be	  up-­‐regulated	  on	  cell	  cycle	  arrest.	  Interestingly	  -­‐	  cell	  cycle	  arrest	  causes	  a	  1.2	  fold	  increase	  in	  HGC1	  expression	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(Bachewich	  et	  al.	  2005),	  whereas	  on	  FKH2	  over-­‐expression	  HGC1	  is	  up-­‐regulated	  four-­‐fold.	  This	  suggest	  that	  the	  increase	  in	  HGC1	  is	  due	  to	  a	  higher	  level	  of	  Fkh2,	  and	  not	  due	  to	  the	  associated	  cell	  cycle	  arrest	  phenotype;	  providing	  support	  for	  the	  idea	  that	  HGC1	  is	  a	  direct	  regulatory	  target	  of	  Fkh2.	  
	  
5.5.5.	  Conclusion	  
	   Taken	  together	  these	  results	  show	  that	  Fkh2	  has	  a	  phosphorylation	  dependent	  function	  during	  hyphal	  growth,	  regulating	  the	  expression	  of	  genes	  for	  invasive	  growth	  and	  pathogenesis.	  Absence	  of	  Fkh2	  phosphorylation	  results	  in	  decreased	  invasive	  growth,	  suggesting	  that	  the	  phosphorylation	  will	  be	  an	  important	  requirement	  for	  virulence.	  This	  appears	  to	  mechanistically	  through	  a	  phosphorylation	  dependent	  interaction	  with	  the	  chromatin	  modifier	  Pob3.	  Finally	  –	  over-­‐expression	  of	  FKH2	  results	  in	  constitutively	  filamentous	  growth,	  likely	  as	  a	  result	  of	  cell	  cycle	  perturbation.	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6	   	   	   	   	   	   	  	  	  	  	  	  General	  Discussion	  	  
	   This	  study	  initially	  sought	  to	  identify	  regulatory	  targets	  of	  Cdk1	  that	  are	  differentially	  phosphorylated	  between	  yeast	  and	  hyphal	  growth.	  Of	  the	  four	  proteins	  investigated	  (Orf19.3469,	  Orf19.1948,	  Sfl1	  and	  Fkh2),	  only	  the	  transcription	  factor	  Fkh2	  showed	  a	  different	  pattern	  of	  phosphorylation	  timing	  during	  yeast	  and	  hyphal	  growth.	  During	  yeast	  growth	  Fkh2	  expression	  and	  phosphorylation	  is	  regulated	  in	  concert	  with	  cell	  cycle	  progression;	  whereas	  during	  hyphal	  growth,	  phosphorylation	  and	  de-­‐phosphorylation	  occurs	  before	  the	  beginning	  of	  the	  cell	  cycle.	  Fkh2	  and	  its	  homologues	  are	  involved	  in	  cell	  cycle	  progression,	  being	  themselves	  regulated	  in	  a	  cell	  cycle	  dependent	  manner	  (Bensen	  et	  al.	  2002;	  Zhu	  et	  al.	  2000;	  Shimada	  et	  al.	  2008).	  The	  loss	  of	  cell	  cycle	  dependent	  regulation	  of	  Fkh2	  during	  hyphal	  growth	  suggested	  a	  specialised	  function	  in	  this	  morphology.	  Further	  analysis	  of	  this	  phosphorylation	  showed	  that	  Fkh2	  is	  phosphorylated	  at	  CDK	  consensus	  sites	  on	  hyphal	  induction.	  However,	  unexpectedly,	  the	  phosphorylation	  is	  not	  dependent	  on	  the	  CDKs	  Cdk1	  or	  Pho85,	  although	  there	  may	  be	  redundancy	  between	  these	  two	  kinases.	  Other	  kinase	  mutants	  were	  tested	  that	  can	  phosphorylate	  CDK	  consensus	  motifs	  (hog1,	  ssn3,	  
tpk1	  and	  crk1)	  and	  are	  important	  for	  hyphal	  growth,	  but	  again	  the	  absence	  of	  these	  kinases	  did	  not	  affect	  the	  phosphorylation	  status	  of	  Fkh2.	  	   Although	  the	  kinase	  responsible	  for	  phosphorylating	  Fkh2	  remains	  elusive,	  the	  role	  of	  Fkh2	  phosphorylation	  was	  examined	  using	  phospho-­‐site	  mutants.	  Blocking	  Fkh2	  phosphorylation	  causes	  minor	  morphological	  defects	  during	  yeast	  and	  hyphal	  growth	  in	  liquid	  media,	  which	  are	  not	  as	  severe	  as	  those	  previously	  observed	  on	  FKH2	  deletion.	  However,	  blocking	  the	  phosphorylation	  of	  Fkh2	  has	  a	  strong	  negative	  effect	  on	  filamentous	  invasive	  growth	  on	  solid	  media,	  as	  observed	  by	  the	  inability	  to	  invade	  the	  agar	  substratum.	  The	  reduced	  invasive	  capacity	  of	  the	  
fkh2(6ACDK)	  strain	  implies	  that	  phosphorylation	  of	  Fkh2	  may	  be	  important	  for	  virulence.	  This	  is	  currently	  under	  investigation	  by	  our	  collaborators	  in	  London,	  whose	  initial	  results	  appear	  to	  support	  the	  above	  hypothesis.	  	  	   In	  order	  to	  understand	  how	  blocking	  Fkh2	  phosphorylation	  lead	  to	  the	  observed	  loss	  of	  invasive	  capacity,	  global	  transcriptional	  analysis	  was	  carried	  out	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in	  the	  Fkh2	  phosphorylation	  blocked	  mutant.	  In	  addition	  to	  this	  more	  comprehensive	  transcriptional	  data	  was	  generated	  for	  the	  FKH2	  deletion	  strain,	  along	  with	  data	  on	  over-­‐expressing	  FKH2	  to	  investigate	  the	  hyper-­‐filamentous	  phenotype.	  The	  transcriptional	  analysis	  showed	  that	  blocking	  Fkh2	  phosphorylation	  causes	  altered	  expression	  of	  a	  different	  set	  of	  genes	  than	  deletion	  of	  FKH2.	  Thus	  the	  phosphorylation	  of	  Fkh2	  serves	  to	  alter	  and	  not	  simply	  impair	  its	  function.	  The	  most	  notable	  transcriptional	  changes	  in	  the	  microarray	  experiments	  were	  observed	  during	  hyphal	  growth,	  with	  deletion	  of	  FKH2	  or	  blocking	  Fkh2	  phosphorylation	  having	  a	  more	  negative	  impact	  on	  hyphal	  rather	  than	  yeast	  transcription.	  A	  simple	  explanation	  for	  this	  is	  that	  during	  yeast	  growth	  the	  presence	  and	  phosphorylation	  of	  Fkh2	  may	  serve	  a	  primarily	  repressive	  function.	  However,	  although	  fewer	  than	  down-­‐regulated,	  there	  are	  many	  genes	  that	  show	  up-­‐regulation	  on	  deletion	  of	  Fkh2	  or	  blocking	  Fkh2	  phosphorylation.	  This	  would	  imply	  that	  Fkh2	  acts	  as	  both	  an	  activator	  and	  repressor	  of	  gene	  expression.	  As	  this	  dual	  activational-­‐repressive	  ability	  is	  not	  dependent	  on	  phosphorylation	  it	  would	  be	  of	  interest	  to	  investigate	  how	  it	  is	  achieved,	  possibly	  due	  to	  the	  different	  sequences	  in	  Fkh2	  DNA	  binding	  sites,	  the	  location	  of	  the	  site	  in	  the	  upstream	  sequence	  of	  the	  gene,	  or	  through	  interactions	  with	  other	  transcription	  factors.	  The	  key	  observation	  from	  the	  microarray	  experiments	  is	  that:	  expression	  of	  genes	  required	  for	  host-­‐interaction,	  biofilm	  formation	  and	  pathogenesis	  are	  specifically	  down-­‐regulated	  on	  blocking	  Fkh2	  phosphorylation	  compared	  with	  
FKH2	  deletion.	  For	  the	  pathogenesis	  related	  genes	  that	  are	  also	  down-­‐regulated	  on	  
FKH2	  deletion,	  the	  decrease	  in	  expression	  is	  not	  as	  severe	  as	  for	  blocking	  Fkh2	  phosphorylation,	  suggesting	  pathogenesis	  gene	  regulation	  is	  a	  phosphorylation	  dependent	  function	  of	  Fkh2.	  Fkh2	  phosphorylation	  was	  also	  shown	  to	  repress	  known	  negative	  regulators	  of	  filamentous	  invasive	  growth.	  Therefore	  the	  early	  hyphal	  phosphorylation	  of	  Fkh2	  is	  an	  unexpected	  but	  necessary	  event	  for	  the	  positive	  regulation	  of	  the	  virulence	  program	  in	  C.	  albicans.	  	   The	  mechanism	  by	  which	  Fkh2	  affects	  transcription	  of	  genes	  required	  for	  pathogenesis	  appears	  to	  be	  via	  interaction	  of	  Fkh2	  with	  the	  chromatin	  modifier	  Pob3	  early	  on	  hyphal	  induction,	  suggesting	  epigenetic	  regulation	  of	  the	  aforementioned	  genes	  may	  be	  occurring.	  Epigenetic	  regulation	  of	  invasive	  growth	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and	  pathogenesis	  genes	  on	  hyphal	  induction	  by	  Fkh2	  would	  complement	  previous	  data;	  which	  suggests	  that	  the	  promoters	  of	  certain	  ‘hyphal-­‐specific’	  genes	  occupied	  by	  Nrg1	  are	  re-­‐modeled	  on	  hyphal	  induction,	  and	  that	  this	  is	  a	  requirement	  for	  the	  long	  term	  maintenance	  of	  filamentous	  growth	  (Lu	  et	  al.	  2011).	  This	  study	  by	  Lu	  et	  al.	  proposes	  an	  early	  ‘window	  of	  opportunity’	  on	  hyphal	  induction	  where	  such	  epigenetic	  changes	  occur.	  The	  timing	  of	  the	  window	  appears	  to	  fit	  well	  with	  the	  observed	  phosphorylation	  pattern	  of	  Fkh2	  during	  hyphal	  growth,	  and	  would	  explain	  why	  the	  phosphorylation	  is	  observed	  as	  a	  singular	  event.	  It	  was	  shown	  that	  Fkh2’s	  interaction	  with	  Pob3	  is	  phosphorylation	  dependent;	  suggesting	  that	  epigenetic	  regulation	  may	  be	  occurring	  due	  phosphorylation	  of	  Fkh2	  bringing	  Pob3	  to	  the	  required	  promoters.	  The	  presence	  of	  Fkh2	  and	  Pob3	  on	  the	  promoters	  of	  the	  specific	  genes	  could	  be	  tested	  by	  chromatin	  IP	  with	  the	  Fkh2	  phosphorylation	  mutants,	  and	  by	  looking	  at	  the	  histone	  occupancy	  of	  the	  pathogenesis	  related	  genes	  regulated	  by	  Fkh2.	  	   A	  key	  problem	  during	  this	  project	  has	  been	  defining	  the	  kinase	  responsible	  for	  phosphorylating	  Fkh2,	  with	  it	  no	  longer	  being	  possible	  to	  make	  assumptions	  of	  the	  kinase	  involved.	  To	  this	  end	  a	  different	  approach	  has	  been	  taken	  to	  attempt	  to	  find	  the	  elusive	  kinase.	  This	  involves	  screening	  the	  kinase	  mutant	  library	  produced	  by	  Blankenship	  et	  al	  (Blankenship	  et	  al.	  2010)	  based	  on	  the	  ability	  of	  the	  kinase	  mutant	  to	  invade	  the	  agar	  substratum	  on	  solid	  media	  with	  serum.	  As	  blocking	  Fkh2	  phosphorylation	  results	  in	  reduced	  invasive	  growth,	  it	  can	  be	  speculated	  that	  the	  kinase	  responsible	  for	  the	  phosphorylation	  would	  have	  a	  similar	  phenotype.	  This	  screen	  showed	  that	  mutants	  of	  components	  of	  the	  pheromone	  response	  MAPK	  pathway,	  the	  PAK	  cla4	  and	  MAPKK	  hst7,	  have	  reduced	  invasive	  capacity	  similar	  to	  that	  observed	  for	  the	  fkh2(6ACDK)	  and	  fkh2(15ACDK)	  strains	  (See	  included	  CD).	  Another	  mutant	  that	  shows	  decreased	  invasion	  of	  the	  agar	  substratum	  is	  sok1.	  Sok1	  is	  not	  a	  protein	  kinase,	  but	  over-­‐expression	  has	  been	  shown	  to	  rescue	  PKA	  pathway	  defects	  in	  S.	  cerevisiae	  (Ward	  &	  Garrett	  1994),	  suggesting	  a	  role	  in	  regulating	  this	  pathway.	  The	  final	  MAPK	  in	  the	  pheromone	  response	  pathway,	  Cek1,	  provides	  a	  good	  starting	  point	  for	  future	  attempts	  to	  elucidate	  the	  kinase	  responsible	  for	  Fkh2	  phosphorylation;	  unfortunately	  however	  this	  strain	  is	  not	  available	  in	  above	  mentioned	  kinase	  mutant	  library.	  CEK1	  deletion	  has	  previously	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been	  shown	  to	  reduce	  filamentous	  invasive	  growth	  on	  solid	  media,	  supporting	  the	  above	  hypothesis.	  Further	  to	  this,	  anecdotal	  evidence	  for	  the	  role	  of	  Cek1	  is	  also	  present.	  Cek1	  is	  regulated	  by	  the	  quorum	  sensing	  molecule	  farnesol	  (Román,	  Alonso-­‐Monge,	  et	  al.	  2009);	  and	  it	  is	  only	  when	  Fkh2-­‐YFP	  expressing	  cells	  are	  washed	  in	  water	  before	  re-­‐inoculation	  that	  the	  early	  hyphal	  phosphorylation	  of	  Fkh2	  is	  clear.	  Washing	  away	  the	  farnesol	  from	  the	  over-­‐night	  culture	  would	  mean	  that	  repression	  of	  Cek1	  would	  be	  relieved	  quicker,	  allowing	  the	  observed	  spike	  of	  Fkh2	  phosphorylation.	  Other	  evidence	  comes	  from	  the	  microarray	  experiments	  where,	  as	  previously	  mentioned,	  the	  MSB2	  sensor	  upstream	  of	  the	  MAPK	  pathway	  shows	  reduced	  expression	  in	  fkh2(6ACDK)	  strain.	  This	  suggests	  that	  a	  positive	  feedback	  loop	  could	  be	  present	  that	  would	  enforce	  the	  signal	  through	  the	  MAPK	  pathway.	  Therefore	  future	  experiments	  to	  elucidate	  the	  kinase	  should	  begin	  by	  looking	  at	  Cek1.	  	  	   In	  addition	  to	  the	  kinase	  responsible	  for	  Fkh2	  phosphorylation,	  the	  de-­‐phosphorylation	  of	  Fkh2	  remains	  uninvestigated.	  The	  late	  cell	  cycle	  timing	  of	  Fkh2	  de-­‐phosphorylation	  during	  yeast	  growth	  suggests	  that	  Cdc14	  may	  be	  responsible;	  however	  this	  would	  unlikely	  be	  the	  case	  during	  hyphal	  growth,	  with	  Fkh2	  being	  dephosphorylated	  before	  Cdc14	  is	  known	  to	  be	  expressed	  (Clemente-­‐Blanco	  et	  al.	  2006).	  It	  would	  therefore	  be	  of	  interest	  to	  further	  investigate	  the	  phosphatase(s)	  responsible	  for	  the	  de-­‐phosphorylation	  of	  Fkh2.	  	   In	  conclusion,	  we	  have	  shown	  in	  this	  study	  that	  Fkh2	  switches	  from	  cell	  cycle	  dependent	  phospho-­‐regulation	  during	  yeast	  growth,	  to	  a	  specific	  early	  phospho-­‐regulatory	  event	  during	  hyphal	  growth,	  which	  is	  independent	  of	  the	  cell	  cycle.	  The	  early	  hyphal	  phosphorylation	  is	  a	  necessary	  event	  for	  the	  maintenance	  of	  filamentous	  invasive	  growth,	  being	  required	  for	  positive	  regulation	  of	  genes	  involved	  in	  invasive	  growth	  and	  pathogenesis.	  Therefore	  we	  can	  propose	  a	  new	  mechanism,	  by	  which	  C.	  albicans	  specifically	  modifies	  a	  key	  component	  of	  its	  cell	  cycle	  transcription	  machinery	  in	  the	  switch	  from	  commensalism	  to	  pathogenicity.	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